Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABHD1 "FLJ36128, LABH1" ENSG00000143994 "Abhydrolase domain containing 1" Q96SE0 2 27123789-27130812 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.6" "Group enriched" "Detected in many" 9 "Early spermatids: 295.1;Late spermatids: 1030.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.5;T-47d: 3.3;U-266/70: 3.0;U-266/84: 2.8" "Low region specificity" "Detected in all" HPA044390 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA044390: AB_10959380" "unprognostic (1.20e-3)" "unprognostic (6.07e-3)" "unprognostic (7.71e-4)" "unprognostic (1.63e-2)" "unprognostic (6.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-3)" "unprognostic (2.75e-1)" "unprognostic (1.76e-1)" "unprognostic (9.09e-4)" "unprognostic (9.76e-2)" "unprognostic (1.70e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-2)" "unprognostic (3.09e-2)" "unprognostic (7.97e-2)" 1.2 0.6 0.8 0.1 0.7 0.0 0.5 1.5 1.1 0.1 0.3 0.1 0.0 0.3 0.4 0.1 0.2 0.2 0.5 0.7 0.8 0.3 3.3 0.1 0.2 0.9 0.7 0.4 0.1 0.4 0.2 0.0 0.9 0.7 0.0 0.4 1.5 0.2 1.9 0.0 0.1 0.3 0.9 0.1 0.2 21.6 0.9 0.0 0.4 1.7 0.1 0.0 0.0 0.9 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 1.5 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 3.0 2.8 0.0 0.1 0.1 0.1 0.0 0.2 0.8 0.6 0.0 0.2 0.5 0.3 0.3 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.7 1.5 1.1 0.7 0.8 0.9 0.7 0.9 0.9 0.9 0.9 0.8 0.0 0.0 4.9 1.0 0.0 3.3 0.0 2.8 5.1 1.9 2.8 3.1 1.5 0.0 0.0 8.4 0.2 0.9 0.2 0.0 0.3 295.1 0.4 0.6 1.9 0.0 3.2 0.6 0.2 0.0 1.3 0.0 0.5 1.3 1.6 2.5 3.9 0.1 0.0 0.8 0.2 0.0 0.3 0.3 1030.5 6.5 1.2 0.0 1.9 0.5 8.1 3.1 2.0 2.2 0.0 0.0 5.7 0.5 3.6 0.2 3.0 0.7 4.9 0.0 2.4 1.2 70.5 3.9 0.3 0.3 0.0 1.8 0.3 0.2 2.2 AC000120.2 ENSG00000285772 "Novel protein" 7 92112159-92179511 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.7;testis: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 25.3;Club cells: 5.6;Respiratory ciliated cells: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;HeLa: 1.6;Karpas-707: 1.5;U-266/70: 1.4" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" 0.3 0.4 0.3 0.2 0.8 0.2 2.5 0.7 1.0 0.0 0.1 0.1 0.0 0.4 0.8 0.1 0.0 0.8 0.0 0.6 0.4 0.3 0.0 0.5 0.2 2.3 0.7 0.0 1.4 0.1 0.4 2.0 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 1.5 0.2 0.4 7.4 0.3 0.2 1.0 0.0 0.2 0.1 3.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.7 1.0 0.1 1.6 0.4 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 1.4 0.2 0.4 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.8 0.7 1.0 0.6 0.4 2.3 0.7 2.0 1.5 0.3 3.7 0.0 16.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC004076.1 ENSG00000268163 "Novel transcript" 19 57437970-57477536 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;retina: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (3.02e-1)" "unprognostic (3.67e-2)" "unprognostic (4.50e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.80e-2)" "unprognostic (5.13e-2)" "unprognostic (6.55e-2)" "unprognostic (5.25e-3)" "unprognostic (4.41e-3)" "unprognostic (7.09e-4)" "unprognostic (2.94e-2)" "unprognostic (2.50e-1)" "unprognostic (7.29e-2)" "unprognostic (6.45e-2)" 0.1 0.2 0.2 0.2 0.4 0.0 0.2 1.3 0.8 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.1 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 1.2 0.0 0.1 1.0 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.5 0.0 0.0 0.7 0.1 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 1.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 1.3 0.8 0.4 0.0 0.2 0.1 0.2 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005154.5 ENSG00000281039 "Novel protein" 7 30497077-30550761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 9.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 21.4" HPA020735 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 58: Brain - Synaptic function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA020735: AB_1845754" "unprognostic (1.15e-2)" "unprognostic (5.67e-3)" "unprognostic (1.07e-2)" "unprognostic (8.33e-2)" "unprognostic (3.92e-2)" "unprognostic (6.95e-3)" "unprognostic (1.57e-1)" "unprognostic (6.37e-4)" "unprognostic (2.55e-2)" "unprognostic (4.34e-3)" "unprognostic (1.50e-4)" 12.8 9.2 19.6 6.9 19.0 28.7 9.6 17.0 26.7 3.8 20.7 8.1 10.9 8.3 24.9 2.8 6.1 7.6 4.4 18.3 19.1 4.4 6.2 12.8 14.0 16.8 17.8 9.2 2.6 7.7 3.1 6.2 16.8 7.8 8.6 20.6 7.0 8.4 10.9 15.2 6.8 5.3 16.1 12.3 8.9 5.2 18.2 8.9 8.3 4.0 11.4 5.8 0.6 19.4 2.0 0.0 7.4 7.5 5.1 11.7 2.8 5.0 5.4 2.8 2.0 1.2 0.7 2.6 1.5 4.1 3.6 5.4 1.0 2.3 2.8 3.3 1.4 2.6 6.2 2.4 4.7 5.9 11.6 8.0 7.0 2.1 4.1 5.8 2.8 5.7 2.2 12.0 4.3 0.4 2.3 7.6 1.6 1.2 0.7 2.2 0.5 4.7 4.5 3.3 1.7 2.7 2.6 1.6 3.6 8.6 4.0 8.2 2.8 2.0 1.5 2.0 1.1 21.4 5.2 2.5 3.5 7.2 6.3 0.0 0.2 0.4 0.5 0.1 0.1 0.0 0.1 0.4 0.4 0.3 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.0 19.6 19.0 17.0 26.7 18.3 19.1 16.8 17.8 16.8 16.1 18.2 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008162.2 ENSG00000278646 "Novel protein similar to cancer/testis antigen family 47, member A12 (CT47A12)" X 120877496-120878924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-266/70: 3.8" HPA042483 Supported Uncertain Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" Nucleoli "HPA042483: AB_2678017" 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008770.2 ENSG00000267179 "Novel protein" 19 11925075-11979290 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" HPA047845 Uncertain Uncertain Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.46e-3)" "unprognostic (9.75e-5)" "unprognostic (1.14e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (2.38e-3)" "unprognostic (1.26e-1)" "unprognostic (1.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.97e-2)" "unprognostic (4.82e-3)" "unprognostic (2.69e-2)" "unprognostic (5.04e-3)" "unprognostic (2.24e-2)" "unprognostic (9.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" 0.1 0.2 0.1 0.3 0.1 0.0 0.4 0.1 0.2 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.3 0.2 0.1 0.4 0.3 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.4 0.2 0.2 0.2 0.6 0.1 0.2 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.9 0.3 0.4 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.7 0.2 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.1 0.5 0.5 0.1 0.5 0.0 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.4 0.2 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 AC008770.4 ENSG00000286098 "Zinc finger protein 844" 19 11987641-12078106 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046982 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "HPA046982: AB_10964399" 0.9 1.0 0.2 1.4 0.3 3.7 2.2 1.2 0.5 1.1 0.7 1.3 0.8 1.4 0.7 1.1 1.5 0.4 1.2 0.3 0.5 2.2 0.7 0.8 1.4 0.5 0.5 3.6 0.9 3.8 0.9 0.5 1.9 2.0 4.2 1.0 1.8 1.7 0.0 1.0 1.2 0.3 1.3 1.0 2.0 0.4 2.1 3.4 3.0 1.2 0.8 0.6 0.7 0.0 1.6 1.9 1.6 1.2 1.2 1.1 0.4 0.6 1.0 1.9 0.4 2.5 2.0 0.6 1.5 0.5 0.1 0.5 0.5 0.4 0.5 3.0 0.1 0.1 1.4 1.1 3.3 1.1 0.2 1.1 0.1 0.9 0.6 2.8 0.3 0.0 1.6 0.1 3.9 1.5 1.7 0.0 0.4 1.3 2.5 2.0 0.7 0.1 1.7 1.5 0.0 0.5 1.6 1.5 0.7 1.5 0.4 0.4 1.2 2.3 2.0 3.6 4.4 2.6 0.0 1.4 0.3 2.3 1.3 3.4 1.3 1.8 1.2 2.1 1.2 1.2 1.8 1.4 2.5 1.8 1.8 2.2 1.6 2.0 1.2 0.9 0.2 0.3 1.2 0.5 0.3 0.5 0.5 0.5 0.5 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010531.1 ENSG00000131152 "Novel protein" 16 87302876-87334273 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.7;U-266/70: 3.4" HPA040850 Approved NA NA "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "HPA040850: AB_10794882" "unprognostic (1.44e-1)" "unprognostic (5.07e-2)" "unprognostic (3.15e-2)" "unprognostic (2.89e-1)" "unprognostic (1.69e-1)" "unprognostic (1.98e-1)" "unprognostic (4.72e-3)" "unprognostic (1.56e-1)" "unprognostic (9.65e-2)" "unprognostic (5.23e-2)" "unprognostic (1.61e-1)" "unprognostic (1.94e-1)" "unprognostic (9.21e-3)" "unprognostic (7.78e-2)" "unprognostic (2.14e-1)" "unprognostic (4.35e-2)" "unprognostic (3.72e-3)" 0.9 0.5 0.5 0.0 0.4 0.3 0.7 2.1 0.8 0.6 0.0 0.7 0.6 0.5 0.0 0.7 0.7 0.2 0.7 0.9 0.3 0.4 1.5 0.3 0.5 0.5 0.3 0.6 0.9 0.2 1.2 0.3 0.3 0.5 0.0 0.1 0.4 0.1 3.9 0.4 0.5 0.1 0.2 0.2 0.6 0.6 0.4 0.1 0.4 0.3 0.2 0.7 0.7 0.4 0.5 0.2 0.1 0.0 1.9 0.8 0.1 0.1 0.0 0.3 0.1 0.6 0.0 1.6 0.3 1.7 0.0 1.6 0.4 0.0 0.2 0.3 1.3 2.7 0.1 1.8 0.9 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.8 0.4 2.4 0.3 0.0 0.6 0.9 2.0 0.5 0.5 0.3 0.8 0.1 1.7 0.0 0.0 1.3 0.3 0.8 0.2 0.6 0.1 0.2 0.0 0.0 1.1 0.1 0.0 0.3 3.4 1.2 1.2 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.1 0.8 0.9 0.3 0.5 0.3 0.3 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC022506.1 ENSG00000285133 "Novel protein" P0DPQ6 12 57517712-57520480 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "basophil: 9.4;neutrophil: 18.9" "Lineage enriched" "Detected in many" 17 "granulocytes: 18.9" "Cell line enriched" "Detected in some" 13 "U-266/70: 25.8" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: U-266 - Adaptive immune response" 4.4 0.0 1.7 3.6 0.3 0.0 0.0 0.1 2.4 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 18.2 0.0 4.6 0.0 1.4 0.4 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 25.8 0.0 0.0 0.0 2.0 0.0 9.4 1.0 0.1 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 18.9 0.9 0.0 0.0 0.0 0.0 1.7 0.3 0.1 2.4 0.0 0.0 0.8 0.3 2.6 1.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC063943.2 ENSG00000288623 "Novel protein" 12 120534697-120534957 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 32.2;choroid plexus: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 22.3" "Cell line enhanced" "Detected in some" "EFO-21: 8.4;MOLT-4: 16.1;REH: 19.4;U-266/70: 26.8;U-266/84: 32.0;U-698: 8.8" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: U-266 - Adaptive immune response" 5.6 0.0 12.0 0.0 10.3 0.0 0.0 2.6 22.3 0.0 12.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 8.5 0.0 0.0 0.9 0.0 32.2 10.4 0.0 0.0 0.0 0.0 12.5 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 8.7 5.2 6.2 0.0 13.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 3.0 0.0 0.0 19.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 26.8 32.0 8.8 0.0 0.0 0.0 19.9 3.3 12.9 1.6 2.3 2.2 4.5 3.0 2.8 3.3 3.6 3.7 3.9 22.3 1.3 3.3 1.7 4.8 2.1 12.0 10.3 2.6 22.3 8.9 8.5 32.2 10.4 12.5 8.7 13.6 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093525.1 ENSG00000259784 "Novel protein" 16 2513965-2527955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;brain: 1.6;intestine: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;REH: 1.4;THP-1: 1.4;U-266/70: 2.0" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 29: U-266 - Adaptive immune response" 0.2 0.1 0.3 0.0 0.5 1.9 0.0 0.5 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.2 0.2 0.7 0.4 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.2 0.1 1.1 0.3 0.1 0.2 0.5 0.1 1.2 0.0 0.1 0.0 0.0 0.1 0.1 0.9 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.7 0.0 0.4 0.0 0.3 0.0 0.2 0.5 0.0 1.5 0.0 0.0 1.1 0.0 0.4 0.0 0.3 0.0 0.5 0.4 0.0 1.0 0.0 0.0 0.3 0.3 0.2 0.4 0.0 0.5 0.0 0.4 0.2 0.0 0.3 1.4 0.4 0.5 0.0 0.0 0.4 0.1 0.0 0.7 0.1 0.1 0.4 1.4 0.0 0.4 0.1 0.2 0.4 2.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.5 1.6 0.3 0.3 0.7 0.4 0.6 0.1 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC242628.1 ENSG00000288626 "Novel protein" 1 147611590-147611796 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.3;brain: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.1;HEL: 1.2;RT4: 2.0;SK-BR-3: 2.5;U-266/70: 6.2" NA NA "Cluster 29: U-266 - Adaptive immune response" 1.3 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.6 0.8 0.2 1.8 0.6 1.2 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "testis: 283.5" "Cell type enhanced" "Detected in many" "Early spermatids: 1097.8;Late spermatids: 723.5;Macrophages: 220.0;Spermatocytes: 387.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;intermediate monocyte: 15.8;myeloid DC: 17.7;non-classical monocyte: 31.0" "Group enriched" "Detected in many" 9 "dendritic cells: 17.7;monocytes: 31.0" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 6.7;U-266/70: 15.0;U-266/84: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Secreted in male reproductive system" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 2.2 0.9 0.9 3.8 1.3 10.7 1.1 1.9 1.4 1.9 1.1 2.9 8.4 1.4 14.2 0.9 2.1 4.1 0.6 0.9 1.0 1.8 2.2 2.8 5.5 1.3 1.2 0.7 2.9 0.3 0.9 2.3 1.3 2.0 2.1 1.8 1.3 1.1 0.4 1.7 8.1 2.1 1.1 9.2 1.9 283.5 1.2 3.0 13.8 0.4 3.6 2.4 0.9 1.5 0.2 0.1 0.8 2.5 0.8 1.2 1.3 0.0 0.0 0.1 0.1 0.0 1.8 0.3 0.8 0.2 0.1 0.0 0.4 0.0 0.2 0.8 0.0 5.3 0.6 0.0 1.8 0.1 6.7 0.1 3.3 0.9 0.1 0.6 0.6 1.7 3.5 0.0 0.1 0.3 0.2 1.9 1.5 4.3 0.0 0.3 0.1 0.3 0.5 0.1 1.0 0.3 0.0 0.7 1.1 1.2 0.0 1.9 0.7 0.1 0.8 0.5 0.0 15.0 10.5 0.5 0.5 2.0 0.0 1.5 12.5 1.2 0.2 15.8 0.0 1.3 0.0 0.0 17.7 1.9 0.2 0.1 2.6 0.7 31.0 4.5 0.0 10.6 0.9 1.3 1.9 1.4 0.9 1.0 1.3 1.2 1.3 1.1 1.2 1.5 0.3 0.0 1.3 0.7 1.5 0.1 0.1 0.0 1.2 1.7 0.5 0.5 1.0 0.0 0.1 0.0 0.0 0.1 1.9 0.9 0.0 0.2 1097.8 0.7 0.5 1.5 0.0 5.7 0.2 0.5 0.3 0.5 0.0 0.8 6.3 0.4 1.8 0.3 9.8 0.0 0.3 0.8 0.0 20.5 3.4 723.5 8.1 220.0 0.0 1.0 7.6 1.1 10.3 0.0 0.4 0.1 1.6 4.5 0.5 0.0 7.6 1.1 0.2 1.3 6.6 0.3 0.2 387.5 7.5 0.3 0.0 0.1 1.0 0.4 1.1 0.1 ADAMDEC1 M12.219 ENSG00000134028 "ADAM like decysin 1" O15204 8 24384285-24406013 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 424.9" "Cell type enhanced" "Detected in some" "Hofbauer cells: 14.8;Kupffer cells: 12.9;Macrophages: 25.5;monocytes: 5.2" "Cancer enhanced" "Detected in all" "testis cancer: 16.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "U-266/70: 10.7;U-266/84: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 28000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (1.17e-2)" "unprognostic (1.80e-2)" "unprognostic (4.15e-3)" "unprognostic (3.60e-1)" "unprognostic (6.21e-2)" "unprognostic (3.84e-3)" "unprognostic (2.12e-1)" "unprognostic (2.90e-1)" "unprognostic (1.61e-1)" "unprognostic (5.99e-3)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (1.74e-2)" "unprognostic (2.06e-1)" "unprognostic (1.35e-2)" "unprognostic (3.66e-2)" "unprognostic (8.23e-2)" 0.6 0.5 0.0 52.1 0.0 0.3 0.6 0.0 0.8 0.4 0.0 215.4 189.4 0.9 0.2 0.9 0.1 3.2 0.4 0.1 0.0 0.2 0.1 1.6 73.3 0.3 0.0 0.1 0.2 0.0 0.0 7.8 0.3 0.8 311.5 0.0 0.7 0.4 0.0 0.4 424.9 11.6 0.0 5.8 5.9 0.3 0.4 5.7 0.3 0.0 27.2 20.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 10.7 2.7 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.8 0.0 1.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.1 0.0 0.0 12.9 2.0 0.0 0.0 25.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 225.2;Microglial cells: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.2 18.0 10.7 18.1 11.8 35.0 22.8 8.1 13.0 24.8 51.4 25.9 18.2 25.6 11.8 19.1 21.4 19.6 19.6 10.2 10.0 32.8 24.8 20.7 16.3 16.3 9.8 28.8 28.2 31.8 12.5 26.8 11.8 18.2 22.5 63.6 24.0 22.8 55.6 23.4 19.4 31.9 9.1 19.4 19.0 6.9 14.2 22.8 54.9 41.8 13.4 18.5 19.0 12.0 15.3 13.5 11.3 12.0 18.3 21.6 15.9 15.1 22.2 11.3 16.7 14.7 27.8 17.3 20.2 18.7 14.4 6.8 18.0 22.8 15.7 29.8 7.2 36.0 38.3 12.3 14.1 35.0 27.4 17.7 16.1 19.4 17.0 16.4 42.1 14.1 22.5 47.5 4.8 4.1 31.6 10.1 15.0 25.6 4.8 24.7 6.7 22.2 33.1 14.5 25.6 4.7 23.1 15.0 7.2 23.5 9.0 28.9 21.3 20.9 18.8 12.9 8.5 41.0 24.8 29.6 17.1 39.5 7.7 5.4 7.4 17.6 8.8 5.4 9.8 12.0 11.8 8.9 8.5 14.5 6.0 5.8 28.4 7.7 3.3 20.7 11.3 4.2 10.7 11.8 8.1 13.0 10.2 10.0 16.3 9.8 11.8 9.1 14.2 12.0 88.0 41.7 55.6 125.7 29.3 24.1 20.2 17.8 33.6 41.7 20.6 11.6 119.8 40.0 28.4 92.0 225.2 1.4 29.1 40.7 3.9 11.9 7.2 32.4 39.1 50.2 32.3 54.5 69.2 12.6 4.2 36.3 42.8 46.2 25.2 40.3 65.0 34.2 13.0 18.5 47.5 35.8 16.2 41.7 32.8 9.3 29.2 34.8 23.2 202.4 16.5 21.4 16.5 74.4 84.0 13.1 31.4 28.6 53.9 21.9 29.8 50.3 36.0 147.2 26.3 41.9 31.2 3.8 11.3 45.3 31.7 32.8 26.4 13.3 29.0 15.8 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591604-1602520 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: AB_2681314" "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favorable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favorable (1.11e-5)" 35.2 46.9 13.7 33.8 15.0 44.6 37.3 12.3 15.2 45.6 15.1 38.6 30.9 35.2 20.1 38.5 39.5 16.5 34.9 13.0 11.9 39.3 70.1 51.5 36.0 16.4 14.1 73.0 66.4 12.6 46.6 17.3 13.5 50.7 9.9 7.5 41.5 15.9 17.4 35.6 49.4 7.6 12.1 83.0 41.3 31.8 16.3 27.2 62.7 9.2 20.1 32.2 38.0 20.3 23.8 29.8 23.4 26.5 11.3 14.4 57.1 25.1 10.2 19.8 16.6 33.3 21.3 35.5 15.8 12.6 27.9 20.4 14.3 12.6 11.8 29.3 49.2 44.3 32.6 31.3 24.1 17.3 71.3 12.8 22.8 14.8 16.4 23.6 13.8 17.7 28.2 21.8 11.7 15.6 38.5 74.4 35.0 5.5 25.6 28.9 27.9 30.0 13.2 16.3 26.1 38.1 19.7 31.5 31.5 19.2 20.6 31.3 26.9 30.8 14.0 26.9 22.1 93.7 17.0 49.1 12.5 27.7 8.4 4.5 0.5 0.9 0.3 0.2 0.4 0.9 0.4 0.7 0.3 0.5 0.3 0.3 1.9 0.7 0.4 0.8 0.2 0.2 13.7 15.0 12.3 15.2 13.0 11.9 16.4 14.1 13.5 12.1 16.3 20.3 41.2 25.6 25.3 1.3 53.5 44.4 36.1 10.6 36.5 24.1 41.5 29.8 12.0 12.8 19.4 12.9 10.4 25.1 67.0 39.9 13.7 21.2 52.1 29.6 32.7 35.1 22.6 14.5 0.8 15.5 32.4 31.5 39.3 41.1 25.4 49.8 32.2 21.3 22.8 16.8 0.8 38.7 12.2 25.7 54.5 18.9 38.8 37.4 40.9 0.0 38.0 21.5 54.6 2.0 2.7 24.4 35.9 31.6 65.0 41.9 22.6 7.9 14.4 15.4 0.0 28.4 23.2 20.6 27.6 31.7 47.2 72.7 51.1 131.7 28.6 46.2 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986165-34008104 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 134.3;liver: 180.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5" "Group enriched" "Detected in all" 4 "liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 175.4;U-266/84: 98.0" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 70000 "Cluster 14: Monocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 8.6 15.0 5.9 5.0 5.5 3.0 6.4 4.6 6.0 6.5 4.6 40.0 18.0 4.7 9.6 15.6 6.2 20.5 10.1 5.4 7.8 134.3 180.6 9.2 3.6 5.9 6.4 7.8 13.8 13.0 5.7 7.7 6.6 39.3 42.9 12.0 60.7 12.5 19.2 4.9 15.9 7.0 5.8 5.4 34.8 4.3 8.4 4.8 8.3 14.9 5.6 8.8 8.5 5.8 12.7 20.2 11.1 14.3 7.7 11.9 19.1 16.6 12.2 7.6 5.7 66.1 15.1 4.1 8.7 23.6 28.6 5.8 2.8 12.0 7.7 12.7 10.9 9.8 13.7 19.0 5.4 6.0 3.0 18.1 6.0 9.7 3.6 10.7 8.5 8.3 3.8 14.7 22.4 9.6 5.0 7.6 10.0 9.4 32.9 6.0 18.6 6.5 33.2 62.4 6.1 8.7 27.6 19.3 16.9 9.1 14.9 5.9 15.6 24.6 5.4 6.2 13.6 175.4 98.0 7.4 7.0 12.1 18.8 0.3 6.0 9.3 8.3 8.0 7.0 7.1 7.2 6.4 8.9 5.2 6.6 4.8 10.0 8.7 14.2 4.6 7.9 6.0 5.9 5.5 4.6 6.0 5.4 7.8 5.9 6.4 6.6 5.8 8.4 5.8 0.8 3.2 4.1 0.0 2.2 0.4 0.4 0.9 1.8 4.3 1.4 0.9 1.1 8.6 3.7 1.8 0.0 1.0 2.2 19.7 5.9 0.8 8.9 2.3 1.2 3.0 4.2 2.1 0.0 3.8 1.0 2.9 4.1 1.5 0.0 1.2 1.1 21.6 1.1 5.0 0.0 5.1 4.1 0.9 0.2 21.6 0.6 1.2 0.0 0.0 1.5 9.3 3.1 0.0 0.0 2.6 4.5 2.2 1.6 0.6 4.7 38.5 3.1 0.9 0.0 1.7 3.7 0.7 0.7 3.4 0.6 0.3 1.5 1.2 4.4 0.4 AMER2 "FAM123A, FLJ25477" ENSG00000165566 "APC membrane recruitment protein 2" Q8N7J2 13 25161679-25172288 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 114.8" "Cell type enhanced" "Detected in some" "Astrocytes: 99.3;Bipolar cells: 105.5;Cone photoreceptor cells: 81.3;Horizontal cells: 153.1;Muller glia cells: 313.0;Oligodendrocytes: 337.1;Rod photoreceptor cells: 112.1" "Cancer enriched" "Detected in single" 24 "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 3.3;SCLC-21H: 2.3;SuSa: 2.3;U-266/70: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039458 Enhanced Supported "Plasma membrane" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" "Plasma membrane" "HPA039458: AB_10795677" "unprognostic (1.69e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-3)" "unprognostic (2.32e-1)" "unprognostic (3.00e-3)" "unprognostic (5.00e-3)" "unprognostic (7.28e-2)" "unprognostic (2.34e-2)" "unprognostic (5.90e-4)" "unprognostic (1.60e-2)" "unprognostic (1.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (1.34e-1)" 0.2 0.1 36.7 0.0 72.0 0.0 0.0 37.9 52.2 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 41.2 37.7 0.0 0.0 0.1 0.0 58.9 49.1 0.0 0.0 0.0 4.1 0.0 41.9 0.1 0.0 25.8 0.0 0.2 0.2 0.1 0.0 0.0 36.8 0.0 0.0 1.2 49.1 0.0 0.0 0.0 0.0 0.0 0.0 114.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 72.0 37.9 52.2 41.2 37.7 58.9 49.1 41.9 36.8 49.1 114.8 0.0 0.0 0.0 99.3 0.1 0.1 0.0 0.0 0.0 105.5 0.1 0.1 1.1 0.0 0.0 0.0 81.3 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.6 0.8 0.0 0.0 21.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 153.1 24.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.8 4.7 0.0 313.0 0.0 28.6 337.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 112.1 0.0 0.2 0.0 2.8 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 AMPD1 "MAD, MADA" ENSG00000116748 "Adenosine monophosphate deaminase 1" P23109 1 114673090-114695618 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 559.2;tongue: 211.4" "Group enriched" "Detected in some" 6 "Plasma cells: 43.8;Skeletal myocytes: 13.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "U-266/70: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026478, HPA028080" Enhanced "Intracellular and membrane" NA NA 38000 "Cluster 37: B-cells - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA026478: AB_10599969, HPA028080: AB_10600776" "unprognostic (1.98e-3)" "unprognostic (1.43e-3)" "unprognostic (8.75e-3)" "unprognostic (8.03e-2)" "unprognostic (1.95e-2)" "unprognostic (5.61e-3)" "unprognostic (8.21e-2)" "unprognostic (4.29e-3)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.36e-5)" "unprognostic (1.68e-1)" "unprognostic (3.70e-1)" "unprognostic (3.36e-1)" "unprognostic (4.02e-1)" 0.1 0.1 0.0 0.5 0.0 0.3 3.0 0.0 0.0 0.2 0.0 5.6 16.4 0.2 0.0 5.8 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.1 0.3 0.0 0.0 0.0 3.5 5.5 0.0 4.4 0.9 559.2 0.0 7.5 0.1 0.0 1.6 3.7 0.1 0.0 0.4 0.1 211.4 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.8 1.9 0.0 0.0 0.0 3.0 4.2 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;testis: 14.0" "Cell type enhanced" "Detected in some" "Astrocytes: 12.1;Excitatory neurons: 24.7;Extravillous trophoblasts: 19.1;Inhibitory neurons: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.9;U-266/70: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.1 3.7 6.8 0.3 11.0 0.5 0.9 4.2 20.3 1.3 0.0 1.3 0.8 0.8 0.8 0.5 1.4 0.5 0.6 10.9 4.1 3.1 10.7 1.0 0.4 2.6 4.0 2.0 3.9 0.6 6.5 0.8 2.4 4.1 0.3 2.7 0.9 0.6 1.2 0.6 1.4 0.2 1.5 1.5 1.8 14.0 5.8 0.4 2.8 0.4 0.1 1.0 0.7 10.8 0.1 0.2 0.0 0.1 2.7 0.2 2.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.2 0.1 0.1 0.4 0.0 2.2 0.3 0.0 0.1 0.1 1.5 0.1 0.3 1.5 0.1 0.2 0.7 0.4 0.1 1.7 0.1 4.9 0.0 0.7 0.0 0.1 2.1 0.6 0.6 0.3 0.0 0.4 0.0 0.2 0.8 0.1 0.1 0.1 0.3 0.5 0.6 0.4 0.0 0.1 1.0 0.8 0.0 16.2 1.5 0.1 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 11.0 4.2 20.3 10.9 4.1 2.6 4.0 2.4 1.5 5.8 10.8 0.1 0.0 1.9 12.1 0.5 0.0 0.2 0.1 0.0 1.2 0.4 0.4 0.9 1.5 1.4 0.0 4.2 0.3 0.0 0.3 0.0 0.1 0.4 0.6 0.2 0.2 3.6 0.0 24.7 0.0 19.1 0.2 1.5 0.4 0.0 0.2 0.7 0.9 0.4 0.0 14.4 0.7 0.0 0.8 0.0 1.7 0.0 0.3 0.0 1.0 0.0 0.9 0.0 3.5 4.4 0.0 0.3 0.0 0.2 0.2 0.5 0.8 0.3 1.2 0.0 0.4 0.2 1.0 2.9 0.2 0.0 1.1 0.2 0.4 0.2 0.2 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125725-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "breast: 38.1" "Group enriched" "Detected in some" 4 "Breast glandular cells: 295.9;Breast myoepithelial cells: 84.8" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "A549: 2.7;U-266/70: 10.4" HPA071849 Uncertain Nucleoli NA NA "Cluster 5: Breast - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 35: Glandular cells - Unknown function" Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 1.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 295.9 84.8 0.3 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 16.3 0.0 0.4 1.0 0.0 0.0 1.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 8.5 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 45.8 1.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 431 "testis: 860.1" "Group enriched" "Detected in some" 61 "Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.5 0.3 0.1 0.4 0.0 0.5 0.0 0.7 0.3 0.1 0.2 0.5 0.1 1.9 0.1 0.4 0.1 0.3 0.4 1.0 0.7 0.2 0.1 0.2 0.6 0.7 0.2 0.7 0.1 0.7 0.0 0.9 0.6 0.1 0.3 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.2 0.1 860.1 1.1 0.1 0.9 0.1 0.2 0.1 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.3 1.2 0.0 2.3 0.0 0.0 0.2 0.1 1.2 0.8 0.0 0.0 0.0 1.4 0.0 0.0 1.7 0.3 0.5 0.0 0.3 0.0 4.6 0.0 1.7 1.1 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 2.0 0.0 0.0 1.5 0.0 0.0 1.0 0.3 0.0 0.8 0.2 0.0 9.8 0.5 0.4 1.4 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.7 0.4 1.0 0.6 0.7 0.9 0.1 1.1 0.5 0.3 0.0 0.0 0.3 0.3 0.0 0.3 0.4 0.0 0.9 0.1 0.3 0.5 1.5 0.1 0.0 0.0 0.1 0.0 0.1 5.9 0.2 3367.0 0.5 0.3 1.6 0.0 0.4 2.8 0.2 0.1 0.2 0.0 0.0 0.0 1.2 0.4 0.0 0.1 3.3 2.8 0.0 0.0 0.0 0.0 861.1 39.4 2.7 1.8 1.0 0.0 1.8 0.0 0.0 1.0 0.1 0.0 29.3 0.1 0.1 0.0 2.0 0.2 0.0 26.3 0.2 0.2 3073.6 29.9 0.0 0.1 0.0 0.1 2.5 0.0 0.1 ARHGAP45 "HA-1, HMHA1, KIAA0223" ENSG00000180448 "Rho GTPase activating protein 45" Q92619 19 1065923-1086628 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019816, HPA079252" Enhanced Supported "Plasma membrane,Cytosol" NA NA 1200000 "Cluster 32: T-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA019816: AB_1853923, HPA079252: " "unprognostic (1.34e-1)" "unprognostic (5.13e-3)" "unprognostic (5.17e-3)" "prognostic favorable (6.02e-4)" "unprognostic (2.26e-1)" "prognostic favorable (7.82e-4)" "unprognostic (1.59e-2)" "unprognostic (2.17e-2)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-2)" "unprognostic (1.00e-1)" "unprognostic (4.59e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (5.33e-2)" 11.2 5.5 3.6 43.1 3.4 68.3 5.5 4.4 7.5 4.2 5.1 12.4 7.2 3.5 0.5 5.5 6.7 5.0 4.4 3.3 4.4 7.8 7.4 39.5 58.4 9.1 5.4 2.0 2.7 0.8 4.5 6.0 6.9 5.9 2.6 8.7 6.4 1.5 2.1 3.9 53.2 2.2 7.6 106.1 10.9 3.5 8.1 32.9 9.0 0.8 18.6 6.6 5.5 11.4 11.2 2.1 0.1 12.1 0.0 0.0 27.8 0.1 0.0 0.0 0.0 29.2 13.9 73.7 3.0 0.0 0.4 9.6 2.1 0.6 0.0 54.7 1.0 10.1 22.6 3.5 0.4 48.6 56.2 0.0 2.9 0.1 0.0 0.0 0.1 46.8 6.8 100.4 0.0 0.6 54.5 43.4 7.6 1.9 5.4 52.0 0.3 74.7 0.0 0.2 0.6 0.2 16.8 0.0 4.5 0.7 3.5 92.3 4.8 0.2 1.9 0.2 0.3 130.8 60.2 58.8 0.3 72.1 5.4 6.7 24.4 25.3 45.7 21.2 38.8 15.9 52.2 54.1 22.5 18.3 68.9 53.6 37.0 28.0 20.9 13.3 43.5 59.8 3.6 3.4 4.4 7.5 3.3 4.4 9.1 5.4 6.9 7.6 8.1 11.4 2.0 48.1 8.4 0.0 17.8 0.0 0.0 0.0 0.0 0.0 15.2 11.0 0.0 0.0 1.8 11.0 0.0 40.1 62.7 0.0 0.0 2.6 0.0 4.5 0.7 1.6 0.0 0.0 0.0 3.8 56.6 1.3 0.0 3.5 3.8 0.2 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 15.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 75.5 30.2 0.1 0.0 0.0 ARX "CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS" ENSG00000004848 "Aristaless related homeobox" Q96QS3 X 25003694-25016420 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.4;ovary: 78.7;skeletal muscle: 26.7" "Group enriched" "Detected in some" 5 "Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (8.28e-2)" "unprognostic (3.06e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.54e-7)" "unprognostic (9.85e-2)" "unprognostic (7.96e-3)" "unprognostic (1.18e-1)" "unprognostic (2.77e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.06e-6)" "unprognostic (6.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" 0.0 0.1 7.6 0.0 10.1 0.0 0.3 0.0 17.4 0.0 0.0 0.9 3.5 0.0 0.1 0.1 1.1 0.0 0.0 10.1 6.0 0.1 0.0 0.4 0.0 0.0 0.0 78.7 1.4 1.8 0.3 0.0 0.1 0.7 0.9 0.0 0.2 0.0 26.7 0.0 0.7 0.0 0.0 0.2 5.5 7.2 0.4 0.0 0.2 1.9 0.4 0.0 0.2 8.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 3.9 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.1 0.0 0.0 8.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 10.1 0.0 17.4 10.1 6.0 0.0 0.0 0.1 0.0 0.4 8.0 0.0 0.0 0.0 14.0 0.3 0.0 2.5 0.5 0.0 0.0 0.3 0.0 0.5 0.0 2.2 0.0 0.0 0.2 0.1 1.9 0.0 0.0 1.2 0.0 0.0 0.1 83.7 0.0 0.2 0.0 2.4 4.7 4.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 53.2 3.6 4.1 0.0 0.0 3.6 131.7 0.2 0.0 3.7 0.0 0.0 0.0 3.5 0.6 0.3 0.8 70.0 0.9 1.3 0.1 0.1 11.3 0.0 0.0 1.5 0.3 0.5 0.3 0.0 0.0 0.1 0.3 66.8 1.9 1.6 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934166-93976739 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 522.2;tongue: 157.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 7 "eosinophil: 50.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 50.8" "Cell line enhanced" "Detected in some" "Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 2.9 0.8 0.8 5.6 2.1 0.5 1.5 0.0 1.9 12.0 0.0 66.5 4.0 31.6 0.3 4.0 26.6 0.5 78.5 0.6 0.0 0.5 0.5 3.0 7.4 0.1 0.0 2.9 0.3 0.2 0.2 0.2 0.3 14.4 0.4 0.0 6.6 0.9 522.2 2.3 18.3 1.6 0.0 4.2 17.2 0.4 0.3 0.4 1.2 157.6 3.2 30.4 8.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.4 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 12.4 0.0 0.2 0.1 0.0 0.0 0.0 5.9 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 42.1 8.6 1.7 0.5 2.6 0.5 0.0 0.2 50.8 1.9 2.7 0.3 1.9 1.7 3.8 4.2 0.4 0.2 0.5 0.1 0.0 7.8 0.4 2.3 1.3 0.8 2.1 0.0 1.9 0.6 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.0 0.3 3.3 0.4 0.1 8.4 0.0 0.2 0.2 0.9 51.1 0.0 2.9 0.0 0.0 0.1 3.0 0.0 0.0 1.4 26.4 1.7 0.3 0.5 0.0 2.7 4.7 0.0 0.5 1.9 1.1 2.5 0.0 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.3 29.9 0.3 5.3 1.8 1.9 5.8 0.8 2.1 0.0 0.7 0.2 0.0 0.4 10.7 0.1 0.0 0.0 0.4 1.1 0.0 27.6 5.0 0.8 8.4 0.1 0.1 2.9 14.5 0.1 0.1 0.3 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 12.5;Early spermatids: 15.6;Granulosa cells: 14.8;Late spermatids: 61.0;Spermatocytes: 10.3" "Group enriched" "Detected in many" 4 "glioma: 3.1;testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 16.7;U-266/84: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA049155: AB_2680657, HPA054805: AB_2732588" "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.8 2.1 8.2 0.3 9.0 0.6 2.7 11.7 10.9 13.3 6.7 7.9 1.1 7.7 1.5 1.9 7.2 0.7 10.9 7.9 8.8 4.8 4.0 3.2 0.8 9.3 7.9 6.4 2.1 0.5 18.1 0.6 10.3 5.3 0.6 8.7 1.6 0.4 6.0 2.9 4.1 0.8 7.0 2.8 3.8 19.9 8.6 0.6 4.1 0.9 0.7 3.1 4.3 11.5 1.5 4.0 1.7 2.7 3.7 0.0 7.4 0.4 0.2 0.3 0.5 0.8 1.9 0.9 0.4 0.2 1.8 2.4 1.0 0.0 0.7 8.9 4.5 1.7 3.4 0.0 0.0 0.1 3.9 0.9 0.7 0.2 0.0 2.9 0.1 1.1 4.2 6.8 0.5 6.3 0.3 0.4 1.8 0.1 3.3 3.1 1.7 0.5 0.3 1.4 2.3 8.2 0.6 0.5 4.3 4.9 1.8 0.4 0.1 1.4 2.1 4.3 1.1 16.7 10.2 0.1 2.3 5.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 9.0 11.7 10.9 7.9 8.8 9.3 7.9 10.3 7.0 8.6 11.5 0.4 0.0 0.5 2.9 0.5 0.6 0.0 0.2 0.0 9.7 0.6 0.6 2.1 0.0 0.2 0.0 12.5 0.2 0.3 0.6 0.0 0.2 15.6 0.9 1.1 0.3 0.0 0.0 3.4 0.4 0.2 0.3 0.5 0.8 8.9 14.8 0.0 0.9 0.6 6.7 4.2 0.1 0.0 0.6 0.9 61.0 1.5 0.4 0.0 0.0 0.6 1.6 0.0 1.5 5.1 0.4 0.0 1.9 0.1 0.3 0.2 0.2 0.6 4.9 0.0 0.7 0.4 10.3 5.6 0.0 0.9 0.7 0.3 0.2 0.2 0.2 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793503-182921629 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 20.6 10.7 4.7 24.9 6.9 70.6 17.4 15.9 7.6 19.1 13.8 26.3 24.3 18.7 14.6 45.4 13.7 21.1 14.1 6.0 6.3 18.0 18.3 16.5 27.9 7.5 6.1 20.5 21.0 29.4 10.3 14.5 7.3 28.3 29.0 30.8 19.4 13.4 11.4 28.2 24.0 19.5 5.6 21.8 51.1 31.6 6.6 44.6 16.8 16.8 28.4 25.7 22.5 15.8 69.7 9.7 20.5 28.7 42.6 46.1 19.3 32.8 41.6 23.2 27.1 23.7 34.0 31.3 53.5 44.0 48.2 40.4 24.6 31.3 40.2 73.9 20.9 76.7 13.1 5.2 24.8 62.3 47.3 31.5 34.7 26.1 37.4 34.1 37.0 48.7 27.7 94.3 37.8 22.9 50.3 19.1 14.5 38.1 19.2 21.2 59.8 37.8 28.1 55.8 12.5 22.0 86.2 10.7 36.9 18.3 11.9 43.7 36.6 35.0 38.7 30.5 56.2 131.0 125.5 58.1 24.1 25.3 20.9 5.5 1.0 4.3 1.7 1.0 1.7 2.1 1.4 1.7 1.1 1.3 1.2 1.8 3.8 1.8 1.0 2.4 1.2 0.8 4.7 6.9 15.9 7.6 6.0 6.3 7.5 6.1 7.3 5.6 6.6 15.8 26.8 16.0 13.2 34.6 27.8 34.3 25.7 15.9 26.2 12.2 13.8 9.7 15.6 18.6 16.5 20.2 14.6 12.8 43.0 44.6 0.0 12.5 34.1 19.0 22.9 15.7 6.7 26.1 81.6 16.5 3.8 19.5 46.4 22.1 11.4 14.0 16.1 16.4 10.4 38.7 64.3 30.5 16.2 19.4 26.4 23.8 19.3 29.3 14.2 45.9 19.9 8.4 27.8 67.8 132.6 25.2 27.0 21.1 55.5 35.8 24.3 7.8 19.8 31.4 19.7 24.1 17.7 18.7 11.4 43.8 44.6 9.6 40.9 7.0 27.3 45.4 ATP6V1FNB ENSG00000272899 "ATP6V1F neighbor" A0A1B0GUX0 7 128866330-128872047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;kidney: 25.1;skeletal muscle: 11.7" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 2.0;Glandular and luminal cells: 1.9" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Region enhanced" "Detected in many" "cerebellum: 11.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;U-266/70: 3.3;U-266/84: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "unprognostic (8.17e-2)" "unprognostic (3.00e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (8.21e-4)" "unprognostic (1.23e-1)" "unprognostic (9.98e-2)" "unprognostic (5.10e-2)" "unprognostic (1.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.20e-1)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.33e-3)" 2.1 0.4 3.2 0.4 2.6 0.3 0.6 11.7 3.7 1.3 0.0 1.1 1.2 0.5 0.2 1.5 1.1 0.8 6.8 2.8 0.7 25.1 0.1 0.5 0.2 0.8 1.0 0.3 0.3 0.4 1.0 0.3 1.1 0.9 0.1 0.7 0.6 0.1 11.7 0.7 4.1 0.4 0.2 0.7 1.7 3.7 1.2 0.2 0.6 0.2 0.2 0.8 0.8 1.8 0.6 0.3 0.3 3.0 0.9 0.4 0.0 0.2 0.4 0.4 0.2 0.2 3.9 1.0 0.2 0.1 0.7 0.7 0.3 0.1 0.2 3.0 0.5 1.2 0.2 0.0 0.5 0.1 2.9 0.4 0.2 0.2 0.2 0.5 0.1 0.3 0.8 1.6 0.3 0.2 0.3 1.5 0.0 0.1 0.2 0.5 1.0 0.5 0.1 0.2 1.2 0.6 0.2 1.5 0.2 0.8 0.3 0.5 0.1 1.5 0.3 2.6 0.2 3.3 3.8 0.7 1.5 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 2.6 11.7 3.7 2.8 0.7 0.8 1.0 1.1 0.2 1.2 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 2.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.9 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 14.4" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 4.1 4.0 3.2 5.9 5.3 2.6 4.1 0.0 14.4 8.4 0.0 8.8 3.8 10.9 4.3 5.0 6.2 5.7 5.8 8.4 0.0 4.1 4.7 6.9 4.2 0.0 1.3 5.4 4.8 5.5 6.5 4.9 0.0 7.4 3.8 13.9 4.6 6.2 14.6 5.7 4.8 7.5 0.0 5.7 5.3 3.0 3.9 2.6 6.1 14.8 3.1 6.7 6.6 0.8 4.5 2.6 0.9 0.0 4.4 5.9 5.8 4.8 11.2 2.9 3.3 2.8 2.8 0.2 6.3 9.3 3.7 4.2 0.3 3.0 4.2 2.6 4.7 0.7 4.4 9.0 7.0 4.2 7.0 4.6 5.7 6.1 5.1 11.2 5.9 0.9 0.0 5.3 2.4 2.3 0.3 4.8 0.9 1.4 4.3 0.3 5.8 4.0 4.0 7.6 0.3 2.5 4.4 5.5 9.1 8.4 3.6 7.2 9.1 4.0 6.1 4.8 4.4 30.7 19.2 0.2 2.6 4.3 10.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.5 0.7 0.2 0.0 0.0 0.4 1.3 0.0 0.2 0.1 0.4 0.3 3.2 5.3 0.0 14.4 8.4 0.0 0.0 1.3 0.0 0.0 3.9 0.8 16.0 48.1 25.9 206.3 20.7 91.4 72.2 22.8 48.9 39.8 20.7 14.4 35.9 25.8 26.0 11.0 100.1 0.6 48.4 23.6 7.9 16.7 4.3 80.5 144.4 21.7 1.2 5.7 582.5 8.5 4.0 32.9 22.4 75.8 38.7 67.4 17.2 25.2 22.4 38.7 519.0 16.5 2.0 39.6 79.1 3.3 10.5 41.7 32.0 217.4 42.3 24.1 33.0 318.2 466.8 32.3 16.3 28.2 82.6 56.6 13.9 8.8 33.2 99.9 52.6 19.0 41.6 1.0 6.9 60.9 48.7 0.4 61.5 6.4 7.7 63.8 ATXN2L "A2D, A2lp" ENSG00000168488 "Ataxin 2 like" Q8WWM7 16 28823035-28837237 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041506, HPA043391, HPA071955" Approved Enhanced Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478" "unprognostic (1.64e-2)" "unprognostic (1.72e-1)" "unprognostic (7.33e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-1)" "unprognostic (6.63e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (5.59e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (7.99e-7)" "unprognostic (1.79e-1)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (2.98e-1)" 67.8 78.2 80.2 51.6 86.2 82.9 65.3 89.9 116.8 83.3 72.7 75.6 43.8 71.3 20.9 81.9 77.8 29.2 68.8 82.2 82.2 85.7 96.1 85.9 62.7 83.2 80.4 81.3 96.8 33.7 116.4 39.0 83.4 80.6 27.0 56.5 70.1 27.9 63.8 76.9 86.3 33.4 75.5 117.0 82.6 178.9 83.5 52.5 83.0 23.7 46.9 75.5 77.7 86.0 77.8 97.6 99.0 112.1 59.9 61.5 116.1 76.3 73.7 82.1 91.3 124.1 90.1 178.6 95.4 54.4 128.6 110.2 93.9 76.9 90.5 140.9 83.3 119.5 124.3 127.4 107.5 135.9 161.2 78.8 90.1 116.4 166.1 72.4 73.2 174.4 158.9 219.9 68.4 109.9 166.1 228.0 100.6 46.9 67.2 216.4 68.5 125.6 48.9 79.6 102.8 81.9 44.6 83.5 95.8 62.3 91.3 141.0 88.2 101.2 83.6 65.8 106.2 311.9 238.1 159.4 76.3 128.1 119.6 0.4 2.1 1.4 1.6 1.9 1.6 4.3 1.9 2.0 1.6 2.9 1.8 2.3 2.4 1.9 1.6 5.6 1.7 1.1 80.2 86.2 89.9 116.8 82.2 82.2 83.2 80.4 83.4 75.5 83.5 86.0 30.2 28.9 33.3 26.1 48.2 36.6 25.1 20.2 66.0 31.6 29.8 26.3 2.1 21.5 19.8 20.2 45.9 23.0 39.1 19.8 1.9 17.8 71.7 37.7 34.9 27.8 24.6 23.1 37.3 20.2 21.9 20.8 31.6 53.1 25.9 23.4 27.1 14.7 24.8 26.9 37.5 23.4 14.2 29.3 33.3 25.7 21.5 36.5 8.8 24.4 26.4 10.0 33.0 18.6 31.5 32.2 19.4 19.9 65.1 33.0 19.7 4.8 18.8 48.9 13.1 28.9 22.1 83.9 28.3 46.3 31.1 34.3 48.4 24.5 23.4 27.4 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 114.8;Syncytiotrophoblasts: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 246.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 130000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 28.4 21.9 20.0 16.0 20.5 19.0 21.6 17.9 21.1 21.8 18.6 19.4 17.2 14.7 18.3 25.1 19.0 14.4 24.9 20.5 22.0 27.7 22.5 25.1 23.4 18.4 19.3 29.0 34.0 21.9 32.5 21.7 19.1 21.8 17.5 8.0 32.3 12.3 24.6 24.6 18.6 10.6 18.2 31.2 27.6 19.4 22.9 16.9 21.9 16.3 20.7 23.7 21.4 19.3 35.2 22.3 32.8 43.6 47.5 24.7 52.5 19.2 34.7 39.6 36.3 44.8 68.4 32.2 54.2 22.1 37.8 34.3 34.9 21.7 22.8 34.1 42.5 18.6 14.2 35.8 34.1 37.0 48.6 33.7 31.1 36.5 39.6 47.0 45.2 41.3 60.3 69.3 32.2 35.4 24.1 34.4 40.9 70.3 48.0 28.5 18.2 79.4 33.5 20.9 46.6 54.7 19.7 50.4 41.7 44.2 50.7 64.8 18.9 19.5 35.4 22.4 57.7 246.6 146.5 43.0 28.5 31.2 32.0 10.7 14.9 12.6 27.0 17.2 24.3 26.2 25.9 26.0 18.0 21.2 25.0 23.2 9.7 25.9 23.3 37.4 43.1 21.0 20.0 20.5 17.9 21.1 20.5 22.0 18.4 19.3 19.1 18.2 22.9 19.3 18.1 19.2 20.0 1.6 34.7 38.5 36.6 26.2 19.9 17.3 32.8 19.9 10.2 15.7 17.7 25.8 2.1 44.8 30.3 15.3 5.9 28.7 10.1 8.2 7.8 24.4 28.8 34.5 6.2 22.9 91.7 24.7 15.3 10.9 9.5 21.0 27.8 13.2 29.7 26.9 7.1 20.7 26.4 16.6 17.9 5.7 9.6 16.2 23.2 4.7 10.2 9.4 47.4 5.0 4.5 31.4 20.0 7.2 114.8 46.1 19.0 20.9 12.4 8.6 26.3 11.1 24.7 14.9 46.9 21.7 41.9 114.2 29.5 11.8 22.7 51.4 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 24.2;lymphoid tissue: 96.4" "Cell type enriched" "Detected in many" 10 "B-cells: 455.9" "Cancer enhanced" "Detected in many" "prostate cancer: 6.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 14 "memory B-cell: 310.4;naive B-cell: 253.0" "Lineage enriched" "Detected in many" 16 "B-cells: 310.4" "Cell line enhanced" "Detected in some" "Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 19000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 8.5 3.6 0.6 35.1 0.6 6.2 2.2 1.5 0.9 2.3 0.2 2.8 2.4 0.8 3.2 0.8 2.3 3.0 0.7 0.5 0.7 3.2 0.3 8.1 82.2 0.8 0.8 0.1 0.5 0.4 1.5 0.8 0.9 5.8 3.3 0.2 2.4 4.7 0.1 0.7 24.2 1.0 0.9 56.1 7.4 3.0 1.0 9.7 12.9 0.2 96.4 7.6 0.7 0.6 0.0 3.0 0.0 0.0 3.4 1.4 0.1 0.1 0.1 0.4 0.6 0.1 4.6 13.6 1.2 0.0 0.0 0.2 0.1 1.5 0.4 0.0 0.0 10.6 2.6 0.0 0.1 9.6 0.0 0.6 0.4 0.0 0.0 1.2 0.1 0.0 0.1 4.0 0.6 0.5 0.0 0.6 0.0 0.4 5.7 0.2 0.6 0.0 0.4 6.1 2.6 0.0 0.3 0.2 0.0 0.1 0.5 2.5 1.3 0.0 0.6 0.0 0.0 31.0 0.0 2.2 0.1 5.3 0.0 10.8 1.7 19.7 0.4 0.5 0.1 310.4 0.1 0.2 10.5 253.0 0.1 0.1 0.9 1.5 0.2 5.2 0.2 11.3 0.6 0.6 1.5 0.9 0.5 0.7 0.8 0.8 0.9 0.9 1.0 0.6 3.5 44.8 27.1 6.8 455.9 0.1 2.2 0.5 0.0 0.2 1.7 0.4 0.5 0.0 10.0 3.7 0.0 2.1 5.8 0.0 0.0 0.2 2.8 13.1 1.0 1.3 0.0 6.1 7.3 0.2 0.6 1.4 6.1 15.2 1.3 0.1 0.0 0.1 1.5 0.0 1.6 0.4 2.0 2.9 25.1 2.0 0.0 13.0 5.4 4.7 2.8 1.8 1.0 1.0 1.3 4.1 1.3 0.4 13.7 4.4 0.2 4.2 2.2 0.1 0.0 0.1 0.8 1.9 5.6 0.8 1.1 0.3 12.9 2.1 1.1 4.3 BCKDHA "MSU, OVD1A" ENSG00000248098 "Branched chain keto acid dehydrogenase E1 subunit alpha" P12694 19 41397808-41425002 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 26.2;Gastric mucus-secreting cells: 23.4;Plasma cells: 25.0;Squamous epithelial cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036640 Supported NA NA 7700 "Cluster 25: Monocytes - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "HPA036640: AB_10671964" "unprognostic (4.50e-2)" "unprognostic (6.85e-2)" "unprognostic (1.14e-1)" "unprognostic (8.58e-3)" "unprognostic (1.26e-2)" "prognostic favorable (9.37e-4)" "unprognostic (2.41e-2)" "unprognostic (8.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.53e-1)" "prognostic favorable (5.33e-10)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.27e-5)" "unprognostic (9.66e-2)" 33.8 78.4 32.0 19.3 35.5 32.4 25.2 37.0 39.3 24.6 37.0 20.9 19.9 17.9 14.1 65.1 28.8 15.4 90.4 32.5 35.1 44.3 110.0 22.4 24.5 34.4 33.8 25.4 46.1 56.3 24.0 19.0 36.2 23.8 15.0 21.7 40.9 23.1 110.0 31.8 18.7 12.7 33.9 24.4 52.5 27.1 35.7 27.0 41.7 122.0 21.2 21.7 31.9 40.0 42.7 75.1 14.2 44.1 22.2 12.8 17.1 11.9 25.3 24.4 29.9 18.2 36.0 34.6 23.7 15.1 11.0 17.1 15.0 25.9 12.1 36.0 41.0 27.1 35.2 21.3 51.5 25.5 17.7 27.6 37.6 16.9 38.2 36.0 45.0 50.9 25.9 68.9 17.6 41.5 28.0 20.0 12.8 61.1 21.1 27.1 22.8 89.6 29.8 19.8 32.5 38.6 39.6 84.7 34.1 12.1 45.4 81.0 29.3 22.2 23.0 12.0 22.0 131.9 55.1 34.1 81.8 56.6 24.6 61.4 149.4 59.7 49.5 123.9 56.7 46.0 47.0 49.1 154.6 49.5 43.2 44.9 46.4 82.4 95.5 62.6 63.9 125.6 32.0 35.5 37.0 39.3 32.5 35.1 34.4 33.8 36.2 33.9 35.7 40.0 0.6 0.0 13.1 4.9 10.0 0.3 0.1 2.6 26.2 0.2 1.5 0.4 0.1 1.5 5.3 5.5 0.0 1.9 0.9 3.8 3.9 14.7 0.7 0.5 0.6 2.4 6.1 15.5 5.8 11.8 1.7 3.7 23.4 0.7 5.1 0.4 2.5 2.4 2.7 0.0 6.2 7.6 8.2 2.2 0.8 0.9 0.6 6.6 3.6 3.7 12.4 0.4 5.2 4.0 5.7 8.4 3.8 0.4 25.0 0.2 6.7 2.3 1.2 1.2 0.0 0.2 3.6 1.8 0.9 27.2 0.9 2.1 6.3 0.3 7.3 0.1 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2 apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 271.6;Inhibitory neurons: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 18 "B-cells: 5.4;T-cells: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: AB_2682776" "unprognostic (1.11e-3)" "prognostic favorable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favorable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (2.63e-1)" 12.8 1.9 5.5 10.2 7.8 5.0 9.6 4.7 3.4 10.7 0.0 6.2 4.4 11.6 2.9 5.9 11.8 6.5 5.3 2.9 6.6 6.7 2.1 3.7 14.7 11.2 7.9 14.5 3.1 13.0 4.7 4.6 7.5 6.4 5.5 2.1 3.7 7.0 16.5 4.8 8.1 6.6 7.9 17.9 3.8 1.5 8.2 18.3 24.0 8.8 14.6 5.4 7.7 5.7 1.7 0.3 6.8 5.9 6.7 1.3 2.4 1.0 0.7 2.4 2.0 3.5 0.4 0.3 1.1 0.9 4.7 0.4 6.7 0.9 1.5 44.2 1.6 0.5 2.0 0.7 2.0 43.7 5.6 1.7 0.8 3.3 5.8 1.1 0.7 4.3 0.8 72.9 2.2 1.4 9.8 10.7 1.5 0.8 1.3 39.5 1.9 26.5 7.4 8.5 7.2 6.4 0.3 0.3 8.5 1.4 0.3 29.9 0.3 9.9 3.3 0.9 5.1 217.4 40.1 2.9 1.9 24.9 6.0 0.3 0.0 0.0 1.9 0.0 7.6 5.4 6.3 3.4 0.1 3.1 3.3 3.2 0.0 0.2 0.3 0.2 8.5 1.3 5.5 7.8 4.7 3.4 2.9 6.6 11.2 7.9 7.5 7.9 8.2 5.7 7.1 0.0 1.1 271.6 84.9 19.5 33.6 1.6 13.6 1.9 39.7 19.7 17.4 18.6 2.4 7.3 0.0 14.0 39.9 2.7 15.6 3.7 0.4 9.8 9.8 5.9 5.4 3.8 60.7 0.0 0.7 15.8 5.6 24.9 15.8 38.8 3.9 1.2 9.4 0.0 102.3 10.5 24.4 15.0 29.6 1.9 8.7 29.0 46.2 88.1 19.7 18.8 18.6 76.4 56.7 0.2 5.9 13.9 50.1 41.6 0.9 18.0 0.1 0.6 26.3 48.8 19.7 0.3 1.3 6.2 17.6 49.1 76.1 24.1 9.8 76.2 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168445 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 118.3;Plasma cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 91.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026332, CAB079899" Approved Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Mitochondria "CAB026332: AB_566386, CAB079899: AB_10981505" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 8.1 7.4 4.2 16.4 5.0 38.8 12.5 3.7 3.7 7.2 4.6 11.0 7.2 6.5 4.9 9.8 7.0 8.8 5.7 3.0 3.9 10.7 14.3 8.5 24.2 4.3 4.0 10.3 10.3 18.8 9.4 6.0 4.5 7.8 11.9 12.1 10.1 7.1 12.3 5.8 11.7 4.8 3.9 16.3 7.0 8.1 4.4 18.9 16.6 7.3 23.0 8.9 8.2 6.7 8.0 2.4 10.8 10.4 9.1 4.7 29.1 1.2 2.3 3.3 3.3 6.6 24.9 32.0 6.5 1.2 18.9 9.5 10.0 3.9 2.0 24.9 18.2 39.7 8.1 10.5 3.9 14.6 8.8 4.8 10.5 3.7 3.8 7.0 4.6 14.2 20.8 46.6 0.7 5.2 15.3 14.7 13.2 6.3 7.5 19.5 10.3 40.7 4.5 13.0 9.3 24.0 11.0 14.5 8.3 7.1 5.0 31.2 1.9 1.7 11.4 3.7 4.3 91.2 19.5 45.3 2.7 10.1 1.5 5.2 3.7 1.8 1.7 2.6 1.8 3.3 2.3 1.9 1.9 1.9 1.5 1.5 5.2 1.7 5.7 0.4 5.9 1.5 4.2 5.0 3.7 3.7 3.0 3.9 4.3 4.0 4.5 3.9 4.4 6.7 33.9 3.2 9.9 2.9 61.3 17.5 18.2 7.0 34.7 7.4 19.5 29.2 19.3 12.8 10.3 9.2 10.4 4.6 43.9 37.6 13.7 9.7 118.3 36.6 10.8 18.0 21.5 26.5 2.2 6.5 7.8 11.6 8.6 54.7 11.4 5.9 14.6 11.3 10.9 0.0 4.8 15.2 12.2 26.8 52.6 39.2 5.9 34.8 23.2 6.5 41.0 12.1 5.2 3.0 5.3 8.8 16.4 3.8 137.9 15.9 16.6 6.4 15.2 21.1 0.0 11.8 11.9 7.3 17.7 66.1 10.9 5.7 41.0 2.5 12.3 16.0 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145569-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.0;U-266/70: 3.1" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 0.2 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.6 0.3 0.1 0.2 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.6 0.2 0.2 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.0 0.6 0.2 0.2 0.1 0.3 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.8 0.0 0.1 0.1 0.7 0.2 0.1 0.1 0.4 0.3 0.4 0.0 1.4 0.3 0.1 0.0 0.5 0.5 0.2 0.1 0.2 0.1 0.5 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.9 0.1 2.0 0.5 0.2 1.3 0.1 0.6 0.0 0.7 0.7 0.1 0.0 0.1 1.6 0.1 0.5 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.5 0.3 0.0 0.0 1.5 0.0 3.1 0.6 1.7 0.3 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.1 1.4 0.8 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.2 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.5 0.0 1.2 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.6 0.0 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924929 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336" "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 8.8 5.8 6.3 5.6 7.7 15.9 8.8 12.5 8.7 8.2 5.4 8.6 4.7 8.3 8.3 7.5 8.0 5.8 7.6 8.3 6.7 7.6 6.6 9.9 6.9 4.0 3.6 9.8 8.3 11.5 9.0 7.2 4.6 8.2 5.4 17.0 7.2 5.9 8.6 10.4 6.9 6.0 3.1 6.7 7.8 13.7 5.2 8.7 10.2 8.4 6.4 9.9 8.5 6.7 6.3 5.2 7.7 9.4 9.1 11.8 12.3 6.8 7.5 5.4 7.6 5.7 6.7 10.8 5.0 7.3 8.4 3.4 6.8 5.5 10.0 9.8 5.4 7.1 5.1 5.2 7.6 11.7 6.8 7.9 6.1 6.0 12.0 8.2 6.6 7.7 11.3 19.1 9.8 3.3 15.6 12.0 6.9 6.2 3.1 10.1 6.5 8.9 5.3 11.9 8.9 7.3 7.9 4.9 7.3 7.5 4.5 7.8 9.7 5.9 4.3 12.9 5.5 21.6 12.9 16.7 9.7 11.3 6.6 1.9 1.0 4.1 1.5 0.9 1.0 1.3 1.5 1.2 0.8 1.1 2.6 1.3 2.0 3.5 1.3 1.0 1.5 0.6 6.3 7.7 12.5 8.7 8.3 6.7 4.0 3.6 4.6 3.1 5.2 6.7 43.4 22.4 45.7 151.1 58.4 21.5 24.6 6.0 23.3 29.7 31.2 21.2 19.8 10.0 18.7 25.8 35.5 15.7 73.5 8.8 7.9 14.3 68.6 50.6 37.4 23.4 19.2 14.9 252.3 9.8 12.9 22.0 21.9 69.2 24.7 45.5 9.3 9.6 9.4 25.2 242.4 9.8 8.2 13.6 37.1 36.5 16.4 30.1 16.0 126.5 14.6 11.3 15.5 206.1 202.6 15.4 8.1 10.1 48.7 23.8 8.0 13.4 20.0 33.0 6.6 24.1 24.7 43.8 26.0 14.5 24.0 75.5 41.4 30.9 8.7 33.4 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091644-9121635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.1" "Cell type enhanced" "Detected in all" "Late spermatids: 643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 42: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: AB_2685850" "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.0 17.4 15.7 18.2 17.8 106.1 17.2 14.9 20.3 15.9 14.0 14.9 14.8 15.2 17.3 19.6 12.8 19.0 15.8 18.8 16.7 18.6 26.8 17.5 20.1 14.1 15.8 14.2 18.6 22.3 9.8 17.1 14.9 15.9 15.0 20.8 14.2 14.7 32.4 17.0 13.6 16.8 13.8 20.9 15.8 17.3 16.8 19.4 18.8 27.8 22.0 17.8 15.2 16.8 17.3 18.9 29.6 27.1 34.4 26.7 15.5 33.2 27.6 18.8 19.3 15.9 22.0 30.8 18.6 38.6 14.8 19.8 27.5 29.4 39.2 20.3 15.4 20.7 27.2 33.6 44.4 26.3 23.2 40.7 45.3 31.5 44.7 30.1 33.1 31.7 31.6 45.7 33.6 24.9 23.5 23.3 36.1 17.7 16.5 39.6 36.1 33.1 24.6 31.3 19.1 21.4 39.9 27.8 35.1 27.4 32.1 26.6 38.3 36.6 24.0 47.6 21.7 51.7 48.0 42.5 32.6 23.2 30.3 5.5 2.8 3.2 3.7 3.1 4.2 2.5 3.1 2.6 2.2 3.0 3.5 3.2 10.9 2.3 3.4 2.8 2.7 1.7 15.7 17.8 14.9 20.3 18.8 16.7 14.1 15.8 14.9 13.8 16.8 16.8 65.3 48.1 37.2 17.6 47.5 76.9 45.4 13.0 78.6 43.6 81.6 53.8 39.3 35.8 19.1 22.0 87.6 29.6 76.0 45.8 19.6 28.1 210.0 75.7 75.1 52.5 48.2 21.7 27.6 29.4 35.7 42.9 35.2 115.7 18.3 51.9 38.6 59.5 32.5 43.7 28.2 35.1 8.2 83.8 65.6 643.5 24.5 83.5 32.0 28.1 49.0 41.8 33.0 24.6 33.3 38.9 37.7 27.1 59.2 52.0 44.5 36.8 15.9 51.2 32.9 78.0 56.3 41.5 22.3 84.5 64.4 57.1 58.8 35.3 34.9 70.1 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134692-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.6" "Group enriched" "Detected in many" 17 "Early spermatids: 423.9;Late spermatids: 881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 19.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 3.1 7.8 1.4 3.2 2.1 1.9 2.9 3.2 2.0 3.4 1.7 6.8 4.4 3.8 1.7 2.5 3.5 2.5 2.2 1.4 2.3 2.8 1.3 2.6 3.3 2.3 1.5 5.4 2.1 3.9 2.2 1.3 2.1 2.8 4.6 2.7 3.5 2.5 0.9 2.3 3.9 3.0 1.7 4.0 4.5 65.6 1.9 4.3 4.1 1.1 3.9 3.8 2.8 2.4 3.2 2.1 5.2 5.4 2.0 0.9 2.5 1.3 4.7 3.7 5.5 4.4 3.0 8.1 2.0 2.6 16.5 1.2 5.3 1.5 4.0 3.8 5.1 4.1 0.3 5.8 4.4 7.0 8.5 3.2 4.6 3.0 0.8 2.8 0.7 6.9 5.7 4.7 1.3 0.0 5.5 7.5 2.1 6.4 2.3 8.7 5.5 1.3 2.7 3.8 1.3 4.1 1.2 5.2 5.1 6.7 0.9 9.2 0.9 2.6 6.6 0.1 2.2 19.3 7.0 11.6 0.7 5.7 10.4 0.4 0.4 0.8 0.6 0.2 0.7 1.0 0.3 0.4 0.6 0.6 0.9 0.7 0.0 1.0 0.3 1.9 1.0 0.3 1.4 2.1 3.2 2.0 1.4 2.3 2.3 1.5 2.1 1.7 1.9 2.4 2.6 0.0 5.0 2.6 8.4 1.1 2.4 0.8 2.8 1.1 1.6 1.8 1.6 4.3 0.3 0.0 0.0 3.4 7.0 6.5 3.9 1.9 423.9 0.9 1.9 2.5 4.2 3.0 0.8 3.9 2.9 2.5 4.6 1.2 0.0 3.4 2.2 0.8 2.5 0.0 1.2 3.5 0.0 6.1 3.1 881.6 7.2 3.8 3.6 7.5 6.1 7.7 13.4 0.5 4.3 3.9 6.1 5.3 8.9 1.3 2.2 0.8 3.2 0.8 0.0 3.0 2.8 37.3 15.2 2.5 0.6 2.3 6.6 2.4 7.0 1.3 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 70.2" "Cell type enhanced" "Detected in many" "Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 154.3;U-266/70: 216.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" "HPA073649: AB_2732233" "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favorable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 17.1 3.3 63.9 2.1 67.9 2.6 13.8 36.8 54.8 6.9 17.1 5.2 7.5 9.4 3.2 6.9 10.9 5.2 4.6 44.9 53.5 13.1 9.9 21.5 2.8 39.6 59.0 3.7 3.0 21.9 4.0 10.4 40.8 3.7 5.1 8.0 22.3 4.5 1.5 17.2 6.7 6.6 31.2 3.7 14.5 3.5 70.2 4.9 15.0 1.8 2.3 5.4 7.8 33.3 13.1 14.4 11.8 0.9 7.1 0.3 20.4 3.1 17.3 4.2 2.5 9.5 23.0 0.7 13.3 14.9 42.3 11.4 9.0 2.3 3.2 0.3 19.4 1.0 38.7 37.1 6.2 2.5 1.0 4.2 2.1 5.3 6.1 26.8 47.1 2.3 0.5 16.2 11.7 30.2 0.1 8.8 7.5 64.5 46.6 3.1 42.2 50.6 21.2 31.5 11.2 8.2 26.1 32.5 154.3 8.3 52.4 7.2 79.3 47.9 0.5 1.6 3.8 216.0 88.9 27.4 0.2 19.2 16.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 63.9 67.9 36.8 54.8 44.9 53.5 39.6 59.0 40.8 31.2 70.2 33.3 2.9 22.4 27.4 258.2 3.8 5.1 2.0 1.4 5.2 4.1 9.2 6.7 1.4 7.2 2.3 3.7 29.2 0.9 1.3 8.5 1.9 1.1 2.0 11.6 4.4 6.0 3.5 1.3 19.2 2.3 1.1 4.1 10.2 54.3 0.0 14.8 25.0 9.3 16.6 0.0 22.2 4.6 0.0 3.5 3.1 3.5 0.0 4.7 28.4 41.2 0.0 1.4 0.0 163.3 1.4 2.4 5.2 6.0 3.6 0.6 6.7 14.3 1.8 18.7 0.0 5.0 2.1 0.2 3.2 1.6 6.7 0.3 1.4 0.5 2.1 2.2 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "brain: 42.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.0 1.0 33.5 0.6 30.5 1.2 0.0 0.0 34.6 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.7 0.0 0.3 42.8 3.4 1.3 0.0 0.1 0.4 4.6 6.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.2 9.7 0.4 0.1 1.0 3.8 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 33.5 30.5 0.0 34.6 42.8 3.4 4.6 6.2 0.9 9.7 3.8 1.1 0.0 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.4 0.0 0.0 188.7 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 116.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.5 0.0 0.2 0.0 73.9 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CACNA1F "AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2" ENSG00000102001 "Calcium voltage-gated channel subunit alpha1 F" O60840 X 49205063-49233371 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Sensory transduction, Transport, Vision" "Calcium channel, Ion channel, Voltage-gated channel" "Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "retina: 125.3" "Group enriched" "Detected in some" 13 "Bipolar cells: 66.5;Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 97.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "U-266/70: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA068379 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 79: Retina - Phototransduction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA068379: AB_2732782" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (4.25e-3)" "unprognostic (1.56e-2)" "unprognostic (8.46e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.04e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (6.08e-7)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.77e-3)" 0.2 0.4 0.7 0.4 0.7 1.9 0.7 2.3 1.4 0.2 0.8 0.6 0.8 0.2 1.0 0.2 0.5 0.2 0.2 0.8 0.4 0.3 0.0 0.6 1.3 0.4 0.1 0.3 0.6 0.0 0.1 0.0 0.5 0.1 0.7 125.3 0.6 0.4 0.0 1.0 1.6 0.2 0.0 0.8 0.6 0.2 0.4 0.8 0.4 0.0 0.5 0.2 0.1 0.8 0.1 0.7 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.8 0.4 0.5 0.4 0.5 0.0 0.0 0.0 0.3 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.2 0.5 0.1 0.3 1.3 0.1 0.0 0.7 0.7 2.3 1.4 0.8 0.4 0.4 0.1 0.5 0.0 0.4 0.8 0.2 0.0 0.5 0.0 1.1 0.0 0.1 0.1 0.0 66.5 1.1 0.9 1.9 0.0 0.0 1.8 133.5 0.1 2.8 0.2 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.4 0.9 0.2 0.2 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.2 6.7 0.4 2.3 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.1 7.4 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.1 0.4 0.1 0.1 97.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.3 0.1 CALCB "CALC2, CGRP-II, FLJ30166" ENSG00000175868 "Calcitonin related polypeptide beta" P10092 11 14904997-15082342 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Hormone "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 18.9;thyroid gland: 20.7" "Group enriched" "Detected in some" 4 "Melanocytes: 5.4;Spermatogonia: 5.1" "Group enriched" "Detected in some" 5 "colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9" "Group enriched" "Detected in many" 4 "hypothalamus: 6.8;medulla oblongata: 8.9;midbrain: 11.6;pons: 18.9;white matter: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0" "Region enriched" "Detected in some" 7 "pons and medulla: 9.6" "Group enriched" "Detected in many" 5 "amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7" HPA059886 Supported "Secreted to blood" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "HPA059886: " "unprognostic (7.84e-2)" "unprognostic (4.07e-1)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.02e-1)" "unprognostic (8.40e-2)" "unprognostic (1.75e-1)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "unprognostic (3.32e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" 0.3 0.0 0.1 0.3 0.2 0.0 0.2 0.5 0.6 0.2 0.1 1.4 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.3 6.8 1.0 0.8 0.1 0.1 8.9 11.6 0.1 1.5 0.3 2.2 0.1 18.9 0.1 0.2 0.1 0.3 0.0 0.8 0.1 0.4 0.1 2.3 0.1 0.1 0.3 1.0 0.0 20.7 0.1 0.1 0.0 0.1 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.2 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 1.9 0.0 0.4 0.1 0.0 10.4 0.0 0.0 0.0 0.6 2.9 0.1 0.1 0.4 0.0 0.2 0.0 0.0 1.1 3.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.0 0.6 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.6 0.3 6.8 8.9 11.6 18.9 2.3 1.0 4.7 0.0 0.0 0.0 0.3 0.2 1.3 0.1 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.4 0.2 0.9 0.5 0.2 0.5 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 5.4 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 5.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237675-121298308 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 135.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 64.8;Horizontal cells: 62.2;Late spermatids: 89.6" "Cancer enriched" "Detected in all" 5 "prostate cancer: 56.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 32.7;eosinophil: 62.1;intermediate monocyte: 42.3;myeloid DC: 15.9;neutrophil: 39.2;non-classical monocyte: 39.5" "Group enriched" "Detected in all" 5 "dendritic cells: 15.9;granulocytes: 62.1;monocytes: 42.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 26.0 16.7 39.6 17.0 56.2 30.8 22.7 135.4 65.5 22.3 14.3 22.8 25.7 22.9 10.8 17.5 27.5 12.9 17.8 44.8 24.8 16.7 30.9 23.6 15.3 20.8 20.1 27.4 16.8 12.4 11.8 15.3 24.9 29.5 19.4 7.1 18.6 23.8 11.5 18.3 26.6 20.7 18.3 39.6 24.0 7.0 23.6 13.4 17.1 11.2 15.6 25.9 21.1 42.7 27.9 20.5 16.3 30.9 46.7 43.0 22.8 22.0 23.8 19.0 17.3 21.4 12.1 43.0 18.1 48.1 14.1 22.7 20.0 25.8 15.1 29.3 35.9 22.0 14.4 21.3 31.1 50.0 20.0 28.2 37.2 18.0 41.4 26.0 45.0 33.5 25.2 23.6 18.4 27.2 55.8 40.6 11.7 24.9 22.7 35.3 18.4 37.7 18.8 32.1 60.2 22.4 31.5 16.5 19.1 12.9 39.7 62.0 32.2 14.8 11.8 13.1 13.0 84.8 55.6 32.7 27.7 34.4 16.0 2.0 32.7 62.1 4.7 42.3 4.6 4.8 3.5 4.2 15.9 2.8 3.2 3.8 39.2 8.6 39.5 3.6 3.3 15.8 39.6 56.2 135.4 65.5 44.8 24.8 20.8 20.1 24.9 18.3 23.6 42.7 25.4 9.6 5.6 9.8 5.7 7.9 6.0 8.1 8.0 22.2 11.6 10.5 8.2 12.8 8.3 9.2 2.1 9.2 10.6 18.2 3.9 9.6 16.0 6.5 19.6 21.9 34.3 12.0 64.8 10.4 8.2 18.0 13.3 10.9 6.3 23.3 15.0 19.7 7.9 62.2 21.4 16.2 8.2 14.8 15.6 89.6 20.5 16.6 8.8 12.2 36.3 5.4 12.3 10.1 19.3 8.5 10.9 31.6 11.9 16.5 26.6 9.6 7.2 7.0 19.7 7.7 20.6 0.8 2.9 13.3 6.0 3.4 7.6 32.7 17.6 6.3 CAPN14 ENSG00000214711 "Calpain 14" A8MX76 2 31173056-31233858 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "esophagus: 144.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.2;Inhibitory neurons: 4.2;Squamous epithelial cells: 8.2;Urothelial cells: 15.5" "Cancer enhanced" "Detected in some" "cervical cancer: 2.9;head and neck cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.1;U-266/70: 3.4" "Not detected" "Not detected" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (5.81e-3)" "unprognostic (1.20e-1)" "unprognostic (4.57e-2)" "unprognostic (1.88e-2)" "unprognostic (3.85e-2)" "unprognostic (3.30e-1)" "unprognostic (3.61e-2)" "unprognostic (4.67e-2)" "unprognostic (1.71e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" "unprognostic (1.60e-1)" "unprognostic (3.71e-4)" "unprognostic (8.42e-2)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (4.47e-4)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 144.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.6 0.8 0.1 0.0 1.7 0.0 0.7 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.6 0.8 0.1 0.2 0.0 0.0 3.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 1.7 4.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.5 0.5 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 8.2 0.0 1.4 0.1 0.0 0.1 15.5 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 66.6" "Cell type enhanced" "Detected in many" "dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol No No "Cluster 5: Granulocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535" "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favorable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 11.5 10.2 1.7 28.6 2.0 66.6 13.9 1.3 2.1 9.6 4.2 16.1 20.5 8.5 13.2 12.9 14.1 13.2 5.2 2.1 1.8 10.7 14.1 19.6 37.7 3.4 3.0 7.7 7.8 2.9 3.4 9.9 2.7 6.9 17.6 4.6 8.4 7.3 3.3 12.1 26.0 9.9 2.4 37.1 15.9 4.3 2.6 24.4 7.9 3.0 29.7 18.0 8.6 2.4 33.6 26.6 7.7 22.2 20.7 29.7 12.0 13.8 13.2 16.0 26.2 36.1 54.9 3.7 29.6 10.7 28.7 16.2 17.2 16.1 31.3 21.1 15.4 31.0 21.9 35.1 17.1 25.6 33.8 25.9 38.0 30.1 23.9 13.4 15.1 26.9 28.6 69.1 14.7 13.1 32.1 25.9 12.6 17.5 23.7 24.7 15.9 55.4 30.8 35.3 2.3 1.1 17.9 29.8 18.0 7.0 8.0 19.1 19.6 17.3 18.0 9.0 10.9 63.1 30.2 21.2 25.3 33.1 16.6 76.1 39.5 77.1 70.7 51.2 66.0 40.9 57.8 75.9 41.6 24.0 37.0 47.2 153.6 70.6 51.5 18.6 75.0 40.6 1.7 2.0 1.3 2.1 2.1 1.8 3.4 3.0 2.7 2.4 2.6 2.4 8.5 25.6 26.7 0.7 50.0 7.5 13.0 6.1 10.2 2.1 12.9 9.3 2.5 10.0 13.0 5.5 10.4 8.5 107.4 37.0 15.6 12.3 5.9 25.6 8.1 10.1 4.2 10.5 2.5 8.4 12.1 9.5 19.4 27.2 24.6 10.4 5.3 11.7 11.9 0.0 1.3 15.2 4.1 25.3 15.7 1.9 2.5 25.0 7.2 10.3 35.6 0.2 132.8 1.0 0.5 11.2 30.1 0.7 73.4 9.7 22.3 23.6 14.2 0.4 0.0 4.5 3.7 0.8 0.4 13.1 7.7 3.4 86.9 10.6 17.4 12.7 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 104.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 9.5 10.2 11.8 12.7 12.7 21.8 11.9 15.7 22.8 14.2 13.4 11.2 11.8 11.5 8.0 8.2 9.1 9.5 7.9 11.6 12.5 9.8 24.2 9.4 18.2 11.6 11.8 12.5 9.4 12.6 6.7 19.1 11.5 9.8 11.2 10.6 18.3 9.3 16.9 8.2 9.4 9.7 11.8 12.6 10.0 36.6 13.1 17.9 10.9 20.7 20.3 10.6 7.5 17.6 19.9 16.0 32.2 31.7 20.6 18.0 25.5 19.7 23.9 33.4 29.2 24.6 9.4 61.7 8.6 18.0 14.2 20.2 47.8 7.8 31.6 33.6 31.4 25.2 17.3 36.6 14.1 40.6 30.9 12.2 16.8 19.3 11.9 14.9 23.5 20.0 36.0 26.6 15.2 25.6 24.1 32.8 26.4 35.3 7.7 48.1 50.8 27.0 14.9 7.6 12.3 16.4 30.4 28.0 12.7 38.0 34.9 17.4 13.7 41.7 28.3 13.3 15.3 61.7 68.9 51.2 14.6 21.9 18.1 13.5 14.6 15.3 10.0 13.2 10.2 10.0 8.3 9.8 14.6 12.4 14.5 11.8 6.7 25.3 12.9 12.7 11.6 14.9 11.8 12.7 15.7 22.8 11.6 12.5 11.6 11.8 11.5 11.8 13.1 17.6 11.1 22.4 14.3 4.2 18.3 10.6 14.4 4.3 6.2 7.7 21.9 14.2 10.4 15.7 8.5 14.7 14.6 16.5 20.4 13.2 7.9 9.9 104.0 20.7 32.5 15.5 20.4 17.4 6.6 10.0 17.8 14.3 6.6 31.0 17.2 11.9 10.8 42.3 9.3 3.3 7.1 12.3 4.1 18.9 19.0 38.2 12.8 15.4 17.8 7.5 14.7 6.2 21.6 4.5 12.8 9.7 8.9 7.9 26.4 22.6 9.0 12.5 13.8 15.2 0.0 9.6 16.1 49.5 48.5 9.5 10.9 24.6 14.7 9.0 12.4 22.3 CCDC163 "C1orf231, CCDC163P, LOC126661" ENSG00000280670 "Coiled-coil domain containing 163" A0A0D9SF12 1 45493866-45500079 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Adipocytes: 1.9;Breast glandular cells: 2.3;Breast myoepithelial cells: 3.4;Cytotrophoblasts: 3.2;Distal tubular cells: 1.9;Exocrine glandular cells: 2.0;Extravillous trophoblasts: 2.0;Glandular and luminal cells: 2.0;Theca cells: 1.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 5.2;U-266/70: 5.7" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.25e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-3)" "unprognostic (9.50e-8)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "unprognostic (6.23e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-1)" "unprognostic (8.38e-6)" "unprognostic (4.73e-3)" "unprognostic (7.69e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (1.61e-1)" 0.3 0.2 0.2 0.4 0.2 0.8 0.4 0.1 0.6 0.5 0.1 0.2 0.3 0.3 0.3 0.1 0.2 0.1 0.1 0.2 0.2 0.4 0.3 0.4 0.3 0.4 0.2 0.2 0.8 0.8 0.2 0.1 0.2 0.1 0.2 0.1 0.7 0.1 0.2 0.3 0.4 0.2 0.1 0.4 0.3 0.1 0.2 0.5 0.8 0.0 0.3 0.1 0.1 0.2 1.7 0.0 0.0 0.2 0.2 0.5 0.6 0.2 0.2 1.6 0.6 1.4 0.7 0.4 0.8 0.2 0.0 1.3 0.2 1.7 1.0 1.3 1.6 0.8 0.7 1.9 1.5 1.4 0.3 0.1 0.1 0.4 0.8 0.4 0.4 1.6 0.6 5.2 0.7 1.3 2.2 0.6 1.1 1.1 1.0 2.0 0.0 0.8 0.5 0.3 0.2 0.8 0.3 2.9 0.9 0.6 0.6 0.0 0.0 0.5 0.7 0.0 0.7 5.7 2.7 1.2 0.4 0.8 0.2 1.0 0.3 0.7 0.7 0.1 0.7 0.4 0.5 0.5 0.0 0.4 0.3 0.6 0.2 0.2 0.0 0.7 0.0 0.4 0.2 0.2 0.1 0.6 0.2 0.2 0.4 0.2 0.2 0.1 0.2 0.2 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 3.4 0.0 0.0 0.0 0.0 0.0 3.2 1.3 0.0 1.9 1.6 0.0 0.9 1.3 0.6 0.0 0.0 0.0 2.0 2.0 0.4 0.0 2.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.6 1.9 0.0 0.0 CCDC180 "BDAG1, C9orf174, CFAP76, DKFZp434I2420, FAP76, KIAA1529" ENSG00000197816 "Coiled-coil domain containing 180" 9 97307304-97378751 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "choroid plexus: 11.8;testis: 13.1" "Cell type enhanced" "Detected in many" "Early spermatids: 133.5;Late spermatids: 297.4;Respiratory ciliated cells: 81.2;Spermatocytes: 48.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6;U-266/70: 4.1;U-266/84: 3.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (9.92e-2)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-3)" "unprognostic (2.94e-2)" "unprognostic (3.52e-2)" "unprognostic (2.94e-1)" "unprognostic (1.52e-1)" "unprognostic (5.53e-5)" "unprognostic (2.33e-2)" "unprognostic (7.34e-3)" "unprognostic (1.64e-1)" "unprognostic (2.54e-1)" "unprognostic (1.41e-2)" "unprognostic (7.50e-3)" 0.7 0.8 1.7 0.6 1.9 0.7 1.2 3.7 2.8 1.2 11.8 0.8 0.4 1.7 2.0 0.5 6.4 0.8 0.9 1.9 1.7 0.9 0.5 2.0 0.9 3.9 5.5 2.4 1.1 0.9 1.2 0.5 2.7 1.1 0.8 6.5 0.8 1.1 0.9 0.5 0.6 1.3 2.7 1.1 0.6 13.1 1.9 0.6 1.8 0.8 0.7 0.5 0.4 2.5 0.0 0.4 0.6 0.3 0.4 1.3 0.0 0.1 0.4 0.4 0.3 0.7 0.4 0.0 0.6 0.0 0.3 0.0 0.4 0.0 0.1 2.6 0.3 0.8 0.9 0.3 0.1 1.0 1.3 0.6 0.4 0.0 0.1 1.5 0.0 1.2 0.6 0.4 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.3 0.0 0.4 0.1 1.2 0.6 4.1 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 3.7 2.8 1.9 1.7 3.9 5.5 2.7 2.7 1.9 2.5 3.0 0.0 10.5 0.0 3.4 0.4 0.5 1.8 1.2 12.6 1.9 2.3 0.8 1.5 11.7 0.0 20.9 0.2 2.0 0.4 1.9 0.4 133.5 39.0 3.7 2.7 1.2 0.8 0.0 1.4 0.0 2.8 0.5 1.4 9.5 11.4 2.9 0.1 0.5 13.5 0.0 1.2 2.0 0.8 0.9 297.4 1.8 1.6 1.8 0.0 3.4 2.7 4.1 0.0 0.0 0.2 0.5 3.0 5.1 0.4 1.7 15.9 81.2 25.0 0.0 6.7 3.0 48.0 6.0 0.5 0.1 0.4 2.7 5.7 1.2 0.4 CCDC197 "C14orf48, LINC00521" ENSG00000175699 "Coiled-coil domain containing 197" 14 93987225-94008863 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (5.01e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 8.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.6 0.0 0.6 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363234 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.8" "Cell type enhanced" "Detected in many" "Early spermatids: 383.4;Endometrial ciliated cells: 156.1;Spermatocytes: 336.8;Spermatogonia: 218.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 159.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favorable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 3.8 5.3 16.1 5.6 15.9 13.7 11.2 13.8 32.8 4.4 16.7 8.8 10.7 4.9 11.3 5.5 12.5 3.4 3.4 15.9 15.4 5.0 4.6 2.3 6.5 15.2 14.9 9.7 4.3 8.1 5.5 5.1 15.4 5.4 10.1 6.2 4.1 4.3 3.1 6.5 8.9 3.5 14.3 4.4 9.3 48.8 15.9 15.8 5.6 3.4 8.8 3.3 3.5 14.8 46.1 50.4 41.6 44.7 7.5 17.6 30.8 29.5 11.1 29.8 28.8 28.2 8.3 49.4 20.2 15.8 42.7 40.2 41.9 18.2 54.3 19.5 58.2 39.4 62.6 74.1 3.8 40.6 15.4 5.7 13.4 26.0 12.5 13.2 23.3 70.1 39.0 15.9 32.1 32.6 79.3 63.1 42.9 31.4 44.1 74.8 152.8 7.4 12.8 15.2 32.2 42.2 44.0 19.5 20.8 23.4 52.8 21.4 11.1 47.8 45.2 91.3 69.4 153.2 159.4 34.8 44.5 2.0 42.7 0.0 0.2 0.4 3.1 1.0 3.7 3.4 3.9 4.2 1.0 4.0 4.5 2.8 0.0 3.7 3.8 2.3 6.7 1.1 16.1 15.9 13.8 32.8 15.9 15.4 15.2 14.9 15.4 14.3 15.9 14.8 5.1 0.0 1.7 4.9 10.1 22.8 22.9 33.2 13.1 10.3 71.4 73.3 9.2 27.1 20.6 23.9 12.5 45.5 3.4 41.0 19.6 14.1 383.4 156.1 12.5 11.1 21.6 91.3 11.5 12.3 25.1 17.2 31.1 15.3 7.0 30.9 10.0 16.0 22.0 3.3 7.5 40.5 18.3 8.9 8.4 82.4 21.5 5.7 14.2 0.0 4.7 26.6 7.2 1.0 1.2 5.5 12.1 20.7 13.9 10.3 6.2 17.6 101.5 20.6 6.6 11.6 18.3 336.8 218.8 33.2 20.6 16.1 9.1 10.3 71.2 15.5 CCL4 "Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4" ENSG00000275302 "C-C motif chemokine ligand 4" P13236 17 36103827-36105621 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 192.9" "Cell type enhanced" "Detected in many" "dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 414.7" "Group enriched" "Detected in all" 6 "granulocytes: 135.0;T-cells: 414.7" "Group enriched" "Detected in some" 6 "U-266/70: 51.6;U-266/84: 13.3" CAB007805 Approved "Secreted to blood" NA NA 144000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB007805: AB_598177" "unprognostic (6.03e-2)" "unprognostic (2.48e-2)" "prognostic favorable (3.54e-4)" "prognostic favorable (1.97e-5)" "unprognostic (2.06e-1)" "unprognostic (7.02e-2)" "unprognostic (9.08e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-1)" "unprognostic (8.57e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (3.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-2)" 38.9 28.0 2.0 32.0 2.0 192.9 10.5 3.4 5.5 16.0 4.1 9.9 7.6 10.3 6.4 15.0 8.2 45.1 4.4 2.0 1.9 6.8 84.2 33.9 34.3 3.2 2.9 5.0 15.6 12.0 2.5 17.8 2.8 7.6 11.1 0.1 5.1 3.4 1.0 0.9 11.4 18.0 2.5 65.3 10.3 2.7 2.1 24.1 5.9 4.5 15.4 56.4 4.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 51.6 13.3 0.2 0.2 0.1 0.0 14.4 3.4 135.0 414.7 4.8 101.6 8.4 46.0 240.6 2.3 17.7 13.8 181.7 55.8 42.8 11.1 2.6 0.5 138.9 2.0 2.0 3.4 5.5 2.0 1.9 3.2 2.9 2.8 2.5 2.1 3.3 52.3 0.0 54.5 0.0 135.9 15.6 1.9 0.3 24.5 1.5 26.3 49.3 11.2 14.3 7.2 0.0 0.0 9.7 3753.7 1.2 0.0 0.4 20.8 3.7 4.7 77.6 1.2 60.9 0.0 0.4 11.3 18.9 118.3 5.5 60.8 0.2 21.4 10.5 849.7 1.7 0.0 1.5 0.0 429.4 428.0 32.6 0.9 1168.2 51.6 3.7 10.5 1.1 1232.8 0.0 0.0 0.2 0.1 0.4 974.5 0.8 0.4 2.8 5.8 5.2 0.0 3.9 20.9 0.4 0.4 11.0 14.5 25.9 1948.3 0.0 0.9 1.6 CCL4L2 ENSG00000276070 "C-C motif chemokine ligand 4 like 2" Q8NHW4 17 36210924-36212878 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.2;lymphoid tissue: 20.5" "Group enriched" "Detected in many" 6 "dendritic cells: 488.0;Hofbauer cells: 358.5;Kupffer cells: 163.4;Macrophages: 585.2;NK-cells: 249.3;T-cells: 303.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 7 "eosinophil: 122.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 122.0" "Group enriched" "Detected in some" 4 "Daudi: 4.1;HMC-1: 5.6;U-266/70: 8.8" "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" "unprognostic (2.46e-2)" "unprognostic (1.44e-2)" "unprognostic (1.16e-1)" "unprognostic (6.07e-2)" "unprognostic (3.82e-1)" "unprognostic (3.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.27e-2)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" "unprognostic (8.51e-2)" "unprognostic (1.99e-3)" 5.5 3.8 0.3 4.4 0.3 32.2 1.5 0.5 1.1 0.9 0.4 1.7 1.5 1.1 0.5 0.7 2.6 6.8 1.3 0.4 0.3 3.1 7.6 12.6 3.2 0.3 0.3 1.9 0.9 2.0 1.1 2.2 0.3 1.9 1.8 0.0 2.0 0.7 0.2 0.4 3.8 1.5 0.3 20.5 1.8 0.2 0.3 1.6 1.4 1.7 0.8 4.8 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 1.5 0.7 0.0 0.0 0.0 0.6 0.3 122.0 15.2 0.3 3.6 0.0 0.6 8.9 0.1 0.1 0.1 8.4 18.2 1.2 0.2 0.0 0.0 5.5 0.3 0.3 0.5 1.1 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.4 18.1 0.0 7.7 0.7 13.9 0.4 0.4 0.0 5.7 0.4 13.8 22.9 8.6 4.3 0.0 0.0 0.0 4.2 488.0 0.2 0.0 0.1 0.2 0.4 1.0 38.1 0.0 14.3 1.1 0.0 6.1 3.9 3.1 0.8 5.1 8.2 7.1 1.3 358.5 1.7 0.4 0.1 0.0 163.4 59.1 1.2 0.0 585.2 1.8 6.5 3.3 1.3 249.3 0.0 0.1 0.1 0.1 0.0 50.6 0.4 0.0 0.2 0.0 2.3 13.1 1.1 6.6 0.1 0.1 1.4 0.4 9.6 303.6 0.1 0.0 1.8 CCR10 GPR2 ENSG00000184451 "C-C motif chemokine receptor 10" P46092 17 42678889-42683917 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.2" "Cell type enhanced" "Detected in many" "B-cells: 14.1;Bipolar cells: 12.8;Plasma cells: 62.7;Sertoli cells: 19.7;Smooth muscle cells: 16.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "plasmacytoid DC: 24.7;T-reg: 72.4" "Group enriched" "Detected in many" 8 "dendritic cells: 24.7;T-cells: 72.4" "Cell line enhanced" "Detected in some" "Karpas-707: 8.4;RPMI-8226: 6.5;U-266/70: 17.1;U-266/84: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB011684, HPA048007, HPA069188" Uncertain Supported "Endoplasmic reticulum" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100" "unprognostic (3.25e-2)" "unprognostic (2.71e-2)" "unprognostic (5.70e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (2.23e-3)" "unprognostic (5.18e-4)" "unprognostic (1.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.21e-3)" "unprognostic (1.01e-2)" "unprognostic (2.32e-11)" "unprognostic (2.84e-2)" "unprognostic (1.53e-1)" "unprognostic (1.88e-2)" "unprognostic (1.87e-1)" 4.5 2.1 1.1 0.7 1.1 0.2 5.2 3.1 2.7 6.6 0.0 4.8 1.8 8.5 0.3 0.8 8.5 0.2 4.4 0.7 6.5 2.8 0.8 4.1 0.3 3.9 4.6 6.2 2.3 0.0 20.2 0.7 6.6 3.8 0.2 0.7 2.2 0.6 4.7 1.5 3.1 0.5 1.0 3.2 2.6 4.0 4.0 0.2 2.8 0.4 0.0 2.4 3.2 1.2 0.5 0.8 0.8 4.7 0.3 0.7 1.1 1.7 0.5 0.2 0.4 0.7 0.3 0.1 0.3 0.3 1.6 0.8 0.0 0.1 0.1 2.0 1.2 0.0 3.2 0.4 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.5 0.1 0.3 2.6 8.4 0.0 0.3 0.1 2.4 0.6 0.0 1.2 0.6 0.1 6.5 1.1 0.0 0.7 1.0 0.4 0.0 0.2 0.3 0.8 0.9 1.9 2.1 0.5 0.7 0.2 17.1 8.4 2.5 1.3 0.6 0.9 0.0 0.6 0.2 0.4 0.1 0.3 5.3 10.9 5.4 0.4 5.9 1.3 1.8 0.2 0.2 0.4 24.7 72.4 1.5 1.1 1.1 3.1 2.7 0.7 6.5 3.9 4.6 6.6 1.0 4.0 1.2 7.3 0.0 0.0 0.7 14.1 0.8 0.3 0.4 0.6 12.8 1.0 1.3 2.1 0.0 0.1 0.0 0.0 0.2 0.6 0.0 3.9 0.3 0.5 1.6 2.9 2.9 1.8 0.0 5.1 0.5 0.3 5.4 1.5 0.9 0.0 0.6 2.2 0.2 1.9 1.7 4.6 0.6 2.0 2.5 3.7 2.5 5.6 1.2 5.4 0.0 3.8 2.5 2.1 1.0 1.3 0.3 0.1 2.6 62.7 0.3 0.2 0.7 1.0 3.2 19.7 2.3 16.7 1.6 2.1 0.3 0.3 0.0 2.9 1.9 0.7 0.1 CCR2 "CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R" ENSG00000121807 "C-C motif chemokine receptor 2" P41597 3 46353744-46360940 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Host-virus interaction, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.9" "Cell type enhanced" "Detected in some" "dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 560.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 2.4" "CAB003793, HPA063255" Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" "Nucleoli fibrillar center" "CAB003793: AB_344889, HPA063255: " "unprognostic (1.09e-2)" "unprognostic (6.28e-4)" "unprognostic (3.49e-2)" "unprognostic (6.35e-4)" "unprognostic (1.89e-2)" "unprognostic (4.16e-4)" "unprognostic (8.06e-2)" "prognostic favorable (5.87e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (3.12e-1)" "unprognostic (1.56e-1)" "unprognostic (5.52e-3)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (4.88e-2)" "unprognostic (4.19e-1)" 2.6 1.9 0.1 25.9 0.1 1.9 3.1 0.1 0.2 1.6 0.3 4.6 7.5 1.2 0.9 1.2 1.2 3.4 1.1 0.1 0.1 1.2 2.1 5.8 11.6 0.4 0.2 1.1 0.8 0.3 0.2 0.8 0.2 1.2 5.1 0.0 3.1 1.7 0.5 1.9 5.7 7.1 0.3 20.4 5.2 1.0 0.2 4.3 1.1 0.5 7.2 5.5 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.7 0.0 185.5 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.3 416.5 177.7 0.0 0.1 3.3 0.1 560.9 146.2 2.6 11.9 12.8 89.2 7.9 24.3 20.2 145.2 1.8 0.6 0.7 3.8 14.0 0.4 113.6 11.4 81.6 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.2 0.3 0.2 0.3 0.1 0.0 1.3 0.0 5.8 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.3 1.5 0.0 0.0 0.0 0.1 40.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 4.4 0.0 0.0 0.0 0.4 1.1 0.1 0.0 0.0 1.8 0.9 0.8 0.0 0.0 0.0 0.0 43.1 10.5 0.7 0.0 25.2 0.0 0.0 34.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 8.2 0.1 0.1 0.0 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711831 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 148.4;lymphoid tissue: 283.9" "Cell type enhanced" "Detected in many" "B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002497, HPA055146" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2000000 "Cluster 7: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: AB_2682716" "prognostic favorable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 11.8 5.9 1.4 115.3 1.5 148.4 18.8 1.5 4.7 10.2 2.3 24.9 20.5 6.7 5.0 8.4 5.7 26.6 4.3 1.3 1.7 4.4 19.9 31.0 283.9 2.6 1.8 3.1 2.0 1.6 1.6 5.8 2.7 8.1 32.5 0.1 14.0 4.4 2.9 3.5 48.3 12.5 2.1 160.0 32.5 2.9 3.2 138.9 5.2 3.4 256.8 41.8 4.5 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 220.9 0.1 0.0 0.0 0.5 0.1 0.0 0.0 6.0 0.0 2.1 0.0 0.0 0.0 27.1 236.9 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.4 78.6 0.0 0.0 78.9 38.4 0.1 0.0 0.0 4.7 0.1 34.3 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.1 0.0 0.3 0.2 0.4 501.4 360.3 89.9 0.2 66.7 0.1 218.1 327.1 230.8 242.8 470.2 335.8 206.2 275.2 283.4 329.7 161.2 277.9 301.6 82.1 160.7 487.4 57.0 229.9 603.5 1.4 1.5 1.5 4.7 1.3 1.7 2.6 1.8 2.7 2.1 3.2 4.1 3.7 0.0 9.6 0.7 336.1 5.5 0.8 0.0 1.8 0.0 2.0 1.7 1.1 2.8 1.3 3.7 0.0 0.6 251.2 0.1 1.9 0.2 0.1 0.7 0.5 2.8 1.2 21.5 0.1 0.2 0.8 2.4 6.6 0.6 90.7 0.1 7.1 2.0 86.4 0.0 0.1 0.1 0.0 245.8 106.5 0.5 1.8 218.3 39.2 1.0 366.6 0.0 454.2 0.5 0.0 0.1 0.0 0.4 127.4 0.4 0.0 4.9 2.2 0.0 0.0 1.7 2.1 0.5 0.3 0.7 3.0 0.4 376.2 0.0 1.2 0.5 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.4" "Cell type enriched" "Detected in some" 4 "monocytes: 239.4" "Cancer enriched" "Detected in many" 4 "renal cancer: 24.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 44.2" "Group enriched" "Detected in many" 35 "B-cells: 24.2;T-cells: 44.2" "Cell line enhanced" "Detected in many" "SiHa: 189.2;THP-1: 157.3;U-251 MG: 234.2;U-266/70: 399.5;U-266/84: 312.7;U-698: 138.1" "Region enriched" "Detected in single" 25 "cerebellum: 11.3" "Low region specificity" "Detected in all" HPA046582 Uncertain Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 2.4 0.1 0.1 3.2 0.1 0.8 1.1 0.5 0.3 0.4 0.3 2.2 0.5 0.1 0.0 0.7 0.2 0.4 0.1 0.1 0.2 0.5 0.2 0.8 3.4 0.2 0.2 0.1 0.3 0.0 0.1 0.1 0.2 0.2 1.5 0.0 0.2 0.0 0.3 1.4 2.2 0.1 0.0 2.9 1.0 0.3 0.1 1.5 0.3 0.9 1.9 1.1 0.5 0.4 1.3 39.1 0.1 75.6 1.7 1.0 0.1 0.0 0.3 0.3 2.6 0.1 0.5 74.2 4.1 0.4 81.8 53.2 46.5 3.6 0.0 0.2 1.6 0.0 56.8 0.1 0.0 0.0 2.2 0.5 0.4 43.9 31.1 12.2 0.3 0.1 1.3 2.5 1.1 0.2 1.3 94.3 0.9 0.0 70.0 20.3 0.1 16.3 24.6 0.2 0.0 0.0 189.2 0.0 0.8 0.2 0.5 157.3 1.0 0.6 32.6 0.0 234.2 399.5 312.7 138.1 41.0 23.8 14.8 0.8 0.1 0.1 3.3 0.0 8.1 24.2 5.3 8.8 0.1 9.9 0.7 2.1 0.2 0.9 0.0 0.3 44.2 1.6 0.1 0.1 0.5 0.3 0.1 0.2 0.2 0.2 0.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 50.9 5.7 0.1 11.1 0.0 0.0 0.1 0.3 0.2 0.0 0.3 1.8 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.4 0.0 1.6 1.8 0.0 0.1 0.7 0.0 11.3 0.5 0.2 1.3 0.1 0.7 0.3 0.4 0.0 0.7 0.0 18.3 0.6 14.6 0.0 0.0 3.0 3.6 0.0 239.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 24.9 0.2 0.0 0.2 0.7 0.0 0.0 0.4 0.9 0.2 0.6 0.4 5.4 0.0 14.1 0.0 0.4 0.0 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790792 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 44.6 60.8 44.3 23.7 43.7 47.0 40.3 40.8 53.8 55.5 35.4 49.3 19.7 49.3 21.1 35.4 65.6 23.7 40.4 50.8 42.0 44.5 65.1 47.2 35.1 44.7 44.1 88.5 44.4 19.2 67.0 18.7 41.1 44.1 12.2 11.1 29.7 23.3 28.3 38.7 40.9 19.1 42.7 65.6 37.4 44.3 42.1 31.9 42.1 17.1 20.9 38.9 40.5 44.4 22.5 40.5 24.9 27.6 27.6 21.4 32.1 22.9 33.3 23.4 20.9 30.3 25.0 39.5 25.7 26.0 32.1 44.2 16.5 37.3 8.9 34.8 19.0 37.1 45.2 25.3 40.2 36.3 56.5 37.9 44.5 24.8 27.7 30.0 48.5 34.8 32.6 51.7 21.2 60.1 39.5 54.5 55.0 34.3 41.9 112.2 21.2 57.0 34.2 24.9 24.5 29.2 34.5 35.8 20.9 19.3 45.0 33.9 56.4 27.8 30.9 24.1 22.3 92.5 76.4 34.7 26.1 24.4 25.9 4.1 3.7 5.8 10.3 5.1 10.1 3.6 5.7 8.3 4.8 6.6 6.3 7.9 5.4 22.4 7.5 9.9 4.4 3.6 44.3 43.7 40.8 53.8 50.8 42.0 44.7 44.1 41.1 42.7 42.1 44.4 43.1 12.8 12.4 39.8 27.1 24.1 27.6 15.8 18.8 13.9 17.9 10.9 14.1 20.0 10.8 11.0 2.1 22.5 28.5 17.1 15.6 31.3 4.4 26.4 22.7 35.6 19.2 15.4 18.1 37.2 22.3 23.0 24.5 25.3 25.3 18.1 33.5 26.4 23.3 25.2 17.0 12.7 8.2 18.8 23.4 6.2 19.6 24.2 16.0 22.5 44.7 17.5 33.0 12.5 16.8 32.9 13.7 31.2 22.2 28.9 14.5 16.7 20.4 7.9 0.0 21.6 22.1 8.9 22.9 19.9 22.0 51.3 24.7 54.5 13.7 31.4 CEACAM16 DFNA4B ENSG00000213892 "CEA cell adhesion molecule 16, tectorial membrane component" Q2WEN9 19 44699151-44710718 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "pancreas: 2.0" "Group enriched" "Detected in some" 7 "Bipolar cells: 7.7;Skeletal myocytes: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045075 Uncertain "Secreted in other tissues" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 50: Fibroblasts - ECM organization" "HPA045075: AB_10959617" "unprognostic (1.27e-1)" "unprognostic (3.73e-1)" "unprognostic (3.12e-1)" "unprognostic (3.32e-2)" "unprognostic (4.72e-1)" "unprognostic (1.42e-2)" "unprognostic (7.76e-2)" "unprognostic (3.59e-2)" "unprognostic (7.81e-3)" "unprognostic (3.88e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (7.94e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 20.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 CEACAM20 UNQ9366 ENSG00000273777 "CEA cell adhesion molecule 20" Q6UY09 19 44501677-44529788 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 37.7" "Cell type enriched" "Detected in single" 97 "Proximal enterocytes: 39.0" "Cancer enriched" "Detected in some" 4 "prostate cancer: 5.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "unprognostic (1.04e-2)" "unprognostic (5.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (1.23e-2)" "unprognostic (3.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.07e-2)" "unprognostic (7.58e-2)" "unprognostic (2.14e-5)" "unprognostic (7.13e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 37.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.4 0.1 0.1 0.0 0.0 0.0 0.0 37.7 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 CELF6 BRUNOL6 ENSG00000140488 "CUGBP Elav-like family member 6" Q96J87 15 72284727-72320157 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Astrocytes: 17.3;Excitatory neurons: 18.9;Inhibitory neurons: 21.9;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 3.6;U-937: 1.9" "HPA046985, HPA053526" Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA046985: AB_2679891, HPA053526: AB_2682178" "unprognostic (6.83e-3)" "unprognostic (7.06e-3)" "unprognostic (9.55e-2)" "unprognostic (2.77e-1)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-4)" "unprognostic (1.16e-1)" "unprognostic (1.14e-2)" "unprognostic (2.16e-1)" 5.2 5.7 17.9 1.0 16.8 2.7 4.8 7.5 17.3 9.6 3.6 8.5 1.1 6.5 7.4 1.6 10.8 1.9 4.0 12.9 28.5 19.6 3.8 5.3 1.8 13.0 23.7 14.3 3.7 0.7 23.8 1.7 23.1 7.2 1.6 22.1 2.8 4.1 1.5 2.4 5.4 2.0 8.2 6.1 3.4 12.3 21.8 1.9 14.6 0.4 1.3 5.4 4.8 10.3 0.0 0.0 0.1 0.0 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.1 1.1 0.5 1.4 0.0 0.0 0.3 0.0 0.5 0.0 1.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.7 0.6 1.0 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.0 3.6 1.1 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 16.8 7.5 17.3 12.9 28.5 13.0 23.7 23.1 8.2 21.8 10.3 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.4 0.0 0.0 0.0 5.5 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 24.9" "Cell type enhanced" "Detected in many" "Astrocytes: 40.1;Microglial cells: 46.9;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 71.0;Plasma cells: 81.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 7.8" "Group enriched" "Detected in many" 4 "dendritic cells: 6.8;T-cells: 7.8" "Cell line enhanced" "Detected in many" "Karpas-707: 59.9;MOLT-4: 55.7;U-266/70: 110.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001116, HPA018498, HPA077688" Uncertain Supported Centrosome NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 63: T-cells - Adaptive immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Centrosome "HPA001116: AB_1078323, HPA018498: AB_1845560, HPA077688: " "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 2.0 0.8 1.4 2.5 2.5 6.2 3.8 4.1 1.5 1.2 1.1 2.0 1.4 2.0 0.6 1.7 2.5 1.0 1.2 1.1 1.3 0.9 0.9 1.4 4.7 2.1 1.4 1.5 0.6 1.7 0.9 1.0 1.7 1.2 1.7 1.6 1.7 1.0 1.8 2.4 1.0 1.9 1.4 2.4 1.7 5.2 1.1 24.9 1.7 0.9 5.2 2.2 1.3 3.0 14.8 7.9 6.8 5.6 1.6 2.6 3.6 15.5 4.8 9.5 9.3 5.3 8.4 34.5 2.8 4.8 6.2 7.8 7.4 4.9 18.0 19.5 4.7 6.7 9.8 2.7 0.8 6.6 8.6 0.6 1.2 13.6 7.3 1.8 7.3 17.0 8.5 59.9 9.1 9.4 55.7 3.7 5.3 4.0 9.4 9.8 16.8 26.7 2.0 7.7 8.6 4.1 13.1 5.4 2.8 6.5 6.0 5.1 6.7 20.5 11.2 5.7 16.4 110.1 4.8 15.2 5.8 9.1 7.3 0.0 0.6 1.3 2.2 0.2 1.7 1.6 2.3 1.6 2.0 0.6 2.0 0.9 0.1 0.9 0.4 6.8 7.8 0.7 1.4 2.5 4.1 1.5 1.1 1.3 2.1 1.4 1.7 1.4 1.1 3.0 2.3 3.2 2.8 40.1 7.5 4.0 2.6 1.1 1.2 6.6 3.2 3.0 3.8 2.8 5.7 3.7 2.1 2.4 12.7 0.6 0.0 1.6 8.5 14.8 3.2 2.7 1.2 7.4 27.3 1.2 9.0 3.5 3.1 2.8 2.5 7.8 3.3 0.3 2.5 6.7 25.5 1.0 2.0 0.0 4.6 5.1 1.5 4.8 3.6 46.9 10.3 4.8 1.0 37.7 71.0 1.2 0.3 1.5 81.1 0.9 0.1 0.5 17.2 13.8 6.6 6.6 2.5 16.7 3.8 4.1 1.7 2.3 8.8 2.3 1.5 1.6 CEP19 "C3orf34, MGC14126" ENSG00000174007 "Centrosomal protein 19" Q96LK0 3 196706277-196712250 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 54.8;Spermatocytes: 66.3;Spermatogonia: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 51.5;eosinophil: 59.0;neutrophil: 144.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 144.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047614, HPA071138" Enhanced Supported Centrosome NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Centrosome "HPA047614: AB_2680103, HPA071138: AB_2686348" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (5.11e-2)" "unprognostic (9.31e-2)" "unprognostic (5.51e-3)" "unprognostic (4.66e-2)" "unprognostic (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (2.36e-2)" "unprognostic (1.91e-1)" "unprognostic (3.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.33e-2)" 1.6 2.6 5.1 3.1 5.3 1.2 1.1 4.7 6.3 1.7 5.7 1.4 0.9 1.6 3.0 1.5 4.1 1.9 1.4 5.4 5.9 2.6 1.1 1.6 2.9 5.2 5.3 1.8 0.7 3.4 3.8 2.0 5.1 1.6 1.0 6.6 1.2 2.1 0.6 1.6 1.2 1.4 5.0 3.4 0.9 9.9 5.8 7.6 2.2 1.8 3.5 1.8 1.5 5.5 6.0 4.1 5.6 3.5 12.6 9.6 1.6 4.8 9.0 5.1 6.6 2.1 3.9 4.4 13.3 2.4 11.1 2.6 3.8 1.1 5.9 6.2 3.8 6.8 2.0 0.6 5.0 3.1 8.3 4.4 5.5 6.6 1.8 9.3 2.0 5.4 3.8 5.4 5.2 3.1 7.8 5.6 2.9 2.6 6.9 9.0 3.4 2.9 5.4 0.5 5.6 4.0 6.4 0.8 7.6 4.7 5.0 5.9 1.7 5.8 1.3 9.1 3.2 16.2 16.6 9.1 8.4 7.9 5.8 51.5 4.0 59.0 5.4 3.2 6.0 3.8 8.0 7.3 2.6 4.4 10.3 6.6 144.2 7.3 3.7 11.0 4.8 3.9 5.1 5.3 4.7 6.3 5.4 5.9 5.2 5.3 5.1 5.0 5.8 5.5 2.6 0.0 2.0 3.6 4.5 2.0 1.3 2.2 5.2 5.8 2.7 3.0 2.0 2.8 2.1 1.8 0.0 1.8 5.1 0.6 5.9 2.0 54.8 14.8 5.2 3.7 0.0 1.3 8.4 0.8 1.5 3.4 0.0 1.3 1.3 5.0 5.0 0.3 3.1 5.0 6.6 0.4 4.1 2.2 4.7 6.3 6.5 2.4 0.0 1.0 15.3 9.5 14.4 1.5 1.4 0.8 0.0 5.3 7.1 0.8 0.1 4.9 21.4 8.3 0.0 2.9 2.2 66.3 39.6 2.1 0.9 0.4 3.9 8.8 0.4 0.5 CES5A "CAUXIN, CES4C1, CES5, CES7, FLJ31547" ENSG00000159398 "Carboxylesterase 5A" Q6NT32 16 55846154-55956031 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "epididymis: 67.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Collecting duct cells: 5.5;Excitatory neurons: 1.4;Hepatocytes: 6.9;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 4.0" "Cancer enriched" "Detected in single" 5 "liver cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 46 "U-266/70: 7.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 29: U-266 - Adaptive immune response" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (2.07e-1)" "unprognostic (2.55e-1)" "unprognostic (6.34e-2)" "unprognostic (4.82e-2)" "unprognostic (3.78e-1)" "unprognostic (2.33e-1)" "unprognostic (3.12e-2)" "unprognostic (1.72e-7)" "unprognostic (1.55e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 67.5 0.0 0.0 0.6 0.1 0.1 0.2 0.0 3.9 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.1 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385317 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;choroid plexus: 7.1;fallopian tube: 4.7" "Cell type enhanced" "Detected in some" "Astrocytes: 45.4;Endometrial ciliated cells: 66.2;Respiratory ciliated cells: 20.4;Rod photoreceptor cells: 14.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 1.6;U-266/70: 3.0" "HPA044633, HPA054859" Uncertain NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA044633: AB_10960684, HPA054859: AB_2682627" "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.9 0.7 0.2 7.1 0.0 0.0 0.1 0.4 0.0 4.7 0.0 0.0 1.6 2.8 0.0 0.1 0.5 0.0 8.1 6.3 0.0 0.0 0.4 1.8 0.0 4.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.7 2.5 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.3 0.9 0.7 1.6 2.8 8.1 6.3 4.4 4.4 2.5 5.3 0.1 0.0 0.0 45.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 2.5 1.8 8.4 0.2 0.0 0.0 0.0 0.0 6.0 66.2 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 2.1 0.3 0.1 0.0 1.9 0.0 0.6 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 20.4 14.7 0.0 0.0 0.1 2.2 4.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 CFHR1 "CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2" ENSG00000244414 "Complement factor H related 1" Q03591 1 196819731-196832189 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 272 "liver: 2081.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 320.0" "Cancer enriched" "Detected in single" 798 "liver cancer: 182.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;HeLa: 1.2;HL-60: 2.0;U-266/70: 2.4" "Not detected" "Not detected" "HPA038915, HPA038922, HPA040726" Supported Approved Vesicles "Secreted to blood" NA NA 13000000000 "Cluster 62: Liver - Hemostasis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101" "unprognostic (2.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.88e-2)" "prognostic favorable (8.71e-6)" "unprognostic (3.02e-1)" "unprognostic (3.70e-1)" "unprognostic (2.50e-1)" "unprognostic (8.48e-2)" "unprognostic (7.21e-4)" "unprognostic (7.01e-4)" "unprognostic (1.13e-1)" "unprognostic (6.41e-2)" 1.5 0.6 0.1 1.8 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.2 7.6 2081.3 0.1 6.7 0.1 0.8 0.3 0.3 0.0 0.1 0.1 0.4 0.2 0.2 0.2 0.1 0.0 0.2 0.1 0.7 0.2 0.1 6.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.9 0.3 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.1 0.1 0.0 2.4 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.4 0.1 0.2 0.1 0.5 3.2 0.0 0.0 2.2 0.4 0.1 0.0 0.0 1.2 0.0 0.1 1.8 11.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.7 0.0 0.0 0.0 9.9 0.0 0.0 0.0 6.0 15.0 320.0 5.6 0.0 0.4 0.0 0.0 16.9 0.4 0.2 1.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 41.0 2.1 0.3 1.5 0.0 0.0 0.3 1.4 5.6 0.1 0.1 CFHR3 "CFHL3, DOWN16, FHR-3, FHR3, HLF4" ENSG00000116785 "Complement factor H related 3" Q02985 1 196774813-196795407 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 582 "liver: 505.7" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 205.5" "Cancer enriched" "Detected in single" 80 "liver cancer: 27.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;SuSa: 1.5;T-47d: 3.6;U-266/70: 6.4" "Secreted to blood" NA NA 582000000 3100000000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (7.16e-2)" "unprognostic (6.77e-2)" "unprognostic (4.46e-1)" "unprognostic (4.20e-3)" "prognostic favorable (2.86e-5)" "unprognostic (1.78e-1)" "unprognostic (2.05e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (6.11e-3)" "unprognostic (2.06e-10)" "unprognostic (2.67e-4)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.32e-1)" 0.8 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.4 505.7 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.3 0.1 0.0 0.4 0.1 0.6 0.0 0.7 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.4 0.0 0.9 0.0 0.0 0.0 0.3 0.0 1.5 3.6 0.0 0.0 0.1 0.2 0.3 0.0 6.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.8 16.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 7.1 205.5 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 CFHR4 "CFHL4, FHR-4, FHR4" ENSG00000134365 "Complement factor H related 4" Q92496 1 196888014-196918713 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 432 "liver: 123.9" "Cell type enriched" "Detected in some" 28 "Hepatocytes: 62.6" "Cancer enriched" "Detected in single" 145 "liver cancer: 13.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 170000000 "Cluster 62: Liver - Hemostasis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (5.97e-1)" "prognostic favorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (4.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (4.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 123.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.2 62.6 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007668-124093598 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 69.0" "Group enriched" "Detected in many" 11 "granulocytes: 69.0;monocytes: 38.7" "Cell line enhanced" "Detected in many" "Karpas-707: 66.0;REH: 90.4;U-266/70: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol NA NA 690000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavorable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 17.0 10.4 9.3 19.8 25.4 7.0 11.4 5.3 14.6 10.6 23.8 19.8 9.8 7.9 8.3 9.4 15.0 12.8 5.5 17.2 6.0 9.6 13.6 17.2 17.8 8.3 8.2 37.0 14.1 2.8 8.4 6.6 6.7 9.7 8.8 2.8 9.4 13.8 13.7 9.2 15.4 10.6 10.2 36.7 11.5 4.3 9.5 9.3 19.8 5.8 14.2 12.4 9.2 11.6 32.3 21.2 7.8 1.7 7.5 4.0 0.1 6.4 8.6 3.4 4.9 0.6 17.1 0.0 20.1 26.4 2.3 35.9 1.5 20.8 2.9 0.2 5.9 0.1 9.3 16.0 2.4 0.0 39.2 2.5 23.5 9.5 8.0 8.3 6.9 0.1 0.0 66.0 17.0 18.0 0.1 0.1 6.8 4.9 0.1 90.4 10.6 21.6 17.1 3.1 0.8 1.7 17.1 9.6 0.0 19.3 7.0 0.1 8.3 0.9 0.3 24.3 1.0 59.5 15.7 16.9 0.2 0.0 0.1 0.0 21.8 15.3 0.0 33.3 0.0 4.5 0.0 0.0 4.2 4.4 0.3 0.0 69.0 0.0 38.7 4.9 0.3 9.1 9.3 25.4 5.3 14.6 17.2 6.0 8.3 8.2 6.7 10.2 9.5 11.6 14.3 22.4 9.6 4.2 13.5 16.8 16.1 15.3 2.2 5.6 10.5 5.2 2.2 12.8 12.1 20.2 0.0 1.8 7.2 0.1 0.0 9.7 29.5 7.4 5.9 18.2 1.8 0.0 43.8 0.7 2.3 8.4 0.5 14.0 5.7 0.4 42.1 9.0 10.5 0.0 33.2 0.0 16.2 50.2 3.6 34.8 10.2 34.0 1.8 43.1 30.3 0.1 2.1 35.2 1.0 9.8 0.0 1.9 34.3 14.7 0.0 0.7 11.9 0.5 19.7 13.4 11.5 10.4 10.0 2.4 11.6 1.0 1.4 0.8 0.1 15.8 CIRBP CIRP ENSG00000099622 "Cold inducible RNA binding protein" Q14011 19 1259384-1274880 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060537 Supported Nucleoplasm NA NA 240000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA060537: AB_2684314" "unprognostic (2.77e-3)" "prognostic favorable (3.63e-4)" "unprognostic (9.80e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.95e-2)" "unprognostic (2.94e-2)" "unprognostic (3.38e-3)" "prognostic favorable (2.50e-4)" "unprognostic (6.43e-2)" "unprognostic (2.29e-2)" "prognostic favorable (2.69e-4)" "unprognostic (1.82e-1)" "prognostic favorable (3.65e-7)" "unprognostic (1.04e-1)" "unprognostic (5.76e-1)" "unprognostic (2.23e-2)" "unprognostic (1.49e-2)" 356.6 367.9 176.0 205.7 176.2 377.9 409.6 177.9 277.1 443.1 147.3 400.6 196.5 471.8 429.7 219.6 496.9 279.3 368.6 162.7 181.6 296.3 200.9 300.9 350.4 167.5 166.0 853.0 614.8 490.8 496.2 230.8 164.4 377.1 227.1 383.9 367.5 418.1 485.7 402.7 304.0 313.3 169.2 332.7 405.2 183.8 193.3 327.9 420.1 304.3 383.8 344.7 307.8 186.5 285.8 60.4 434.3 220.1 188.0 209.3 112.3 307.3 428.7 235.1 209.9 112.7 108.1 570.7 162.3 318.6 27.9 133.5 182.5 277.5 181.2 255.4 52.3 340.6 68.2 145.9 684.8 532.0 237.9 518.9 244.6 152.3 659.7 324.3 215.0 282.6 228.3 445.6 247.2 202.9 274.7 144.4 172.3 162.4 100.2 337.3 347.2 280.3 267.5 237.3 204.1 369.3 323.9 145.6 251.3 140.9 304.6 148.3 264.6 174.5 105.3 415.1 271.0 581.3 689.3 463.7 148.9 216.4 229.7 208.5 88.3 205.5 212.3 153.5 217.7 248.7 190.0 193.5 97.0 268.0 213.2 205.0 147.4 229.4 237.0 272.5 244.6 196.3 176.0 176.2 177.9 277.1 162.7 181.6 167.5 166.0 164.4 169.2 193.3 186.5 341.8 205.1 384.3 169.8 541.8 586.6 641.5 585.8 541.8 758.0 682.4 586.5 258.0 427.5 304.2 298.0 329.4 601.9 504.0 175.5 972.4 386.0 78.8 243.9 292.1 388.3 434.2 244.4 51.8 484.2 271.0 493.6 236.0 241.0 404.2 400.6 436.2 149.6 314.4 684.8 69.2 315.5 514.7 372.1 559.7 199.3 649.9 301.0 734.6 60.9 490.2 1307.9 563.4 90.0 157.2 348.7 281.7 499.5 477.5 434.5 399.6 635.6 295.8 712.7 374.7 956.8 488.0 228.5 504.5 327.6 556.8 737.4 482.5 586.9 270.5 378.6 CLCNKA hClC-Ka ENSG00000186510 "Chloride voltage-gated channel Ka" P51800 1 16018875-16034050 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 344.0" "Cell type enriched" "Detected in some" 4 "Late spermatids: 271.5" "Group enriched" "Detected in some" 7 "renal cancer: 4.4;thyroid cancer: 1.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 7.4" HPA057717 Approved NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA057717: AB_2683509" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (4.02e-1)" "unprognostic (2.76e-3)" "unprognostic (8.20e-2)" "unprognostic (6.16e-2)" "unprognostic (1.18e-2)" "unprognostic (6.92e-3)" "unprognostic (3.49e-2)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (8.13e-3)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (4.37e-3)" "unprognostic (1.28e-1)" 0.7 2.9 0.4 0.0 0.4 0.0 0.9 2.2 0.4 0.6 4.9 0.4 0.0 0.6 0.5 0.0 0.5 0.1 0.6 0.7 0.4 344.0 0.2 0.3 0.0 0.4 0.5 0.9 3.5 48.9 18.2 0.0 0.7 0.8 0.0 2.3 6.9 0.2 0.5 0.7 0.1 0.2 0.3 0.1 3.9 4.5 0.4 0.0 21.6 0.3 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.2 0.4 0.7 0.4 0.4 0.5 0.7 0.3 0.4 0.4 0.0 3.2 0.5 0.3 0.0 0.1 0.1 0.0 0.0 3.9 0.4 0.1 3.8 0.0 0.7 25.8 0.0 0.4 0.0 0.1 25.4 0.3 40.2 0.1 0.0 0.1 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 13.5 0.2 0.1 67.1 0.0 0.0 271.5 0.3 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.1 1.9 1.2 0.0 0.0 0.7 0.1 0.0 0.3 0.2 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 5.1" "Lineage enriched" "Detected in single" 17 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 400000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 18.9 1.5 3.2 4.3 4.4 0.2 6.5 1.5 2.9 19.0 0.5 28.6 20.9 2.1 0.9 2.9 4.5 3.0 102.7 2.1 5.0 54.7 0.3 70.8 1.7 2.1 3.8 0.5 1.1 1.7 3.0 16.5 2.2 2.6 25.8 16.9 2.7 1.4 289.7 1.2 36.6 2.3 1.8 44.5 1.6 1.4 5.5 1.0 7.3 98.3 1.9 2.0 2.6 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.5 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.4 1.6 0.0 11.9 0.3 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.1 0.1 2.0 1.3 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 1.0 0.5 3.2 4.4 1.5 2.9 2.1 5.0 2.1 3.8 2.2 1.8 5.5 1.9 59.6 509.6 30.0 4.6 1.4 0.1 0.1 0.0 1.2 0.3 0.5 0.4 285.7 5.7 26.9 14.7 0.0 0.2 0.7 164.2 0.0 1.7 52.9 4.6 0.5 29.8 13.1 0.4 8.6 0.2 0.1 7.9 0.5 5.7 1.3 0.0 0.7 0.0 0.0 0.0 5.4 23.5 0.0 0.0 0.0 93.8 0.9 0.7 0.0 34.7 0.6 53.8 0.0 0.5 2.9 2.9 51.1 0.7 3.4 3.2 126.0 2.9 11.4 1.8 0.0 6.1 4.3 1.0 0.1 0.1 0.1 2.2 5.8 0.1 13.5 4.3 CLK2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Nuclear bodies" "HPA055366: AB_2682795, HPA059507: AB_2684044" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.43e-4)" 23.7 25.6 11.6 10.7 11.9 11.4 24.4 14.2 14.4 39.2 14.1 24.1 11.7 29.8 12.7 22.6 28.7 9.6 18.5 11.7 12.7 26.8 29.0 22.0 19.6 12.3 11.7 33.9 23.9 14.0 31.4 13.8 12.4 33.1 8.7 9.4 23.3 11.2 16.2 27.5 24.0 10.9 11.7 40.1 20.8 16.2 12.4 18.6 33.2 8.5 15.9 28.1 29.9 13.2 10.8 10.5 29.8 11.4 17.3 9.1 22.5 8.1 12.3 8.2 7.8 13.1 8.7 23.3 9.7 6.6 4.0 17.0 16.8 13.5 6.3 11.4 17.7 20.4 12.9 15.4 14.6 26.8 20.5 7.6 10.7 11.3 20.3 19.0 13.6 16.9 29.6 15.4 10.5 22.2 12.1 11.3 21.2 27.2 17.6 17.7 21.6 28.0 17.9 25.8 11.8 25.1 4.5 10.9 9.9 21.4 15.9 24.9 9.3 4.3 12.1 9.1 9.1 31.6 28.6 22.9 9.9 19.1 5.9 0.5 0.8 1.9 0.8 0.4 1.6 1.2 1.5 0.8 0.9 0.9 1.6 1.6 0.8 0.5 0.4 0.8 0.9 0.6 11.6 11.9 14.2 14.4 11.7 12.7 12.3 11.7 12.4 11.7 12.4 13.2 9.2 16.0 24.3 9.8 13.7 4.6 5.7 4.2 17.6 5.7 7.8 7.5 14.9 12.8 12.6 7.3 4.2 8.0 7.1 5.4 0.0 6.5 6.5 6.9 15.2 11.1 6.7 8.4 8.3 4.4 8.0 11.3 25.0 9.5 10.1 12.1 7.5 8.4 6.9 5.0 6.8 9.1 2.0 11.4 4.5 6.6 7.8 10.4 3.6 9.4 9.5 5.4 8.2 9.5 8.0 4.9 4.8 3.0 17.1 5.7 5.1 3.2 5.1 7.2 6.6 6.4 12.6 8.6 4.3 14.3 4.5 12.4 11.0 7.4 7.2 5.1 COL24A1 ENSG00000171502 "Collagen type XXIV alpha 1 chain" Q17RW2 1 85729233-86156943 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.0" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 167.1" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 9.0;hippocampal formation: 8.2" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 2.7" "Lineage enriched" "Detected in single" 9 "dendritic cells: 2.7" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;Karpas-707: 3.7;NTERA-2: 1.9;RH-30: 2.7;SuSa: 2.8;U-266/70: 6.9" "Secreted to extracellular matrix" NA NA 52000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (3.00e-1)" "unprognostic (6.19e-2)" "unprognostic (2.21e-2)" "unprognostic (6.76e-3)" "unprognostic (1.82e-3)" "unprognostic (2.45e-2)" "unprognostic (2.44e-5)" "unprognostic (1.37e-1)" "unprognostic (4.08e-2)" "unprognostic (6.59e-2)" "unprognostic (3.89e-2)" "unprognostic (1.46e-1)" "unprognostic (3.48e-6)" "unprognostic (2.79e-5)" "unprognostic (5.07e-1)" "unprognostic (1.19e-1)" "unprognostic (9.90e-2)" 0.7 0.0 0.9 0.8 2.7 0.9 0.3 0.0 9.0 6.8 0.0 6.7 1.5 1.2 0.8 0.7 0.1 1.5 1.9 8.2 0.9 0.8 0.0 0.7 0.3 0.0 0.0 2.4 0.0 0.0 1.2 0.1 0.0 1.1 0.8 5.5 0.4 1.4 0.5 0.6 1.7 0.9 0.1 0.3 1.7 0.8 0.0 0.2 0.4 1.7 0.3 5.0 2.9 1.8 0.0 0.0 0.9 0.0 2.1 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.9 0.0 0.5 0.0 0.7 0.0 0.1 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.5 0.0 0.0 0.1 1.9 0.0 0.0 0.0 2.7 0.3 0.3 0.7 0.0 0.0 0.0 0.1 0.3 2.8 0.0 0.6 0.0 1.2 0.1 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.9 2.7 0.0 9.0 8.2 0.9 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.6 6.8 1.1 0.4 0.0 0.2 0.0 1.9 0.5 0.0 2.1 0.0 0.5 5.5 0.0 0.0 11.1 0.0 0.0 0.0 0.1 0.2 3.7 0.4 0.0 2.5 167.1 0.0 0.0 2.8 0.0 0.1 1.3 0.5 0.0 0.0 2.4 0.0 12.9 0.0 0.0 0.0 0.4 0.2 0.9 0.9 10.6 7.5 0.0 40.4 0.0 11.1 6.5 0.0 0.0 0.7 3.3 0.0 0.0 0.1 2.4 1.7 0.0 0.5 1.3 1.0 0.9 0.0 0.1 0.0 0.3 2.8 0.0 0.0 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535873 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 18.2" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9" "Region enriched" "Detected in single" 8 "olfactory bulb: 3.6" "Region enriched" "Detected in some" 31 "spinal cord: 33.5" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 51: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA043844: AB_2732508, HPA060468: AB_2684288" "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 1.0 3.2 0.8 1.6 1.0 0.3 2.8 1.9 2.7 3.3 1.4 11.7 1.2 2.2 14.1 2.1 4.9 1.5 3.7 1.1 0.9 6.3 0.7 1.2 0.2 0.9 3.6 1.2 5.8 0.2 11.2 0.5 1.4 3.9 4.1 6.7 18.2 5.1 5.9 2.1 3.4 1.7 0.2 0.4 6.5 3.7 1.1 0.2 1.2 3.2 0.1 2.9 4.5 1.5 1.5 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.4 0.0 0.0 1.1 0.4 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.2 1.4 0.1 0.2 0.0 0.7 0.9 0.3 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.5 0.7 0.1 0.5 1.3 0.0 9.8 2.8 0.0 0.2 0.6 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.8 1.0 1.9 2.7 1.1 0.9 0.9 3.6 1.4 0.2 1.1 1.5 0.4 0.0 4.1 39.5 0.0 0.3 0.1 0.2 0.0 5.3 1.6 1.5 0.9 0.0 3.3 3.7 18.8 0.3 0.1 0.8 0.0 0.1 2.0 21.1 0.5 0.1 0.0 0.0 23.4 0.2 0.0 3.1 0.0 3.9 1.3 0.5 1.8 0.0 0.1 5.0 22.6 0.5 0.0 0.3 0.3 1.1 0.9 0.1 0.0 7.5 0.0 2.2 0.0 12.5 9.1 0.4 5.4 0.7 0.0 0.1 0.2 0.5 16.3 5.4 0.0 1.8 0.2 0.9 1.0 0.1 0.1 0.3 0.1 0.2 0.3 0.1 CT47A1 CT47.1 ENSG00000236371 "Cancer/testis antigen family 47 member A1" Q5JQC4 X 120982476-120985788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-266/70: 2.2" HPA042483 Supported Uncertain Nucleoli NA NA "Cluster 29: U-266 - Adaptive immune response" Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A11 CT47.11 ENSG00000226929 "Cancer/testis antigen family 47 member A11" Q5JQC4 X 120933840-120937158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-266/70: 1.7" HPA042483 Supported Uncertain Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT83 "CXorf61, FLJ20611, FLJ22913, KK-LC-1" ENSG00000204019 "Cancer/testis antigen 83" Q5H943 X 116461686-116462976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 64.0" "Group enriched" "Detected in some" 153 "Early spermatids: 817.7;Late spermatids: 3229.1" "Cancer enhanced" "Detected in many" "stomach cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 77.6;OE19: 77.0;RPMI-8226: 25.6;U-266/70: 108.5;U-266/84: 61.5" "Not detected" "Not detected" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.59e-2)" "unprognostic (1.69e-2)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 64.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.2 0.0 0.0 0.0 0.0 0.0 77.0 0.8 0.0 0.0 25.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 108.5 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 817.7 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3229.1 8.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.2 7.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 CTAG1A "ESO1, LAGE2A" ENSG00000268651 "Cancer/testis antigen 1A" P78358 X 154585133-154586816 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 173 "U-266/70: 749.2;U-266/84: 332.1" CAB013061 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "CAB013061: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 749.2 332.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAG1B "CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1" ENSG00000184033 "Cancer/testis antigen 1B" P78358 X 154617609-154619282 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-266/70: 671.4" CAB015453 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "CAB015453: AB_784921" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 671.4 41.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTNNA3 "MGC26194, VR22" ENSG00000183230 "Catenin alpha 3" Q9UI47 10 65912523-67696195 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 176.3" "Cell type enriched" "Detected in some" 14 "Oligodendrocytes: 4054.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 1.5;NTERA-2: 1.7;RPMI-8226: 2.4;SCLC-21H: 1.5;U-266/70: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061818 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA061818: AB_2684618" "unprognostic (2.19e-1)" "unprognostic (1.57e-1)" "unprognostic (8.64e-4)" "unprognostic (8.13e-3)" "unprognostic (6.43e-3)" "unprognostic (9.90e-2)" "unprognostic (2.60e-4)" "unprognostic (8.27e-2)" "unprognostic (5.10e-2)" "unprognostic (2.55e-1)" "unprognostic (9.09e-3)" "unprognostic (1.15e-1)" "unprognostic (2.67e-3)" "unprognostic (7.93e-5)" "unprognostic (6.43e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" 0.7 0.5 31.8 0.6 96.9 0.1 0.5 49.3 49.7 1.4 0.0 2.0 0.3 1.3 0.1 1.4 0.7 0.6 18.7 30.3 51.6 0.5 8.5 0.1 0.2 90.9 66.8 1.7 0.1 0.2 0.2 0.4 95.3 0.4 0.6 0.4 0.3 0.2 12.0 0.2 0.8 2.6 52.4 0.3 1.2 2.2 69.7 0.1 0.3 23.4 0.3 0.6 0.6 176.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.6 0.7 0.1 0.0 2.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 6.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.8 96.9 49.3 49.7 30.3 51.6 90.9 66.8 95.3 52.4 69.7 176.3 0.4 0.0 0.0 24.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 75.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 217.8 0.0 1.5 1.2 0.0 0.0 49.8 0.0 0.0 2.5 0.0 0.1 0.0 2.6 0.4 5.7 0.0 0.0 50.6 0.0 0.0 0.8 0.3 275.5 4.4 0.3 0.0 30.0 0.0 1.4 0.0 50.3 4054.6 0.0 0.1 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 9.3 4.0 1.6 0.0 0.1 0.0 0.1 4.6 0.1 0.0 CXCL13 "ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13" ENSG00000156234 "C-X-C motif chemokine ligand 13" O43927 4 77511753-77611834 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 523.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 242.2;Breast myoepithelial cells: 72.4;Endometrial stromal cells: 101.0;monocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052613 Uncertain "Secreted to blood" NA NA 93700 "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 35: Glandular cells - Unknown function" "HPA052613: AB_2681885" "unprognostic (5.25e-3)" "unprognostic (1.19e-2)" "prognostic favorable (9.12e-4)" "prognostic favorable (5.52e-4)" "unprognostic (1.53e-2)" "unprognostic (1.17e-3)" "unprognostic (1.49e-1)" "unprognostic (6.41e-3)" "unprognostic (9.82e-3)" "prognostic favorable (5.41e-4)" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.16e-10)" "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (6.68e-3)" 2.6 0.4 0.1 127.7 0.4 0.1 15.4 0.4 0.3 1.4 0.1 13.3 1.9 3.6 1.6 2.4 0.8 5.8 1.2 0.1 0.1 0.6 28.5 2.9 523.1 1.1 0.1 0.7 0.3 0.2 3.1 0.6 0.1 27.3 16.5 0.2 8.5 1.4 0.0 0.6 68.5 1.2 0.4 338.6 34.9 1.5 0.1 16.2 2.4 0.0 441.3 30.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.3 0.1 0.1 1.1 0.1 0.1 0.4 0.1 0.2 0.9 0.0 0.5 1.3 0.3 0.1 15.8 3.9 0.0 0.0 242.2 72.4 0.0 1.5 0.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.6 101.0 1.7 0.0 10.7 1.9 0.2 0.3 6.3 0.5 1.8 1.3 0.0 3.6 21.3 10.2 0.0 3.9 0.0 0.0 3.4 0.0 0.0 0.0 0.9 0.0 1.9 38.8 0.0 0.0 1.0 0.4 0.1 0.0 0.0 0.2 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.3 7.8 0.0 0.1 4.5 CXXC1 "CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1" ENSG00000154832 "CXXC finger protein 1" Q9P0U4 18 50282343-50287839 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044511 Supported Enhanced Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA044511: AB_10963081" "unprognostic (4.47e-2)" "unprognostic (1.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (5.08e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.10e-2)" "unprognostic (1.00e-1)" "unprognostic (3.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-2)" 18.1 26.7 24.4 22.8 25.4 45.9 19.3 29.8 30.5 28.0 25.9 23.6 27.3 23.3 10.3 23.6 24.9 17.5 19.9 24.6 24.6 25.5 24.5 19.2 34.3 24.6 24.5 30.0 38.7 20.3 21.0 16.0 25.2 24.4 15.9 13.6 32.4 21.4 20.2 29.5 23.5 14.9 22.8 29.6 25.7 22.8 25.0 30.7 23.2 13.1 21.1 25.6 23.7 26.3 24.6 31.9 33.4 46.9 28.9 16.2 46.9 34.3 28.4 38.5 32.1 21.6 19.6 60.2 17.6 22.0 18.5 44.6 51.6 37.0 21.7 51.9 33.0 57.9 42.3 39.5 19.6 126.4 68.7 19.5 32.9 38.0 51.0 26.0 25.0 58.8 29.9 63.8 27.3 37.7 71.6 67.7 47.8 16.9 22.4 74.5 26.9 56.5 26.8 13.9 48.4 47.2 18.0 17.8 21.6 21.2 22.9 56.9 29.2 45.1 28.4 18.4 29.6 119.1 87.7 52.5 28.4 58.6 35.5 24.7 18.8 34.0 24.0 22.0 25.0 26.9 21.6 23.6 21.9 27.5 23.1 18.9 8.1 22.6 18.8 15.5 26.4 20.6 24.4 25.4 29.8 30.5 24.6 24.6 24.6 24.5 25.2 22.8 25.0 26.3 18.1 19.2 27.4 21.9 27.8 26.8 13.1 21.7 21.1 15.3 20.2 17.4 7.3 18.6 23.8 18.4 14.6 34.5 23.7 31.4 13.7 19.4 13.8 20.9 13.8 18.3 35.3 14.9 10.2 21.8 39.2 16.6 33.1 17.6 8.2 20.5 16.8 15.3 22.0 8.4 8.7 25.0 26.4 20.2 17.2 9.8 19.9 21.0 8.8 7.5 21.3 19.3 43.3 9.5 9.4 21.8 26.1 19.5 41.5 13.3 26.5 14.9 21.4 13.5 6.6 19.5 16.9 49.4 22.1 24.5 30.1 37.1 27.7 18.3 26.5 12.0 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 105.6;lymphoid tissue: 114.3" "Cell type enhanced" "Detected in many" "B-cells: 240.4;dendritic cells: 244.3;Langerhans cells: 552.9;Macrophages: 164.0;monocytes: 490.1;NK-cells: 181.3;Plasma cells: 392.5;T-cells: 366.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 54.6;HDLM-2: 44.3;Karpas-707: 146.4;RPMI-8226: 46.9;U-266/70: 246.5;U-266/84: 99.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA007191 Approved Approved Nucleoplasm,Cytosol No NA "Cluster 51: Monocytes - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 9.2 2.7 1.4 70.0 1.7 105.6 7.7 1.5 3.7 5.7 4.0 12.8 27.3 3.2 2.1 6.9 3.4 11.8 4.1 1.4 1.9 5.2 12.3 26.1 91.5 3.1 1.8 1.5 3.4 0.9 1.4 4.4 2.6 3.3 14.6 0.5 14.3 3.9 1.1 2.8 23.1 7.0 2.5 42.2 41.6 2.5 2.3 53.6 4.0 2.2 114.3 20.8 3.7 3.2 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 54.6 0.1 0.6 0.0 0.1 0.0 0.0 0.1 44.3 0.0 0.3 0.0 0.0 0.0 7.8 6.4 0.0 0.0 0.2 0.0 4.0 0.0 0.2 0.0 146.4 0.7 0.0 0.0 6.3 0.3 0.8 0.1 0.0 0.1 46.9 5.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 2.0 0.2 246.5 99.8 24.1 2.4 6.8 0.0 248.9 37.6 109.9 121.8 122.5 122.5 91.5 127.9 115.7 56.1 91.6 205.5 161.0 203.6 90.2 247.9 28.1 136.5 154.8 1.4 1.7 1.5 3.7 1.4 1.9 3.1 1.8 2.6 2.5 2.3 3.2 3.2 3.2 12.2 0.0 240.4 20.9 1.0 0.0 0.6 0.0 24.4 2.5 2.1 5.7 1.3 1.8 0.0 0.7 244.3 0.6 15.6 0.3 1.4 0.3 0.4 4.5 1.8 14.9 0.1 1.9 13.6 6.4 29.0 0.8 7.0 0.0 6.8 1.7 25.2 0.0 0.1 3.7 0.0 86.1 552.9 2.0 0.0 164.0 83.6 12.2 490.1 0.0 181.3 0.0 0.0 0.3 0.3 0.0 392.5 0.7 0.4 1.1 0.0 0.1 0.0 1.5 4.5 0.0 0.6 1.2 17.8 3.0 366.6 0.0 3.8 0.5 DAZ4 ENSG00000205916 "Deleted in azoospermia 4" Q86SG3 Y 24833843-24907040 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "stomach 1: 23.7;testis: 11.8" "Cell type enriched" "Detected in single" 40 "Gastric mucus-secreting cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 124 "U-266/70: 153.6;U-266/84: 153.1" HPA047113 Approved NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.7 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 153.6 153.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340197-53535903 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.9;testis: 7.6" "Cell type enhanced" "Detected in some" "Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Approved "Golgi apparatus" NA NA 64000 "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA055376: AB_2682798, HPA069552: AB_2686151" "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.0 0.6 1.2 0.2 6.3 0.0 0.0 0.0 3.9 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 6.9 3.6 0.2 0.0 1.4 0.0 0.7 4.7 0.1 0.3 0.0 0.6 0.0 1.5 0.3 0.1 0.3 0.1 1.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 7.6 1.1 1.0 0.0 0.0 0.3 0.1 0.1 0.9 0.1 0.1 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 112.5 57.1 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.3 0.0 3.9 6.9 3.6 0.7 4.7 1.5 0.0 1.1 0.9 1.4 0.0 6.0 10.1 0.3 0.0 0.1 0.0 0.0 2.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 205.7 0.0 0.0 0.1 0.0 0.0 439.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 455.8 0.0 0.0 0.0 0.0 174.9 1.2 0.2 0.0 54.4 0.0 0.2 0.0 1305.9 58.6 0.0 0.0 1.2 5.7 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.1 2.6 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 DCDC1 "DCDC5, FLJ46154" ENSG00000170959 "Doublecortin domain containing 1" M0R2J8 11 30830369-31369810 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;choroid plexus: 10.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 39.0;Endometrial ciliated cells: 47.7;Late spermatids: 18.0;Respiratory ciliated cells: 61.6;Rod photoreceptor cells: 19.0;Spermatocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Low region specificity" "Detected in all" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.0 0.1 0.9 0.0 1.0 0.0 0.3 0.3 0.4 0.4 10.6 0.0 0.0 0.2 1.7 0.0 4.1 1.8 0.0 2.4 1.3 0.9 2.7 0.4 0.0 4.5 4.5 0.2 1.0 1.1 1.8 0.0 2.7 0.0 0.0 3.6 0.1 0.1 0.0 0.2 0.0 0.0 3.4 0.0 0.0 2.4 1.7 0.0 0.7 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 0.4 2.4 1.3 4.5 4.5 2.7 3.4 1.7 1.3 0.2 0.0 1.5 3.3 0.1 0.3 0.3 0.9 0.0 6.0 0.8 0.9 1.0 2.8 4.8 0.0 20.9 0.0 0.0 0.0 0.0 0.9 39.0 47.7 0.8 0.2 0.0 0.0 5.3 0.0 0.0 0.7 0.0 1.7 0.0 0.3 0.0 3.4 0.1 0.0 1.9 0.0 2.0 0.6 0.3 18.0 1.5 0.1 0.0 1.0 0.0 4.6 0.0 1.5 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 61.6 19.0 0.0 0.1 0.7 15.4 4.4 0.0 0.0 0.0 0.1 0.4 0.0 0.1 DENND11 "KIAA1147, LCHN" ENSG00000257093 "DENN domain containing 11" A4D1U4 7 141656728-141702166 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.2;B-cells: 3.8;Cardiomyocytes: 4.3;dendritic cells: 8.5;Hofbauer cells: 7.6;Plasma cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HDLM-2: 5.5;HEK 293: 5.3;U-266/70: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029467, HPA061437" Approved Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA029467: AB_10602915, HPA061437: AB_2684517" "unprognostic (1.27e-1)" "unprognostic (5.68e-2)" "unprognostic (7.05e-2)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "prognostic favorable (6.24e-4)" "unprognostic (6.49e-2)" "unprognostic (3.63e-2)" "unprognostic (3.02e-2)" "unprognostic (4.27e-1)" "unprognostic (7.62e-2)" "unprognostic (3.75e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-3)" "unprognostic (1.78e-1)" 8.7 5.9 7.1 1.0 8.0 0.9 9.6 5.4 10.2 8.0 4.3 11.0 3.6 7.0 0.5 12.5 8.1 0.5 6.8 10.7 5.3 8.8 14.7 13.3 1.6 9.0 7.7 7.5 17.4 1.0 11.8 0.3 8.6 9.0 1.5 2.8 20.6 0.7 5.7 8.7 14.4 0.6 7.0 14.2 17.8 1.4 6.9 0.6 12.4 0.5 1.2 8.5 11.3 10.6 1.9 1.5 0.9 1.2 0.5 0.2 0.3 0.4 0.3 0.3 0.3 1.9 1.3 0.1 3.1 0.3 0.8 0.6 1.0 0.8 0.7 5.5 5.3 0.9 0.8 0.3 0.1 1.7 0.3 0.2 0.7 0.2 0.3 0.8 1.3 1.0 0.0 0.3 0.2 0.7 1.5 1.2 1.5 2.1 1.0 3.6 0.2 1.7 0.6 1.0 1.4 2.7 1.2 2.1 0.2 0.5 0.8 0.2 4.3 0.2 1.0 0.4 2.2 7.5 1.8 2.4 0.6 2.3 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.1 8.0 5.4 10.2 10.7 5.3 9.0 7.7 8.6 7.0 6.9 10.6 9.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.7;skeletal muscle: 41.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "basophil: 3.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "U-2197: 11.8;U-266/70: 25.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 0.9 0.5 0.8 0.3 0.8 1.0 1.9 0.9 0.9 4.2 2.2 0.6 0.7 1.5 0.8 17.7 0.9 1.2 1.1 1.1 0.4 0.6 2.0 1.5 0.4 0.6 0.6 1.1 1.2 1.7 0.6 0.1 0.7 1.4 0.6 1.5 2.7 1.4 41.6 12.4 0.6 1.1 0.3 0.4 0.9 5.5 0.6 0.4 1.4 1.7 3.4 2.6 7.0 0.5 2.1 0.0 0.1 1.4 1.7 1.8 0.4 0.6 1.1 0.7 1.1 0.3 0.0 0.1 0.9 4.1 1.4 7.4 1.4 4.6 0.7 0.1 1.8 1.2 0.4 0.1 0.5 0.0 1.8 1.8 4.4 2.7 2.3 0.1 0.2 0.5 0.2 0.3 2.4 6.0 0.2 0.1 0.9 0.0 1.1 0.0 6.2 0.1 0.1 5.7 0.0 0.0 4.5 0.1 0.5 1.1 0.9 0.3 0.3 1.0 1.5 11.8 0.2 25.4 4.8 0.0 1.0 0.0 0.8 3.0 0.0 0.9 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.8 0.8 0.9 0.9 1.1 0.4 0.6 0.6 0.7 0.3 0.6 0.5 6.6 28.9 2.2 3.3 3.3 109.1 138.2 32.5 60.3 20.4 5.2 5.3 8.7 11.5 21.3 7.3 20.9 0.1 1.9 1.1 0.0 7.2 29.5 100.3 15.7 8.6 0.0 0.0 2.8 7.5 0.1 6.9 5.6 192.7 2.5 8.1 15.4 11.7 0.3 0.0 0.8 0.9 4.1 2.2 9.3 12.9 5.0 14.0 7.2 9.4 1.1 2.3 1.0 5.0 3.5 33.0 0.2 2.2 17.6 79.5 0.1 0.8 46.8 10.3 0.0 21.7 6.6 47.9 59.7 114.9 171.8 0.0 3.7 1.3 1.5 340.4 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.6;pancreas: 60.8;salivary gland: 51.1" "Cell type enriched" "Detected in many" 6 "Plasma cells: 1428.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "plasmacytoid DC: 187.4" "Lineage enriched" "Detected in many" 14 "dendritic cells: 187.4" "Cell line enhanced" "Detected in some" "Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 2.6 3.2 1.4 4.3 1.4 1.8 5.4 1.3 2.2 6.1 1.9 30.6 10.0 3.7 0.2 4.3 7.1 2.3 7.7 1.3 1.6 5.7 9.1 9.2 9.2 1.8 2.2 2.0 60.8 0.8 8.1 0.8 1.7 3.3 10.9 0.2 51.1 3.8 2.7 0.8 33.7 0.7 1.7 61.6 29.4 24.8 1.7 1.6 14.6 0.2 17.6 3.6 2.3 1.5 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.5 4.8 0.9 0.0 1.4 0.0 1.1 1.3 0.0 0.5 4.8 0.4 4.6 0.0 0.7 3.2 0.6 0.0 0.2 0.5 0.0 0.1 0.1 0.5 0.8 26.9 0.0 0.0 1.3 2.2 1.0 2.3 0.3 4.2 0.0 23.6 0.9 0.3 0.6 0.1 0.1 0.0 0.2 0.7 0.0 1.5 0.0 0.0 0.0 0.4 0.1 48.5 6.3 8.3 0.8 6.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 13.8 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.0 0.0 187.4 0.0 1.3 1.4 1.4 1.3 2.2 1.3 1.6 1.8 2.2 1.7 1.7 1.7 1.5 0.5 0.0 1.1 0.3 183.8 1.8 1.5 3.7 0.6 1.1 19.3 1.8 3.5 1.5 4.1 0.0 2.1 0.8 141.7 2.7 0.0 0.5 113.2 33.8 0.9 1.1 1.8 8.2 0.3 5.8 6.2 2.2 7.7 1.7 2.5 15.7 4.6 7.8 3.4 0.0 1.7 7.9 4.1 2.2 2.1 158.2 2.5 5.4 224.1 1.9 0.5 0.8 0.0 1.0 0.5 1.1 0.5 4.1 1428.8 2.5 0.8 0.5 30.3 0.6 0.0 0.8 2.6 67.0 32.9 1.3 2.0 15.5 17.9 2.1 10.7 2.0 DGKB "DAGK2, DGK, DGK-BETA, KIAA0718" ENSG00000136267 "Diacylglycerol kinase beta" Q9Y6T7 7 14145049-14974777 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 32.3" "Group enriched" "Detected in some" 8 "Excitatory neurons: 937.7;Inhibitory neurons: 576.6;Oligodendrocyte precursor cells: 254.3" "Cancer enriched" "Detected in single" 11 "glioma: 1.7" "Group enriched" "Detected in many" 7 "basal ganglia: 32.3;cerebral cortex: 14.4;hippocampal formation: 9.2;hypothalamus: 11.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;fHDF/TERT166: 2.6;SCLC-21H: 1.3;U-266/70: 3.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 192.8" HPA020321 Supported NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA020321: " "unprognostic (9.89e-2)" "unprognostic (9.72e-5)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.32e-2)" "unprognostic (3.37e-1)" "unprognostic (7.34e-2)" "unprognostic (5.91e-2)" "unprognostic (6.19e-2)" "unprognostic (8.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (5.98e-2)" "unprognostic (2.37e-3)" "unprognostic (6.13e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-4)" 0.2 2.6 2.5 0.2 32.3 0.0 0.1 0.0 14.4 2.3 0.0 1.4 0.0 3.3 0.0 0.5 1.6 0.3 0.4 9.2 11.9 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.5 2.0 0.0 0.1 0.3 0.0 0.5 1.4 0.0 0.0 0.6 0.1 0.9 0.1 0.1 1.4 0.0 0.5 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 32.3 0.0 14.4 9.2 11.9 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 70.5 0.0 0.1 0.3 0.0 0.0 26.4 0.0 0.0 1.6 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.2 5.3 0.7 0.0 0.0 937.7 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.0 576.6 0.0 0.0 0.0 0.5 1.9 1.2 0.1 1.8 43.1 0.0 0.1 0.0 254.3 17.3 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 1.6 6.6 0.5 4.9 0.2 0.5 0.1 0.4 0.0 0.1 0.1 0.0 0.3 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933699-48944969 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 17.3;kidney: 18.0" "Group enriched" "Detected in many" 11 "Proximal enterocytes: 213.7;Proximal tubular cells: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.2" "Group enriched" "Detected in many" 33 "granulocytes: 4.2;T-cells: 2.3" "Cell line enhanced" "Detected in some" "JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.2 0.4 1.6 0.0 1.6 0.1 0.2 1.9 3.3 0.3 1.0 0.3 10.5 0.1 0.0 0.8 0.3 0.2 0.1 1.7 1.7 18.0 0.4 1.1 0.2 1.2 1.3 0.6 0.4 0.5 1.8 1.3 1.2 3.2 0.0 1.7 0.4 0.1 0.2 0.2 17.3 0.0 1.3 1.7 0.7 1.9 2.7 0.1 0.1 0.0 0.2 0.3 0.4 1.6 1.4 0.0 0.1 0.7 0.4 0.3 0.5 0.0 0.2 0.2 0.7 1.4 1.1 0.0 0.2 0.0 0.9 0.4 0.5 1.0 0.4 0.5 1.1 2.0 0.5 0.5 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.3 0.0 3.2 0.7 0.2 0.0 0.3 0.0 0.1 0.3 2.1 0.9 0.7 0.1 1.0 0.1 0.4 2.1 1.1 0.2 0.1 0.5 0.1 1.0 0.0 0.0 0.0 0.8 0.3 0.0 3.2 2.8 0.8 0.7 0.0 0.2 4.2 0.0 0.5 0.7 0.0 0.4 0.0 0.8 0.3 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.6 0.2 1.6 1.6 1.9 3.3 1.7 1.7 1.2 1.3 1.2 1.3 2.7 1.6 0.5 3.2 6.4 1.0 1.0 0.8 2.4 3.3 2.2 2.4 1.0 3.4 0.7 1.5 4.6 3.7 0.0 0.2 0.4 1.5 9.8 2.2 0.7 0.3 0.5 0.8 0.0 0.4 1.0 0.4 0.2 0.5 4.1 0.8 1.3 0.1 0.0 0.0 12.9 0.0 1.2 5.0 2.0 0.8 0.0 2.4 0.0 1.7 0.0 0.0 0.0 1.6 0.0 0.0 0.5 1.5 3.6 0.0 0.0 3.5 213.7 77.8 0.5 4.5 0.0 1.2 0.4 0.0 0.8 3.1 0.1 0.1 0.6 0.4 2.7 3.2 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681880 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 30.6 43.2 44.6 23.9 48.1 21.7 29.6 51.0 57.5 35.7 50.0 40.9 28.0 33.2 15.6 29.5 38.6 20.1 41.0 46.5 48.6 34.2 41.0 29.6 32.7 46.4 45.1 40.6 49.7 47.0 52.8 19.7 50.0 34.8 29.5 69.1 34.1 27.9 92.6 41.3 32.8 29.1 47.7 31.6 44.2 16.0 45.9 45.2 28.7 70.5 34.7 36.7 33.1 56.2 70.8 50.8 80.8 41.5 34.2 57.7 18.6 44.0 64.9 82.8 82.9 35.4 33.8 71.7 49.4 48.2 75.6 41.0 55.7 63.0 57.4 64.2 37.8 48.8 51.4 47.1 43.8 57.2 72.1 47.2 74.8 49.7 85.2 82.9 59.1 141.5 45.1 49.5 61.5 137.0 105.1 83.3 64.2 90.3 85.1 65.8 29.1 106.6 63.5 34.6 106.7 144.4 44.0 64.2 76.0 48.1 59.0 96.5 29.8 94.4 38.2 93.5 69.2 160.0 184.9 49.9 59.7 66.2 94.5 37.0 58.8 82.7 51.0 54.1 53.0 86.2 59.0 52.8 63.4 82.1 77.7 56.8 18.2 64.2 72.8 64.9 77.6 70.0 44.6 48.1 51.0 57.5 46.5 48.6 46.4 45.1 50.0 47.7 45.9 56.2 40.3 41.7 30.7 10.1 54.8 55.6 79.2 93.0 38.7 75.8 48.3 64.5 8.6 37.1 49.1 33.1 45.9 47.1 52.2 35.2 86.1 53.7 20.9 38.2 24.5 35.0 41.3 26.7 11.9 37.6 55.1 35.0 33.6 27.9 24.1 46.0 30.4 34.6 42.8 42.1 12.5 60.8 79.3 37.6 42.5 27.5 45.1 35.3 49.8 6.5 62.7 115.2 53.5 8.0 14.7 48.7 70.1 34.6 51.1 73.3 87.9 84.1 49.6 129.2 46.0 39.6 53.8 33.3 62.3 39.7 51.0 71.8 51.1 37.4 54.3 71.0 DMP1 ENSG00000152592 "Dentin matrix acidic phosphoprotein 1" Q13316 4 87650280-87664361 "Disease related genes, Human disease related genes, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037465 Approved "Secreted to extracellular matrix" NA NA 64000 "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA037465: AB_10672492" "unprognostic (6.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-3)" "unprognostic (1.80e-1)" "unprognostic (4.96e-3)" "unprognostic (7.73e-2)" "unprognostic (3.88e-1)" "unprognostic (1.11e-1)" "unprognostic (1.35e-2)" "unprognostic (8.50e-9)" "unprognostic (5.82e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (1.74e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569867-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 350.9;Plasma cells: 409.3;Syncytiotrophoblasts: 569.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 116.5;Karpas-707: 109.3;U-266/70: 191.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 21.9 58.4 16.2 21.5 17.1 40.8 29.9 18.0 22.5 34.8 27.0 20.6 23.4 23.9 62.8 13.3 19.4 22.3 45.3 16.8 23.5 63.2 103.8 21.4 21.1 18.8 21.3 27.9 71.6 21.4 43.5 41.6 20.8 28.4 19.4 23.1 41.7 44.6 34.8 10.9 20.7 21.9 19.6 17.6 25.7 33.7 18.5 15.9 77.8 26.3 31.1 28.9 11.5 20.0 9.4 10.6 14.2 16.3 38.6 27.6 31.2 33.6 40.8 18.2 21.8 10.7 17.5 12.4 36.6 10.7 56.6 11.2 16.0 8.3 18.7 13.2 8.7 6.6 7.2 33.0 116.5 9.8 12.3 19.5 63.2 10.8 58.6 41.1 19.3 7.0 9.7 109.3 29.0 14.0 9.3 11.5 14.2 11.0 5.9 6.0 14.3 65.8 15.1 6.1 9.8 20.5 12.4 55.7 65.2 39.4 10.4 13.6 22.4 19.1 9.0 24.0 11.8 191.8 66.0 14.0 16.8 12.7 17.6 75.9 19.3 9.4 34.1 15.0 59.0 24.5 36.2 34.2 14.3 21.2 20.2 23.5 5.3 26.0 17.0 78.1 22.6 30.3 16.2 17.1 18.0 22.5 16.8 23.5 18.8 21.3 20.8 19.6 18.5 20.0 65.7 3.2 28.8 10.1 110.3 185.6 102.4 123.1 71.7 40.3 129.4 58.9 65.6 44.3 75.1 53.3 8.4 106.7 95.0 28.0 49.0 47.5 350.9 46.1 38.1 55.3 66.6 44.9 14.5 45.7 123.0 121.2 51.0 92.5 92.1 16.2 33.5 185.9 40.1 20.2 15.6 76.8 69.2 37.8 190.5 211.4 38.2 60.2 339.7 11.2 16.0 90.4 23.7 8.5 11.2 33.0 32.3 46.3 409.3 144.7 31.3 155.6 35.4 33.3 39.5 49.4 129.0 157.0 89.9 39.4 158.7 569.4 115.1 18.6 28.8 79.5 DNAJC27 "RabJS, RBJ" ENSG00000115137 "DnaJ heat shock protein family (Hsp40) member C27" Q9NZQ0 2 24943636-24972094 "Predicted intracellular proteins" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 22.2" "Cell type enhanced" "Detected in many" "Early spermatids: 59.8;Spermatocytes: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036815, HPA036816" Uncertain Approved Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA036815: , HPA036816: AB_10673506" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (4.53e-2)" "unprognostic (3.09e-1)" "unprognostic (5.17e-3)" "unprognostic (5.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.13e-1)" "unprognostic (4.60e-2)" "unprognostic (7.44e-4)" "unprognostic (8.84e-2)" "prognostic favorable (8.48e-5)" "unprognostic (3.35e-1)" "unprognostic (3.66e-1)" "unprognostic (3.05e-2)" "unprognostic (1.78e-3)" 5.6 3.4 4.3 2.1 5.6 3.8 3.7 7.1 7.0 3.7 4.1 3.7 1.9 4.2 5.0 2.2 4.6 3.0 4.9 4.6 8.7 3.8 2.0 2.7 2.7 7.5 6.5 7.0 2.7 5.1 6.1 2.9 8.2 3.3 2.7 13.3 2.2 3.1 4.6 2.9 2.7 3.0 5.7 2.9 2.9 22.2 6.0 3.5 3.3 7.0 2.4 3.1 2.9 6.5 2.8 1.2 2.6 2.6 3.6 3.0 2.0 2.1 3.2 2.2 1.9 1.3 1.3 2.6 0.5 1.5 1.8 2.2 1.9 1.3 2.3 1.1 1.6 1.6 1.6 1.2 2.3 1.5 2.2 2.3 2.2 1.7 3.5 2.5 0.9 3.1 1.1 2.4 2.4 1.0 2.7 2.6 1.7 1.0 1.1 1.6 5.1 1.4 2.1 1.5 0.9 3.2 2.0 1.5 3.0 2.7 1.3 1.1 0.8 2.9 2.0 1.5 2.0 6.1 2.3 3.1 1.5 2.4 1.3 0.0 0.2 0.9 0.2 0.1 0.5 0.4 0.3 0.2 0.2 0.3 0.4 0.5 0.0 1.3 0.3 0.1 0.3 0.2 4.3 5.6 7.1 7.0 4.6 8.7 7.5 6.5 8.2 5.7 6.0 6.5 7.8 9.6 10.0 19.2 11.2 2.0 5.6 3.6 8.0 24.1 9.8 8.5 25.4 4.3 3.0 7.3 37.5 3.6 10.8 4.5 3.9 2.6 59.8 12.5 9.7 7.7 15.5 11.8 18.2 2.5 2.0 8.8 8.2 5.2 10.8 9.5 6.1 3.4 3.3 37.0 22.1 5.9 6.1 3.2 4.6 32.5 8.7 5.9 1.8 7.5 4.3 12.2 4.1 12.1 24.1 1.7 0.9 6.4 8.8 4.6 4.3 3.1 17.3 25.1 0.0 12.8 23.9 70.7 17.0 8.3 3.3 4.2 11.3 23.2 5.4 3.8 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673576 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 12.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 11.4;Early spermatids: 42.6;Horizontal cells: 20.2;Spermatogonia: 40.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059723 Approved Nucleoplasm,Mitochondria NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" "HPA059723: " 0.4 0.2 2.5 0.0 2.6 0.2 0.4 2.7 3.3 0.5 2.3 0.4 0.1 0.3 0.2 0.4 0.6 0.0 0.4 2.5 2.6 1.1 1.0 0.6 0.1 2.7 2.7 0.4 0.8 0.4 1.3 0.1 2.6 0.9 0.4 0.0 0.3 0.2 0.7 0.6 0.6 0.2 2.6 1.0 0.3 12.2 2.8 0.6 0.6 0.1 0.6 0.3 0.4 2.7 0.1 0.2 0.3 0.2 0.3 0.1 0.7 0.0 0.3 1.1 1.0 0.3 0.2 0.3 0.1 0.2 0.1 0.3 0.7 0.3 0.4 0.2 0.7 0.1 0.7 0.1 0.4 0.2 0.4 0.2 1.1 0.9 0.5 0.1 0.4 0.3 0.2 0.0 0.4 0.1 0.0 1.1 0.2 0.0 0.7 0.9 0.1 0.1 0.5 0.1 0.5 0.4 0.0 0.0 0.3 0.2 0.1 0.2 0.0 0.3 0.6 0.2 0.0 1.6 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.6 2.7 3.3 2.5 2.6 2.7 2.7 2.6 2.6 2.8 2.7 0.4 3.2 1.1 3.9 1.3 0.5 0.9 0.8 0.0 11.4 1.1 1.0 0.0 1.5 0.7 3.7 4.2 0.3 0.7 0.5 0.0 0.2 42.6 1.2 1.4 0.9 1.2 2.7 3.6 0.4 0.6 0.7 0.5 1.6 0.0 1.7 1.1 1.9 0.6 20.2 3.5 0.9 0.0 1.3 1.5 7.2 0.6 1.0 0.0 1.0 0.2 2.5 1.0 2.5 3.6 0.4 0.1 0.4 0.6 2.0 0.4 0.1 0.5 6.6 0.0 1.7 0.8 6.2 40.0 1.0 1.0 0.3 1.9 0.4 0.9 1.6 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 2.2 1.7 2.6 1.5 3.3 4.5 2.2 2.1 4.3 2.9 2.3 3.3 1.6 2.5 2.1 1.6 2.6 1.4 2.0 2.1 3.2 2.5 2.8 3.3 2.5 4.7 2.8 3.3 1.7 0.4 2.2 0.8 5.0 2.4 1.4 4.0 1.8 1.3 2.0 2.3 3.3 1.4 2.4 2.8 2.0 10.3 3.5 2.1 2.4 0.8 2.0 2.4 2.5 6.2 2.1 2.0 2.4 1.9 2.0 2.9 2.6 1.0 1.2 0.7 0.9 1.3 2.3 2.4 0.4 1.0 1.8 3.7 1.1 1.1 0.9 1.5 2.3 1.8 3.7 1.5 1.3 2.1 0.8 2.0 1.8 2.2 3.6 1.2 0.6 3.1 2.0 2.3 1.0 0.6 0.9 3.0 2.6 0.7 2.0 1.4 0.9 1.5 1.3 1.6 1.1 2.2 0.8 2.2 1.9 1.8 1.3 2.5 1.2 1.3 1.4 1.8 1.4 6.6 5.0 3.0 1.3 2.6 1.7 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.0 0.2 0.2 0.1 2.6 3.3 2.1 4.3 2.1 3.2 4.7 2.8 5.0 2.4 3.5 6.2 2.3 0.0 3.4 69.5 3.8 0.9 1.2 1.9 0.6 9.9 2.7 3.0 3.8 0.0 4.3 0.0 4.2 0.3 4.0 2.2 0.0 0.3 12.7 4.0 1.5 2.8 0.0 35.6 41.4 0.4 0.2 2.2 2.6 3.6 1.3 4.7 3.3 4.8 0.8 10.1 32.8 1.7 0.0 2.5 1.5 13.9 0.9 4.0 0.0 19.7 2.2 3.4 3.1 36.2 67.4 0.4 1.6 1.2 1.7 1.8 2.2 0.6 7.3 9.5 0.0 2.1 1.7 19.5 2.0 1.5 3.8 0.7 2.4 1.8 2.1 1.8 DPEP3 ENSG00000141096 "Dipeptidase 3" Q9H4B8 16 67975663-67980549 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 47.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 290.4;Spermatogonia: 289.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 16.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 6.7;NK-cell: 1.8" "Group enriched" "Detected in many" 8 "granulocytes: 6.7;NK-cells: 1.8" "Cell line enriched" "Detected in single" 10 "U-266/70: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031870, HPA058607" Enhanced NA NA 27000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA031870: AB_2674079, HPA058607: AB_2683775" "unprognostic (9.93e-2)" "unprognostic (2.81e-3)" "unprognostic (1.86e-1)" "unprognostic (9.52e-2)" "unprognostic (3.61e-2)" "unprognostic (1.37e-2)" "unprognostic (1.55e-1)" "unprognostic (6.52e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.49e-3)" "unprognostic (9.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-3)" "unprognostic (1.13e-1)" "unprognostic (3.98e-2)" "unprognostic (1.51e-1)" 0.4 0.1 0.2 0.2 0.2 1.7 0.0 0.2 0.4 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.3 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.3 2.0 0.3 47.0 0.3 0.1 0.0 0.6 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.5 0.5 0.2 6.7 1.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.3 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 20.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 41.3 4.4 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.4 0.0 0.0 0.1 0.7 0.0 26.3 0.0 0.0 290.4 289.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 65.6" "Group enriched" "Detected in many" 4 "Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 9.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 6.7 5.3 4.0 0.5 3.9 3.0 4.7 7.0 6.9 11.4 6.6 5.2 0.6 7.8 4.1 1.4 6.4 2.8 19.2 3.0 4.3 12.7 0.2 1.3 0.9 2.4 3.0 11.0 2.7 9.0 10.5 1.2 1.5 9.3 1.3 14.4 1.6 4.7 0.5 1.6 1.7 3.5 0.8 1.7 2.9 65.6 3.3 0.7 13.1 0.6 0.6 6.3 5.1 4.2 1.0 2.6 2.2 5.4 0.6 0.0 0.2 1.8 1.8 2.4 3.1 0.4 0.8 2.8 1.8 0.7 2.9 0.4 2.7 0.3 3.6 1.5 1.7 4.6 1.4 1.7 0.5 3.4 1.4 1.5 0.1 1.1 0.0 6.1 0.8 2.2 1.9 2.9 3.9 1.7 0.2 1.4 2.1 0.4 2.4 0.0 1.8 0.0 4.6 0.5 7.0 0.7 0.6 0.2 1.0 0.9 1.9 0.9 0.5 3.2 4.2 0.5 4.6 7.5 9.3 0.0 3.4 1.6 3.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 4.0 3.9 7.0 6.9 3.0 4.3 2.4 3.0 1.5 0.8 3.3 4.2 6.7 3.2 0.0 23.2 0.2 0.5 2.9 0.1 2.2 49.6 1.9 1.8 32.3 1.5 3.8 12.9 14.6 2.0 0.3 0.1 5.9 0.4 329.9 5.6 7.1 1.7 0.0 7.2 124.1 0.0 1.3 2.2 0.5 2.1 2.5 1.2 1.4 0.1 0.3 3.3 137.2 0.1 6.1 0.0 0.4 363.0 7.2 0.4 7.2 11.2 0.1 9.2 0.0 124.1 5.0 0.2 0.0 8.6 0.5 2.9 0.0 6.4 11.6 6.7 26.3 3.8 19.9 143.3 4.9 0.2 0.4 1.4 0.8 3.6 0.1 1.1 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240565256 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 39.7;Spermatocytes: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 8.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "U-266/70: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.5 2.4 1.6 1.3 1.7 5.4 1.7 3.0 1.8 2.2 0.5 2.5 1.1 2.1 1.7 3.1 2.6 0.8 3.4 1.3 1.7 3.2 3.2 2.2 1.9 1.7 1.2 2.2 3.0 0.9 3.9 0.6 1.4 3.5 1.0 1.2 2.8 0.8 9.8 2.0 3.6 0.6 1.1 4.7 2.7 6.2 1.5 1.1 3.5 4.0 1.5 2.3 2.2 2.0 1.0 0.8 1.1 1.4 0.7 0.4 1.3 1.0 0.6 0.8 0.5 0.5 2.4 1.7 0.6 0.6 1.3 3.1 0.9 0.3 0.7 2.2 4.0 2.1 2.2 1.3 0.5 1.6 3.7 1.0 0.9 0.6 0.6 1.6 0.4 2.3 1.6 1.9 0.7 1.1 1.7 2.5 0.9 1.4 0.9 2.3 2.4 2.1 0.6 1.6 2.8 1.5 0.9 1.1 1.3 0.7 1.2 2.2 1.0 1.9 1.6 1.3 1.0 8.2 2.1 2.8 1.2 1.0 1.5 8.9 1.1 0.5 1.2 0.7 1.4 1.0 1.2 1.3 0.6 1.8 1.4 1.2 1.9 1.5 0.7 1.9 0.9 0.9 1.6 1.7 3.0 1.8 1.3 1.7 1.7 1.2 1.4 1.1 1.5 2.0 5.7 0.0 4.5 1.3 11.4 3.7 7.7 4.7 6.2 6.7 12.3 10.0 13.8 10.0 3.8 12.9 4.2 7.8 18.4 11.0 15.6 5.1 35.2 11.2 5.5 4.1 8.4 8.8 3.8 5.8 4.8 4.3 14.8 10.2 7.0 6.2 3.3 8.6 11.5 8.4 4.9 9.8 6.1 10.0 6.1 39.7 3.1 13.6 7.2 1.9 10.5 9.9 23.7 2.5 3.6 4.4 10.4 1.5 16.8 8.0 15.7 15.6 11.7 6.8 6.6 4.1 7.2 45.8 18.7 10.7 5.4 7.0 14.9 7.6 11.2 8.7 ELF2 "EU32, NERF, NERF-1A, NERF-1B, NERF-2" ENSG00000109381 "E74 like ETS transcription factor 2" Q15723 4 139028112-139177218 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006057, HPA071166" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nuclear bodies" "HPA006057: AB_1078733, HPA071166: AB_2686351" "unprognostic (7.21e-2)" "unprognostic (3.84e-2)" "unprognostic (7.41e-2)" "unprognostic (3.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-2)" "unprognostic (7.05e-3)" "unprognostic (1.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.21e-2)" "unprognostic (2.48e-2)" "unprognostic (3.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.97e-3)" 23.7 14.2 12.1 15.2 17.3 47.3 24.5 19.2 16.1 21.8 9.6 24.6 15.0 24.7 18.5 17.3 20.7 17.8 20.1 11.1 15.6 15.5 20.4 19.0 19.9 15.6 14.9 28.2 16.7 20.0 22.6 26.8 15.9 21.5 19.2 30.7 21.4 21.7 36.0 23.2 17.6 23.0 13.2 19.6 17.4 37.4 14.5 32.8 23.0 33.6 21.4 19.2 18.4 20.2 15.9 11.3 27.9 21.4 28.2 31.7 26.9 18.4 31.8 19.6 21.8 22.2 31.2 32.3 18.5 25.7 10.4 16.8 41.2 26.3 20.5 20.2 18.6 28.5 26.4 20.0 20.7 32.1 22.1 31.1 24.8 19.3 23.3 25.7 29.5 18.0 46.8 18.4 17.7 27.8 37.8 28.6 17.0 36.4 13.1 36.0 36.8 30.1 25.1 27.2 28.4 32.6 23.1 28.5 17.6 32.4 19.7 38.5 25.0 18.3 15.9 16.7 12.4 40.8 48.6 28.3 13.5 32.4 17.2 13.3 8.3 14.1 12.0 7.2 13.2 17.5 11.8 10.8 9.9 19.3 14.6 13.5 9.1 12.9 7.9 18.0 9.4 5.3 12.1 17.3 19.2 16.1 11.1 15.6 15.6 14.9 15.9 13.2 14.5 20.2 103.0 48.1 22.5 64.0 57.6 53.2 41.1 36.1 120.1 42.0 50.3 40.4 37.0 40.0 39.1 40.5 75.0 32.6 71.9 31.0 43.0 26.4 26.0 60.0 54.3 67.1 47.3 43.5 73.6 24.2 32.3 63.7 35.7 56.3 34.8 44.0 53.2 46.9 22.2 67.3 75.3 38.1 42.7 52.2 40.1 24.6 52.5 59.5 30.2 98.4 49.2 37.3 77.2 83.9 279.4 24.1 33.5 38.0 51.0 52.6 35.9 23.1 48.2 57.7 39.5 81.4 59.2 59.7 42.0 79.0 47.6 23.7 50.7 33.6 27.7 39.6 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522116 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 297.2;Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.1 7.7 4.0 9.0 6.2 29.8 11.8 8.4 7.0 11.2 5.0 10.6 6.5 11.0 2.0 10.3 10.6 5.7 10.5 3.6 4.2 12.6 14.1 16.6 7.6 4.7 4.2 13.0 10.0 4.1 11.3 10.0 3.8 9.9 2.3 1.2 8.3 3.6 20.1 15.3 12.8 3.6 4.0 17.3 10.1 38.5 6.1 6.8 8.2 9.9 4.3 10.5 11.0 3.9 12.7 5.7 3.2 6.8 3.4 4.2 22.7 10.0 8.8 7.5 7.1 7.1 9.8 15.6 11.8 6.7 5.2 8.6 4.7 11.1 3.8 13.3 10.9 9.4 5.9 6.3 5.2 10.3 11.8 8.6 9.3 9.8 7.7 5.6 5.4 8.5 13.5 21.8 4.0 10.3 12.5 11.9 10.6 7.8 16.8 10.9 4.8 17.4 5.3 8.8 5.7 6.4 7.4 12.3 11.0 4.1 6.4 12.4 9.0 8.6 6.6 11.6 9.3 34.8 23.4 11.7 11.4 17.6 12.5 0.3 5.9 4.5 4.5 4.1 7.3 2.9 2.6 3.9 5.0 2.1 1.7 2.7 18.1 2.3 2.1 8.6 3.1 4.1 4.0 6.2 8.4 7.0 3.6 4.2 4.7 4.2 3.8 4.0 6.1 3.9 12.3 6.4 6.1 9.1 16.3 28.0 26.4 11.9 23.3 4.5 19.7 10.7 5.1 11.5 7.2 3.7 4.2 47.5 29.5 15.2 11.7 8.7 297.2 22.9 16.0 11.4 19.7 10.3 9.1 8.0 17.6 17.2 12.8 37.7 11.4 5.1 7.5 15.5 19.3 1.7 11.2 10.1 6.1 12.8 21.7 235.9 6.5 20.4 7.2 9.4 13.8 5.3 4.1 7.1 8.0 10.8 3.7 3.0 53.6 14.2 11.8 7.0 8.4 3.4 19.7 13.0 16.7 18.2 24.7 19.4 30.4 68.7 19.2 5.9 7.1 19.9 ENPP4 "AP3Aase, KIAA0879, NPP4" ENSG00000001561 "Ectonucleotide pyrophosphatase/phosphodiesterase 4" Q9Y6X5 6 46129989-46146688 "Enzymes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 21.9;U-266/84: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016594 Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA016594: AB_1848171" "unprognostic (9.87e-2)" "unprognostic (1.74e-1)" "unprognostic (2.75e-2)" "unprognostic (2.01e-1)" "unprognostic (2.92e-1)" "unprognostic (1.90e-1)" "unprognostic (8.13e-2)" "unprognostic (5.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-1)" "unprognostic (8.51e-2)" "unprognostic (4.36e-1)" "prognostic favorable (6.95e-7)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (2.56e-1)" 15.1 13.6 11.7 7.3 20.9 38.0 7.8 19.5 19.5 10.3 6.4 12.1 10.9 4.0 11.6 5.1 10.8 8.0 15.1 10.8 16.0 18.4 8.2 20.7 7.7 20.5 19.3 2.1 11.9 22.3 9.0 3.5 19.9 16.4 12.8 12.2 21.3 19.7 22.1 2.3 10.1 7.0 18.5 13.9 14.8 8.3 17.5 8.5 12.5 25.3 6.5 6.8 2.1 30.2 0.1 1.1 0.7 1.5 0.0 0.0 0.1 1.7 1.6 4.0 0.3 1.9 13.4 15.2 12.7 2.1 9.9 0.2 4.1 0.6 0.8 18.5 11.1 8.5 0.0 0.0 0.5 10.5 14.9 2.1 0.0 0.1 0.0 1.1 1.4 10.5 0.0 0.0 1.5 1.8 7.8 1.0 2.7 16.9 0.5 5.9 2.7 5.7 8.3 1.7 18.0 0.0 0.0 2.8 0.0 4.1 7.6 4.3 0.0 0.0 6.7 0.3 11.2 21.9 26.6 5.2 10.3 0.0 1.4 0.0 0.4 0.9 9.2 1.1 5.4 2.8 3.4 6.8 1.5 1.2 3.2 5.8 0.3 4.4 2.6 1.6 1.2 3.0 11.7 20.9 19.5 19.5 10.8 16.0 20.5 19.3 19.9 18.5 17.5 30.2 43.5 76.9 27.0 23.5 11.6 0.9 3.2 2.3 0.6 9.3 11.0 2.4 23.1 14.3 25.4 29.5 14.6 0.5 23.5 27.2 0.0 12.9 18.3 28.8 2.0 16.0 15.7 3.0 26.4 12.2 0.3 8.5 10.7 17.3 15.8 4.5 6.1 8.6 5.8 26.9 19.2 13.8 4.1 24.8 11.0 26.0 1.2 19.0 3.6 6.5 15.2 21.6 34.0 32.2 125.3 9.7 16.1 11.3 10.3 12.6 16.3 12.6 70.6 6.2 0.0 22.1 5.4 9.1 9.8 0.3 0.6 0.3 14.7 3.7 11.3 14.8 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase family member 5" Q9UJA9 6 46159185-46170980 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 243.6" "Cell type enhanced" "Detected in many" "Muller glia cells: 100.1;Respiratory ciliated cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.9" "Lineage enriched" "Detected in many" 5 "T-cells: 14.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 620000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.8 8.6 6.2 1.1 7.6 0.2 13.4 6.9 12.6 12.8 4.0 2.6 1.5 1.8 243.6 1.8 15.4 7.0 4.4 7.0 9.7 24.3 0.5 8.8 1.2 5.8 13.0 9.7 9.7 46.3 19.8 1.7 6.2 29.4 3.2 30.6 14.4 31.0 10.7 1.6 1.9 0.9 4.5 5.7 6.7 35.5 14.0 8.2 51.0 10.3 1.4 5.6 1.8 6.3 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.5 0.1 0.3 11.1 1.8 3.6 0.2 3.7 0.0 0.6 1.5 0.1 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 1.9 0.0 0.5 2.3 5.4 0.0 0.0 0.2 0.2 4.5 0.6 4.7 0.2 0.0 4.6 0.0 6.2 8.7 0.0 0.0 0.0 1.2 0.0 0.1 5.3 7.9 0.0 2.8 0.0 0.1 0.0 0.0 0.0 14.9 0.1 8.0 0.5 3.0 9.7 0.0 0.8 0.9 8.7 1.1 2.8 0.0 0.0 0.0 3.2 6.2 7.6 6.9 12.6 7.0 9.7 5.8 13.0 6.2 4.5 14.0 6.3 0.4 12.8 12.2 16.3 1.6 0.9 4.8 0.5 1.2 10.6 18.1 10.8 7.5 8.6 6.1 23.9 4.2 4.9 4.2 1.9 1.9 11.6 0.7 15.3 0.8 0.4 8.3 0.0 24.6 7.5 2.9 4.2 2.0 5.4 4.5 4.0 0.4 0.1 0.4 10.1 14.5 2.8 2.0 0.0 0.4 3.8 2.8 0.5 0.0 1.9 0.6 100.1 23.7 9.0 10.5 2.2 2.3 12.0 0.1 12.0 1.7 16.3 47.3 3.4 6.6 25.7 1.8 0.5 2.4 1.1 0.6 0.3 3.2 21.2 2.9 3.3 ENPP7 "alk-SMase, NPP7" ENSG00000182156 "Ectonucleotide pyrophosphatase/phosphodiesterase 7" Q6UWV6 17 79730943-79742219 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 104.6" "Group enriched" "Detected in some" 7 "Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7" "Cancer enriched" "Detected in some" 6 "liver cancer: 6.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA024603 Approved "Intracellular and membrane" NA NA 450000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "HPA024603: AB_1848174" "unprognostic (4.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.49e-2)" "unprognostic (4.83e-2)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (1.24e-1)" "unprognostic (1.01e-1)" "unprognostic (8.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (5.21e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.6 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 9.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 24.2;ovary: 6.3;testis: 8.4" "Cell type enhanced" "Detected in some" "Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Region enhanced" "Detected in many" "cerebellum: 24.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 9.3;U-266/70: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA "Cluster 6: Brain - Smell perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.2 0.0 6.5 0.0 12.7 0.0 0.2 24.2 10.9 0.8 0.0 3.2 0.1 0.9 0.3 0.8 1.9 0.9 0.3 11.4 0.0 0.4 0.0 0.1 0.0 0.0 0.2 6.3 0.5 0.1 0.1 0.0 1.1 1.0 0.7 1.1 0.1 0.6 0.0 0.0 0.3 1.4 0.1 0.0 0.6 8.4 3.5 0.2 2.0 0.1 0.1 1.4 0.6 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 9.3 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.4 0.0 0.9 28.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 12.7 24.2 10.9 11.4 0.0 0.0 0.2 1.1 0.1 3.5 0.0 0.0 0.0 0.0 421.5 0.1 0.3 0.3 0.0 5.2 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.8 0.1 1.4 0.1 0.0 0.0 423.8 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 879.2 0.0 0.0 0.0 0.0 208.7 3.1 0.2 0.0 30.0 0.0 1.0 0.0 31.2 9.0 0.1 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.3 0.0 0.2 0.1 14.7 2.7 6.0 0.0 0.1 0.0 0.4 0.0 0.1 ERN1 "IRE1, IRE1P" ENSG00000178607 "Endoplasmic reticulum to nucleus signaling 1" O75460 17 64039080-64130819 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Transcription, Transcription regulation, Unfolded protein response" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 53.0;pancreas: 66.7" "Cell type enhanced" "Detected in many" "Plasma cells: 325.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 17.9" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0" "Cell line enhanced" "Detected in many" "Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009495, HPA027730" Supported NA Yes "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB009495: AB_2098712, HPA027730: AB_10602494" "unprognostic (2.52e-1)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (2.81e-2)" "unprognostic (9.14e-2)" "unprognostic (2.72e-2)" "unprognostic (4.55e-1)" "unprognostic (6.17e-2)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.65e-1)" "unprognostic (1.89e-1)" "unprognostic (1.36e-2)" "unprognostic (3.11e-2)" 9.5 53.0 1.5 5.4 1.7 13.4 7.5 2.6 3.2 22.6 2.1 7.7 6.3 10.1 6.4 9.5 14.3 6.2 6.1 1.6 2.4 5.6 23.5 16.5 5.8 1.7 1.0 16.9 66.7 4.3 19.5 5.6 1.3 9.9 4.5 8.8 15.7 7.1 6.8 11.3 10.6 5.6 1.0 15.8 16.2 2.8 1.6 6.8 10.2 2.4 6.6 8.3 11.7 1.7 4.0 4.0 2.2 4.8 4.8 4.4 9.8 4.1 9.7 2.8 1.3 2.5 2.3 6.6 3.2 2.8 3.5 3.6 1.9 4.5 6.1 1.6 1.5 6.0 3.2 2.4 19.6 3.2 2.1 3.8 8.1 6.4 21.5 3.5 5.0 4.7 4.2 74.6 2.8 3.9 4.5 1.0 0.6 3.6 3.2 4.2 4.2 40.2 1.1 5.5 7.1 3.5 4.3 6.1 5.7 3.5 3.8 5.9 5.9 2.5 4.1 6.4 2.7 77.4 23.9 4.8 4.0 2.1 4.2 17.9 0.9 0.4 4.9 0.4 9.0 0.2 3.3 4.1 0.4 0.3 0.9 0.9 4.9 2.5 0.3 7.7 0.8 1.0 1.5 1.7 2.6 3.2 1.6 2.4 1.7 1.0 1.3 1.0 1.6 1.7 31.9 0.0 36.1 7.2 27.8 22.0 54.3 8.3 15.4 4.0 35.0 29.7 8.6 11.5 8.6 12.9 6.2 8.1 106.4 10.0 1.9 12.6 2.3 26.1 49.1 18.3 79.7 11.2 8.6 27.3 8.8 42.2 52.0 79.4 8.2 11.8 13.9 26.8 8.0 3.3 6.1 8.2 8.2 15.7 71.3 1.7 4.7 60.4 74.7 12.2 10.2 3.5 28.8 6.0 4.6 17.9 7.3 6.0 325.8 44.7 7.9 4.4 6.1 26.5 0.0 19.0 25.7 4.0 4.1 27.7 45.0 54.9 88.2 12.0 9.6 60.1 ESCO1 "EFO1, ESO1, KIAA1911" ENSG00000141446 "Establishment of sister chromatid cohesion N-acetyltransferase 1" Q5FWF5 18 21529284-21600884 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042497 Approved NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA042497: AB_10794278" "unprognostic (8.12e-2)" "unprognostic (2.90e-2)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-3)" "unprognostic (1.38e-2)" "unprognostic (1.25e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-3)" "unprognostic (1.72e-3)" "unprognostic (6.80e-3)" "unprognostic (9.29e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.48e-1)" "unprognostic (3.72e-2)" 6.0 5.3 5.8 6.1 6.4 16.3 10.4 10.0 8.8 8.0 5.3 6.7 6.3 6.8 10.1 7.5 5.6 5.2 5.7 5.4 7.3 8.0 9.9 5.3 10.1 6.1 6.2 7.4 7.2 10.1 9.0 8.7 6.5 7.2 5.9 7.8 8.0 6.6 10.3 7.8 7.0 4.8 5.9 8.3 6.9 20.2 6.3 11.1 7.3 5.3 9.9 6.9 7.2 7.0 9.3 4.3 9.3 4.7 8.3 8.8 9.6 5.6 10.7 7.9 11.1 8.8 6.3 16.3 12.5 7.1 8.7 13.3 11.6 7.9 10.9 17.1 7.8 12.7 6.1 14.9 13.5 21.3 12.3 7.4 16.6 6.1 15.9 10.4 10.9 11.9 17.7 16.4 10.9 10.7 15.9 22.4 19.3 17.7 9.9 10.2 11.9 18.3 15.7 13.9 14.4 10.3 10.5 13.2 24.3 14.6 9.7 14.4 6.1 10.1 10.2 7.4 7.0 38.8 24.0 18.8 10.0 12.2 10.1 4.9 0.5 3.9 3.3 1.1 2.8 2.2 2.7 3.1 1.1 1.9 2.6 3.3 3.2 2.2 0.9 0.8 3.1 1.0 5.8 6.4 10.0 8.8 5.4 7.3 6.1 6.2 6.5 5.9 6.3 7.0 29.1 12.8 29.5 29.0 35.5 10.7 21.0 24.4 17.1 43.1 22.6 17.4 36.2 10.0 24.2 11.0 20.9 26.0 47.0 15.8 19.6 26.2 14.4 28.6 23.9 18.5 11.4 13.7 48.8 13.4 16.2 20.1 27.5 36.7 29.2 24.4 16.8 7.6 13.7 30.3 55.2 19.4 24.4 9.5 12.4 9.2 21.1 21.3 16.0 31.9 24.1 17.0 46.4 35.7 50.1 18.8 23.6 22.6 31.6 23.5 19.9 15.7 19.7 35.5 26.3 23.1 20.4 119.1 93.6 15.7 12.5 37.6 38.4 37.4 14.1 27.3 EYA2 EAB1 ENSG00000064655 "EYA transcriptional coactivator and phosphatase 2" O00167 20 46894624-47188844 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 55.6" "Cell type enhanced" "Detected in many" "Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 69.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027024, HPA059291" Uncertain Supported Cytosol NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Cytosol "HPA027024: AB_1848334, HPA059291: AB_2683967" "unprognostic (1.08e-1)" "unprognostic (5.71e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.30e-5)" "unprognostic (3.32e-2)" "unprognostic (1.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.65e-1)" "unprognostic (7.06e-2)" "unprognostic (2.15e-1)" "unprognostic (2.78e-1)" "unprognostic (4.17e-3)" "unprognostic (1.56e-1)" 12.0 1.5 12.3 2.4 14.1 0.0 11.0 15.6 12.3 55.6 11.2 9.3 0.3 17.2 3.7 34.2 34.0 1.8 5.0 10.7 11.8 4.7 2.1 2.2 0.8 14.6 14.4 0.7 1.9 9.4 5.3 6.3 13.7 23.6 3.1 1.2 31.2 9.3 2.5 5.3 1.1 1.8 11.8 0.6 8.9 5.6 13.4 18.8 14.6 3.4 6.6 4.9 16.5 11.0 0.2 4.4 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 2.5 1.9 0.3 40.1 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.1 0.3 2.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 7.7 0.1 0.0 0.6 0.1 0.0 0.1 0.8 0.5 0.0 0.0 58.3 0.0 0.0 24.8 0.0 3.0 5.3 0.2 0.0 0.0 4.5 0.3 8.8 110.9 139.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 14.1 15.6 12.3 10.7 11.8 14.6 14.4 13.7 11.8 13.4 11.0 0.4 0.0 0.0 153.8 0.9 0.6 47.5 50.4 14.8 0.4 7.8 7.6 0.5 2.8 33.0 0.0 6.2 27.7 0.0 2.5 0.0 0.9 0.2 43.7 3.9 0.6 1.2 0.0 1.5 0.0 3.0 4.8 9.2 53.8 1.3 9.8 0.4 3.3 7.4 0.0 5.1 0.6 34.6 0.0 0.4 0.3 0.0 1.1 3.6 13.1 2.6 0.0 0.0 48.7 1.0 1.1 1.7 0.7 3.4 10.9 0.0 6.3 22.2 0.4 0.0 0.3 2.8 0.2 7.4 16.0 0.3 10.8 0.6 4.2 3.6 34.6 F8A3 ENSG00000277150 "Coagulation factor VIII associated 3" P23610 X 155456914-155458620 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 10.0;dendritic cells: 4.9;Erythroid cells: 8.2;Kupffer cells: 5.1;Plasma cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "eosinophil: 3.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "OE19: 35.9;U-266/70: 43.1;U-266/84: 43.1" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.83e-1)" "unprognostic (9.94e-2)" "unprognostic (3.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.94e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (7.03e-2)" "unprognostic (2.03e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-1)" "unprognostic (7.96e-2)" 7.1 6.4 3.7 5.1 4.3 7.0 5.5 2.9 10.8 5.0 2.6 5.7 4.3 5.3 4.9 4.9 4.3 4.1 7.4 3.9 4.4 6.1 11.0 4.1 4.8 3.5 3.4 3.6 6.5 17.8 3.0 2.9 4.0 3.9 2.6 3.3 5.8 2.9 12.0 4.1 5.6 0.9 3.4 6.5 5.3 1.5 3.8 7.9 5.4 5.0 2.3 4.5 3.8 4.1 0.3 0.1 2.2 0.0 8.9 6.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 12.3 0.1 15.4 0.0 12.1 2.6 0.0 0.0 0.0 6.0 16.0 10.2 0.1 10.1 22.1 7.5 0.0 0.0 9.4 7.1 0.0 5.9 0.0 0.0 0.0 15.5 0.0 23.2 0.1 4.2 35.9 0.0 0.1 0.0 11.9 9.3 7.8 0.0 4.4 8.4 0.0 0.0 19.8 0.0 13.8 5.4 21.1 0.0 15.3 25.4 43.1 43.1 0.1 6.3 0.0 0.1 0.0 0.3 3.2 0.7 0.1 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.4 0.5 0.1 0.2 0.4 0.1 0.1 3.7 4.3 2.9 10.8 3.9 4.4 3.5 3.4 4.0 3.4 3.8 4.1 1.3 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.6 1.8 1.7 0.6 0.2 10.0 0.0 1.8 0.0 2.0 4.9 2.2 0.0 0.6 0.0 0.2 0.2 0.9 0.0 8.2 0.0 1.5 1.5 1.2 1.1 0.1 0.0 0.1 0.7 3.8 2.3 0.0 0.0 1.3 0.0 5.1 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.6 2.1 0.0 0.0 1.3 0.3 0.0 4.8 0.4 1.2 2.6 0.0 0.9 0.0 1.8 0.8 0.0 0.0 2.1 0.0 2.9 3.4 0.2 0.8 0.3 FAM117A ENSG00000121104 "Family with sequence similarity 117 member A" Q9C073 17 49710332-49789180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 76.5" "Cell type enhanced" "Detected in many" "dendritic cells: 56.4;Erythroid cells: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 50.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 82.0;U-266/84: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022531 Approved Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "HPA022531: AB_2101087" "prognostic favorable (5.30e-5)" "unprognostic (8.06e-3)" "unprognostic (2.82e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (3.90e-3)" "unprognostic (1.69e-1)" "prognostic favorable (8.25e-7)" "unprognostic (4.05e-1)" "unprognostic (3.58e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.99e-2)" "unprognostic (3.73e-2)" "unprognostic (9.12e-2)" "unprognostic (1.45e-1)" "unprognostic (4.07e-2)" "unprognostic (4.66e-2)" 13.5 7.3 7.6 14.8 6.8 76.5 12.5 10.0 5.9 12.6 37.4 22.8 10.6 20.4 9.6 9.4 16.7 10.4 18.9 9.6 4.8 9.0 11.7 12.1 22.9 6.3 4.6 21.6 16.0 18.6 14.6 5.4 6.1 10.0 8.5 8.0 13.5 11.3 4.0 19.1 18.7 16.7 3.3 34.2 13.3 19.0 6.7 23.5 14.5 6.3 17.4 20.2 10.5 5.0 7.2 1.7 11.4 0.2 5.0 1.0 20.2 2.4 4.0 4.3 7.1 51.2 11.8 34.4 12.4 1.4 19.1 4.1 9.0 8.5 3.3 2.4 14.5 37.9 0.1 16.6 5.6 5.8 29.1 4.9 7.1 7.1 3.9 4.4 7.8 28.9 46.9 28.1 4.1 18.6 37.5 31.1 17.0 10.0 5.7 11.6 9.6 18.4 6.7 6.4 11.1 7.5 2.4 1.1 8.5 11.1 16.7 21.5 0.7 4.2 3.4 4.6 2.0 82.0 60.2 23.0 3.6 8.4 3.5 50.4 1.7 9.1 8.5 1.1 9.2 23.6 5.5 7.2 1.3 15.3 4.5 6.2 3.6 12.8 0.3 3.6 5.9 3.4 7.6 6.8 10.0 5.9 9.6 4.8 6.3 4.6 6.1 3.3 6.7 5.0 15.5 6.4 9.3 5.2 19.5 9.1 1.3 2.1 7.4 15.1 14.6 21.7 22.2 1.5 4.1 7.3 14.6 1.1 56.4 2.2 5.9 2.0 4.1 4.2 5.9 9.9 10.7 104.4 4.5 3.5 1.9 9.3 9.2 7.9 2.5 2.9 7.1 8.6 1.2 5.0 4.0 4.9 6.1 2.9 4.5 5.6 14.3 7.6 7.2 1.9 13.0 3.5 37.0 2.0 2.3 3.8 1.0 15.4 34.9 2.6 0.5 3.6 1.5 4.0 0.0 14.2 10.2 15.5 14.5 8.8 14.1 0.8 27.9 5.5 2.7 1.1 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 114.4" "Cell type enriched" "Detected in some" 7 "Early spermatids: 1680.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 2.0;U-266/84: 2.2" HPA042144 Enhanced NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.9 0.2 0.5 0.6 0.5 11.8 0.7 0.5 0.9 0.6 0.6 0.5 0.2 0.4 0.0 0.5 0.5 0.3 0.5 0.5 0.6 0.7 0.8 1.0 1.3 0.6 0.6 0.2 0.6 0.3 0.9 0.1 0.6 0.7 0.4 0.2 0.7 0.3 0.9 1.2 0.9 0.2 0.5 2.6 0.6 114.4 0.6 0.6 0.4 0.4 0.9 0.5 0.5 0.6 0.0 1.0 0.2 0.0 0.0 0.1 0.1 0.4 0.7 0.9 0.3 0.7 0.0 0.1 0.7 0.4 0.2 0.6 0.5 0.3 0.8 0.2 0.4 0.4 0.0 0.2 0.1 1.1 1.6 0.6 0.9 0.1 0.5 0.0 0.0 0.7 0.0 0.9 0.0 1.1 0.4 1.0 0.2 0.0 0.5 0.3 0.2 0.0 0.6 0.3 0.6 0.1 0.3 1.4 0.2 0.2 0.6 0.2 0.0 0.1 0.2 0.6 0.0 2.0 2.2 0.3 0.1 0.4 0.1 0.0 0.3 1.0 0.6 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.5 0.5 0.9 0.5 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.3 0.0 1.9 0.0 0.1 0.1 0.5 0.4 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.5 0.3 0.0 0.9 1680.6 0.2 0.1 0.9 1.2 0.0 0.6 1.6 0.5 0.1 0.0 0.3 1.3 0.1 0.4 0.2 0.6 0.0 0.4 0.2 0.0 1.6 0.7 238.2 11.5 1.0 0.0 0.0 0.9 0.0 2.1 0.0 0.9 0.8 0.1 8.2 0.0 0.3 0.4 1.0 1.1 0.0 0.0 0.1 0.4 12.8 7.1 0.0 0.0 0.0 0.4 0.1 0.1 0.6 FAM227B "C15orf33, FLJ32800" ENSG00000166262 "Family with sequence similarity 227 member B" Q96M60 15 49326962-49620929 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049774, HPA061695" Uncertain Approved "Nuclear speckles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA049774: AB_2680873, HPA061695: AB_2684588" "unprognostic (1.19e-2)" "unprognostic (2.57e-1)" "unprognostic (1.89e-2)" "unprognostic (4.74e-3)" "unprognostic (1.17e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-4)" "unprognostic (3.32e-2)" "unprognostic (9.21e-2)" "unprognostic (6.57e-3)" "unprognostic (6.32e-3)" "unprognostic (6.41e-2)" "unprognostic (7.48e-5)" "unprognostic (2.70e-1)" "unprognostic (9.01e-2)" "unprognostic (7.47e-2)" "unprognostic (1.76e-1)" 1.1 5.1 4.2 1.9 5.1 1.5 6.6 4.2 5.2 4.7 4.6 4.3 2.8 6.3 7.3 3.5 7.7 3.4 7.3 3.9 4.8 7.7 7.5 2.7 4.8 4.8 5.0 9.9 6.4 5.6 6.4 1.3 5.2 5.7 2.8 7.9 5.3 5.1 7.9 3.9 2.3 3.9 4.9 2.8 3.6 10.4 4.5 6.8 7.4 8.9 4.4 3.5 2.2 6.3 0.8 0.7 5.1 2.8 1.5 3.0 0.6 2.1 2.8 3.2 5.1 0.7 2.4 1.5 4.9 3.5 3.7 0.8 1.8 3.1 3.7 3.7 1.5 3.2 1.3 1.7 4.2 1.5 1.3 3.1 4.0 1.8 2.0 6.2 3.0 7.7 5.4 2.4 7.1 3.5 3.2 1.3 2.0 1.2 1.3 2.7 4.5 8.1 4.8 1.0 3.8 5.3 1.9 2.5 6.2 3.7 3.1 1.1 2.2 2.2 1.7 3.0 1.3 12.2 9.8 4.8 2.4 3.9 2.4 5.8 0.2 1.7 3.4 0.5 4.5 2.8 3.5 4.6 0.3 3.5 5.8 5.6 0.3 2.7 0.6 3.4 3.4 2.0 4.2 5.1 4.2 5.2 3.9 4.8 4.8 5.0 5.2 4.9 4.5 6.3 1.1 9.6 4.8 39.5 5.8 2.8 5.4 5.4 3.4 4.3 6.2 7.6 10.8 1.5 9.4 3.7 0.0 1.7 3.3 1.3 25.4 3.9 41.0 19.1 3.1 2.8 8.4 2.1 12.8 3.2 1.5 3.7 3.6 3.2 3.8 1.8 1.8 4.1 0.6 5.0 12.1 1.8 6.1 0.6 2.0 21.1 4.1 2.0 3.6 5.6 0.6 11.7 4.1 16.1 55.1 2.5 1.6 3.0 6.1 2.6 1.9 12.5 21.3 8.0 0.0 4.7 2.0 48.7 13.2 2.5 4.3 0.4 5.7 6.3 2.2 2.6 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9295682 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 3.1;testis: 5.9" "Group enriched" "Detected in some" 16 "Spermatocytes: 114.8;Spermatogonia: 96.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "U-266/70: 27.8;U-266/84: 32.1" HPA035135 Uncertain Uncertain Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.0 0.1 0.3 0.0 0.2 0.3 0.0 0.3 0.3 0.1 0.2 0.2 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 3.1 0.1 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.8 0.0 0.4 0.2 5.9 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 27.8 32.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.4 0.5 0.1 0.0 1.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 4.9 0.2 1.7 0.4 0.0 0.0 0.3 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 6.6 0.6 0.2 114.8 96.5 0.0 0.3 0.0 0.2 0.0 0.0 0.2 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536092 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 201.8;Excitatory neurons: 529.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 23.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 14.2 9.5 37.9 15.0 43.1 19.8 14.2 54.3 66.9 8.7 6.7 9.5 7.8 8.6 24.3 14.3 15.6 9.2 24.7 48.2 23.0 6.7 11.2 11.4 16.1 17.1 20.9 9.1 12.8 7.8 9.2 9.4 18.1 7.8 10.3 18.0 11.8 7.5 26.0 63.1 10.4 9.1 11.8 16.2 13.0 22.8 29.4 14.7 10.3 19.7 20.3 11.9 10.7 47.4 9.8 8.0 19.1 14.2 12.2 9.4 16.2 13.4 12.9 8.5 8.1 15.7 12.0 24.7 3.9 13.7 6.5 5.2 16.9 30.9 12.1 16.2 8.0 11.9 10.7 10.9 12.7 29.2 10.6 14.8 45.7 15.2 24.4 8.4 15.2 20.5 19.2 25.7 10.8 13.7 34.9 10.6 9.7 8.0 6.1 32.2 8.0 5.3 9.8 17.0 12.7 10.2 8.5 11.3 7.5 21.6 6.4 12.6 15.6 11.3 12.6 5.4 8.2 79.0 47.5 24.4 9.4 9.2 8.3 23.5 2.7 1.6 4.0 3.0 2.7 2.8 3.1 2.7 1.6 1.8 3.4 2.5 4.8 7.1 2.2 2.1 2.9 1.3 37.9 43.1 54.3 66.9 48.2 23.0 17.1 20.9 18.1 11.8 29.4 47.4 29.5 9.6 22.9 80.0 48.1 201.8 36.5 29.9 120.1 74.9 32.1 30.9 61.8 12.8 15.1 9.2 31.3 10.9 54.7 22.2 3.9 14.3 17.4 37.7 37.3 36.1 14.5 30.1 529.6 13.5 39.9 27.2 21.4 61.6 15.8 19.1 17.9 18.3 10.5 11.8 186.5 16.4 32.6 18.8 47.0 10.2 15.2 33.7 28.4 172.4 28.0 37.0 35.0 102.5 99.8 18.7 18.2 11.3 174.5 36.3 8.9 7.5 11.9 41.4 13.1 33.2 25.5 74.1 87.2 57.0 174.9 31.2 46.2 18.7 14.9 70.5 FCRL4 "CD307d, FCRH4, IGFP2, IRTA1" ENSG00000163518 "Fc receptor like 4" Q96PJ5 1 157573747-157598085 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 10.5" "Cell type enhanced" "Detected in single" "B-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "U-266/70: 4.6" "Not detected" "Not detected" HPA054030 Approved NA NA "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "HPA054030: " "unprognostic (6.06e-2)" "unprognostic (3.41e-3)" "unprognostic (2.57e-1)" "unprognostic (5.08e-2)" "unprognostic (4.69e-4)" "unprognostic (2.06e-2)" "unprognostic (6.38e-2)" "unprognostic (1.99e-1)" "unprognostic (2.14e-1)" "unprognostic (3.37e-1)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.3 0.0 0.0 0.2 0.0 0.0 10.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635185 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 86.0;U-266/70: 153.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 25.0 6.8 12.8 62.2 11.9 207.8 16.0 11.9 19.1 7.6 11.5 6.0 3.9 8.1 1.7 5.2 15.6 12.7 8.7 11.4 12.3 7.5 10.8 86.5 27.5 13.6 12.7 2.9 5.8 1.6 2.7 7.9 14.5 7.2 4.0 0.7 6.6 2.4 3.2 4.5 10.1 16.3 12.5 141.1 5.9 2.5 17.2 8.4 7.4 6.5 20.0 17.8 7.3 12.6 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1.7 29.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 3.8 5.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 153.1 2.1 6.5 0.0 19.5 0.0 30.8 381.4 229.4 189.5 469.1 11.3 54.0 15.8 89.1 196.1 84.0 8.0 78.4 272.9 264.5 405.2 9.0 1.2 494.1 12.8 11.9 11.9 19.1 11.4 12.3 13.6 12.7 14.5 12.5 17.2 12.6 8.6 6.4 20.0 0.0 24.9 2.8 0.6 0.2 0.0 0.0 0.4 0.6 1.6 1.5 5.7 1.8 0.0 0.5 55.2 0.0 0.0 0.0 0.3 0.1 0.2 14.9 0.0 7.4 0.2 0.2 0.7 2.7 1.5 0.1 13.3 0.1 6.8 1.9 56.8 0.0 0.1 0.0 0.0 182.2 63.8 0.7 0.3 155.9 1.8 6.5 159.7 0.1 259.5 1.0 0.4 0.0 1.2 0.0 4.2 0.4 0.0 0.7 1.5 0.0 0.0 0.7 0.6 0.2 0.5 0.5 1.1 1.0 28.0 0.0 0.0 2.5 FHIT "AP3Aase, FRA3B" ENSG00000189283 "Fragile histidine triad diadenosine triphosphatase" P49789 3 59747277-61251459 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 94.0" "Cell type enhanced" "Detected in many" "Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "naive CD4 T-cell: 87.6" "Lineage enriched" "Detected in all" 12 "T-cells: 87.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.5;U-266/70: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002684, HPA018840, HPA018909" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 12000 "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoli fibrillar center, Plasma membrane" "CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537" "unprognostic (2.36e-3)" "unprognostic (6.38e-2)" "unprognostic (1.59e-1)" "unprognostic (4.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.16e-2)" "unprognostic (2.77e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-1)" "unprognostic (6.77e-2)" "prognostic favorable (1.36e-4)" "unprognostic (1.54e-1)" "unprognostic (5.96e-2)" "unprognostic (1.29e-2)" "unprognostic (1.80e-2)" 5.6 24.4 13.7 6.2 18.3 8.0 9.0 13.0 17.3 5.4 94.0 6.9 6.4 3.5 6.9 5.0 6.6 9.8 15.8 19.7 16.4 24.9 9.6 4.7 7.6 18.9 17.0 6.8 13.0 18.1 7.9 3.0 18.9 5.3 5.8 7.6 8.5 4.7 10.6 8.1 5.3 4.7 15.0 5.0 8.6 5.5 15.9 12.1 11.7 7.2 5.3 6.7 4.2 19.8 0.1 0.0 1.4 0.0 0.6 0.1 2.5 0.1 0.2 0.1 0.0 2.7 4.2 4.0 0.7 0.1 3.0 0.0 12.7 3.2 0.0 2.2 5.0 3.3 2.0 6.4 3.3 8.7 0.1 9.1 5.2 0.2 6.9 0.3 0.0 3.7 2.5 11.9 0.2 3.6 15.2 6.7 1.2 12.2 0.9 11.3 0.0 17.5 15.3 2.0 2.9 4.3 1.5 9.9 10.1 5.3 0.4 0.2 0.0 1.7 0.4 0.1 2.4 34.6 11.3 0.0 4.0 0.1 1.9 6.8 4.6 0.5 2.2 2.9 1.4 4.1 17.2 1.8 5.7 3.1 87.6 15.6 0.8 7.2 1.3 5.8 20.5 11.9 13.7 18.3 13.0 17.3 19.7 16.4 18.9 17.0 18.9 15.0 15.9 19.8 4.1 6.4 10.6 609.8 19.7 7.6 20.7 30.0 46.7 12.6 41.2 31.2 10.0 38.6 17.5 27.6 58.4 42.0 12.4 6.9 78.2 19.1 45.8 14.6 7.9 7.0 7.7 17.7 276.6 4.7 8.5 10.1 18.3 19.0 5.7 25.7 14.6 23.4 20.9 30.3 450.5 12.9 22.4 10.2 7.1 163.0 19.3 12.9 12.4 337.3 8.6 19.7 6.2 1086.7 1111.0 9.7 15.0 9.8 23.8 12.0 20.7 126.6 12.4 20.7 0.0 10.7 6.2 19.1 7.5 33.7 11.2 32.7 11.5 23.0 20.1 18.8 FILIP1 "FILIP, KIAA1275" ENSG00000118407 "Filamin A interacting protein 1" Q7Z7B0 6 75291859-75493800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 582.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053564 Enhanced Approved "Plasma membrane,Actin filaments" No NA "Cluster 38: Heart - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane, Actin filaments" "HPA053564: AB_2682192" "unprognostic (4.90e-2)" "unprognostic (3.77e-2)" "unprognostic (9.77e-3)" "unprognostic (3.83e-1)" "unprognostic (1.52e-1)" "unprognostic (4.98e-1)" "unprognostic (2.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.17e-3)" "unprognostic (3.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-3)" "unprognostic (3.97e-3)" "unprognostic (2.34e-1)" "unprognostic (4.65e-2)" "unprognostic (7.66e-3)" 6.8 1.5 1.5 2.9 1.8 0.2 2.4 0.1 2.5 1.8 0.7 11.7 1.8 8.5 0.9 9.5 4.8 5.7 53.8 4.1 0.5 1.8 3.2 7.6 1.2 0.2 0.5 1.3 1.4 12.4 1.4 5.1 0.3 3.9 3.3 0.4 1.2 3.4 35.8 0.6 2.6 13.2 0.5 0.3 3.2 2.1 0.8 1.1 2.3 48.9 0.9 10.9 1.6 1.5 0.0 1.3 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 6.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.0 0.0 1.7 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.1 0.1 0.0 0.1 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.9 0.7 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 1.5 1.8 0.1 2.5 4.1 0.5 0.2 0.5 0.3 0.5 0.8 1.5 82.1 128.2 82.6 5.9 0.5 0.6 0.5 2.8 0.0 3.5 0.5 0.8 582.5 0.0 9.1 0.0 0.0 0.8 0.5 0.1 1.9 0.1 54.2 18.2 1.7 45.9 0.0 2.7 9.7 0.4 0.3 60.3 0.0 19.2 1.3 1.7 72.1 0.7 1.3 0.0 12.8 0.1 8.2 1.9 1.2 17.6 2.5 1.8 1.8 5.6 0.0 2.5 1.0 6.0 10.0 0.0 0.0 4.5 0.0 0.8 0.4 0.1 62.4 3.5 92.1 70.2 114.2 7.1 7.9 0.7 0.9 0.8 1.8 11.9 0.1 0.4 FMR1NB "CT37, FLJ25736, NY-SAR-35" ENSG00000176988 "FMR1 neighbor" Q8N0W7 X 147981337-148026665 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 333 "testis: 58.1" "Group enriched" "Detected in some" 10 "Spermatocytes: 502.2;Spermatogonia: 296.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "U-266/70: 67.5;U-266/84: 57.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA011284, CAB026403" Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "CAB026403: , HPA011284: AB_1078898" "unprognostic (2.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (4.38e-2)" "unprognostic (4.11e-3)" "unprognostic (2.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 67.5 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.1 0.1 0.0 0.5 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 18.4 5.6 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 39.5 0.0 0.0 502.2 296.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277978-109309284 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 11.4" "Cell type enhanced" "Detected in some" "Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.2 1.8 0.5 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.8 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 11.4 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 2.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMPD4 "KIAA0316, PDZD10, PDZK10" ENSG00000169933 "FERM and PDZ domain containing 4" Q14CM0 X 11822423-12724523 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.6;parathyroid gland: 3.7;retina: 4.1" "Group enriched" "Detected in some" 5 "Excitatory neurons: 941.1;Inhibitory neurons: 772.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;U-2197: 2.1;U-266/70: 3.3;U-266/84: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (2.05e-1)" "unprognostic (3.70e-2)" "unprognostic (3.50e-2)" "unprognostic (2.68e-3)" "unprognostic (8.84e-2)" "unprognostic (1.05e-2)" "unprognostic (3.56e-2)" "unprognostic (2.09e-2)" "unprognostic (1.62e-2)" "unprognostic (6.32e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.25e-1)" 0.0 0.0 4.6 0.0 4.5 0.0 0.0 0.1 7.6 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.7 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.1 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.1 0.0 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.2 3.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.5 0.1 7.6 4.3 0.3 0.0 0.8 0.0 0.0 1.7 3.5 0.2 0.0 0.0 50.3 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 3.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 941.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.2 772.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 11.2 0.0 0.5 0.0 39.7 11.7 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.2 0.0 0.0 FSD2 "RP11-127F21, SPRYD1" ENSG00000186628 "Fibronectin type III and SPRY domain containing 2" A1L4K1 15 82755362-82806070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "heart muscle: 52.3;skeletal muscle: 154.3;tongue: 44.3" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 81.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 3.6;U-266/70: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046263 Approved Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "HPA046263: AB_2679604" "unprognostic (2.80e-1)" "unprognostic (3.54e-1)" "unprognostic (6.63e-2)" "unprognostic (6.30e-2)" "unprognostic (7.71e-2)" "unprognostic (1.83e-1)" "unprognostic (5.97e-2)" "unprognostic (7.66e-2)" "unprognostic (1.07e-1)" "unprognostic (9.37e-2)" "unprognostic (3.05e-2)" "unprognostic (2.21e-1)" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-2)" "unprognostic (1.59e-2)" 0.2 0.7 0.2 0.9 0.2 0.8 0.1 0.7 0.4 0.0 0.0 0.1 0.9 0.4 0.6 1.9 0.3 0.3 52.3 0.3 0.5 0.3 0.1 0.2 1.1 0.1 0.1 0.6 0.6 0.7 0.1 0.3 0.2 1.2 0.0 2.4 0.8 0.0 154.3 1.5 0.8 0.1 0.0 0.6 0.6 0.7 0.3 0.0 0.9 44.3 0.1 0.1 0.0 0.6 0.7 0.7 1.1 1.3 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.6 1.2 2.3 0.5 0.0 0.6 2.8 0.0 0.0 0.2 0.4 3.1 1.3 3.6 1.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 0.7 0.0 1.0 1.2 2.0 0.0 0.7 0.4 1.4 1.0 0.5 0.6 0.8 0.8 0.6 0.1 1.3 1.1 0.9 0.5 0.5 0.9 0.5 0.9 1.0 0.5 1.6 0.8 0.6 1.0 4.7 2.1 0.8 1.0 2.8 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.7 0.4 0.3 0.5 0.1 0.1 0.2 0.0 0.3 0.6 0.4 0.0 2.2 1.3 0.2 0.4 1.0 0.2 0.0 2.1 0.5 0.3 81.6 1.5 0.8 0.0 6.2 0.1 0.3 0.1 0.0 0.0 4.8 1.7 0.3 1.2 1.2 0.0 3.9 0.4 0.1 3.0 0.0 1.6 1.3 0.6 0.0 0.0 0.3 11.8 3.6 0.0 2.0 0.3 2.1 6.1 0.3 0.2 0.0 1.0 0.1 0.7 0.0 4.0 3.3 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.5 4.5 0.0 4.5 0.6 0.6 0.3 0.0 0.6 0.3 0.4 0.2 0.1 0.3 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor subunit gamma1" Q8N1C3 4 46035769-46124054 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 44.7" "Cell type enriched" "Detected in some" 8 "Astrocytes: 135.5" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035622, HPA058102" Approved Supported "Plasma membrane" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" "HPA035622: AB_10603669, HPA058102: " "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 0.1 0.1 21.6 0.0 20.6 0.0 0.0 19.0 27.3 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.4 31.7 0.0 0.0 0.0 0.0 24.8 38.0 1.2 0.0 0.0 0.6 0.0 23.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.1 0.0 0.2 44.7 0.0 0.1 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 20.6 19.0 27.3 19.4 31.7 24.8 38.0 23.9 21.1 44.7 23.1 0.3 0.0 0.0 135.5 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 11.2 0.0 15.4 0.0 2.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.6 0.0 1.8 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GABRR2 ENSG00000111886 "Gamma-aminobutyric acid type A receptor subunit rho2" P28476 6 89254464-89315299 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "retina: 31.4" "Cell type enriched" "Detected in some" 18 "Bipolar cells: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2;U-266/70: 5.1;U-266/84: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.05e-2)" "unprognostic (1.47e-4)" "unprognostic (1.56e-1)" "unprognostic (1.88e-4)" "unprognostic (4.19e-1)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (9.13e-2)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-1)" "unprognostic (1.41e-1)" "unprognostic (1.54e-6)" "unprognostic (3.69e-2)" "unprognostic (7.81e-2)" "unprognostic (5.79e-2)" "unprognostic (7.15e-3)" 0.4 0.3 0.5 1.2 0.4 0.7 0.2 0.7 0.6 0.2 0.3 0.3 0.7 0.5 0.4 0.1 0.1 0.3 0.2 0.4 0.3 0.4 0.1 0.3 0.8 0.5 0.6 0.2 0.1 0.0 0.0 0.3 0.5 0.3 0.4 31.4 0.3 0.2 0.8 0.3 0.7 0.3 0.3 0.8 0.3 0.2 0.6 1.2 0.3 0.2 0.6 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 2.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.1 0.8 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.6 0.0 0.7 0.1 0.2 0.1 0.0 0.3 5.1 1.4 0.2 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.7 0.6 0.4 0.3 0.5 0.6 0.5 0.3 0.6 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.3 0.0 1.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALM ENSG00000143891 "Galactose mutarotase" Q96C23 2 38666081-38741237 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 86.5;kidney: 120.2" "Cell type enhanced" "Detected in many" "Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 68.3" "Group enriched" "Detected in all" 5 "granulocytes: 39.1;T-cells: 68.3" "Cell line enhanced" "Detected in many" "Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035472, HPA035473, HPA064835" Enhanced Approved Nucleoplasm NA NA 620000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723" "unprognostic (5.02e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (9.20e-2)" "unprognostic (1.88e-2)" "unprognostic (9.99e-3)" "unprognostic (1.63e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (6.65e-2)" "unprognostic (6.45e-2)" "prognostic favorable (9.06e-5)" "unprognostic (1.70e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "prognostic favorable (1.32e-4)" 9.0 86.5 5.2 12.2 5.1 3.8 10.4 6.0 6.1 9.3 8.3 34.7 71.4 8.1 23.0 5.8 35.8 16.5 13.0 4.9 4.8 120.2 72.5 14.3 16.0 5.4 6.1 15.5 15.0 21.3 3.0 7.7 5.4 10.2 33.3 4.4 8.7 20.8 13.1 3.8 52.8 10.4 5.7 6.6 14.9 4.4 7.0 11.0 15.1 12.3 10.2 10.8 6.4 6.0 0.2 27.1 8.1 0.0 27.3 15.4 14.9 3.2 10.3 7.5 12.2 32.4 14.4 10.9 18.9 15.3 14.5 4.3 11.7 0.7 14.5 49.5 19.3 5.9 7.1 62.7 10.0 2.4 0.4 11.1 0.4 17.5 0.0 10.5 8.2 0.0 17.2 71.1 13.9 0.9 23.4 41.0 12.4 59.2 8.6 15.2 0.6 21.3 9.3 45.1 1.5 11.2 0.1 18.9 14.7 10.2 9.0 5.4 3.4 2.5 0.5 18.6 1.0 76.4 54.3 0.3 17.9 7.0 0.3 39.1 4.8 4.2 21.5 3.3 31.8 6.8 33.1 31.2 10.3 4.7 11.7 10.2 11.3 5.5 0.7 0.8 68.3 11.9 5.2 5.1 6.0 6.1 4.9 4.8 5.4 6.1 5.4 5.7 7.0 6.0 9.7 28.9 11.0 13.4 10.0 6.6 6.7 3.4 10.8 3.6 7.8 4.2 23.4 24.3 6.5 69.9 0.0 23.6 19.0 83.2 25.4 12.1 1.4 28.5 11.6 10.0 13.2 8.2 2.3 15.1 31.4 16.1 17.9 10.1 7.0 16.8 14.6 48.1 94.8 3.3 1.4 40.5 4.1 18.6 43.6 1.3 20.2 34.7 17.8 4.7 9.9 38.2 18.6 0.5 1.3 6.8 64.5 97.8 14.7 5.7 161.1 222.1 14.8 6.8 6.6 16.6 10.4 1.0 2.3 3.2 6.0 6.3 44.0 43.3 80.4 5.7 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "kidney: 2099.3;liver: 2804.2;pancreas: 2935.3" "Group enriched" "Detected in many" 8 "Hepatocytes: 1495.2;Proximal tubular cells: 3703.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 11.0;dendritic cells: 6.8" "Group enriched" "Detected in many" 4 "RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria NA NA 600000 "Cluster 43: B-cells - Humoral immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 14.4 21.4 133.9 12.4 138.4 1.8 25.4 152.5 216.5 9.9 94.3 19.6 175.5 8.4 10.5 25.1 11.6 47.7 57.2 131.1 140.9 2099.3 2804.2 7.3 18.4 148.0 135.4 165.2 2935.3 2.7 8.3 74.7 153.4 12.4 11.5 7.5 57.5 15.1 142.5 137.6 110.2 14.5 149.2 33.6 99.2 78.2 140.4 12.6 63.0 46.9 29.7 18.0 15.5 181.2 12.9 6.5 4.4 0.6 0.1 0.2 0.8 0.1 0.1 0.0 0.2 1.4 21.4 34.4 1.0 0.0 5.7 2.2 17.0 0.6 0.4 1.9 0.3 2.8 0.4 0.3 0.8 20.7 2.6 0.8 0.7 0.0 0.4 0.0 0.3 7.8 0.4 0.7 0.2 0.6 2.2 0.6 11.2 31.3 0.0 0.5 210.1 1.5 3.5 55.8 23.5 4.1 6.9 0.4 1.2 2.1 2.9 23.7 0.0 0.0 0.5 0.2 6.3 126.3 165.5 0.8 1.6 0.3 1.0 0.0 1.1 0.3 0.2 1.6 0.0 11.0 0.0 0.2 6.6 5.4 0.0 1.4 0.0 0.1 0.6 6.8 0.0 1.0 133.9 138.4 152.5 216.5 131.1 140.9 148.0 135.4 153.4 149.2 140.4 181.2 2.4 3.2 1.1 67.3 42.3 54.3 14.9 5.2 5.7 8.1 16.9 9.5 35.5 228.8 5.4 71.7 0.0 1.0 0.8 3.1 295.4 58.2 8.8 1.3 0.4 7.3 0.0 29.3 6.8 290.0 1.2 19.8 69.8 2.7 3.8 219.5 23.9 1495.2 89.6 8.4 3.3 3.1 2.0 80.3 80.3 18.3 4.4 50.6 23.2 20.6 3.1 19.1 2.1 57.3 196.3 97.3 3.9 3.4 7.2 6.4 98.4 3703.0 1.9 3.8 6.6 38.4 16.8 22.0 9.7 16.0 133.7 1.8 17.6 4.1 3.4 20.4 GEM KIR ENSG00000164949 "GTP binding protein overexpressed in skeletal muscle" P55040 8 94249253-94262350 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 229.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 721.1;Fibroblasts: 395.9;Langerhans cells: 155.5;Smooth muscle cells: 359.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "myeloid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 83.0;U-266/70: 140.6;U-87 MG: 104.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 24.3" HPA024798 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA024798: AB_10602137" "unprognostic (1.24e-1)" "unprognostic (2.12e-1)" "unprognostic (4.82e-3)" "unprognostic (1.22e-1)" "unprognostic (4.76e-1)" "unprognostic (3.94e-1)" "unprognostic (2.17e-1)" "unprognostic (4.00e-1)" "unprognostic (1.45e-1)" "unprognostic (9.04e-2)" "unprognostic (7.92e-2)" "unprognostic (9.15e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (1.65e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.93e-3)" 56.1 58.4 10.9 35.6 9.6 2.6 36.7 8.3 12.3 57.9 38.7 105.7 16.6 97.2 9.7 59.5 39.0 229.6 63.4 11.0 20.8 32.3 20.2 33.1 23.8 12.7 12.2 19.9 15.7 2.9 27.3 7.3 11.0 31.7 35.9 44.4 13.1 16.8 4.2 10.9 31.1 77.3 8.4 21.9 48.0 3.8 12.2 12.6 23.6 10.8 14.2 90.6 33.6 12.3 1.6 6.1 2.7 0.6 22.9 30.4 0.4 16.1 83.0 21.4 29.8 2.3 4.1 0.0 1.0 6.1 40.1 0.5 2.7 1.4 28.0 12.2 1.4 0.0 0.6 0.0 3.0 0.0 26.3 13.1 0.1 34.1 18.9 24.4 0.9 1.4 0.7 2.7 12.7 0.8 1.0 0.2 4.0 3.4 18.3 0.0 4.9 0.1 7.8 0.0 20.4 12.1 0.0 0.1 2.8 3.4 2.0 0.1 1.2 29.4 8.1 19.2 33.4 140.6 0.9 0.1 104.7 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 10.9 9.6 8.3 12.3 11.0 20.8 12.7 12.2 11.0 8.4 12.2 12.3 18.4 6.4 25.4 22.2 8.9 68.1 85.7 9.6 721.1 26.8 8.6 35.1 90.8 4.3 4.0 1.8 18.8 0.4 4.1 8.2 0.0 7.3 4.7 26.0 49.2 19.0 25.0 0.0 0.7 0.4 1.4 395.9 54.0 50.3 13.4 1.0 7.1 0.1 2.8 30.3 3.4 2.6 2.0 0.6 155.5 0.3 3.4 43.3 92.5 0.0 0.8 41.9 0.0 0.0 0.3 2.7 17.2 5.7 46.5 20.2 2.1 2.6 1.2 21.4 32.9 55.5 359.5 1.3 1.1 24.1 49.9 3.4 33.4 0.9 4.2 10.6 GET1-SH3BGR ENSG00000285815 "GET1-SH3BGR readthrough" 21 39380332-39515506 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 6.1;skeletal muscle: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.1;U-266/70: 6.7" HPA018527 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA018527: AB_1858860" 0.9 1.8 2.2 0.0 2.3 0.2 0.6 2.3 2.2 0.6 2.5 0.3 0.5 0.8 0.6 0.1 0.7 0.7 1.2 1.9 2.3 0.5 0.2 0.2 0.4 2.9 2.2 1.5 0.6 0.2 0.6 2.4 0.5 0.2 6.1 0.3 0.8 4.8 0.1 0.4 0.2 2.1 0.4 0.5 0.8 2.4 0.2 0.4 1.3 0.3 0.3 3.6 0.4 0.0 0.0 0.9 2.2 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.8 0.7 1.9 0.3 0.3 0.0 0.6 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.3 3.1 0.3 0.1 0.7 1.6 0.0 0.0 1.3 0.1 0.4 0.2 0.0 1.6 0.8 0.2 1.0 0.0 0.5 0.4 0.7 0.4 1.8 0.8 0.0 0.8 0.0 0.5 0.0 0.1 0.4 6.7 1.8 0.9 1.6 1.4 0.2 1.7 0.2 0.0 0.6 0.4 1.2 1.1 0.3 0.3 0.4 0.2 0.9 0.8 1.9 1.0 0.3 4.6 0.3 0.3 2.2 2.3 2.3 2.2 1.9 2.3 2.9 2.2 2.4 2.1 2.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLCCI1 "FAM117C, GIG18, TSSN1" ENSG00000106415 "Glucocorticoid induced 1" Q86VQ1 7 7968796-8094272 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.7" "Cell type enhanced" "Detected in all" "Excitatory neurons: 193.3;Inhibitory neurons: 149.3;Oligodendrocyte precursor cells: 276.5;Plasma cells: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 37.7;U-266/70: 86.8;U-698: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001674, HPA005987" Approved Approved Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 3: T-cells - Adaptive immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli "HPA001674: AB_1078971, HPA005987: AB_1078970" "unprognostic (6.12e-2)" "unprognostic (7.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.45e-1)" "unprognostic (6.17e-3)" "unprognostic (1.02e-2)" "unprognostic (4.40e-1)" "unprognostic (1.68e-3)" "unprognostic (3.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.17e-3)" "unprognostic (3.35e-1)" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.56e-1)" "unprognostic (3.09e-1)" "unprognostic (9.20e-3)" 4.4 3.5 0.7 7.1 4.4 7.4 3.2 6.0 7.4 4.3 0.0 4.5 5.2 2.5 1.0 2.0 2.0 3.4 1.2 0.7 3.1 3.1 3.4 8.9 12.2 0.9 0.8 4.2 1.1 4.9 2.1 3.8 0.8 2.7 4.0 7.4 3.8 1.6 2.1 4.0 3.8 2.2 0.0 7.1 5.3 10.9 2.4 33.7 16.7 1.6 14.8 4.4 1.4 5.7 5.3 0.8 8.4 2.1 2.5 3.6 1.7 4.4 6.1 2.5 2.4 2.7 1.7 14.3 1.0 3.6 4.3 0.8 7.7 2.3 3.3 7.2 6.0 4.3 10.1 1.9 4.1 6.8 6.0 1.7 2.8 1.7 5.6 4.2 2.3 5.3 15.7 37.7 4.5 3.0 3.1 6.7 20.9 2.3 5.2 15.3 6.3 7.7 2.5 6.0 13.8 26.9 6.7 8.2 0.5 22.3 9.8 17.5 1.9 4.6 2.0 4.1 2.3 86.8 29.8 40.4 4.8 7.0 3.5 2.0 0.0 0.7 1.1 0.1 1.0 0.7 1.1 0.8 0.0 1.4 0.6 0.7 0.5 2.1 0.0 1.0 2.0 0.2 0.7 4.4 6.0 7.4 0.7 3.1 0.9 0.8 0.8 0.0 2.4 5.7 7.2 83.3 49.5 98.9 28.5 10.3 8.2 4.3 5.7 63.4 13.3 11.2 6.9 1.5 21.6 7.3 43.8 11.6 50.2 3.6 1.9 1.2 87.6 9.5 12.8 4.0 19.3 6.9 193.3 1.6 11.4 8.0 4.6 10.2 5.7 41.5 6.4 9.2 13.5 8.4 149.3 7.6 8.2 2.7 4.6 20.5 8.1 9.4 8.8 112.4 3.1 19.4 71.1 276.5 73.2 3.4 2.6 11.3 132.0 19.6 2.4 2.0 15.4 21.5 6.6 6.6 9.8 76.0 36.0 8.1 13.1 28.7 36.1 8.5 4.3 13.6 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-122" ENSG00000186417 Gliomedin Q6ZMI3 15 51341655-51408005 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.8" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 510.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050873, HPA059441" Uncertain Supported "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA 410000 "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Plasma membrane" "HPA050873: , HPA059441: AB_2684018" "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 18.5 2.3 18.1 1.6 51.1 0.7 9.7 35.0 28.6 1.8 0.0 3.5 0.2 0.5 0.5 0.5 1.2 3.4 5.0 15.5 31.2 0.4 0.1 8.7 0.2 47.6 48.9 0.5 0.5 0.4 0.6 3.9 56.4 2.4 6.4 1.3 1.4 0.7 1.0 5.0 0.6 0.6 26.0 2.9 2.1 0.2 41.7 0.1 0.8 0.9 0.2 1.5 1.5 84.8 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.3 2.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 18.1 51.1 35.0 28.6 15.5 31.2 47.6 48.9 56.4 26.0 41.7 84.8 40.1 0.0 2.6 2.0 0.0 6.2 0.0 0.3 0.0 9.2 0.2 0.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 47.0 0.0 0.0 0.0 0.0 0.1 3.7 1.2 0.0 7.4 0.0 0.6 7.9 4.6 0.2 0.0 4.5 0.0 0.2 4.9 0.0 17.2 1.7 0.0 14.9 9.5 0.0 0.3 16.1 3.6 42.2 0.0 0.3 0.0 2.0 510.8 0.1 28.6 0.0 0.0 0.1 0.0 0.1 0.9 0.8 0.0 4.7 9.8 0.1 0.1 0.0 4.0 100.4 0.6 0.4 5.1 1.6 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702694 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "brain: 360.9" "Cell type enhanced" "Detected in many" "B-cells: 145.4;Distal tubular cells: 123.3;Horizontal cells: 169.9;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 206.1;Plasma cells: 169.7" "Cancer enhanced" "Detected in all" "glioma: 21.9;melanoma: 20.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0" "Group enriched" "Detected in many" 4 "B-cells: 57.2;dendritic cells: 48.0" "Cell line enhanced" "Detected in many" "Daudi: 22.3;REH: 66.5;SK-MEL-30: 31.2;U-266/70: 61.0;U-266/84: 30.0" "Region enriched" "Detected in all" 6 "basal ganglia: 1277.2" HPA057790 Supported Supported NA NA 72000 "Cluster 43: B-cells - Humoral immune response" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "HPA057790: AB_2683527" "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favorable (3.05e-4)" "prognostic favorable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favorable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favorable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.5 5.7 70.8 5.3 360.9 6.6 4.4 83.9 127.9 5.5 14.0 6.7 5.2 7.2 5.1 12.0 8.2 3.5 26.4 70.1 66.0 10.5 4.2 4.0 9.9 97.2 87.9 12.2 8.0 6.2 17.4 1.4 76.8 9.5 3.1 15.1 26.0 5.7 3.4 2.6 14.2 3.5 76.0 19.4 6.8 8.9 154.1 2.7 5.8 8.1 9.4 7.9 3.3 81.4 0.2 0.0 3.2 7.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.7 22.3 1.0 0.3 0.3 0.2 3.5 0.0 0.1 0.0 3.1 0.6 0.1 2.7 1.6 0.0 12.9 0.4 0.5 0.0 0.2 0.2 0.0 2.7 0.3 14.2 0.0 2.2 0.6 1.4 2.6 0.4 1.4 66.5 0.0 6.2 0.3 0.0 0.1 9.2 0.1 0.1 31.2 2.1 0.4 5.6 0.1 0.1 3.0 0.2 0.2 61.0 30.0 4.7 0.2 7.0 16.5 3.5 1.5 8.0 0.4 0.5 1.1 57.2 0.5 0.4 6.0 50.1 1.2 0.7 11.8 0.2 0.1 48.0 0.0 3.0 70.8 360.9 83.9 127.9 70.1 66.0 97.2 87.9 76.8 76.0 154.1 81.4 14.5 6.4 4.2 40.8 145.4 2.5 13.0 0.3 5.2 10.5 22.9 30.1 55.1 15.7 3.3 9.2 8.4 0.6 56.1 0.9 123.3 17.0 5.4 2.1 2.3 11.7 6.1 8.6 26.5 4.8 1.1 6.6 5.6 3.5 12.7 8.6 19.2 11.4 63.2 169.9 38.8 2.0 0.0 8.5 15.0 11.4 2.5 12.3 51.6 45.9 11.2 84.7 3.1 102.5 206.1 2.7 1.8 2.6 169.7 7.5 0.7 22.6 2.9 11.1 6.6 7.1 5.4 2.7 2.6 1.5 2.0 3.4 6.9 2.1 2.2 7.2 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "liver: 4.1;testis: 15.1" "Cell type enriched" "Detected in some" 8 "Early spermatids: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 15.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L2 "CT105, FLJ36144" ENSG00000174450 "Golgin A6 family like 2" Q8N9W4 15 23439038-23447243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "testis: 53.7" "Cell type enriched" "Detected in some" 8 "Early spermatids: 567.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-266/70: 5.0;U-266/84: 1.2" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.45e-1)" "unprognostic (4.86e-2)" "unprognostic (4.12e-1)" "unprognostic (1.92e-2)" "unprognostic (1.24e-1)" "unprognostic (5.52e-2)" "unprognostic (8.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 567.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 64.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GOLGA6L4 ENSG00000184206 "Golgin A6 family like 4" A6NEF3 15 84235773-84245368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Early spermatids: 118.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 1.1;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 1.1;NK-cells: 2.3" "Cell line enhanced" "Detected in many" "HEK 293: 4.3;U-266/70: 5.7" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (3.66e-1)" "unprognostic (3.74e-1)" "unprognostic (3.53e-1)" "unprognostic (6.83e-2)" "unprognostic (4.49e-2)" "unprognostic (1.41e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-1)" "unprognostic (7.23e-2)" "unprognostic (6.23e-2)" "unprognostic (1.72e-3)" "unprognostic (4.70e-2)" "unprognostic (1.48e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" 6.7 7.1 1.5 1.3 1.5 2.2 6.3 1.0 2.8 8.8 1.9 5.7 0.8 5.9 3.5 4.2 5.5 1.7 4.4 1.5 1.7 4.9 4.9 4.7 1.3 1.4 1.3 15.0 6.3 0.9 4.8 1.3 1.4 5.8 1.8 3.1 4.4 1.3 2.9 4.5 3.9 1.8 1.2 3.3 4.2 10.2 1.3 0.7 6.3 1.1 0.7 5.6 7.6 1.5 0.2 0.1 1.4 1.6 1.7 1.6 0.1 1.3 0.5 0.0 0.4 0.0 0.3 1.1 1.3 1.1 0.5 0.3 1.1 0.4 0.3 0.7 4.3 0.7 1.4 1.1 0.4 1.5 2.1 0.6 0.7 0.2 0.4 2.1 2.1 1.7 2.6 1.8 0.8 1.0 0.1 1.3 0.6 0.0 0.5 0.3 0.3 1.0 1.3 1.4 0.6 1.1 0.8 0.6 0.9 2.9 0.6 1.0 1.6 0.4 1.0 1.2 1.3 5.7 1.8 0.5 0.6 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 2.3 0.0 0.2 0.0 0.0 1.5 1.5 1.0 2.8 1.5 1.7 1.4 1.3 1.4 1.2 1.3 1.5 5.0 0.0 2.0 0.0 0.9 3.6 1.6 2.1 1.2 7.8 2.1 2.8 1.2 1.5 3.8 1.8 12.5 1.1 1.7 0.6 0.0 4.3 118.3 2.8 6.6 5.0 1.2 0.8 0.2 4.4 0.1 5.9 5.6 4.9 5.1 8.3 4.6 3.9 1.8 0.0 0.1 0.4 0.0 1.6 7.7 17.1 6.8 2.2 7.2 0.0 0.7 3.0 2.1 0.0 0.0 11.2 2.7 5.7 1.7 1.5 0.4 0.6 2.3 8.7 13.1 6.0 5.9 22.8 4.7 2.7 4.5 0.8 3.4 10.9 1.2 0.7 GOLGA6L7 GOLGA6L7P ENSG00000261649 "Golgin A6 family like 7" A0A1B0GV03 15 28841833-28848675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;U-266/70: 1.3;U-266/84: 1.3" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (3.65e-5)" "unprognostic (3.84e-1)" "unprognostic (6.81e-2)" "unprognostic (1.66e-2)" "unprognostic (5.10e-2)" "unprognostic (5.62e-11)" "unprognostic (2.53e-1)" "unprognostic (3.14e-1)" "unprognostic (2.59e-1)" 0.0 0.2 0.7 0.0 0.5 0.1 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.5 1.0 0.3 0.1 1.4 0.6 1.6 0.1 0.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 GOLM1 "bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73" ENSG00000135052 "Golgi membrane protein 1" Q8NBJ4 9 86026146-86100173 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 396.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6" "Cancer enhanced" "Detected in all" "prostate cancer: 343.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 372.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010638, HPA011929, CAB015341" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 81000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" "unprognostic (1.10e-1)" "prognostic favorable (8.14e-5)" "unprognostic (1.97e-1)" "unprognostic (4.40e-3)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.89e-3)" "unprognostic (2.81e-1)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" "unprognostic (5.59e-3)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (2.87e-3)" "unprognostic (1.23e-1)" 22.2 159.8 72.5 33.8 78.8 6.6 39.5 69.2 84.5 70.0 99.0 195.7 235.1 40.1 15.7 13.6 38.1 131.0 12.7 72.1 93.8 74.7 19.0 14.7 9.7 73.4 76.1 36.9 41.6 37.6 36.4 17.2 69.9 143.2 163.9 25.5 173.4 10.5 9.4 14.9 61.3 28.4 80.1 41.7 396.2 17.4 108.0 45.4 68.1 4.8 5.6 38.3 14.9 79.2 146.0 139.5 102.4 116.7 129.3 74.3 108.0 64.8 46.6 99.9 80.5 69.4 282.9 2.7 62.6 126.2 96.6 109.4 63.7 64.1 71.9 5.0 101.2 45.3 89.1 3.4 76.8 67.3 34.9 113.4 34.2 94.1 34.0 124.9 172.9 21.2 28.7 4.2 57.3 68.4 8.3 49.6 161.9 188.9 99.6 42.9 116.9 21.8 166.0 61.2 115.1 72.0 88.2 189.0 73.8 66.1 106.7 68.1 110.5 25.9 72.6 79.3 78.3 372.3 37.4 0.9 112.2 29.8 57.8 1.9 3.6 0.4 3.5 2.6 0.4 0.6 0.2 0.5 0.4 0.6 0.4 0.7 4.2 0.7 4.2 1.5 0.1 1.8 72.5 78.8 69.2 84.5 72.1 93.8 73.4 76.1 69.9 80.1 108.0 79.2 13.8 9.6 15.3 30.3 1.7 2.3 10.8 11.3 4.6 20.1 41.4 21.1 4.9 80.1 80.9 35.0 8.4 8.4 10.7 362.8 25.4 168.4 339.0 78.0 49.8 20.5 73.1 11.2 47.0 222.2 35.0 30.4 245.6 56.8 1.3 65.9 8.6 11.1 11.8 67.3 43.2 95.5 325.5 5.0 2.6 391.6 18.3 6.6 23.2 6.5 6.9 16.9 12.3 82.0 19.3 282.9 265.2 13.2 3.2 72.6 71.8 16.0 78.6 6.7 0.0 13.5 19.5 10.3 38.7 2.9 1.0 6.4 5.2 60.7 245.6 29.1 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 83.4;stomach 1: 52.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.3 9.7 8.7 5.9 16.3 2.3 2.4 6.5 12.1 2.4 83.4 10.2 3.8 1.9 12.3 5.9 1.6 5.7 7.0 12.2 5.3 20.1 7.3 3.0 6.3 5.5 5.3 2.5 18.2 8.9 2.3 4.4 5.2 7.5 3.7 10.0 3.6 8.4 4.7 13.2 4.0 6.1 3.5 5.4 52.6 2.2 7.1 3.0 8.3 4.4 3.6 4.1 2.7 6.1 0.7 0.3 0.8 2.0 4.9 2.7 0.5 3.8 1.3 0.6 2.1 0.3 0.2 2.2 1.2 2.8 1.3 0.2 1.3 1.1 2.1 0.8 1.5 2.3 1.1 0.2 0.9 0.7 1.1 3.9 3.1 1.9 0.6 4.0 1.0 3.0 0.3 5.5 4.2 0.6 1.6 0.8 0.4 2.3 1.5 1.9 5.6 1.0 2.0 1.3 5.9 5.0 1.2 0.8 2.0 2.5 0.3 0.3 2.6 2.7 1.0 3.9 0.5 14.6 2.2 0.3 3.0 0.6 9.9 1.3 2.2 0.1 1.8 4.0 1.6 1.1 3.1 2.9 0.6 1.0 2.5 3.9 7.3 3.6 5.7 0.3 5.5 1.4 8.7 16.3 6.5 12.1 12.2 5.3 5.5 5.3 5.2 3.5 7.1 6.1 18.5 12.8 3.6 31.3 9.8 42.7 4.0 4.0 29.0 34.9 5.8 6.1 26.0 2.8 6.8 11.0 125.1 1.5 12.2 0.6 1.9 1.9 0.7 1.4 24.1 9.8 12.7 15.2 99.4 6.0 1.2 9.7 9.7 0.6 1.3 4.0 16.1 16.1 6.1 50.5 131.1 0.8 2.0 50.4 23.0 1.8 14.9 27.0 152.9 8.4 34.3 16.7 11.3 130.2 21.2 3.5 0.1 32.0 14.3 3.1 0.4 41.7 0.5 25.8 0.0 16.9 9.5 3.3 3.2 7.5 28.6 0.8 25.7 52.4 1.0 1.8 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037995-170085392 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.9;parathyroid gland: 216.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006970 Approved Supported "Plasma membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 12.2 1.7 0.7 15.9 1.0 107.9 22.5 1.0 1.6 11.2 0.9 72.0 73.8 5.8 57.9 2.9 5.4 18.6 1.0 0.6 0.7 59.8 4.1 15.0 27.9 1.4 0.9 0.6 18.4 216.6 1.4 4.1 1.1 26.7 72.6 104.7 19.3 6.3 1.3 1.2 98.6 4.4 0.8 25.2 43.0 5.2 0.9 9.5 6.7 2.7 30.4 26.8 1.0 1.2 64.2 1.5 0.3 0.5 0.3 0.4 15.6 0.4 0.5 0.4 1.9 11.7 8.1 29.4 12.9 0.6 4.0 0.7 8.8 0.5 1.0 45.9 17.7 19.1 1.0 24.3 0.2 38.2 24.8 0.2 0.9 2.0 2.3 2.8 1.4 13.7 6.4 73.9 0.4 41.5 2.9 8.4 10.3 39.1 2.4 5.3 1.1 123.9 32.3 86.8 6.1 1.8 0.8 95.8 4.5 8.2 55.9 197.2 1.9 0.2 0.4 7.1 4.8 206.2 127.9 51.4 0.8 40.3 2.8 2.9 1.1 9.3 0.5 0.4 1.0 8.0 1.0 0.4 2.4 12.3 3.0 1.1 11.3 0.4 0.2 3.2 0.3 1.2 0.7 1.0 1.0 1.6 0.6 0.7 1.4 0.9 1.1 0.8 0.9 1.2 35.2 9.6 51.1 0.7 25.9 0.4 3.2 4.1 0.0 9.5 48.5 18.3 1.0 28.6 22.7 62.5 39.6 3.1 11.6 88.9 54.8 10.3 33.7 20.6 4.4 8.7 194.8 0.4 1.5 72.0 21.1 1.0 50.0 54.0 1.3 0.1 20.0 0.9 7.4 15.2 0.6 133.9 18.3 11.7 11.2 36.3 0.6 17.0 28.4 7.5 62.3 16.6 0.0 1.0 0.9 60.3 118.6 0.4 56.8 25.4 362.1 151.4 27.9 153.2 0.0 0.8 1.4 7.4 13.1 0.9 0.9 27.2 4.2 1.2 199.7 35.5 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203216 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.3" "Cell type enriched" "Detected in some" 4 "T-cells: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 110.3" "Lineage enriched" "Detected in many" 15 "T-cells: 110.3" "Cell line enriched" "Detected in some" 25 "U-266/70: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 3.7 1.6 0.5 21.3 1.5 1.2 1.9 1.7 3.8 4.3 12.3 4.3 4.5 1.5 0.5 2.5 3.0 6.2 0.9 1.1 0.4 1.3 4.3 6.4 17.4 2.5 0.7 0.8 0.7 0.2 0.5 0.5 0.7 1.9 4.6 0.0 1.7 0.8 0.2 0.9 12.9 1.1 0.1 13.0 5.9 0.3 1.1 13.0 1.8 0.1 11.3 9.3 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 3.5 27.9 0.2 110.3 0.0 40.2 53.5 2.3 0.5 24.1 21.1 0.8 7.3 0.5 2.2 21.4 9.4 0.5 1.5 1.7 3.8 1.1 0.4 2.5 0.7 0.7 0.1 1.1 1.2 0.4 0.0 2.2 0.3 2.3 1.1 0.4 0.0 0.6 4.8 0.3 0.3 1.0 0.0 1.3 0.0 2.1 0.4 25.8 0.1 0.0 0.0 0.2 0.1 0.6 0.5 0.0 2.7 0.8 0.0 0.0 2.3 4.6 0.1 2.5 0.0 1.8 1.6 0.1 21.9 0.3 0.5 0.0 2.2 8.1 0.1 0.0 4.8 0.0 0.0 14.0 5.7 6.2 0.5 0.0 0.0 0.0 0.0 14.9 0.2 0.0 0.5 0.0 0.1 0.0 0.5 1.2 0.8 0.7 0.1 0.6 0.7 107.6 0.1 0.0 0.3 GPR25 ENSG00000170128 "G protein-coupled receptor 25" O00155 1 200872981-200874178 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "stomach 1: 2.0" "Group enriched" "Detected in some" 7 "Plasma cells: 15.1;T-cells: 6.9" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 27.5;T-reg: 44.1" "Group enriched" "Detected in many" 57 "B-cells: 14.4;T-cells: 44.1" "Cell line enriched" "Detected in single" 6 "U-266/70: 1.3" "Low region specificity" "Detected in many" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.80e-3)" "unprognostic (1.73e-2)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (2.21e-3)" "unprognostic (4.49e-5)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-2)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (1.29e-6)" "unprognostic (1.48e-2)" "unprognostic (3.71e-2)" "unprognostic (2.42e-2)" "unprognostic (3.22e-6)" 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 2.0 0.4 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 11.2 14.4 27.5 8.6 0.0 1.4 0.8 2.4 0.2 0.5 0.0 0.1 44.1 6.3 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.0 0.0 0.0 GPR89B "GPR89, GPR89C, SH120" ENSG00000188092 "G protein-coupled receptor 89B" P0CG08 1 147928393-147993592 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA076096 Approved "Endoplasmic reticulum" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum" "HPA076096: AB_2686777" "unprognostic (7.78e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.19e-3)" "unprognostic (1.05e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-4)" "unprognostic (1.23e-2)" "unprognostic (2.38e-2)" "unprognostic (1.61e-1)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.69e-1)" "unprognostic (7.15e-4)" 6.1 7.1 5.3 0.2 5.0 3.1 6.4 7.7 8.2 7.7 5.6 5.4 1.7 6.8 2.5 5.7 6.2 1.8 5.6 5.2 5.4 12.5 7.2 5.4 1.4 7.9 6.6 6.6 4.4 3.1 4.8 2.1 8.6 6.2 2.2 2.0 7.3 2.5 8.8 8.5 7.0 1.1 5.5 5.0 6.4 10.5 5.8 2.6 4.8 6.0 1.3 6.3 6.2 7.2 5.8 0.3 3.5 3.8 5.9 4.1 6.5 4.4 1.8 6.3 9.1 7.7 4.3 4.8 5.1 5.7 4.8 5.4 7.7 0.8 5.3 5.9 6.8 6.6 2.1 4.1 6.3 0.4 3.0 2.0 9.0 5.6 10.4 2.2 3.4 8.2 2.7 8.5 3.5 12.3 9.8 4.4 5.9 6.4 4.4 3.9 9.8 6.8 6.4 5.8 3.0 2.8 9.0 2.2 5.0 5.2 7.2 4.0 1.8 2.5 1.4 2.6 6.5 17.6 11.2 8.0 5.6 4.1 2.8 3.5 2.5 2.4 2.3 1.9 3.3 2.2 3.2 2.4 1.8 3.0 3.1 2.7 1.3 4.4 1.5 2.0 2.6 2.1 5.3 5.0 7.7 8.2 5.2 5.4 7.9 6.6 8.6 5.5 5.8 7.2 4.4 6.4 5.3 11.1 16.3 0.1 8.2 0.1 24.5 3.0 6.2 4.7 6.6 5.7 3.8 5.5 2.1 13.4 8.8 6.0 0.0 7.2 8.1 2.8 3.0 4.1 4.8 6.7 32.2 7.1 14.1 6.3 16.3 3.2 7.0 4.4 3.3 6.7 4.2 0.0 32.4 7.2 0.0 2.2 0.3 3.7 5.6 3.7 0.0 11.2 4.1 2.4 6.2 19.1 27.8 6.8 7.8 3.4 30.0 4.3 20.4 21.9 3.6 4.0 0.0 3.5 4.0 31.1 10.6 16.1 0.0 15.7 16.1 4.7 5.9 3.6 GPRC6A bA86F4.3 ENSG00000173612 "G protein-coupled receptor class C group 6 member A" Q5T6X5 6 116792085-116829083 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Enteroendocrine cells: 1.8" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 29: U-266 - Adaptive immune response" "Cluster 30: Mammary glandular cells - Lactation" "unprognostic (9.16e-2)" "unprognostic (2.48e-1)" "unprognostic (4.38e-3)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPT "ALT1, GPT1" ENSG00000167701 "Glutamic--pyruvic transaminase" P24298 8 144502973-144507174 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 179.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9" "Cancer enriched" "Detected in many" 7 "liver cancer: 38.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031059, HPA031060, CAB032997, CAB032999" Enhanced NA NA 17000000 "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178" "unprognostic (8.22e-3)" "unprognostic (2.52e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (3.38e-1)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-5)" "unprognostic (9.42e-2)" "unprognostic (2.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.41e-1)" "unprognostic (9.22e-2)" "prognostic favorable (2.19e-4)" "unprognostic (2.83e-2)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.98e-2)" 22.6 2.4 2.2 4.6 1.9 2.3 12.5 3.3 4.7 0.7 3.5 36.0 18.3 0.5 0.4 2.4 1.3 2.4 40.3 2.1 0.4 13.9 179.6 0.4 0.3 0.8 0.5 1.1 10.3 1.4 2.9 0.1 0.6 1.8 5.8 0.6 14.6 1.2 50.1 17.1 18.0 0.4 0.2 0.6 15.0 2.6 0.9 0.0 0.9 24.3 0.2 0.6 1.3 0.9 0.2 0.8 0.2 0.5 0.4 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.9 0.4 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.7 1.3 0.3 1.5 2.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.4 0.2 2.8 0.0 1.3 0.4 0.4 0.3 0.6 0.5 0.5 0.1 1.5 0.0 0.9 0.5 0.8 0.2 0.7 0.1 0.1 1.9 0.1 0.2 0.1 0.6 0.7 0.1 2.9 0.2 0.2 0.4 0.9 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.2 1.9 3.3 4.7 2.1 0.4 0.8 0.5 0.6 0.2 0.9 0.9 0.2 0.0 0.0 14.4 5.3 1.7 1.3 1.2 0.6 0.9 14.1 4.6 8.5 34.3 1.8 7.3 0.0 0.0 0.4 176.9 21.5 1.1 16.5 0.5 0.4 1.1 2.4 43.2 0.8 2.4 3.3 0.3 51.0 0.7 8.9 0.3 14.3 237.3 0.1 3.3 0.5 30.4 0.0 14.4 2.1 48.1 0.6 1.2 1.8 1.0 0.1 15.6 0.0 2.0 0.0 1.3 88.4 0.4 0.1 1.2 139.7 164.9 0.5 2.0 0.0 2.0 0.4 1.0 0.6 2.4 4.5 0.0 1.8 0.4 62.1 1.6 GRIN3B GluN3B ENSG00000116032 "Glutamate ionotropic receptor NMDA type subunit 3B" O60391 19 1000419-1009732 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.9;fallopian tube: 4.1" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 15.1;Respiratory ciliated cells: 18.5;Spermatogonia: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Region enriched" "Detected in single" 9 "spinal cord: 4.8" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (7.86e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-2)" "unprognostic (3.43e-3)" "unprognostic (1.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (9.20e-2)" "unprognostic (1.49e-1)" "unprognostic (3.78e-3)" "unprognostic (9.35e-3)" "unprognostic (3.62e-2)" "unprognostic (3.34e-5)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" 0.1 0.1 0.3 0.1 0.4 0.1 0.1 0.6 0.5 0.8 0.2 0.1 0.2 0.1 0.0 0.1 4.1 0.0 0.1 0.2 0.5 0.7 0.1 1.4 0.3 2.0 1.9 0.2 0.2 0.0 0.5 0.1 2.9 0.2 0.0 0.3 0.2 0.0 0.1 0.4 0.1 0.0 0.5 0.9 0.1 0.5 0.2 0.0 0.4 0.0 0.0 0.1 0.2 0.8 0.1 0.4 0.3 0.1 0.1 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.1 0.2 0.3 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.2 0.3 0.0 3.5 0.9 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.5 0.2 0.5 2.0 1.9 2.9 0.5 0.2 0.8 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 15.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 1.7 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 0.0 0.1 1.5 10.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705742-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 64000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: AB_2685329" "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.4 19.0 16.5 23.4 19.1 105.4 18.4 20.0 44.3 20.3 20.8 20.5 20.5 20.0 12.1 22.4 22.1 17.7 20.0 18.4 19.3 18.4 17.1 28.9 23.0 19.3 17.0 27.4 22.0 19.2 25.5 16.0 17.0 23.8 17.6 34.7 21.2 15.5 31.7 27.5 22.9 16.6 15.5 28.0 20.4 20.3 16.7 20.0 24.9 19.9 23.0 18.7 19.4 23.9 29.2 10.5 37.4 30.2 12.6 19.7 18.3 27.4 28.7 39.0 33.9 22.0 16.3 27.9 9.8 26.9 17.5 26.6 45.5 28.8 21.6 49.2 32.8 48.7 36.9 16.3 23.9 57.7 24.3 20.3 22.0 31.2 48.7 21.3 24.3 20.2 29.4 56.5 21.8 12.1 32.1 26.1 27.0 16.7 20.8 61.8 38.2 36.7 13.8 23.3 51.0 17.7 33.3 21.0 19.6 16.2 19.0 24.2 26.1 22.3 22.0 16.4 21.2 51.8 18.7 38.5 20.1 29.0 16.9 3.5 3.1 3.9 4.7 4.6 4.2 4.6 3.5 4.9 3.4 3.8 2.5 3.7 7.8 2.3 5.1 1.7 3.3 3.4 16.5 19.1 20.0 44.3 18.4 19.3 19.3 17.0 17.0 15.5 16.7 23.9 17.8 9.6 8.4 7.8 31.8 27.8 36.0 12.7 15.4 32.6 17.5 15.5 11.2 5.7 12.4 12.9 22.9 7.2 35.9 40.3 5.9 13.2 4.5 22.2 14.3 13.1 16.2 35.3 5.5 19.3 7.9 14.5 23.4 26.4 14.0 17.5 13.6 12.4 8.6 20.2 7.9 24.3 16.2 18.4 43.9 5.4 16.1 19.3 10.6 4.7 26.6 13.2 20.6 5.5 15.2 19.9 21.1 19.2 52.8 47.4 29.8 6.1 16.6 41.0 26.3 19.9 14.5 17.2 7.7 19.2 34.2 19.0 31.9 15.5 13.0 51.0 GZMH "CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2" ENSG00000100450 "Granzyme H" P20718 14 24606480-24609699 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.9;lymphoid tissue: 25.2" "Group enriched" "Detected in many" 10 "dendritic cells: 575.2;NK-cells: 492.3;T-cells: 302.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 1678.5;memory CD4 T-cell: 490.7;memory CD8 T-cell: 1389.6;naive CD8 T-cell: 1214.0" "Lineage enriched" "Detected in all" 7 "T-cells: 1678.5" "Cell line enhanced" "Detected in single" "U-266/70: 1.0" "Low region specificity" "Detected in many" HPA029200 Enhanced "Secreted to blood" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA029200: AB_10602908" "unprognostic (3.72e-3)" "unprognostic (1.47e-3)" "unprognostic (5.35e-2)" "prognostic favorable (2.00e-6)" "unprognostic (8.80e-2)" "unprognostic (1.65e-3)" "unprognostic (2.08e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-2)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.80e-1)" "unprognostic (3.35e-2)" "unprognostic (2.77e-3)" 3.4 5.2 1.2 3.1 1.3 33.9 4.6 1.3 2.4 2.6 1.6 2.7 2.4 2.0 5.0 3.6 3.5 7.0 2.5 1.1 1.3 1.2 6.7 15.9 25.2 2.0 1.2 2.8 0.8 0.7 2.4 1.6 1.5 1.4 2.5 0.0 7.9 2.1 1.9 0.6 2.8 3.4 1.3 24.4 4.7 0.8 1.4 3.8 1.5 0.6 4.5 7.5 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.2 31.6 3.4 1.7 1678.5 3.6 30.2 7.6 490.7 1389.6 3.3 4.6 155.1 1214.0 18.6 250.8 5.4 44.6 4.5 1436.5 1.2 1.3 1.3 2.4 1.1 1.3 2.0 1.2 1.5 1.3 1.4 1.3 2.9 0.0 4.6 0.0 3.3 1.1 0.1 0.0 0.0 0.0 1.7 1.5 1.4 8.6 0.0 0.0 0.0 0.1 575.2 0.0 0.0 0.1 0.1 0.3 0.3 1.5 0.0 8.6 0.0 0.0 0.0 1.2 1.1 0.4 1.3 0.0 7.5 1.2 0.1 0.0 0.0 0.0 0.0 9.3 3.4 0.2 0.0 4.5 3.6 1.9 3.1 0.0 492.3 0.0 0.1 0.0 0.0 0.0 43.7 0.2 0.0 2.6 0.7 0.0 0.0 1.9 1.3 0.1 0.0 0.4 1.8 0.0 302.2 0.0 0.1 0.1 H1-10 "H1FX, H1X, MGC15959, MGC8350" ENSG00000184897 "H1.10 linker histone" Q92522 3 129314771-129316286 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1004.3" "Cell type enhanced" "Detected in some" "Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 937.8" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 121.4 54.7 39.9 42.6 43.9 1004.3 145.0 60.6 68.6 162.4 25.2 125.0 44.6 143.1 9.2 107.8 142.2 13.9 82.0 43.1 48.4 162.7 100.1 115.8 44.3 29.5 26.0 168.9 100.0 30.1 112.6 25.4 25.1 124.5 11.9 13.9 98.7 20.8 110.7 258.4 106.7 13.2 27.8 127.7 115.7 40.9 38.2 131.5 94.4 12.3 18.3 130.9 140.7 46.4 141.8 73.4 135.8 59.3 13.6 16.1 129.1 60.5 43.5 70.4 74.3 44.5 75.5 17.8 65.5 21.6 47.2 139.1 57.3 39.0 10.8 129.4 111.7 53.8 55.5 61.1 57.3 62.6 14.1 32.4 51.9 28.7 64.7 32.0 40.7 241.7 83.7 308.5 10.0 147.9 290.9 124.1 127.2 25.8 81.6 207.4 58.1 170.9 22.1 29.1 216.0 250.1 64.1 31.7 196.3 26.1 124.1 125.1 40.9 54.4 283.5 53.5 51.2 937.8 385.2 156.9 44.5 58.6 61.1 0.5 5.5 17.8 4.4 4.2 4.0 5.7 6.7 5.2 7.9 5.3 8.4 4.3 1.2 5.2 3.9 11.4 6.1 2.4 39.9 43.9 60.6 68.6 43.1 48.4 29.5 26.0 25.1 27.8 38.2 46.4 188.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 66.8 73.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 114.2 46.9 0.0 0.0 0.0 0.0 0.0 0.0 93.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 68.4 17.6 0.0 0.0 0.0 H1-7 "H1FNT, H1T2, HANP1" ENSG00000187166 "H1.7 linker histone" Q75WM6 12 48328980-48330279 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 217.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA046204 Approved NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "HPA046204: AB_2679586" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "unprognostic (1.95e-1)" "unprognostic (1.50e-3)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-5)" "unprognostic (1.91e-1)" "unprognostic (7.68e-4)" "unprognostic (3.41e-1)" "unprognostic (2.87e-2)" "unprognostic (5.79e-3)" "unprognostic (9.84e-2)" 0.2 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.5 0.2 0.3 0.0 0.0 0.3 0.1 217.1 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AC18 "H2A.2, H2A/q, H2AFO, HIST2H2AA, HIST2H2AA3" ENSG00000203812 "H2A clustered histone 18" Q6FI13 1 149842188-149842736 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.5;Hofbauer cells: 1.0;Syncytiotrophoblasts: 2.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 116.8;U-266/70: 472.4;U-266/84: 300.7" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.89e-1)" "unprognostic (2.20e-1)" 73.9 37.8 7.8 16.5 7.1 175.8 47.2 8.4 18.6 121.9 51.9 46.1 11.4 13.9 7.7 79.5 50.5 14.6 59.9 8.5 19.9 88.7 74.7 152.6 12.7 21.6 12.9 54.6 24.0 0.1 31.4 21.8 14.1 200.5 3.4 0.0 46.9 6.5 42.7 116.2 31.7 5.5 14.0 127.6 59.8 117.5 13.7 15.1 31.1 3.8 2.3 42.7 135.9 11.4 14.7 0.0 1.1 0.0 11.1 7.8 0.0 29.8 12.3 17.3 14.5 0.3 7.3 7.5 20.5 11.7 0.7 4.6 1.6 5.5 2.0 15.3 0.0 3.7 31.7 8.8 11.4 0.0 7.9 55.0 9.9 4.2 4.8 0.0 4.5 0.0 43.6 116.8 6.0 21.6 0.0 28.9 0.0 30.1 31.4 6.1 0.0 47.8 7.4 11.8 2.7 1.2 50.4 10.1 1.6 0.0 41.2 12.8 10.1 7.8 58.3 1.5 2.6 472.4 300.7 11.5 26.3 59.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 7.1 8.4 18.6 8.5 19.9 21.6 12.9 14.1 14.0 13.7 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 H2AC19 "H2A/r, HIST2H2AA4" ENSG00000272196 "H2A clustered histone 19" Q6FI13 1 149851061-149851624 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 26.6" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 1820.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 1820.8" "Cell line enhanced" "Detected in many" "SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.63e-1)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (8.47e-2)" 63.3 27.8 32.4 10.1 36.7 20.9 40.2 57.3 31.8 111.3 43.3 39.5 10.8 10.0 0.0 66.7 45.2 6.9 34.4 31.6 38.9 52.0 58.3 140.4 3.8 43.5 36.7 53.3 13.7 3.0 27.2 4.7 42.4 156.3 1.0 6.1 41.1 0.0 30.3 102.5 31.9 0.0 45.7 124.6 64.4 109.9 32.3 9.6 29.1 2.6 1.4 47.4 124.3 50.6 14.9 41.0 4.2 9.4 0.0 0.0 12.9 31.6 0.0 0.0 0.0 26.4 13.9 0.0 36.4 0.0 10.0 23.0 0.0 0.0 0.0 20.4 53.9 5.4 35.5 15.5 0.0 5.2 27.4 0.0 0.0 0.0 0.0 9.7 0.0 18.7 32.9 61.2 0.0 85.0 18.5 5.6 15.7 75.7 31.8 14.3 6.4 20.1 0.0 5.9 37.8 16.1 98.8 21.2 9.1 5.3 38.5 8.9 0.0 6.9 71.4 14.1 4.5 270.8 249.5 20.8 0.0 26.9 11.6 314.7 206.9 388.5 34.8 121.2 35.8 72.9 30.4 32.6 135.6 93.1 22.8 21.6 1820.8 41.6 151.6 193.3 48.3 215.9 32.4 36.7 57.3 31.8 31.6 38.9 43.5 36.7 42.4 45.7 32.3 50.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 H2AC7 "H2A.3, H2A/g, H2AFG, HIST1H2AD" ENSG00000196866 "H2A clustered histone 7" P20671 6 26198784-26199293 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 17.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 17.5;U-266/84: 6.3" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA Yes "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 29: U-266 - Adaptive immune response" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.03e-2)" "unprognostic (1.11e-2)" "unprognostic (7.27e-2)" "unprognostic (3.56e-1)" "unprognostic (9.17e-2)" "unprognostic (1.45e-1)" "unprognostic (9.09e-3)" "unprognostic (6.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.34e-1)" "unprognostic (1.81e-1)" "unprognostic (2.88e-2)" "unprognostic (1.10e-9)" "unprognostic (2.00e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" 0.7 0.2 0.4 0.3 1.7 2.9 0.6 4.1 2.1 3.3 3.6 0.5 0.0 0.1 0.0 2.5 0.6 0.3 0.4 1.0 1.9 0.6 1.2 2.1 0.5 3.1 1.7 0.7 0.1 0.0 0.3 0.2 2.1 2.1 0.1 0.0 0.5 0.0 0.0 1.1 0.5 0.0 3.9 1.2 0.6 0.3 3.0 1.8 0.3 0.0 0.3 0.3 2.8 6.8 1.1 0.0 0.2 0.2 0.0 0.0 0.2 0.7 0.1 1.1 0.0 1.3 0.4 0.7 1.2 0.2 0.1 0.3 0.0 0.1 0.2 0.0 1.0 0.3 1.4 1.3 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.7 2.5 1.3 0.0 0.0 3.7 1.5 1.1 0.0 1.1 1.0 0.4 0.9 0.4 0.1 1.4 0.2 0.6 0.8 0.1 0.0 1.4 0.3 0.0 1.1 3.1 0.0 1.0 17.5 6.3 2.2 1.0 1.3 0.4 2.3 0.3 3.8 1.3 1.9 1.3 2.7 2.0 4.0 1.1 7.6 1.9 1.9 17.9 1.8 2.2 6.2 2.7 0.8 0.4 1.7 4.1 2.1 1.0 1.9 3.1 1.7 2.1 3.9 3.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AC8 "H2A.1, H2A/a, H2AFA, HIST1H2AE" ENSG00000277075 "H2A clustered histone 8" P04908 6 26216975-26217483 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.2;breast: 40.7" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8" "Cancer enhanced" "Detected in all" "prostate cancer: 40.9" "Group enriched" "Detected in all" 5 "cerebellum: 41.2;white matter: 17.5" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.0" "CAB012242, HPA041189" Supported Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 50: Non-specific - Ribosome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB012242: AB_470265, HPA041189: AB_2677357" "unprognostic (4.26e-2)" "unprognostic (1.55e-2)" "unprognostic (4.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (1.50e-1)" "unprognostic (2.48e-2)" "unprognostic (7.22e-2)" "unprognostic (1.24e-2)" "unprognostic (6.99e-2)" "unprognostic (1.21e-3)" "unprognostic (1.30e-2)" "unprognostic (7.64e-2)" "unprognostic (1.15e-1)" "unprognostic (2.41e-1)" "unprognostic (2.20e-1)" "unprognostic (9.36e-2)" 4.3 2.4 2.1 1.6 5.6 19.3 40.7 41.2 6.0 14.7 4.6 7.9 3.6 1.6 16.7 8.6 7.8 1.8 4.2 5.1 3.7 11.6 5.7 7.9 2.9 2.3 1.1 6.8 1.0 0.4 3.4 1.6 3.7 32.9 2.1 1.5 4.7 1.2 0.2 16.5 4.6 0.6 1.7 9.5 5.2 4.3 3.3 9.4 5.8 0.1 0.8 2.2 17.4 17.5 4.1 0.0 3.0 0.0 4.9 0.9 0.8 1.3 2.0 4.3 2.9 2.0 3.3 0.2 10.8 0.4 3.9 3.4 1.5 2.0 1.7 4.5 3.7 2.7 5.9 2.6 0.9 0.3 4.1 8.4 0.9 1.8 0.2 1.2 2.1 0.8 11.4 2.9 0.4 7.5 9.3 7.9 3.5 14.1 3.7 7.3 2.4 14.7 1.8 2.3 11.9 5.0 10.9 3.7 2.4 2.0 14.9 4.1 0.0 0.2 0.8 1.8 1.8 37.0 0.0 0.0 1.5 5.5 2.7 18.2 2.2 8.2 2.8 2.6 4.1 4.7 3.3 4.6 5.9 6.0 1.7 2.3 10.1 4.5 1.6 17.6 4.4 10.4 2.1 5.6 41.2 6.0 5.1 3.7 2.3 1.1 3.7 1.7 3.3 17.5 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 H2BC14 "dJ160A22.3, H2B/e, H2BFE, HIST1H2BM" ENSG00000273703 "H2B clustered histone 14" Q99879 6 27815022-27815489 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.5;lymphoid tissue: 3.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9" "Not detected" "Not detected" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.5 0.0 0.1 0.3 0.5 3.5 0.0 1.2 0.6 1.1 0.2 0.3 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.4 0.4 0.3 0.2 0.5 1.5 0.4 0.7 0.2 0.0 0.0 0.0 0.1 0.7 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.6 1.0 0.2 0.4 0.8 3.1 0.2 0.0 1.1 0.0 1.0 1.1 1.5 0.0 0.2 0.0 0.0 0.0 1.0 0.3 0.2 0.3 1.5 0.3 0.2 1.9 0.0 0.0 0.4 0.9 0.0 0.0 0.0 1.1 0.0 0.7 0.2 0.6 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 14.8 0.0 0.4 4.0 9.9 2.8 0.9 0.6 6.2 0.0 0.3 0.0 0.0 0.2 1.7 0.6 0.9 0.0 0.1 0.8 3.0 0.0 0.0 1.6 1.0 0.1 12.3 0.5 5.9 0.9 1.0 0.7 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.4 0.3 0.1 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 1.2 0.6 0.4 0.4 0.4 0.7 0.7 0.6 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2BC18 HIST2H2BF ENSG00000203814 "H2B clustered histone 18" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 30.8" "Lineage enriched" "Detected in many" 14 "granulocytes: 30.8" "Cell line enriched" "Detected in many" 7 "U-266/70: 49.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 10.2 6.7 4.2 1.3 5.0 3.0 5.3 10.0 3.7 36.5 13.1 6.5 0.6 1.1 2.5 9.6 9.7 1.0 7.4 3.4 7.0 8.9 7.2 28.0 0.9 6.0 7.4 35.3 4.7 0.3 5.6 2.2 6.7 30.2 0.9 2.9 6.9 0.9 0.7 17.8 3.3 0.6 5.4 15.8 12.9 3.7 5.5 2.8 6.1 0.5 0.7 6.1 34.7 7.9 0.7 1.0 0.5 1.0 0.6 0.1 0.5 1.0 0.2 0.8 1.0 0.5 1.3 0.7 0.4 0.2 0.8 2.1 0.2 0.0 0.1 2.1 0.7 0.7 3.0 0.1 0.4 0.4 2.7 1.2 0.0 0.4 0.5 0.4 0.1 0.5 1.8 3.8 0.0 1.5 5.2 3.1 0.7 3.6 1.5 0.5 1.7 1.2 0.2 0.2 2.7 0.9 6.6 0.3 0.5 1.0 2.0 0.4 0.0 0.7 0.0 1.1 0.6 49.7 1.7 2.0 1.0 0.5 0.2 0.0 1.4 0.3 0.8 0.5 0.8 0.7 1.1 0.4 0.9 2.1 0.5 0.4 30.8 0.7 0.6 0.8 0.2 0.2 4.2 5.0 10.0 3.7 3.4 7.0 6.0 7.4 6.7 5.4 5.5 7.9 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 H2BC21 "H2B, H2B.1, H2B/q, H2BE, H2BFQ, HIST2H2BE" ENSG00000184678 "H2B clustered histone 21" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 86.5;Syncytiotrophoblasts: 160.2" "Cancer enhanced" "Detected in all" "prostate cancer: 87.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 58.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.6" "Cell line enhanced" "Detected in many" "Karpas-707: 56.8;U-266/70: 93.7;U-266/84: 53.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes "Cluster 50: Neutrophils - Cellular senescence" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 17.8 15.3 35.1 7.2 40.2 21.2 17.7 38.7 38.7 60.8 38.7 22.0 5.2 7.4 22.8 41.7 27.5 5.5 77.3 33.5 37.2 46.3 18.0 37.2 6.2 41.6 38.0 61.7 13.4 9.5 32.5 14.8 39.0 95.2 6.1 69.1 23.5 6.6 62.8 84.0 14.8 6.2 41.0 27.3 32.0 13.7 38.9 20.1 15.2 29.2 3.4 25.1 79.5 55.8 2.8 2.8 4.5 0.9 23.5 6.3 2.2 9.7 6.5 4.0 1.3 1.1 4.4 0.5 2.6 8.6 5.7 10.9 3.6 1.7 2.2 3.4 2.8 0.8 11.5 2.1 7.4 0.8 12.6 21.4 7.9 1.7 6.6 4.8 1.3 4.0 12.0 56.8 5.0 16.8 3.1 5.1 2.8 22.6 5.8 3.6 1.7 13.7 3.8 2.3 30.3 4.9 33.4 4.5 2.7 10.7 23.4 2.4 1.7 3.0 33.6 2.2 0.9 93.7 53.8 2.6 4.0 3.6 1.9 21.3 4.8 8.2 1.3 6.2 2.3 1.5 1.8 2.1 3.3 3.8 2.2 2.2 58.6 1.3 12.3 8.9 2.2 10.1 35.1 40.2 38.7 38.7 33.5 37.2 41.6 38.0 39.0 41.0 38.9 55.8 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.5 0.0 0.0 0.0 0.0 25.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 20.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 160.2 0.3 0.0 0.0 0.0 H2BC7 "H2B/g, H2BFG, HIST1H2BF" ENSG00000277224 "H2B clustered histone 7" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 7.4" "Cell type enhanced" "Detected in single" "Hofbauer cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "U-266/70: 24.8;U-266/84: 18.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.9 0.2 0.6 0.2 1.1 1.2 1.6 4.0 0.9 3.3 1.5 1.4 0.0 0.1 0.0 3.2 1.8 0.2 0.4 0.8 0.6 1.4 0.6 1.7 0.3 1.9 1.7 0.8 0.2 0.0 0.6 0.2 2.4 7.4 0.2 0.6 1.1 0.0 0.0 0.9 0.7 0.0 2.1 2.3 0.7 0.6 1.2 1.7 0.6 0.1 0.4 0.4 4.5 2.4 0.5 0.3 0.2 0.5 0.3 0.0 0.2 0.2 0.1 0.7 0.1 0.7 0.1 0.6 1.0 0.0 0.3 1.0 0.5 0.1 0.3 0.8 0.2 0.4 1.8 0.2 0.1 0.1 0.9 0.3 0.1 0.2 0.1 0.0 0.1 0.5 2.0 4.5 0.0 0.1 4.0 1.6 0.6 0.8 0.6 1.5 0.7 3.0 0.1 0.1 2.4 0.4 4.9 0.9 0.1 0.3 4.4 0.2 0.1 0.3 2.2 0.0 0.6 24.8 18.8 1.3 0.1 1.2 0.5 0.0 0.0 0.6 0.2 0.1 0.6 0.2 0.2 0.3 0.1 1.0 0.2 0.5 2.4 0.2 0.3 0.3 0.2 0.5 0.6 1.1 4.0 0.9 0.8 0.6 1.9 1.7 2.4 2.1 1.2 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 H2BC9 "H2B/j, H2BFJ, HIST1H2BH" ENSG00000275713 "H2B clustered histone 9" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.2;vagina: 4.3" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.7;neutrophil: 3.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Cell line enhanced" "Detected in many" "U-266/70: 16.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.5 0.2 0.4 0.6 0.4 1.4 0.6 0.3 0.5 1.9 0.8 2.0 3.0 0.4 0.8 4.2 0.8 0.3 0.2 0.3 0.4 0.9 0.2 1.6 0.8 0.8 0.7 0.1 0.0 0.1 0.1 0.2 0.7 3.5 0.8 0.0 1.3 0.0 0.0 0.6 1.7 0.1 0.6 3.7 0.7 0.6 0.7 2.9 1.0 0.1 0.5 0.4 4.3 1.1 1.8 0.1 7.0 0.0 0.0 0.1 1.1 0.9 0.3 1.2 0.6 2.4 1.1 0.0 1.7 0.1 1.8 3.4 0.0 0.6 1.7 0.9 0.1 1.3 6.1 0.4 0.0 0.0 4.0 0.3 0.3 0.4 0.5 0.0 0.3 1.0 2.7 6.2 0.1 2.0 3.8 2.7 1.6 0.0 1.8 4.0 0.0 0.9 0.0 2.7 3.2 2.9 4.2 1.4 0.6 0.3 2.0 3.3 0.0 0.6 0.0 0.7 3.1 16.9 4.5 0.0 0.5 1.5 3.8 3.7 0.2 0.6 0.3 0.0 0.1 0.6 0.2 0.4 0.6 0.3 0.0 0.1 3.0 0.8 0.1 0.2 0.4 5.2 0.4 0.4 0.3 0.5 0.3 0.4 0.8 0.7 0.7 0.6 0.7 1.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 29.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 H2BE1 ENSG00000285480 "H2B.E variant histone 1" A0A2R8Y619 7 151207837-151210378 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 4.5;U-266/84: 3.3" "Low region specificity" "Detected in some" HPA043013 Uncertain NA NA "Cluster 29: U-266 - Adaptive immune response" "HPA043013: AB_2678269" 0.8 0.3 0.9 0.4 1.2 0.6 0.8 1.2 1.3 0.3 0.6 0.1 0.2 1.1 0.2 0.6 0.2 0.9 0.2 0.9 1.6 0.0 0.2 0.8 1.2 1.2 1.1 0.7 0.0 0.0 0.2 1.3 0.1 0.1 0.0 0.0 0.3 0.9 4.7 0.3 0.5 1.0 1.0 0.2 0.3 1.2 0.5 0.1 0.3 0.4 0.0 1.3 0.0 0.4 0.0 0.3 1.0 1.2 0.0 0.3 0.1 0.1 0.0 1.0 0.6 0.7 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.6 1.8 0.2 0.2 0.0 0.5 0.3 0.8 1.3 0.2 0.0 1.8 0.3 0.4 0.4 0.2 1.5 0.0 0.3 0.1 0.1 0.1 0.0 0.6 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 1.2 0.5 0.0 0.2 0.6 0.1 4.5 3.3 0.1 0.4 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 1.2 1.3 0.9 1.6 1.2 1.1 1.3 1.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2BU1 HIST3H2BB ENSG00000196890 "H2B.U histone 1" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;cervix: 4.7;vagina: 3.5" "Cell type enhanced" "Detected in single" "Syncytiotrophoblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "T-47d: 3.0;U-266/70: 15.1;U-266/84: 3.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 0.7 0.7 0.8 0.0 0.5 0.2 0.2 3.5 0.7 4.7 0.1 0.2 0.1 0.1 0.1 1.4 1.0 0.0 0.8 0.4 1.6 0.6 0.1 0.9 0.1 0.9 0.8 0.6 0.1 0.0 0.9 0.0 1.1 0.8 0.0 0.5 0.3 0.0 0.1 1.2 0.3 0.0 0.4 0.8 0.3 0.2 1.9 0.0 0.4 0.0 0.1 0.4 3.5 0.5 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.8 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.6 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.7 0.0 0.1 1.2 0.4 0.8 0.3 0.2 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 15.1 3.8 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.3 0.2 0.1 0.1 0.8 0.5 3.5 0.7 0.4 1.6 0.9 0.8 1.1 0.4 1.9 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 H3C13 HIST2H3D ENSG00000183598 "H3 clustered histone 13" Q71DI3 1 149813225-149813693 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 7.7;U-266/70: 19.2" HPA042570 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042570: AB_2678056" "unprognostic (3.35e-2)" "unprognostic (1.84e-1)" "unprognostic (4.73e-2)" "unprognostic (2.88e-2)" "unprognostic (9.27e-3)" "unprognostic (3.39e-1)" "unprognostic (1.83e-2)" "unprognostic (9.61e-2)" "unprognostic (1.48e-2)" "unprognostic (7.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.59e-1)" "unprognostic (8.93e-4)" "unprognostic (6.95e-2)" "unprognostic (1.57e-1)" "unprognostic (2.04e-2)" "unprognostic (2.48e-3)" 0.8 0.8 3.5 0.8 2.0 3.2 0.5 13.3 2.3 0.9 4.0 0.8 0.2 0.4 0.0 1.1 0.6 0.8 0.8 2.1 6.6 0.7 0.7 1.1 0.7 3.3 3.3 1.5 0.7 0.0 0.4 0.2 3.4 1.0 0.0 0.1 0.2 0.0 0.1 0.7 1.2 0.0 4.0 1.3 1.1 0.8 11.1 0.5 0.6 0.0 0.1 0.4 0.8 3.6 0.6 0.0 0.1 2.3 0.3 0.0 0.2 1.3 0.0 0.0 0.0 0.3 0.4 0.5 0.3 0.0 0.2 0.8 0.0 0.0 0.0 1.2 0.4 0.2 3.5 0.0 0.2 0.0 1.7 0.6 0.0 0.4 0.2 0.3 0.0 0.6 1.7 1.5 0.0 1.2 2.0 7.7 1.7 0.4 3.1 1.0 0.0 1.3 0.0 0.8 0.4 0.3 1.1 0.0 0.1 0.1 0.4 0.4 0.4 1.1 0.0 0.7 0.0 19.2 2.1 1.3 0.3 0.4 0.6 0.0 1.2 0.5 0.9 1.5 1.8 0.9 1.2 1.4 1.0 4.7 0.4 0.3 9.8 0.4 0.5 2.2 0.1 0.3 3.5 2.0 13.3 2.3 2.1 6.6 3.3 3.3 3.4 4.0 11.1 3.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 H3C4 "H3/b, H3FB, HIST1H3D" ENSG00000197409 "H3 clustered histone 4" P68431 6 26196784-26197286 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.2;brain: 15.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.7;MOLT-4: 5.4;U-266/70: 11.7;U-266/84: 6.9" HPA042570 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA042570: AB_2678056" "unprognostic (8.64e-2)" "unprognostic (1.27e-2)" "unprognostic (9.06e-3)" "unprognostic (2.00e-1)" "unprognostic (6.59e-2)" "unprognostic (1.43e-2)" "unprognostic (8.62e-2)" "unprognostic (1.56e-1)" "unprognostic (2.95e-1)" "unprognostic (2.69e-2)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.78e-6)" "unprognostic (2.44e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" 0.6 0.8 4.3 0.1 4.1 12.2 0.6 15.9 3.2 2.3 5.7 1.0 0.6 0.2 0.0 2.0 0.9 0.5 0.5 1.1 2.6 0.9 1.5 1.4 0.4 4.8 5.2 0.8 0.2 0.0 0.6 0.2 4.8 2.8 0.0 0.1 1.0 0.1 0.0 0.7 0.7 0.1 6.7 1.7 0.6 0.8 4.5 1.8 0.6 0.0 0.3 0.7 2.8 10.9 1.5 0.0 0.2 1.2 0.8 0.3 0.7 0.0 0.3 1.6 1.1 2.9 0.6 2.7 1.3 0.4 0.0 0.4 0.7 0.1 0.0 1.5 0.2 0.1 1.3 2.0 0.1 0.9 1.8 0.1 0.1 1.2 0.3 0.0 0.5 1.1 1.2 5.7 0.0 0.6 5.4 4.6 0.2 0.1 0.9 2.7 0.3 3.1 0.0 0.0 0.8 0.1 0.0 1.0 0.8 0.0 0.6 1.6 1.4 0.3 2.9 0.0 1.5 11.7 6.9 0.6 1.5 0.3 0.4 14.8 1.6 4.2 3.4 1.6 8.6 8.3 2.5 3.5 3.9 13.0 2.6 4.6 22.2 3.2 3.5 5.1 3.3 0.9 4.3 4.1 15.9 3.2 1.1 2.6 4.8 5.2 4.8 6.7 4.5 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3C8 "H3/h, H3FH, HIST1H3G" ENSG00000273983 "H3 clustered histone 8" P68431 6 26269405-26271815 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.1;Extravillous trophoblasts: 1.8;Hofbauer cells: 1.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.7;SiHa: 6.8;U-266/70: 6.3" HPA042570 Approved NA NA "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042570: AB_2678056" "unprognostic (1.88e-1)" "prognostic favorable (8.75e-4)" "unprognostic (3.14e-1)" "unprognostic (2.58e-1)" "unprognostic (6.94e-2)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-1)" "unprognostic (2.02e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (1.21e-3)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (3.90e-2)" "unprognostic (7.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.3 0.4 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.1 0.1 0.2 0.4 0.1 0.0 0.2 0.0 0.2 0.2 0.7 0.0 0.7 0.0 0.0 0.1 0.3 0.3 0.1 0.7 0.3 2.7 0.0 0.0 0.3 0.0 0.7 2.2 0.9 0.4 0.5 0.6 0.0 0.1 1.9 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.2 0.5 0.0 1.5 0.0 1.6 0.8 0.3 1.3 2.4 0.0 0.6 0.0 1.0 0.5 0.5 0.2 0.3 6.8 2.1 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.0 0.1 6.3 0.2 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 H4C15 "H4/o, HIST2H4B" ENSG00000270276 "H4 clustered histone 15" P62805 1 149854045-149861210 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.8;SiHa: 7.5;U-266/70: 8.6;U-266/84: 7.6" "Low region specificity" "Detected in all" HPA042201 Supported NA Yes 25000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042201: AB_2677898" "unprognostic (8.20e-2)" "unprognostic (2.69e-1)" "unprognostic (1.77e-1)" 2.0 3.2 2.5 0.1 2.5 2.1 1.7 2.4 3.5 2.6 1.3 4.0 1.7 2.2 2.5 1.0 2.8 0.7 2.2 2.5 1.8 2.4 1.7 1.7 1.3 1.6 1.8 1.8 1.6 2.0 4.9 0.9 1.6 3.5 1.0 3.1 1.4 1.1 2.4 2.3 1.7 2.2 2.7 2.3 2.2 0.8 1.6 4.6 2.0 1.1 0.6 2.8 1.5 2.0 0.0 0.0 0.8 0.2 0.8 0.8 0.1 1.4 2.6 0.2 0.0 0.0 0.5 0.8 1.3 0.7 0.2 0.0 0.4 0.0 0.1 1.5 0.5 0.0 3.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 1.1 1.0 1.9 0.0 4.5 0.1 3.1 0.2 0.5 0.1 0.8 0.0 1.1 0.3 0.1 0.3 0.6 4.8 2.9 7.5 0.8 0.3 0.0 1.6 0.1 1.8 0.3 1.8 0.5 0.2 8.6 7.6 1.2 0.7 0.2 1.1 1.8 1.3 1.6 1.4 2.1 2.5 1.8 1.6 1.2 1.9 4.3 1.3 2.3 5.8 1.3 1.2 2.4 2.5 3.4 2.5 2.5 2.4 3.5 2.5 1.8 1.6 1.8 1.6 2.7 1.6 2.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 H4C5 "H4/j, H4FJ, HIST1H4E" ENSG00000276966 "H4 clustered histone 5" P62805 6 26204552-26206038 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 69.4" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.2;Cytotrophoblasts: 2.7;dendritic cells: 1.8;Extravillous trophoblasts: 1.6;Hofbauer cells: 4.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 69.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 6.1;U-266/70: 11.3" HPA042201 Supported NA NA 25000000 "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042201: AB_2677898" "unprognostic (8.62e-2)" "unprognostic (4.86e-2)" "unprognostic (5.71e-3)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" "unprognostic (5.08e-3)" "unprognostic (7.99e-2)" "unprognostic (1.21e-1)" "unprognostic (6.57e-2)" "unprognostic (2.34e-3)" "unprognostic (4.34e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" 0.8 0.5 12.1 0.4 14.5 2.1 0.8 69.4 14.4 3.8 0.5 1.9 0.9 0.5 0.8 2.6 2.7 0.2 1.1 10.8 8.1 3.1 1.0 1.0 0.5 3.9 3.2 2.8 0.5 0.2 2.2 0.5 6.9 7.5 0.5 1.5 1.3 0.3 0.0 1.9 0.9 0.2 15.2 1.5 1.6 2.0 7.2 1.9 1.5 0.0 0.4 0.6 3.6 16.8 1.1 0.7 1.3 3.1 0.5 0.0 0.7 1.1 0.3 0.5 0.4 0.4 1.1 0.4 1.5 0.3 0.7 1.9 0.7 0.1 0.7 0.9 0.8 0.3 1.5 0.7 0.0 0.5 1.2 0.3 0.0 0.4 0.3 0.3 0.4 1.0 2.3 2.6 0.1 0.4 6.1 2.8 1.3 0.5 1.0 2.7 1.4 2.7 0.5 0.4 3.7 0.9 0.8 1.3 0.4 0.4 1.2 0.5 0.5 1.5 2.1 0.4 0.9 11.3 4.7 1.7 0.3 1.1 1.1 2.7 2.1 1.8 2.0 1.8 2.9 2.5 3.0 2.0 3.1 5.4 3.2 2.6 2.6 2.3 5.5 2.7 2.0 1.2 12.1 14.5 69.4 14.4 10.8 8.1 3.9 3.2 6.9 15.2 7.2 16.8 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 133301.6" "Cell type enriched" "Detected in many" 24 "Erythroid cells: 672352.3" "Group enriched" "Detected in all" 4 "cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1" "Region enriched" "Detected in all" 11 "cerebral cortex: 3368.5" "Group enriched" "Detected in all" 5 "neutrophil: 658.1;plasmacytoid DC: 379.7" "Group enriched" "Detected in all" 11 "dendritic cells: 379.7;granulocytes: 658.1" "Cell line enhanced" "Detected in some" "HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2" "CAB009526, HPA043234" Enhanced NA NA 10000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB009526: AB_2143058, HPA043234: AB_2678378" "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 1641.5 481.4 155.7 217.3 219.2 133301.6 637.4 235.7 3368.5 546.2 384.6 278.2 28.8 78.8 45.6 505.7 829.6 792.7 2658.8 108.9 154.4 2333.1 1907.3 4039.6 26.8 209.6 243.5 289.0 158.5 50.5 808.2 6345.0 303.0 312.0 148.9 31.0 548.1 290.6 578.8 135.3 169.8 66.3 316.2 9225.9 269.1 170.6 171.4 196.8 1152.0 12902.5 40.3 320.1 633.5 180.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.4 0.3 0.0 0.0 5.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.1 4.2 0.0 0.0 0.0 0.0 99.5 25.3 73.7 37.8 1.3 4.0 21.5 6.8 1.1 35.2 13.8 13.7 39.9 658.1 47.9 5.0 379.7 1.4 22388.9 155.7 219.2 235.7 3368.5 108.9 154.4 209.6 243.5 303.0 316.2 171.4 180.7 441.7 3.2 8.4 0.0 280.5 157.0 2.3 5.1 0.0 4.0 54.7 72.0 3.4 217.3 4.5 7.3 4.2 2.2 369.9 5.2 50.9 0.0 0.0 6.8 6.6 151.7 3.6 672352.3 0.0 0.0 11.3 276.1 0.0 5.1 0.0 4.6 443.4 420.5 7.3 3.3 0.0 7.2 6.1 1452.1 702.6 0.0 0.0 1091.0 27383.1 0.0 72.7 9.7 38.1 0.0 0.0 0.1 3.5 0.0 1.9 0.0 0.1 272.4 84.9 117.8 0.0 126.0 396.8 0.0 0.0 0.0 252.5 2.2 769.8 0.3 3.0 0.1 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 57 "bone marrow: 2797.6" "Cell type enriched" "Detected in some" 318 "Erythroid cells: 22112.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5" "CAB037087, HPA043234" Supported NA NA 6600000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB037087: AB_260051, HPA043234: AB_2678378" "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 2.2 0.3 0.5 0.6 0.6 2797.6 0.7 0.8 2.7 0.1 0.7 0.5 0.0 0.1 0.0 0.3 2.8 0.1 2.5 0.5 0.4 3.2 7.5 6.2 0.5 0.6 0.5 0.3 0.2 4.5 2.2 19.5 0.7 0.2 0.3 0.1 2.2 0.3 0.5 0.6 0.2 0.0 0.6 49.1 0.3 0.1 0.5 4.3 1.0 11.5 0.2 0.2 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 74.5 0.0 0.0 0.0 0.3 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.4 25.5 0.0 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.2 0.0 1.6 0.0 105.0 0.5 0.6 0.8 2.7 0.5 0.4 0.6 0.5 0.7 0.6 0.5 1.0 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 22112.3 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 13.6 13.4 0.1 0.0 0.0 0.0 0.0 16.9 1.9 0.1 0.0 6.2 69.4 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112629-43566001 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.4;kidney: 7.8" "Cell type enhanced" "Detected in some" "Early spermatids: 135.6;Excitatory neurons: 533.3;Inhibitory neurons: 157.3;Late spermatids: 72.0;Oligodendrocyte precursor cells: 277.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebral cortex: 16.4" "Group enriched" "Detected in some" 4 "basophil: 4.9;neutrophil: 3.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "A549: 3.8;GAMG: 3.7;U-266/70: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Uncertain Supported Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.1 0.0 1.5 0.2 1.7 0.5 0.2 0.0 16.4 0.1 0.0 0.2 0.0 0.2 0.6 1.0 0.1 1.9 0.0 0.7 0.0 7.8 0.1 0.1 0.4 0.2 0.0 0.3 0.0 0.2 0.0 0.1 0.1 1.3 0.1 2.2 0.4 0.2 0.9 0.6 0.1 0.1 0.0 0.1 0.3 1.8 0.2 0.0 0.5 2.6 0.2 0.3 0.1 3.8 0.0 3.8 0.3 0.5 0.0 0.0 0.0 1.2 2.2 0.1 0.5 0.0 0.0 0.2 2.3 2.2 3.7 0.2 0.0 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.8 0.9 0.3 12.0 0.4 0.0 2.7 0.3 0.0 4.9 0.8 0.7 0.3 0.5 0.2 0.6 0.3 0.1 0.1 1.0 0.3 0.3 3.3 0.6 0.6 0.9 0.1 0.0 1.5 1.7 0.0 16.4 0.7 0.0 0.2 0.0 0.1 0.0 0.2 3.8 0.0 0.0 0.0 7.8 0.1 0.4 0.3 0.0 0.0 15.4 0.1 0.3 1.4 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.0 0.0 135.6 1.1 3.6 0.2 0.0 0.0 533.3 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.4 0.1 0.0 45.4 157.3 0.1 0.0 0.0 1.4 72.0 0.3 0.2 0.0 24.4 0.1 0.6 0.0 277.9 4.8 0.0 1.4 0.4 0.0 0.4 4.3 15.8 0.0 1.9 0.0 0.6 0.4 3.2 3.3 0.3 0.3 0.0 0.6 0.2 0.5 0.3 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors, Transporters" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.7" "Cell type enhanced" "Detected in many" "Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.5 0.9 8.8 1.0 12.0 0.1 5.7 9.4 7.6 8.0 3.0 2.5 1.3 7.5 16.4 1.8 13.5 1.7 30.7 7.2 10.4 3.1 5.3 3.2 0.5 12.7 10.0 7.1 3.3 2.6 5.5 3.7 10.6 2.1 1.3 5.7 2.0 2.7 16.2 2.4 2.1 1.7 14.1 1.9 2.0 6.6 11.8 0.7 3.1 4.9 0.6 2.7 4.7 12.2 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.5 7.1 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.6 0.0 0.4 0.0 0.0 3.2 0.0 0.3 0.5 0.6 0.9 0.0 0.1 2.3 0.0 0.0 0.0 6.6 3.2 1.9 0.0 14.8 0.3 0.0 0.1 0.8 17.6 0.3 0.1 0.6 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 12.0 9.4 7.6 7.2 10.4 12.7 10.0 10.6 14.1 11.8 12.2 2.8 3.2 1.1 12.4 0.7 3.8 0.5 8.7 3.4 0.4 9.8 5.7 21.5 0.0 2.7 0.0 8.4 0.0 1.4 0.1 9.8 0.1 49.9 46.1 4.2 6.0 0.0 2.7 0.1 1.8 0.1 3.3 1.1 36.8 0.0 73.9 1.8 8.0 0.1 1.7 0.4 0.0 2.0 0.8 3.0 80.6 6.5 0.6 3.6 5.6 0.0 34.8 3.1 2.5 23.4 1.1 0.1 23.3 3.1 0.3 0.0 6.4 5.4 5.2 52.6 17.5 41.8 16.2 15.1 7.7 2.0 0.0 2.0 2.8 0.1 0.3 HLA-B AS ENSG00000234745 "Major histocompatibility complex, class I, B" P01889 6 31353872-31357188 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 2493.7" "Cell type enhanced" "Detected in all" "monocytes: 5683.6;NK-cells: 7881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 638.3;EFO-21: 547.1;U-266/70: 1285.6;U-698: 377.2" CAB015418 Enhanced NA NA 190000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB015418: AB_831547" "unprognostic (2.87e-2)" "unprognostic (1.49e-1)" "unprognostic (4.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.81e-1)" "unprognostic (5.16e-3)" "unprognostic (8.51e-2)" "prognostic favorable (2.90e-4)" "unprognostic (2.69e-3)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (7.83e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-2)" 944.9 581.6 5.5 429.4 8.1 53.5 850.0 5.5 14.4 552.0 6.0 912.0 4.7 567.1 222.1 434.4 488.6 461.2 563.1 4.6 6.7 731.7 488.9 1646.3 1061.9 9.6 10.4 296.9 268.7 24.2 288.3 106.6 7.5 439.2 238.5 8.1 485.9 3.8 237.9 936.4 1295.6 75.4 7.7 2493.7 540.1 132.6 6.7 4.4 593.2 3.8 414.9 476.2 582.0 7.9 638.3 0.0 0.0 0.1 13.5 98.9 3.8 0.5 1.2 0.5 1.1 0.0 1.9 22.7 547.1 111.0 203.2 231.9 116.4 112.4 0.0 2.3 29.9 8.3 0.8 0.0 79.8 0.2 2.4 200.2 0.5 0.0 13.9 183.3 0.4 39.8 1.3 30.2 0.0 0.3 1.5 161.4 0.6 0.0 0.1 19.7 3.4 4.7 163.5 0.6 0.9 3.7 5.5 1.4 1.4 0.2 32.6 6.2 134.7 21.4 4.8 4.9 2.3 1285.6 291.0 377.2 1.1 6.5 0.6 141.1 196.5 232.6 233.0 163.6 215.7 162.4 194.8 198.8 150.8 113.0 150.9 212.0 420.5 179.3 123.6 127.3 213.1 400.2 5.5 8.1 5.5 14.4 4.6 6.7 9.6 10.4 7.5 7.7 6.7 7.9 2836.3 913.5 1007.9 14.0 2936.9 1165.9 761.2 1139.6 396.1 27.7 533.2 550.2 168.5 1382.6 948.3 388.1 6.2 31.4 3876.2 3264.3 68.4 4206.8 63.9 311.6 349.2 2480.7 836.0 550.3 1.4 1771.3 182.3 777.7 1044.4 773.2 620.5 212.5 2189.2 701.5 2602.0 60.6 3.4 2121.8 1129.1 4229.7 2158.6 65.7 644.9 2674.7 891.2 126.5 5683.6 209.2 7881.6 25.1 3.9 2085.3 2327.5 306.9 2983.6 993.4 4541.4 183.9 829.4 27.3 1314.8 356.3 729.7 652.9 91.6 360.3 1004.3 50.9 3661.2 1219.5 1527.4 1161.2 HSF4 CTM ENSG00000102878 "Heat shock transcription factor 4" Q9ULV5 16 67164681-67169945 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Excitatory neurons: 30.9;Horizontal cells: 43.7;Inhibitory neurons: 30.0;Leydig cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 17.1;T-47d: 12.9;U-266/70: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048584 Supported "Nuclear speckles" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "Nuclear speckles" "HPA048584: AB_2680452" "unprognostic (1.90e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (9.20e-3)" "unprognostic (2.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.06e-2)" "unprognostic (2.45e-1)" "unprognostic (2.85e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (2.19e-6)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (8.74e-3)" 12.4 23.7 43.6 1.3 44.3 1.8 12.7 44.6 69.2 17.9 39.2 10.1 4.8 12.4 4.8 11.0 21.1 3.6 20.0 44.6 43.7 17.1 20.3 8.7 1.6 45.0 41.9 19.8 35.9 4.3 30.1 3.3 46.4 28.3 1.8 5.6 19.0 1.9 25.9 14.5 6.1 2.1 41.3 6.0 14.4 7.0 43.3 1.1 17.9 4.1 1.1 18.8 10.9 45.8 1.6 1.1 0.0 1.1 0.5 3.0 5.2 0.5 0.6 0.2 0.0 2.4 3.5 0.1 2.5 1.1 0.7 5.9 0.4 0.7 0.2 2.3 2.2 0.6 4.5 3.1 2.3 0.3 4.4 1.3 4.8 0.2 2.5 17.1 0.9 4.0 1.5 5.1 2.3 1.5 0.8 1.8 0.1 3.4 3.2 2.0 1.7 8.7 4.4 2.5 3.5 7.6 4.9 3.0 7.8 2.1 12.9 4.5 0.9 1.6 1.6 6.4 1.5 22.3 3.7 1.5 4.9 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 44.3 44.6 69.2 44.6 43.7 45.0 41.9 46.4 41.3 43.3 45.8 2.6 3.2 7.7 38.5 1.1 3.1 3.4 2.9 4.6 10.8 9.1 7.7 5.3 4.3 2.7 3.7 2.1 1.0 0.7 2.9 0.0 1.0 0.5 4.1 2.8 1.6 1.2 0.0 30.9 1.3 0.6 6.0 14.8 7.0 1.3 2.3 2.9 5.7 21.9 43.7 30.0 3.0 2.0 0.8 2.5 1.8 32.9 4.6 10.6 5.6 1.5 8.8 0.0 4.0 15.2 1.4 3.5 22.2 1.5 4.0 0.4 2.4 4.8 11.4 0.0 5.4 3.2 0.4 2.3 3.6 3.4 0.7 0.9 1.9 2.9 2.0 HTR2C "5-HT2C, 5HTR2C, HTR1C" ENSG00000147246 "5-hydroxytryptamine receptor 2C" P28335 X 114584078-114910061 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "choroid plexus: 271.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 24.2;Inhibitory neurons: 55.3;Oligodendrocyte precursor cells: 10.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 2.7;RPMI-8226: 1.4;U-266/70: 4.8;U-266/84: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (2.14e-1)" "unprognostic (6.09e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (3.42e-2)" "unprognostic (9.22e-4)" "unprognostic (1.37e-1)" "unprognostic (6.84e-2)" 0.0 0.0 8.5 0.0 23.1 0.0 0.0 1.2 8.1 0.3 271.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 17.4 0.0 0.0 0.0 0.0 13.2 9.9 0.0 0.0 0.0 0.4 0.1 9.8 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.4 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 23.1 1.2 8.1 12.7 17.4 13.2 9.9 9.8 3.2 12.1 2.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 24.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 10.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289952-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 40.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Cardiomyocytes: 33.9;Erythroid cells: 8.2;Excitatory neurons: 17.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 239 "amygdala: 13.6;basal ganglia: 15.4;cerebral cortex: 26.2;hippocampal formation: 40.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 16.3;K-562: 13.2;RPMI-8226: 14.7;U-266/70: 17.5;U-87 MG: 9.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 14 "amygdala: 40.8;basal ganglia: 45.1;cerebral cortex: 50.7;hippocampal formation: 76.2;olfactory bulb: 27.4" "HPA008943, HPA009083, CAB025178" Enhanced NA NA 3300000 "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.3 0.0 13.6 0.0 15.4 0.6 0.2 0.0 26.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.2 40.2 0.0 1.0 0.0 6.2 0.2 0.0 0.0 2.1 0.0 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.6 0.0 0.0 0.2 0.5 0.0 3.5 0.0 0.0 7.4 0.0 0.0 0.3 5.0 0.8 0.2 0.5 0.0 0.1 5.6 2.3 0.0 0.0 6.5 0.2 0.0 0.0 0.2 1.0 16.3 6.1 0.5 0.1 0.0 3.1 0.0 0.6 0.1 0.0 0.0 0.0 2.0 13.2 0.1 0.0 0.8 0.0 2.3 0.0 0.3 4.9 0.1 0.0 14.7 0.2 0.0 0.9 0.1 2.3 0.2 0.5 0.0 2.7 0.0 0.0 1.5 0.0 0.9 0.0 17.5 3.1 3.5 9.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 15.4 0.0 26.2 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.4 2.8 1.6 0.4 0.3 0.2 0.3 1.8 0.7 1.6 5.2 33.9 0.0 1.3 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.5 0.6 0.5 2.8 0.0 8.2 17.7 0.0 0.1 1.1 1.1 1.3 2.5 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.3 1.7 0.0 0.0 2.1 0.0 2.8 0.3 0.0 0.0 1.5 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.4 0.5 0.0 0.0 0.7 1.7 1.7 1.3 0.4 0.1 0.1 0.7 0.1 0.2 0.2 IDUA "MPS1, MPSI" ENSG00000127415 Alpha-L-iduronidase P35475 4 986997-1004564 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025901, HPA046979, HPA054254" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 170000 "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429" "unprognostic (3.62e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (7.23e-2)" "unprognostic (1.45e-1)" "unprognostic (2.31e-2)" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.43e-2)" "unprognostic (1.89e-3)" "unprognostic (2.64e-2)" "unprognostic (4.61e-3)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "prognostic favorable (8.04e-5)" 13.5 17.6 3.4 2.2 3.4 2.9 16.1 9.2 7.5 17.5 2.9 10.3 3.6 15.4 2.4 9.9 16.3 3.7 11.6 3.8 1.5 15.9 13.6 13.9 3.5 3.2 2.1 17.0 21.0 2.8 17.2 1.7 2.4 18.5 1.8 1.8 16.6 4.5 3.7 8.9 14.3 2.0 1.0 18.9 17.1 5.6 2.9 3.4 17.0 0.7 1.3 12.0 13.9 2.6 1.8 0.4 0.0 1.1 12.7 3.6 5.3 10.7 8.5 1.2 1.7 0.6 6.4 0.8 10.7 5.0 1.0 0.5 0.1 0.3 0.4 6.1 0.6 1.0 0.8 0.1 5.8 0.8 4.6 9.3 3.1 0.6 0.0 3.4 1.0 0.7 0.6 0.0 1.6 0.0 2.2 2.5 0.8 11.9 5.5 2.7 0.0 1.1 3.5 0.9 0.1 3.3 0.3 0.0 5.7 1.3 1.2 2.3 9.3 9.0 1.6 2.6 1.2 29.0 1.4 0.4 7.8 3.3 1.8 0.0 1.5 0.0 1.4 1.2 1.8 0.1 1.1 0.9 1.8 0.2 1.3 0.7 0.0 1.5 1.7 1.1 0.6 0.5 3.4 3.4 9.2 7.5 3.8 1.5 3.2 2.1 2.4 1.0 2.9 2.6 8.7 6.4 5.0 4.9 5.2 3.6 11.5 1.1 8.6 2.0 8.5 9.1 2.6 1.5 1.5 7.3 4.2 0.4 4.3 5.0 0.0 1.6 0.9 4.1 9.0 4.9 10.7 1.3 4.4 2.4 1.7 13.4 16.8 6.0 2.5 8.2 6.1 2.6 6.5 0.0 2.9 4.2 0.0 5.0 3.6 0.9 19.6 7.3 5.4 1.0 1.6 1.1 4.1 5.5 3.3 1.4 6.9 10.5 15.7 7.7 6.9 1.4 1.4 2.1 0.0 5.5 4.4 3.7 1.6 4.7 1.8 0.4 5.6 4.7 4.3 7.9 IFNAR2 IFNABR ENSG00000159110 "Interferon alpha and beta receptor subunit 2" P48551 21 33229901-33265675 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 211.2;U-266/70: 261.6;U-266/84: 145.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1500000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.00e-2)" "unprognostic (7.83e-3)" "unprognostic (4.98e-2)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-3)" "unprognostic (8.05e-2)" "unprognostic (4.17e-2)" "unprognostic (2.11e-2)" "unprognostic (7.65e-2)" "unprognostic (4.42e-1)" "prognostic unfavorable (7.54e-7)" "unprognostic (9.70e-3)" "unprognostic (2.39e-1)" "unprognostic (5.12e-3)" "unprognostic (1.85e-2)" 21.3 9.0 13.2 33.2 13.6 29.1 16.4 11.5 14.8 12.7 9.7 16.7 17.4 11.7 8.2 8.0 11.7 21.0 13.4 11.0 14.3 14.3 28.7 22.6 33.5 16.7 14.0 11.8 10.0 12.5 10.1 22.9 15.1 10.1 17.4 8.3 13.7 11.3 9.0 7.0 16.2 18.3 13.6 41.0 14.8 5.3 15.8 33.9 10.7 10.8 36.4 38.2 9.0 14.0 17.0 18.4 9.9 23.7 11.9 27.3 16.2 18.1 45.1 14.2 15.7 24.4 20.8 28.3 12.8 25.4 22.8 10.9 15.2 9.2 15.0 18.3 19.9 100.9 19.1 22.2 17.5 17.5 38.0 20.7 8.7 16.8 18.5 24.8 46.0 41.5 30.2 211.2 13.7 9.1 44.0 19.6 18.3 24.2 11.7 14.9 53.4 50.7 30.8 31.9 26.6 14.2 29.5 28.2 23.9 10.4 4.4 30.5 32.2 15.3 9.3 12.5 10.1 261.6 145.3 64.3 20.5 60.3 37.5 44.5 38.5 63.8 31.2 65.0 32.2 25.7 37.9 29.3 36.6 17.1 27.5 30.8 101.2 35.2 73.4 101.0 65.8 41.3 13.2 13.6 11.5 14.8 11.0 14.3 16.7 14.0 15.1 13.6 15.8 14.0 35.6 60.9 16.1 19.6 49.4 6.8 43.8 41.7 2.8 6.6 11.4 12.4 2.2 20.0 23.6 11.0 6.2 28.9 64.4 6.0 3.9 67.5 3.0 6.7 10.0 39.0 3.0 27.6 44.4 62.7 72.1 15.4 4.6 8.5 31.7 11.8 44.6 19.6 44.9 20.2 42.3 4.4 4.1 73.5 17.1 3.3 7.5 58.5 19.6 74.9 47.9 6.4 89.6 51.3 29.4 73.8 5.9 9.1 188.8 89.5 17.3 10.2 35.2 5.6 0.0 16.8 12.5 4.2 19.9 4.3 5.7 23.5 43.9 2.5 4.9 83.2 IGFLR1 "FLJ22573, TMEM149, U2AF1L4" ENSG00000126246 "IGF like family receptor 1" Q9H665 19 35738801-35742453 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 49.9" "Cell type enhanced" "Detected in many" "dendritic cells: 29.9;granulocytes: 38.7;Langerhans cells: 33.7;Macrophages: 28.8;monocytes: 115.6;Plasma cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 899.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 899.7" "Cell line enhanced" "Detected in many" "HMC-1: 32.9;Karpas-707: 26.0;U-266/70: 34.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA012369, HPA070778" Uncertain Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Plasma membrane" "HPA012369: AB_1858095, HPA070778: " "unprognostic (5.97e-3)" "prognostic favorable (6.55e-4)" "unprognostic (1.94e-1)" "unprognostic (5.42e-2)" "unprognostic (8.31e-3)" "unprognostic (2.34e-4)" "unprognostic (6.71e-2)" "unprognostic (1.74e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.59e-5)" "unprognostic (1.44e-3)" "unprognostic (3.52e-1)" "unprognostic (8.72e-12)" "unprognostic (2.74e-1)" "unprognostic (1.22e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-3)" 7.6 10.9 6.1 19.5 6.8 14.4 6.2 6.0 9.3 4.9 6.0 6.5 6.1 3.4 5.5 4.0 6.4 6.1 4.5 5.9 11.1 14.0 49.9 11.3 33.0 9.1 6.8 4.4 9.3 1.4 5.5 4.5 7.4 6.2 6.4 4.6 7.8 1.5 4.5 4.4 13.2 4.4 5.6 28.6 7.9 6.7 7.1 12.6 7.2 2.1 23.2 7.3 3.5 7.5 2.2 10.0 3.5 8.3 1.1 1.7 2.0 1.5 1.1 1.8 4.7 3.0 2.4 4.0 3.2 0.7 0.6 1.6 2.0 2.1 0.9 3.3 5.0 15.0 3.4 9.1 2.8 1.7 32.9 2.7 1.3 3.5 0.8 0.6 1.9 7.7 4.9 26.0 0.5 7.4 5.1 16.7 1.6 9.4 2.7 6.0 3.3 8.3 1.7 3.2 2.4 4.5 3.4 2.4 1.8 1.3 3.4 7.8 0.5 4.2 2.0 2.6 4.0 34.0 7.5 2.8 4.9 5.8 3.0 147.9 190.9 184.1 94.2 167.7 106.6 169.3 107.3 88.8 253.2 172.1 95.8 77.0 208.6 144.9 125.3 899.7 136.3 139.5 6.1 6.8 6.0 9.3 5.9 11.1 9.1 6.8 7.4 5.6 7.1 7.5 0.3 0.0 13.5 2.6 24.5 0.6 0.3 0.0 0.0 0.4 1.3 1.3 1.2 1.5 5.0 0.0 0.0 0.6 29.9 1.2 1.9 1.9 0.0 0.8 0.6 0.8 3.0 6.1 0.3 4.2 1.8 0.9 1.1 0.7 38.7 0.6 2.2 20.3 14.6 0.0 0.4 1.8 0.0 15.7 33.7 0.6 0.0 28.8 5.4 1.9 115.6 2.7 12.3 2.5 1.0 1.4 0.3 0.0 42.1 0.2 0.9 10.8 3.6 0.4 0.0 1.0 0.9 0.4 0.5 1.9 0.9 0.3 20.8 0.4 2.4 0.0 IGHA1 ENSG00000211895 "Immunoglobulin heavy constant alpha 1" P01876 14 105703995-105708665 "Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9" "Group enriched" "Detected in many" 10 "B-cells: 17763.5;Plasma cells: 34095.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 203 "memory B-cell: 2571.8;naive B-cell: 1114.6" "Lineage enriched" "Detected in many" 284 "B-cells: 2571.8" "Cell line enhanced" "Detected in many" "HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 130000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (8.87e-5)" "unprognostic (5.36e-3)" "unprognostic (2.10e-2)" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "prognostic favorable (3.81e-5)" "unprognostic (1.17e-1)" "unprognostic (3.86e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.83e-7)" "unprognostic (8.10e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" 200.6 41.7 1.4 1121.1 1.0 918.5 953.5 0.7 6.5 214.3 4.2 5973.6 7411.2 79.9 3.5 641.9 203.5 662.9 73.8 0.6 1.3 278.5 327.7 1305.3 1420.6 3.5 1.1 40.6 115.1 3.5 38.3 6.7 1.1 202.5 1338.5 0.0 8904.9 69.0 10.8 56.7 3788.8 69.5 1.4 6397.6 6664.9 23.2 1.0 131.0 447.3 0.4 1949.0 1616.2 302.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.8 0.0 0.0 3.6 0.0 0.0 0.0 17.4 0.0 3.7 0.0 0.0 0.0 5.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 4.1 14.4 5.5 0.0 0.0 3.8 4.3 34.7 0.0 0.0 9.7 22.3 2.6 0.0 0.0 0.0 0.0 1.6 5.1 0.0 3.9 4.2 3.2 78.2 24.0 2.2 0.0 2.4 0.0 3.8 3.0 0.6 1.3 0.3 1.0 2571.8 0.7 1.1 1.5 1114.6 0.4 1.0 9.0 0.9 0.9 1.7 1.0 508.3 1.4 1.0 0.7 6.5 0.6 1.3 3.5 1.1 1.1 1.4 1.0 1.9 11.8 131.4 783.5 0.0 17763.5 0.0 26.0 0.0 1.2 0.0 22.4 4.6 4.7 22.8 46.4 0.0 0.0 0.7 55.5 20.8 0.0 0.0 0.0 0.1 0.1 26.5 28.4 167.0 0.0 0.0 0.5 56.5 99.4 0.1 584.8 0.0 353.8 225.1 1.6 0.0 0.0 13.6 0.0 57.8 0.0 0.0 0.0 34.6 0.0 0.0 6.7 0.0 11.3 0.0 0.0 0.0 12.8 0.0 34095.8 33.2 0.0 1.4 16.0 0.0 0.0 2.0 13.6 0.0 0.0 0.8 0.0 6.0 2514.2 0.0 27.9 1.2 IGHA2 ENSG00000211890 "Immunoglobulin heavy constant alpha 2 (A2m marker)" P01877 14 105583731-105588395 "Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 5017.7;salivary gland: 3728.4" "Group enriched" "Detected in many" 22 "B-cells: 3713.4;Plasma cells: 10918.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 876 "memory B-cell: 279.6;naive B-cell: 123.8" "Lineage enriched" "Detected in single" 1214 "B-cells: 279.6" "Group enriched" "Detected in some" 42 "U-266/70: 181.9;U-266/84: 63.9" "Not detected" "Not detected" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 67000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (1.98e-9)" "unprognostic (3.20e-2)" "unprognostic (2.23e-2)" "unprognostic (1.53e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.40e-5)" "unprognostic (4.56e-2)" "unprognostic (2.59e-1)" "unprognostic (3.17e-1)" "unprognostic (3.69e-2)" "unprognostic (1.20e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.50e-6)" "unprognostic (2.12e-1)" "unprognostic (3.28e-2)" "unprognostic (9.70e-2)" "unprognostic (4.47e-1)" 24.3 3.7 0.0 14.2 0.0 12.4 329.7 0.0 0.0 47.6 0.0 5017.7 15.3 8.9 0.0 219.7 35.0 0.9 4.8 0.0 0.0 49.7 35.1 134.2 6.8 0.0 0.0 5.3 30.3 0.0 4.9 0.3 0.0 37.7 8.8 0.0 3728.4 0.1 2.1 17.8 2261.3 1.0 0.0 700.9 670.1 1.1 0.0 22.4 59.8 0.0 13.0 93.4 67.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.9 181.9 63.9 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 279.6 0.0 0.1 0.1 123.8 0.0 0.1 0.2 0.0 0.1 0.1 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.2 12.4 0.0 3713.4 0.0 2.4 0.0 2.8 0.0 1.4 0.3 1.2 5.7 0.6 0.0 0.0 0.1 3.2 3.7 0.0 0.0 0.0 0.0 0.0 15.6 8.5 56.2 0.0 0.0 0.0 8.0 10.7 0.0 15.2 0.0 78.9 6.0 0.3 0.0 0.0 2.9 0.0 10.8 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 10918.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 23.6 0.0 0.0 12.3 0.0 0.4 325.4 0.0 4.8 0.2 IGHE ENSG00000211891 "Immunoglobulin heavy constant epsilon" P01854 14 105597691-105601728 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.9;lymphoid tissue: 4.6;thyroid gland: 2.6" "Cell type enriched" "Detected in some" 50 "Plasma cells: 462.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "U-266/70: 3818.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 77000000 "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (3.18e-2)" "unprognostic (1.28e-2)" "unprognostic (1.54e-3)" "unprognostic (4.99e-1)" "unprognostic (4.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.04e-2)" "unprognostic (3.88e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-2)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 1.9 0.0 0.0 4.6 1.4 0.0 0.0 0.2 2.6 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.6 3818.2 371.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 462.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 IGHV1-2 V35 ENSG00000211934 "Immunoglobulin heavy variable 1-2" P23083 14 105986582-105987083 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 462.7;lymphoid tissue: 1157.3" "Cell type enriched" "Detected in some" 38 "Plasma cells: 609.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 52 "memory B-cell: 285.2;naive B-cell: 347.4" "Lineage enriched" "Detected in many" 57 "B-cells: 347.4" "Cell line enriched" "Detected in some" 8 "U-266/70: 14302.7" "Immunoglobulin genes" NA NA 4000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.63e-3)" "unprognostic (1.09e-3)" "unprognostic (1.88e-1)" "unprognostic (9.46e-2)" "unprognostic (5.78e-2)" "prognostic favorable (1.67e-5)" "unprognostic (9.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (2.37e-1)" "unprognostic (1.99e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.17e-2)" "unprognostic (8.59e-2)" "unprognostic (3.19e-1)" "unprognostic (1.17e-2)" 16.7 43.1 0.3 364.1 0.2 76.0 84.1 0.0 1.2 41.5 0.5 462.7 223.7 13.1 1.3 34.5 58.5 54.4 26.2 0.0 0.1 13.7 18.9 60.7 404.9 0.4 0.0 36.5 3.0 0.6 1.3 0.6 0.2 23.2 283.8 0.0 222.4 52.5 0.4 4.5 121.9 7.5 0.2 393.2 216.1 35.0 0.1 72.1 33.7 0.0 1157.3 255.5 8.9 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 2.6 0.0 0.0 2.3 0.4 2.8 0.0 0.0 3.1 0.6 0.5 0.0 0.0 1.3 1.8 0.1 0.0 0.6 0.0 0.0 0.2 0.3 0.0 1.5 0.0 1.3 14302.7 1755.5 0.5 0.0 0.4 0.0 0.3 0.6 0.1 0.3 0.0 0.2 285.2 1.6 0.7 0.2 347.4 1.5 0.6 6.1 0.2 0.3 0.5 1.1 34.0 0.3 0.2 0.0 1.2 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.6 0.0 0.0 1.3 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 609.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 IGHV1-45 ENSG00000211961 "Immunoglobulin heavy variable 1-45" A0A0A0MS14 14 106506996-106507491 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 18.9;lymphoid tissue: 30.3;stomach 1: 17.5" "Cell type enriched" "Detected in single" 20 "Plasma cells: 2.0" "Cancer enriched" "Detected in many" 7 "lung cancer: 15.4" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.2;U-266/84: 1.3" "Immunoglobulin genes" NA NA 380000000 "Cluster 32: T-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.57e-4)" "unprognostic (5.07e-3)" "unprognostic (2.12e-3)" "unprognostic (1.46e-1)" "unprognostic (7.64e-3)" "unprognostic (2.90e-1)" "unprognostic (3.50e-2)" "unprognostic (3.16e-1)" "unprognostic (1.48e-1)" "unprognostic (1.05e-1)" "unprognostic (4.05e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-2)" "unprognostic (2.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.16e-1)" 0.2 0.1 0.0 3.7 0.0 1.8 18.9 0.0 0.0 0.3 0.0 4.5 1.1 0.5 0.0 6.4 0.2 0.6 0.1 0.0 0.0 0.2 0.2 3.5 7.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 6.1 0.0 11.5 0.0 0.0 0.1 2.3 0.7 0.0 6.9 17.5 0.1 0.0 2.9 0.3 0.0 30.3 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.1 0.6 0.3 0.0 1.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1OR21-1 IGHV1/OR21-1 ENSG00000277282 "Immunoglobulin heavy variable 1/OR21-1 (non-functional)" 21 10649400-10649835 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.3;lymphoid tissue: 6.3;stomach 1: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "lung cancer: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "memory B-cell: 2.0;naive B-cell: 1.7" "Lineage enriched" "Detected in single" 15 "B-cells: 2.0" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (3.93e-3)" "unprognostic (2.55e-2)" "unprognostic (1.28e-2)" "unprognostic (8.48e-5)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (3.32e-1)" 0.0 0.6 0.0 3.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 3.3 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.0 0.9 3.4 0.1 0.0 0.5 0.0 0.0 6.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ1 J1 ENSG00000211597 "Immunoglobulin kappa joining 1" A0A0A0MT89 2 88861886-88861923 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 3082.3;lymphoid tissue: 3301.5;salivary gland: 1202.6;stomach 1: 2816.8;urinary bladder: 1106.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 418 "memory B-cell: 38345.4;naive B-cell: 32121.1;plasmacytoid DC: 14778.6" "Group enriched" "Detected in all" 390 "B-cells: 38345.4;dendritic cells: 14778.6" "Cell line enriched" "Detected in many" 4 "U-266/70: 21925.7" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" 70.6 227.2 1.9 3301.5 1.5 424.8 363.1 1.3 9.2 71.7 5.0 1960.8 3082.3 41.6 0.0 278.0 18.1 157.4 31.0 3.2 2.2 31.7 92.0 382.5 839.3 3.4 2.4 127.7 50.3 2.0 0.0 6.3 2.9 50.4 1743.7 0.2 1202.6 16.4 6.9 8.8 2231.5 61.2 3.4 1516.0 2816.8 31.2 2.1 115.3 6.2 0.0 2770.1 1106.5 0.0 2.9 22.9 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 7.4 0.0 9.9 2.5 0.0 0.0 14.6 0.0 0.0 0.0 851.1 0.0 10.1 0.0 0.0 0.0 34.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 10.3 12.1 11.8 0.0 0.0 23.1 0.0 4365.8 0.0 0.0 10.3 18.7 0.0 0.0 4.9 0.0 0.0 31.0 0.0 0.0 9.7 2.4 34.6 21925.7 5461.9 93.7 0.0 6.3 0.0 48.3 44.8 22.7 19.1 17.9 25.4 38345.4 27.2 13.8 57.2 32121.1 20.1 20.9 68.0 38.9 26.9 14778.6 29.9 3897.0 1.9 1.5 1.3 9.2 3.2 2.2 3.4 2.4 2.9 3.4 2.1 2.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV3-20 ENSG00000239951 "Immunoglobulin kappa variable 3-20" P01619 2 89142574-89143160 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 3080.6;lymphoid tissue: 5246.5" "Cell type enriched" "Detected in some" 138 "Plasma cells: 52154.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 329 "memory B-cell: 1602.7;naive B-cell: 1222.4" "Lineage enriched" "Detected in many" 373 "B-cells: 1602.7" "Group enriched" "Detected in many" 215 "U-266/70: 3769.9;U-266/84: 1732.3" HPA047702 Approved "Immunoglobulin genes" NA NA 20000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (1.86e-4)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (1.97e-2)" "unprognostic (1.13e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-1)" "unprognostic (1.37e-1)" "unprognostic (3.93e-3)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (7.35e-2)" "unprognostic (5.08e-1)" "unprognostic (6.64e-2)" "unprognostic (2.70e-2)" 104.8 56.4 0.9 1791.2 0.9 380.3 736.4 0.5 4.2 326.9 2.6 3080.6 1714.2 59.0 7.8 302.1 105.2 637.2 55.7 0.5 1.6 106.2 113.5 454.0 2815.6 2.1 8.4 153.5 32.8 5.8 9.6 1.8 1.4 56.1 2731.8 0.2 1270.5 224.5 3.3 13.4 1355.8 82.8 10.4 2699.1 1412.9 24.7 1.2 671.5 224.3 1.8 5246.5 1644.0 70.0 1.5 2.5 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.5 0.0 2.1 0.0 0.0 0.0 6.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 2.0 5.9 2.8 0.0 0.0 3.0 6.0 10.4 0.0 0.0 7.7 12.8 1.4 0.0 0.1 0.0 0.0 0.8 4.4 0.0 2.0 1.5 4.3 3769.9 1732.3 1.8 0.0 2.3 0.0 4.0 1.2 0.7 0.7 0.4 0.8 1602.7 0.8 0.6 3.5 1222.4 0.4 0.7 4.2 0.8 1.0 0.9 0.8 196.9 0.9 0.9 0.5 4.2 0.5 1.6 2.1 8.4 1.4 10.4 1.2 1.5 0.1 3.2 1.3 0.0 376.9 0.0 0.0 0.0 5.2 0.0 0.1 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 9.4 0.0 0.0 0.0 55.3 124.4 0.0 1.3 0.0 3.6 5.0 0.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 52154.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 26.7 0.0 0.2 0.0 IGKV3D-11 ENSG00000211632 "Immunoglobulin kappa variable 3D-11" A0A0A0MRZ8 2 90172802-90173414 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.6;lymphoid tissue: 58.5;stomach 1: 27.7" "Cell type enriched" "Detected in some" 34 "Plasma cells: 196.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 468 "memory B-cell: 152.5;naive B-cell: 146.1" "Lineage enriched" "Detected in single" 478 "B-cells: 152.5" "Cell line enhanced" "Detected in single" "U-266/70: 2.1" HPA047702 Approved "Immunoglobulin genes" NA NA 6700000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (6.40e-5)" "unprognostic (7.90e-3)" "unprognostic (1.91e-2)" "unprognostic (2.24e-3)" "prognostic favorable (5.58e-5)" "unprognostic (2.65e-2)" "unprognostic (2.13e-1)" "unprognostic (2.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.49e-1)" "unprognostic (3.61e-1)" "prognostic unfavorable (2.20e-6)" "unprognostic (1.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "unprognostic (1.24e-2)" 1.3 0.7 0.3 35.9 0.2 8.9 6.4 0.0 0.1 1.7 0.0 38.6 32.2 0.8 0.0 2.4 2.1 2.7 0.5 0.0 0.1 2.1 1.3 12.4 13.0 0.1 0.3 1.5 0.5 0.0 0.1 0.0 0.1 0.7 26.6 0.0 18.8 0.3 0.0 0.1 23.6 0.7 0.2 29.9 27.7 0.2 0.0 4.2 2.3 0.0 58.5 17.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 152.5 0.0 0.0 0.1 146.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 30.2 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 IGKV3D-20 ENSG00000211625 "Immunoglobulin kappa variable 3D-20" A0A0C4DH25 2 90038848-90039479 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 131.8;lymphoid tissue: 275.4" "Cell type enriched" "Detected in some" 38 "Plasma cells: 289.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 1042 "memory B-cell: 197.3;naive B-cell: 99.0" "Lineage enriched" "Detected in single" 1388 "B-cells: 197.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 19.5" HPA047702 Approved "Immunoglobulin genes" NA NA 11000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (6.82e-4)" "unprognostic (4.70e-3)" "unprognostic (3.16e-2)" "unprognostic (8.10e-3)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (3.37e-1)" "unprognostic (1.68e-1)" "unprognostic (5.15e-2)" "unprognostic (2.53e-2)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (7.10e-2)" "unprognostic (2.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" 4.0 6.3 0.0 81.2 0.0 16.0 32.4 0.0 0.6 12.2 0.1 131.8 55.9 2.7 0.0 15.3 4.2 16.2 6.4 0.0 0.1 3.0 6.4 20.6 73.5 0.2 0.1 7.1 3.3 0.0 0.3 0.1 0.1 3.7 88.1 0.0 64.0 3.3 0.1 2.6 77.7 6.0 0.3 88.4 82.5 1.2 0.0 16.2 5.2 0.0 275.4 38.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.5 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 197.3 0.0 0.1 0.1 99.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 289.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 IGKV6-21 "A26, IGKV621" ENSG00000211611 "Immunoglobulin kappa variable 6-21 (non-functional)" A0A0C4DH24 2 89159751-89160366 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 97.3;lymphoid tissue: 141.0" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1715.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 194 "memory B-cell: 28.8;naive B-cell: 9.8" "Lineage enriched" "Detected in single" 289 "B-cells: 28.8" "Cell line enriched" "Detected in some" 6 "U-266/70: 10.5" "Immunoglobulin genes" NA NA 250000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.82e-4)" "unprognostic (1.80e-2)" "unprognostic (4.99e-3)" "unprognostic (2.32e-2)" "unprognostic (1.51e-3)" "unprognostic (1.93e-1)" "unprognostic (6.32e-2)" "unprognostic (4.74e-2)" "unprognostic (8.91e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" 2.2 0.4 0.0 41.6 0.0 12.0 37.4 0.0 0.1 3.3 0.0 97.3 38.8 1.8 0.6 8.4 1.9 5.9 0.5 0.0 0.0 2.7 2.6 11.9 64.4 0.2 0.0 2.1 0.8 0.0 0.1 0.0 0.0 1.5 79.3 0.0 43.5 9.0 0.0 0.5 38.5 5.0 0.1 63.8 36.3 0.9 0.0 10.2 3.5 0.0 141.0 37.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1715.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGLC1 IGLC ENSG00000211675 "Immunoglobulin lambda constant 1" 22 22895375-22895834 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 3264.2;lymphoid tissue: 5586.9;stomach 1: 2335.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 37.3;granulocytes: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 743 "memory B-cell: 5729.2;naive B-cell: 5821.4" "Lineage enriched" "Detected in all" 749 "B-cells: 5821.4" "Cell line enriched" "Detected in many" 5 "U-266/70: 600.3" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" 132.3 163.1 2.2 1208.8 1.9 641.9 903.4 1.7 7.0 190.8 4.4 3038.0 3264.2 63.1 2.1 535.0 113.2 640.0 104.5 1.7 2.2 148.2 114.7 470.6 2372.4 3.9 1.7 135.6 69.8 8.0 13.2 1.9 2.2 71.5 2133.6 0.7 2047.0 124.0 4.9 28.8 1389.9 78.0 2.6 3332.0 2335.3 23.7 2.3 873.2 224.5 0.0 5586.9 1948.8 79.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.0 0.0 1.0 0.0 1.9 0.2 0.0 0.0 6.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 9.1 0.0 0.0 1.1 10.2 2.0 0.0 0.0 2.3 8.9 33.4 0.0 0.0 6.3 11.1 1.4 0.0 0.0 0.0 0.0 0.3 2.5 0.0 1.3 4.3 2.6 600.3 119.9 36.5 0.0 3.5 0.0 4.2 7.7 2.0 3.7 1.7 2.9 5729.2 3.8 2.5 6.0 5821.4 0.9 2.2 7.6 2.8 4.8 5.2 3.4 897.2 2.2 1.9 1.7 7.0 1.7 2.2 3.9 1.7 2.2 2.6 2.3 3.4 0.0 6.4 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 IGLC2 IGLC ENSG00000211677 "Immunoglobulin lambda constant 2" P0DOY2 22 22900976-22901437 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 9734.6;lymphoid tissue: 19988.7;stomach 1: 10849.9" "Group enriched" "Detected in many" 40 "B-cells: 24632.2;Plasma cells: 18795.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 36 "memory B-cell: 11361.1;naive B-cell: 10650.3" "Lineage enriched" "Detected in all" 37 "B-cells: 11361.1" "Group enriched" "Detected in many" 190 "RPMI-8226: 62032.1;U-266/70: 102644.1;U-266/84: 83511.6" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.76e-5)" "unprognostic (2.29e-2)" "unprognostic (4.54e-3)" "unprognostic (1.46e-2)" "unprognostic (4.02e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.96e-2)" "unprognostic (7.52e-2)" "unprognostic (7.15e-2)" "unprognostic (7.69e-3)" "unprognostic (2.83e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (4.47e-9)" "unprognostic (2.00e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" 386.6 782.7 7.7 3871.2 6.2 2741.4 2183.6 4.6 14.9 815.5 11.4 8217.0 9734.6 194.3 207.0 1690.0 231.5 2091.8 318.3 4.6 5.7 301.6 382.3 1442.8 5543.4 11.1 5.0 540.2 112.7 16.8 31.0 7.5 6.6 264.0 5055.4 0.7 5934.2 384.9 8.6 74.2 5290.6 306.2 6.6 7090.0 10849.9 256.0 5.4 2071.4 491.7 0.6 19988.7 6482.1 176.7 10.7 120.6 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 221.4 12.0 0.0 0.0 61.9 0.0 0.0 0.0 30.5 0.0 7.7 0.0 0.0 0.0 19.2 343.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 64.7 0.0 0.0 70.1 27.7 52.3 0.0 0.0 45.3 436.2 62032.1 0.0 0.0 46.7 45.7 5.6 43.0 17.3 0.0 17.7 57.2 11.7 0.0 38.9 23.4 78.2 102644.1 83511.6 298.8 0.7 21.9 0.7 9.9 18.6 5.6 5.8 3.0 5.7 11361.1 5.8 4.5 10.9 10650.3 3.5 4.7 118.0 5.8 8.7 303.3 6.5 2385.6 7.7 6.2 4.6 14.9 4.6 5.7 11.1 5.0 6.6 6.6 5.4 10.7 4.1 32.1 121.0 0.0 24632.2 0.0 0.3 0.0 1.2 0.0 16.1 3.0 3.9 44.3 8.1 0.0 0.0 0.3 8.0 28.0 0.0 0.0 0.0 0.0 0.1 86.3 62.5 222.4 0.0 0.0 0.3 42.5 14.8 0.0 65.6 0.0 222.8 539.9 2.1 0.0 0.0 21.5 0.0 134.5 0.0 0.0 0.0 8.5 0.0 0.0 11.4 0.0 15.5 0.0 0.0 0.0 20.6 0.0 18795.5 0.0 0.0 1.4 1.5 0.0 0.0 0.2 10.2 0.0 0.0 2.8 0.0 0.1 538.6 0.0 23.7 0.0 IGLJ3 ENSG00000211678 "Immunoglobulin lambda joining 3" 22 22904850-22905025 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "intestine: 552.2;lymphoid tissue: 227.6;salivary gland: 149.1;stomach 1: 462.5;urinary bladder: 147.8" "Group enriched" "Detected in some" 44 "B-cells: 4.5;Plasma cells: 4.3" "Group enriched" "Detected in some" 13 "colorectal cancer: 5.1;endometrial cancer: 10.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Group enriched" "Detected in many" 24 "memory B-cell: 1223.9;naive B-cell: 1139.6" "Lineage enriched" "Detected in many" 25 "B-cells: 1223.9" "Group enriched" "Detected in some" 7 "Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (1.19e-1)" "unprognostic (2.06e-3)" "unprognostic (2.05e-1)" "unprognostic (1.37e-1)" "unprognostic (5.00e-1)" 5.7 29.4 0.4 212.4 0.3 37.4 32.5 0.1 1.5 9.7 0.4 130.1 552.2 3.2 0.0 40.0 4.0 32.7 3.1 0.1 0.1 2.9 9.9 41.7 132.1 0.4 0.2 31.1 1.9 0.0 0.0 0.1 0.1 9.6 71.4 0.0 149.1 1.6 0.0 1.5 205.9 6.1 0.0 207.6 462.5 6.1 0.1 23.2 0.8 0.0 227.6 147.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 69.6 2.5 6.7 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.0 42.8 22.5 4.3 0.0 0.0 0.0 0.8 1.6 0.7 0.9 0.3 4.3 1223.9 0.8 0.5 1.3 1139.6 0.4 0.5 8.5 0.6 1.2 49.2 0.8 193.9 0.4 0.3 0.1 1.5 0.1 0.1 0.4 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ7 ENSG00000211684 "Immunoglobulin lambda joining 7" 22 22921390-22921435 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 12.3;lymphoid tissue: 19.0;stomach 1: 17.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.0;endometrial cancer: 1.5" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Group enriched" "Detected in some" 222 "memory B-cell: 314.0;naive B-cell: 370.8" "Lineage enriched" "Detected in many" 240 "B-cells: 370.8" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.0" NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" 0.7 4.1 0.1 14.5 0.1 1.1 0.0 0.3 3.4 0.0 0.0 6.1 12.3 0.0 0.0 2.1 0.0 3.3 0.0 0.2 0.9 0.0 0.0 2.0 3.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.8 1.9 0.0 5.9 0.0 0.0 0.0 5.4 0.0 0.0 3.8 17.5 1.8 0.1 0.3 0.0 0.0 19.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.6 314.0 0.0 0.0 0.0 370.8 0.0 0.0 0.0 0.0 1.5 0.2 0.0 27.6 0.1 0.1 0.3 3.4 0.2 0.9 1.2 0.4 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV2-18 ENSG00000211664 "Immunoglobulin lambda variable 2-18" A0A075B6J9 22 22734607-22735089 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 271.5;lymphoid tissue: 224.4" "Cell type enriched" "Detected in some" 210 "Plasma cells: 2488.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 44 "memory B-cell: 321.2;naive B-cell: 126.9" "Lineage enriched" "Detected in many" 64 "B-cells: 321.2" "Group enriched" "Detected in some" 7 "RPMI-8226: 13.4;U-266/70: 22.3;U-266/84: 7.2" "Immunoglobulin genes" NA NA 570000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.06e-5)" "unprognostic (2.81e-2)" "unprognostic (7.47e-3)" "unprognostic (1.13e-2)" "prognostic favorable (7.75e-4)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (7.58e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (1.95e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-2)" 3.4 0.3 0.0 73.0 0.0 23.7 67.1 0.0 0.3 6.7 0.1 271.5 262.0 4.2 0.0 39.6 10.8 36.3 12.5 0.0 0.0 2.0 2.8 12.6 37.6 0.1 0.0 4.1 1.1 2.1 0.2 0.1 0.4 1.7 138.6 0.0 64.3 4.9 0.1 0.3 150.2 6.5 0.0 95.8 72.5 0.5 0.0 22.1 2.8 0.0 224.4 18.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 13.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 22.3 7.2 0.1 0.1 0.1 0.0 0.2 1.8 0.0 1.6 0.0 0.8 321.2 0.3 1.3 0.1 126.9 0.7 0.6 0.5 5.0 0.1 0.2 0.1 69.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2488.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGLV2-33 ENSG00000211656 "Immunoglobulin lambda variable 2-33 (non-functional)" A0A075B6J2 22 22588155-22588688 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.3;lymphoid tissue: 2.7;salivary gland: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 1.9" "Lineage enriched" "Detected in single" 30 "B-cells: 2.9" "Group enriched" "Detected in some" 9 "RPMI-8226: 1.5;U-266/70: 5.1;U-266/84: 3.4" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (1.29e-2)" "unprognostic (1.79e-3)" "unprognostic (2.13e-1)" "unprognostic (4.30e-1)" "unprognostic (2.64e-3)" "unprognostic (2.47e-2)" "unprognostic (2.06e-1)" "unprognostic (6.68e-2)" 0.0 0.1 0.0 1.5 0.0 1.3 0.4 0.0 0.0 0.0 0.0 2.2 4.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 2.6 0.0 0.0 0.0 2.3 0.2 0.0 1.5 1.5 0.0 0.0 0.1 0.0 0.0 2.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV2-8 ENSG00000278196 "Immunoglobulin lambda variable 2-8" P01709 22 22822658-22823289 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1141.8;lymphoid tissue: 1012.4" "Cell type enriched" "Detected in some" 80 "Plasma cells: 5288.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 125 "memory B-cell: 1439.0;naive B-cell: 2097.3" "Lineage enriched" "Detected in all" 149 "B-cells: 2097.3" "Group enriched" "Detected in many" 617 "U-266/70: 64161.5;U-266/84: 56786.5" "Immunoglobulin genes" NA NA 1500000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.92e-4)" "unprognostic (1.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "prognostic favorable (5.07e-5)" "unprognostic (2.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" "unprognostic (5.05e-2)" "unprognostic (1.61e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.04e-2)" "unprognostic (2.67e-1)" "unprognostic (9.90e-2)" "unprognostic (1.62e-1)" 18.7 7.0 1.1 325.0 0.6 96.0 155.2 0.3 2.4 26.0 1.7 1141.8 977.0 9.4 3.5 91.4 7.9 132.4 30.5 0.3 0.3 15.4 24.3 59.2 228.2 0.8 0.3 57.2 30.3 1.4 1.4 0.2 0.7 9.0 250.6 0.0 255.5 60.3 0.6 1.9 451.5 20.1 0.8 437.7 433.9 3.4 0.3 90.6 23.7 0.0 1012.4 259.0 10.3 1.0 62.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.6 0.0 0.0 23.1 0.0 0.0 0.0 22.3 0.0 0.5 0.0 0.0 0.0 0.7 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.0 0.0 11.3 1.9 14.8 0.0 0.0 97.9 0.9 10.1 0.0 0.0 1.4 2.8 0.2 0.0 9.3 0.0 0.0 29.5 0.9 0.0 9.8 0.6 38.9 64161.5 56786.5 20.4 0.0 10.1 0.0 1.2 2.4 0.6 2.1 0.7 0.9 1439.0 1.3 1.5 1.9 2097.3 0.4 1.0 14.1 1.3 1.4 0.6 0.7 174.0 1.1 0.6 0.3 2.4 0.3 0.3 0.8 0.3 0.7 0.8 0.3 1.0 0.0 3.2 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.5 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5288.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 IGLV3-9 ENSG00000211670 "Immunoglobulin lambda variable 3-9" A0A075B6K5 22 22819010-22819756 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 313.9;stomach 1: 117.3" "Cell type enriched" "Detected in some" 9 "Plasma cells: 13.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 51 "memory B-cell: 64.7;naive B-cell: 168.7" "Lineage enriched" "Detected in many" 74 "B-cells: 168.7" "Cell line enriched" "Detected in some" 5 "U-266/70: 41.3" HPA003285 Approved "Immunoglobulin genes" NA NA 1500000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "prognostic favorable (2.59e-4)" "unprognostic (6.52e-3)" "unprognostic (1.95e-1)" "unprognostic (5.40e-2)" "prognostic favorable (9.80e-5)" "unprognostic (1.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.68e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.47e-2)" "unprognostic (4.58e-2)" "unprognostic (4.55e-2)" "unprognostic (3.22e-1)" 1.8 23.5 0.1 84.6 0.0 27.8 14.9 0.0 0.1 7.3 0.1 87.1 58.7 2.0 0.0 20.8 1.8 18.6 7.6 0.0 0.0 3.2 6.2 17.1 139.8 0.7 0.0 3.9 2.4 0.2 0.1 0.0 0.1 1.4 64.0 0.0 46.2 3.1 0.1 1.5 60.3 5.2 0.0 64.6 117.3 1.6 0.1 35.0 3.8 0.0 313.9 72.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.3 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.9 0.3 0.0 41.3 5.8 0.7 0.0 3.9 0.0 0.0 0.1 0.0 1.2 0.0 2.2 64.7 1.3 1.4 0.0 168.7 0.4 1.8 0.1 0.5 0.1 0.0 0.1 6.5 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 IGLV8-61 ENSG00000211638 "Immunoglobulin lambda variable 8-61" A0A075B6I0 22 22098700-22099212 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 805.8;lymphoid tissue: 984.2" "Cell type enriched" "Detected in some" 4 "B-cells: 25.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Group enriched" "Detected in some" 630 "memory B-cell: 257.8;naive B-cell: 529.3" "Lineage enriched" "Detected in single" 848 "B-cells: 529.3" "Cell line enhanced" "Detected in some" "Daudi: 2.2;RPMI-8226: 3.6;SH-SY5Y: 1.8;U-266/70: 6.6" "Low region specificity" "Detected in all" "Immunoglobulin genes" NA NA 620000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.07e-3)" "unprognostic (2.73e-2)" "prognostic favorable (3.84e-4)" "unprognostic (1.07e-2)" "unprognostic (5.24e-2)" "unprognostic (1.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.75e-3)" "unprognostic (2.05e-1)" "unprognostic (2.11e-1)" "unprognostic (3.32e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-1)" 9.4 4.9 0.1 125.5 0.2 63.9 78.3 0.1 3.5 43.5 1.0 201.1 805.8 22.7 0.8 10.6 5.6 46.4 11.7 0.1 0.2 5.3 13.7 82.2 257.2 0.2 0.1 9.2 13.4 1.3 0.8 0.0 0.7 10.5 191.0 0.0 108.6 1.0 0.2 4.0 161.6 13.0 0.8 275.7 179.2 3.3 0.1 16.5 11.5 0.0 984.2 247.8 3.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.0 0.2 3.6 0.0 0.0 1.0 1.8 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.3 6.6 1.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.2 0.1 257.8 0.3 0.0 0.4 529.3 0.0 0.0 0.2 0.1 0.4 0.1 0.2 32.7 0.1 0.2 0.1 3.5 0.1 0.2 0.2 0.1 0.7 0.8 0.1 1.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IL23A "IL-23, IL-23A, IL23P19, P19, SGRF" ENSG00000110944 "Interleukin 23 subunit alpha" Q9NPF7 12 56334174-56340410 "FDA approved drug targets, Predicted secreted proteins" "Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "urinary bladder: 44.5" "Cell type enhanced" "Detected in many" "Ductal cells: 43.4;Ionocytes: 73.2;Langerhans cells: 151.8;Pancreatic endocrine cells: 70.5;Spermatocytes: 41.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "MAIT T-cell: 14.1;memory B-cell: 18.9;memory CD4 T-cell: 25.7;memory CD8 T-cell: 12.5;naive B-cell: 21.5;naive CD4 T-cell: 28.1;naive CD8 T-cell: 17.6;T-reg: 15.6" "Group enriched" "Detected in many" 12 "B-cells: 21.5;T-cells: 28.1" "Cell line enhanced" "Detected in some" "A-431: 15.3;CAPAN-2: 25.6;U-266/70: 42.1;U-266/84: 20.5" "Region enhanced" "Detected in some" "white matter: 3.9" "Not detected" "Not detected" HPA001554 Approved Approved Cytosol "Secreted to blood" NA NA 11000 "Cluster 30: Non-specific - Translation" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "HPA001554: AB_1079135" "unprognostic (2.34e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.06e-1)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (4.40e-1)" "unprognostic (1.43e-3)" "unprognostic (1.30e-1)" "unprognostic (6.79e-2)" "unprognostic (3.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-10)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.83e-1)" "unprognostic (4.50e-3)" 0.6 0.3 0.3 2.1 0.2 3.2 0.3 0.1 0.2 0.4 0.1 0.4 0.2 1.0 0.5 4.5 0.4 0.9 0.3 0.4 0.2 0.6 1.1 1.2 4.2 0.3 0.2 0.3 0.7 0.0 0.6 0.6 0.2 0.5 0.3 0.1 1.3 0.2 0.2 0.7 1.9 0.0 0.2 2.2 0.7 4.4 0.3 7.2 0.4 0.0 8.8 44.5 0.5 0.3 15.3 0.3 0.5 0.5 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.5 25.6 0.9 7.5 0.0 0.8 1.3 0.0 2.5 0.1 1.1 0.5 0.4 0.3 1.2 0.0 0.3 0.9 0.1 0.0 0.0 0.7 3.1 0.0 3.5 0.6 6.2 0.1 0.6 0.6 0.8 2.2 0.3 0.4 0.4 0.2 0.6 8.9 7.4 0.5 0.6 0.3 0.4 1.4 2.1 0.2 7.0 0.5 0.5 0.5 0.4 1.8 42.1 20.5 2.1 0.5 3.7 0.4 0.0 0.4 0.0 2.8 0.0 14.1 18.9 25.7 12.5 0.9 21.5 28.1 17.6 0.2 2.0 0.1 0.1 15.6 10.0 0.3 0.2 0.1 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.3 0.3 0.5 3.2 2.2 0.0 13.6 3.6 12.1 16.2 0.6 0.0 1.2 1.4 0.4 0.0 23.7 1.8 0.0 0.4 1.5 1.1 1.9 43.4 6.9 11.1 1.0 1.4 0.0 0.0 0.3 7.4 0.5 2.3 1.5 16.6 0.0 0.3 0.0 0.5 2.5 0.0 0.2 1.0 73.2 0.8 151.8 4.2 0.3 14.7 8.8 0.0 34.7 0.5 0.0 0.0 0.3 70.5 0.1 0.7 7.4 6.1 0.4 0.6 15.3 0.5 0.0 0.4 1.4 41.9 6.9 0.6 4.0 0.0 14.4 0.2 2.0 16.3 INHBE "activin, MGC4638" ENSG00000139269 "Inhibin subunit beta E" P58166 12 57452323-57459280 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "liver: 148.4" "Cell type enriched" "Detected in single" 43 "Hepatocytes: 35.0" "Cancer enriched" "Detected in some" 27 "liver cancer: 34.4" "Region enhanced" "Detected in some" "cerebellum: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016843, CAB034017" Enhanced Supported Vesicles "Secreted to blood" NA NA 3500000 "Cluster 17: Basophils - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 2: Hepatocytes - Metabolism" Vesicles "CAB034017: AB_2233745, HPA016843: AB_1851796" "unprognostic (7.34e-2)" "unprognostic (6.73e-2)" "unprognostic (3.45e-1)" "unprognostic (4.69e-5)" "unprognostic (2.61e-1)" "unprognostic (2.50e-1)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.79e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.66e-8)" "unprognostic (4.09e-3)" "unprognostic (1.56e-1)" "unprognostic (3.57e-2)" "unprognostic (7.52e-3)" 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.3 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 148.4 0.1 0.1 0.9 0.0 0.0 0.9 0.1 1.0 0.0 1.1 0.3 0.0 0.1 0.0 0.0 1.5 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.0 1.4 0.5 0.0 0.2 0.1 0.2 0.2 0.4 0.3 0.5 0.0 0.5 0.3 2.9 7.8 0.2 9.2 0.4 0.1 4.0 1.9 0.7 0.2 0.4 1.8 0.0 1.2 18.3 0.2 0.1 0.3 11.9 50.8 2.3 2.4 4.9 5.3 1.2 11.4 0.4 0.0 1.8 5.0 79.1 0.0 0.0 0.2 0.2 0.5 0.1 0.3 0.2 36.9 8.8 0.0 0.1 19.5 0.9 0.0 0.0 7.6 0.3 0.6 8.7 0.3 0.2 4.0 0.1 0.6 263.5 9.2 3.8 1.5 0.4 0.3 0.9 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.3 0.1 0.1 0.9 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain ArfGEF 3" Q9UPP2 12 66767-178455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 39.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.8;Excitatory neurons: 81.6;Horizontal cells: 114.4;Inhibitory neurons: 76.2;Spermatocytes: 48.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 7.1;U-266/70: 9.1;U-266/84: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039025 Supported Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 4.0 0.8 6.6 0.5 8.2 0.7 1.4 17.0 39.1 2.2 0.0 0.6 0.4 2.4 0.3 0.3 3.3 1.5 1.3 9.8 5.6 2.0 0.2 2.0 0.4 5.4 2.3 1.6 0.8 0.0 8.7 0.9 1.7 1.2 0.2 7.5 0.3 2.9 1.0 0.2 0.5 1.2 4.7 0.4 0.5 1.4 8.3 3.2 0.4 0.4 0.1 0.9 1.6 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 2.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 6.6 8.2 17.0 39.1 9.8 5.6 5.4 2.3 1.7 4.7 8.3 15.9 9.9 3.2 0.0 1.6 0.0 0.3 0.0 0.0 0.6 50.8 0.1 0.1 2.2 0.0 0.0 0.0 8.4 0.0 2.1 0.1 0.0 0.0 0.8 0.1 0.9 3.3 0.0 0.0 81.6 0.0 0.0 1.3 0.0 0.2 2.5 0.1 2.2 0.4 1.6 114.4 76.2 0.0 0.0 0.8 0.6 4.3 0.6 1.4 0.0 7.5 0.1 6.6 1.0 4.5 1.4 0.2 0.0 0.0 0.0 0.1 0.7 5.2 0.0 16.1 0.0 0.5 1.1 48.6 21.8 0.1 0.1 0.0 0.5 0.1 0.2 0.1 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain 4" Q14624 3 52812962-52830688 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "liver: 1863.4" "Group enriched" "Detected in many" 5 "Early spermatids: 119.2;Hepatocytes: 134.6;Late spermatids: 126.5" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;JURKAT: 2.0;U-266/70: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" NA NA 3060000 58000000000 "Cluster 15: NK-cells - Transcription" "Cluster 62: Liver - Hemostasis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 4.2 18.5 4.1 1.2 4.2 10.0 3.0 3.7 5.0 4.2 3.5 3.6 1.0 2.9 1.7 1.4 3.8 1.1 3.2 3.9 3.6 5.4 1863.4 4.9 1.7 3.9 3.8 2.4 48.9 0.1 4.3 0.7 3.9 4.0 1.0 3.3 2.1 1.8 40.3 2.5 3.4 1.5 3.6 7.4 3.9 1.8 3.8 2.2 5.2 2.8 1.2 5.3 3.3 3.9 0.0 0.1 0.4 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.4 0.0 0.0 0.2 2.4 0.1 1.0 0.0 1.2 0.4 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.0 0.3 0.8 0.0 0.1 0.2 0.3 0.4 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.4 0.3 0.0 0.1 0.4 0.5 0.3 0.1 0.0 0.4 0.4 0.0 3.0 1.4 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.1 4.2 3.7 5.0 3.9 3.6 3.9 3.8 3.9 3.6 3.8 3.9 0.7 0.0 1.1 22.5 0.9 0.8 0.3 0.3 0.0 10.0 0.6 1.3 1.1 2.8 0.8 0.0 12.5 0.0 0.4 0.1 0.0 0.3 119.2 0.7 0.7 0.8 0.0 8.4 11.6 2.6 0.0 0.6 1.1 0.4 0.0 2.7 2.5 134.6 0.5 5.0 8.6 0.2 0.0 2.2 1.0 126.5 1.2 1.3 0.0 5.6 1.9 2.3 2.1 3.0 3.1 2.3 0.5 1.9 0.7 0.2 0.0 0.3 0.3 6.0 6.6 6.2 2.4 1.3 1.5 0.0 0.3 0.3 1.2 3.2 0.1 0.1 JSRP1 "FLJ32416, JP-45" ENSG00000167476 "Junctional sarcoplasmic reticulum protein 1" Q96MG2 19 2252252-2269759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "skeletal muscle: 335.4" "Cell type enhanced" "Detected in many" "B-cells: 31.7;Melanocytes: 46.2;Plasma cells: 139.4;Skeletal myocytes: 132.6" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 10 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "Karpas-707: 164.1;RPMI-8226: 109.8;U-266/70: 444.1;U-266/84: 57.8" "Group enriched" "Detected in many" 6 "amygdala: 8.4;basal ganglia: 11.6;cerebral cortex: 9.9;hippocampal formation: 4.4;white matter: 5.1" "Not detected" "Not detected" HPA044741 Enhanced Approved "Endoplasmic reticulum" NA NA 13000 "Cluster 24: B-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA044741: AB_10794295" "unprognostic (9.41e-3)" "unprognostic (1.52e-2)" "unprognostic (1.39e-1)" "unprognostic (5.85e-2)" "unprognostic (2.15e-1)" "unprognostic (9.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.80e-2)" "unprognostic (2.44e-2)" "unprognostic (1.87e-2)" "unprognostic (8.64e-5)" "unprognostic (3.63e-1)" "unprognostic (4.43e-1)" "unprognostic (2.07e-1)" "unprognostic (2.71e-1)" 0.2 0.1 0.4 0.9 0.4 0.4 0.4 0.4 0.4 0.3 0.2 1.5 2.9 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.4 0.6 0.3 0.7 0.5 0.3 0.3 0.1 0.5 0.0 0.3 0.0 0.3 1.9 0.1 0.0 8.9 0.0 335.4 0.3 1.4 0.0 0.3 5.4 1.7 1.9 0.5 0.1 0.6 18.6 0.6 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 26.8 0.0 0.0 0.2 0.0 0.0 0.0 46.6 0.1 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.1 7.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 26.7 109.8 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 444.1 57.8 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.5 0.3 0.1 0.0 5.3 0.0 31.7 0.5 0.3 0.2 0.6 0.8 0.6 0.4 0.6 1.5 0.1 0.0 2.1 0.2 0.7 1.7 0.0 1.8 19.0 0.7 0.3 0.3 5.4 1.3 0.2 1.0 0.6 1.1 1.5 1.1 6.3 2.9 0.7 0.6 0.5 0.0 0.1 2.3 2.0 1.3 2.2 18.2 0.6 1.1 46.2 0.0 0.0 0.5 1.0 0.0 0.1 1.0 0.3 0.0 139.4 0.3 0.6 0.4 1.7 0.5 0.0 132.6 0.6 7.6 1.9 0.2 1.0 0.3 5.0 0.5 0.7 0.2 KASH5 "CCDC155, FLJ32658" ENSG00000161609 "KASH domain containing 5" Q8N6L0 19 49388219-49417990 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 54.5" "Cell type enriched" "Detected in single" 18 "Cardiomyocytes: 1.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 10 "cerebellum: 4.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.3;U-266/70: 3.6;U-698: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA019937, HPA019940" Enhanced NA NA "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA019937: AB_1848877, HPA019940: AB_1848879" "unprognostic (1.31e-1)" "unprognostic (4.23e-2)" "unprognostic (2.28e-2)" "unprognostic (1.09e-2)" "unprognostic (3.99e-1)" "unprognostic (1.79e-1)" "unprognostic (6.41e-2)" "unprognostic (5.31e-2)" "unprognostic (8.96e-2)" "unprognostic (1.84e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-1)" "unprognostic (7.11e-9)" "unprognostic (6.50e-2)" "unprognostic (4.18e-1)" "unprognostic (3.08e-3)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.7 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.6 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614106-233672514 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 157.8;Horizontal cells: 200.2;Prostatic glandular cells: 222.9;Urothelial cells: 371.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 69 "plasmacytoid DC: 6.9" "Lineage enriched" "Detected in single" 69 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "HeLa: 64.7;SCLC-21H: 62.5;U-266/70: 137.3;U-266/84: 134.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 117.0" "HPA016049, CAB022588" Approved Approved Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 45: Intestine - Brush border" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 3.9 4.1 17.7 2.9 19.8 0.3 5.7 58.0 28.4 7.8 50.4 15.7 16.9 6.1 30.9 20.9 10.9 12.1 41.0 24.3 13.7 9.2 12.1 4.4 1.0 23.5 17.8 7.3 5.5 16.2 22.2 6.8 24.1 6.4 13.9 18.5 15.1 11.3 0.4 13.3 12.6 3.8 15.4 0.9 38.1 0.9 16.3 0.5 7.2 0.9 4.4 11.5 14.4 21.3 33.2 18.3 0.1 0.0 0.0 0.0 50.2 8.8 0.0 0.0 0.0 0.0 52.9 0.0 20.7 6.8 7.3 47.1 8.9 15.2 0.0 0.1 15.8 0.0 64.7 0.0 0.5 0.0 1.8 3.9 17.0 0.0 12.4 1.1 0.2 17.7 7.9 15.0 0.0 12.6 12.2 0.1 10.9 38.5 41.0 0.0 2.7 3.7 16.0 28.4 62.5 11.8 33.5 14.3 0.0 1.0 4.1 0.1 0.0 0.1 25.8 0.0 1.0 137.3 134.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 17.7 19.8 58.0 28.4 24.3 13.7 23.5 17.8 24.1 15.4 16.3 21.3 0.4 9.6 22.9 5.9 0.6 63.3 136.7 32.6 3.4 2.9 23.0 6.0 54.7 12.8 44.6 18.4 4.2 0.5 3.0 91.0 1.9 29.2 1.1 52.7 26.4 3.5 29.3 0.0 157.8 48.3 14.0 31.2 50.4 89.3 0.0 15.0 0.0 8.9 0.6 200.2 61.0 56.3 24.4 0.3 4.4 0.2 1.5 1.0 10.6 12.2 0.0 72.6 0.0 36.2 73.2 96.3 82.4 0.0 0.2 222.9 10.6 8.8 42.9 5.1 0.0 2.3 6.9 0.6 3.2 19.1 47.6 0.8 1.4 0.5 31.2 371.6 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870281 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 33.1" "Group enriched" "Detected in many" 4 "Astrocytes: 168.8;Skeletal myocytes: 121.5" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.7;memory B-cell: 2.6" "Group enriched" "Detected in many" 11 "B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4" "Cell line enhanced" "Detected in some" "Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 0.9 1.1 24.9 3.9 24.2 0.3 0.7 15.1 12.8 2.7 0.0 7.4 3.0 4.9 0.6 1.7 5.7 1.5 2.1 16.9 18.5 2.1 0.2 1.5 3.5 14.4 33.1 0.8 0.3 1.1 1.2 0.0 16.5 1.6 2.4 0.3 1.3 1.2 6.1 0.3 2.2 6.0 12.9 3.5 2.4 0.5 25.7 1.0 1.9 5.3 5.5 3.1 1.6 11.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 39.3 3.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 26.1 0.5 0.0 0.3 0.0 0.1 0.8 0.1 0.0 65.5 0.6 0.1 0.2 0.0 0.8 0.0 2.5 0.0 16.2 18.7 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 62.3 8.8 21.4 0.6 0.0 6.2 4.7 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 24.9 24.2 15.1 12.8 16.9 18.5 14.4 33.1 16.5 12.9 25.7 11.0 8.7 12.8 2.7 168.8 3.9 1.3 0.6 0.7 0.6 0.5 0.1 0.0 3.4 0.0 2.1 0.0 2.1 0.1 0.0 0.0 3.9 0.2 3.4 26.6 0.6 25.9 4.2 0.0 18.2 0.2 0.0 16.3 0.0 5.8 0.0 2.0 13.9 0.3 0.4 0.0 13.6 0.0 4.1 0.0 3.0 7.7 0.3 0.9 0.0 11.2 0.0 2.2 0.0 12.1 5.0 0.0 2.2 0.0 30.9 0.5 0.0 0.3 18.3 0.4 0.0 121.5 1.3 0.7 0.2 0.8 1.7 0.0 0.5 22.5 0.0 0.7 KCTD19 FLJ40162 ENSG00000168676 "Potassium channel tetramerization domain containing 19" Q17RG1 16 67289428-67326760 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 32.9" "Group enriched" "Detected in some" 8 "Early spermatids: 49.2;Spermatocytes: 72.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.6;neutrophil: 2.9;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 2.9" "Cell line enhanced" "Detected in some" "JURKAT: 6.4;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049310, HPA053321" Uncertain NA NA "Cluster 6: Non-specific - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA049310: AB_2680706, HPA053321: AB_2682110" "unprognostic (2.44e-1)" "unprognostic (2.14e-2)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.60e-2)" "unprognostic (9.01e-2)" "unprognostic (9.32e-2)" "unprognostic (1.75e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-4)" "unprognostic (4.44e-1)" "unprognostic (2.76e-3)" "unprognostic (1.19e-2)" "unprognostic (2.91e-2)" "unprognostic (9.71e-2)" "unprognostic (8.44e-2)" 0.1 0.0 2.9 0.8 3.0 3.2 0.1 4.5 3.7 0.2 1.2 0.1 0.3 0.4 1.3 0.5 0.4 0.8 0.0 2.6 2.5 0.2 0.1 0.2 0.1 4.4 3.1 0.0 0.1 0.1 0.2 0.3 4.7 0.1 0.2 0.3 0.3 0.1 0.6 1.5 0.3 0.2 1.8 0.3 0.4 32.9 5.6 0.5 0.4 0.1 0.1 0.4 0.0 7.3 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.6 0.4 0.6 0.3 0.6 0.3 0.5 0.3 0.0 0.0 0.0 0.6 0.0 2.0 0.4 1.5 0.6 0.4 0.0 0.3 0.2 0.2 0.4 0.5 0.6 0.3 0.0 0.1 6.4 0.4 0.1 0.0 0.0 0.5 0.5 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.2 0.4 0.8 0.1 0.3 0.1 0.6 0.1 0.3 0.6 0.0 0.4 1.7 0.0 5.6 1.1 0.3 0.6 0.0 0.5 1.6 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.2 2.9 0.4 0.2 2.7 0.2 0.4 2.9 3.0 4.5 3.7 2.6 2.5 4.4 3.1 4.7 1.8 5.6 7.3 0.1 0.0 2.3 0.7 0.1 0.4 1.5 0.0 0.0 1.1 0.3 0.1 1.3 0.0 1.3 0.0 6.2 0.2 4.2 0.0 0.0 0.1 49.2 0.1 0.1 0.3 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.3 7.5 0.9 0.5 3.6 0.0 0.6 0.2 0.0 1.0 0.4 0.0 0.0 0.7 0.1 1.0 0.1 0.1 0.0 2.5 0.0 1.2 0.6 72.7 6.1 0.0 0.3 0.1 0.4 0.2 0.2 1.4 KDSR "DHSR, FVT1, SDR35C1" ENSG00000119537 "3-ketodihydrosphingosine reductase" Q06136 18 63327726-63367228 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Cancer-related genes, Disease variant, Palmoplantar keratoderma, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 90.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003673, HPA044884" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "CAB003673: AB_425440, HPA044884: AB_2679131" "unprognostic (4.44e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-2)" "unprognostic (4.56e-2)" "unprognostic (5.88e-3)" "unprognostic (7.50e-3)" "unprognostic (1.80e-2)" "unprognostic (2.66e-1)" "unprognostic (2.97e-1)" "unprognostic (1.97e-1)" "unprognostic (2.70e-2)" "unprognostic (6.81e-2)" "prognostic favorable (9.53e-6)" "unprognostic (3.32e-2)" "unprognostic (5.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-3)" 32.3 22.4 12.8 8.1 19.9 4.8 25.4 19.5 16.7 26.9 12.3 24.6 7.0 22.7 20.8 22.4 18.9 12.6 20.7 12.7 16.4 20.1 36.7 21.5 7.0 20.6 17.7 21.3 15.7 13.1 12.1 8.5 20.0 16.3 7.4 7.0 22.8 11.6 16.7 44.5 15.1 13.3 17.6 8.4 16.4 6.1 16.6 7.1 17.2 8.9 6.8 23.9 23.4 22.4 14.9 6.5 6.7 7.5 52.6 39.0 13.0 48.8 29.7 10.5 13.9 2.7 10.0 15.1 20.3 19.1 17.4 64.6 8.7 27.3 12.8 28.6 14.5 11.6 8.7 3.4 40.1 22.0 7.8 37.4 50.7 16.8 47.9 19.3 10.5 9.9 9.5 21.0 28.1 6.2 23.6 9.7 8.0 3.7 23.5 15.5 19.7 21.9 29.0 9.6 8.5 16.4 23.4 11.3 21.9 8.8 6.1 12.1 24.9 44.0 10.6 14.8 21.3 90.4 44.9 8.7 33.2 13.0 13.4 0.1 5.2 0.5 6.5 8.1 26.6 5.7 13.6 10.2 8.0 4.7 9.3 6.1 1.3 14.2 3.9 3.8 19.1 5.3 12.8 19.9 19.5 16.7 12.7 16.4 20.6 17.7 20.0 17.6 16.6 22.4 53.1 35.3 49.1 21.9 30.1 158.6 131.7 47.0 122.3 37.4 63.4 63.6 27.7 62.9 43.5 38.6 27.1 58.8 15.6 34.6 15.6 50.7 1.0 43.9 53.0 48.1 20.4 17.4 19.1 36.7 70.4 82.0 26.5 64.9 26.0 52.3 51.8 88.3 36.4 40.4 24.2 31.8 42.7 32.2 47.7 6.5 71.1 39.9 56.9 14.0 31.5 56.5 13.4 21.6 57.0 47.4 44.6 70.7 24.5 104.3 43.4 39.6 41.2 41.1 32.9 73.7 48.4 1.3 5.2 89.7 143.1 91.4 37.7 51.1 40.3 94.7 KIAA1958 FLJ39294 ENSG00000165185 KIAA1958 Q8N8K9 9 112486827-112669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5" "Cell type enhanced" "Detected in many" "Astrocytes: 169.8;Excitatory neurons: 64.2;Inhibitory neurons: 55.1;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 166.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020625 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Cytosol" "HPA020625: AB_1852451" "unprognostic (3.09e-3)" "unprognostic (1.04e-1)" "unprognostic (1.61e-2)" "unprognostic (1.33e-1)" "unprognostic (7.48e-2)" "unprognostic (2.08e-2)" "unprognostic (2.01e-1)" "unprognostic (4.95e-2)" "unprognostic (1.14e-1)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (7.67e-2)" "unprognostic (5.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.58e-1)" 1.1 6.6 5.5 1.1 10.5 4.9 2.2 9.3 6.9 5.1 4.4 1.4 1.7 3.4 0.9 1.5 3.0 1.3 1.3 3.9 6.6 5.8 3.4 2.1 1.3 8.2 8.9 9.9 2.6 1.4 1.8 0.7 7.0 1.5 1.5 10.0 3.0 2.4 0.9 1.6 1.9 3.1 7.5 1.5 4.8 5.8 10.7 3.9 2.4 0.8 1.3 1.4 1.9 14.5 3.7 5.2 20.7 6.0 1.4 0.3 9.9 2.7 0.9 3.2 3.6 9.5 2.4 11.8 3.1 8.9 2.2 3.2 15.3 1.5 4.5 3.6 6.2 4.6 7.3 6.7 0.8 7.0 5.6 0.6 1.2 4.2 2.0 2.9 2.6 11.0 11.0 2.9 1.0 4.2 11.0 4.0 11.4 8.6 2.4 8.8 11.8 3.3 4.3 5.1 10.6 11.2 4.5 4.7 2.7 11.4 4.3 7.1 0.5 1.1 6.1 0.7 3.3 5.3 10.4 6.9 1.4 4.8 0.8 0.4 0.7 0.0 0.5 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 0.4 5.5 10.5 9.3 6.9 3.9 6.6 8.2 8.9 7.0 7.5 10.7 14.5 0.5 3.2 19.3 169.8 3.7 4.7 3.4 1.5 6.8 20.6 7.9 4.2 4.3 4.3 6.2 1.8 14.6 1.2 3.0 4.6 7.9 3.2 4.1 12.1 8.1 1.4 4.8 3.8 64.2 6.7 1.0 3.3 8.2 8.0 0.0 20.3 0.4 8.0 1.0 6.7 55.1 4.4 12.2 7.5 4.6 2.5 6.5 4.2 1.8 15.9 2.5 8.3 3.1 127.6 166.4 3.3 6.2 5.3 5.0 6.5 5.0 11.0 5.9 12.1 6.6 2.5 4.1 1.5 8.0 5.3 4.7 0.8 1.6 29.9 5.2 5.7 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023714 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.1;brain: 21.6;retina: 21.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "basophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Cluster 11: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 1.6 0.8 16.1 9.4 16.4 34.1 1.3 0.0 16.5 0.9 0.0 2.4 2.0 0.7 0.4 0.8 1.2 2.1 0.7 21.6 8.3 0.9 1.5 4.8 12.9 5.9 5.7 0.7 0.8 6.0 0.6 0.9 6.5 0.8 1.8 21.4 1.4 0.7 0.3 0.7 6.7 0.8 1.5 12.3 2.5 13.7 9.5 11.8 1.0 0.4 8.0 2.3 0.8 7.9 1.3 1.5 11.8 0.5 0.0 0.0 3.0 0.1 0.0 0.3 0.1 0.7 0.4 39.1 0.5 0.0 3.4 0.3 1.2 0.3 0.4 1.9 0.4 9.7 0.2 0.2 1.0 29.4 41.0 1.0 4.1 0.4 0.7 0.0 1.5 78.8 4.6 49.6 0.0 0.2 24.5 11.2 5.2 3.9 0.0 8.4 0.1 43.8 0.2 0.0 7.2 1.0 0.6 0.5 0.6 2.1 0.2 8.9 2.8 0.0 3.3 0.0 0.2 90.2 44.7 19.3 3.9 12.8 0.3 6.0 0.0 0.6 0.8 0.2 0.9 0.4 0.6 0.8 0.1 0.3 0.5 0.6 1.0 1.3 0.3 0.1 0.6 0.4 16.1 16.4 0.0 16.5 21.6 8.3 5.9 5.7 6.5 1.5 9.5 7.9 1.5 0.0 3.8 22.5 11.0 1.0 0.5 0.2 0.0 25.7 0.4 0.8 1.5 0.0 0.1 1.8 58.4 0.0 17.4 1.2 0.0 0.5 20.4 0.1 0.2 1.8 0.0 4.8 15.6 1.6 0.1 0.6 1.1 0.4 6.3 0.5 1.4 0.3 1.7 1.7 11.8 1.4 0.0 4.4 3.1 82.1 0.9 5.3 0.0 8.4 2.7 20.0 13.4 14.6 4.0 2.4 0.3 0.0 12.0 0.4 0.2 0.0 0.1 26.1 6.6 0.6 1.1 1.9 3.7 0.1 1.0 0.0 18.0 0.1 1.1 2.0 LARGE1 "KIAA0609, LARGE" ENSG00000133424 "LARGE xylosyl- and glucuronyltransferase 1" O95461 22 33162226-33922841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 8.5;Alveolar cells type 2: 8.2;Ductal cells: 7.1;Endometrial stromal cells: 10.5;Exocrine glandular cells: 7.9;Glandular and luminal cells: 8.6;Hofbauer cells: 6.0;Pancreatic endocrine cells: 6.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 18.3;basal ganglia: 23.4;cerebral cortex: 33.2;hippocampal formation: 45.4;white matter: 16.4" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.16e-1)" "unprognostic (7.77e-3)" "unprognostic (3.79e-1)" "unprognostic (1.74e-3)" "unprognostic (1.63e-1)" "unprognostic (1.48e-2)" "unprognostic (4.90e-2)" "unprognostic (1.39e-2)" "unprognostic (5.21e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-2)" "unprognostic (1.35e-2)" "unprognostic (7.12e-3)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-3)" 11.9 10.1 18.3 5.9 23.4 0.4 9.1 3.4 33.2 15.3 19.7 27.8 9.2 22.4 8.1 6.7 13.5 9.0 58.4 45.4 2.2 8.4 8.1 6.5 5.1 1.0 2.9 20.8 8.3 6.0 7.4 4.1 4.7 15.2 8.7 13.2 5.9 24.8 49.5 8.5 11.4 15.7 0.0 5.8 16.7 7.6 6.3 2.0 5.3 27.5 5.0 21.6 11.5 16.4 4.1 12.3 19.5 8.4 3.2 0.6 7.4 14.1 7.1 2.7 0.0 2.6 0.4 19.5 2.4 14.0 4.6 1.6 11.6 0.0 0.1 0.3 9.8 0.0 0.0 13.1 4.1 0.1 2.0 1.8 0.9 0.2 0.0 0.0 0.1 0.2 0.2 2.7 3.2 16.5 0.1 9.5 7.7 16.3 0.4 10.6 20.2 3.5 2.5 18.1 7.0 2.4 8.4 11.4 13.6 13.7 16.4 0.6 0.1 8.8 13.8 5.2 3.7 21.3 23.4 0.4 16.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 18.3 23.4 3.4 33.2 45.4 2.2 1.0 2.9 4.7 0.0 6.3 16.4 8.5 0.0 8.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 4.2 4.2 0.0 0.0 2.5 1.8 0.0 0.3 0.9 0.0 0.0 7.1 0.0 5.7 10.5 1.9 0.0 0.0 0.0 7.9 0.7 2.9 0.0 8.6 1.3 3.9 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.4 0.0 0.0 2.0 1.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.8 1.2 0.0 0.0 LARP1B "DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2" ENSG00000138709 "La ribonucleoprotein 1B" Q659C4 4 128061286-128222931 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 393.1;Late spermatids: 449.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036280 Approved Approved Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA036280: AB_10673126" "unprognostic (1.84e-1)" "unprognostic (7.55e-2)" "unprognostic (9.39e-3)" "unprognostic (4.87e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.79e-1)" "unprognostic (2.63e-1)" "unprognostic (6.39e-2)" "unprognostic (3.36e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-1)" "prognostic favorable (5.13e-5)" "unprognostic (8.46e-2)" "unprognostic (5.94e-2)" "unprognostic (2.08e-1)" "unprognostic (7.50e-2)" 10.5 8.2 5.1 8.0 6.1 14.4 11.5 8.5 9.7 11.5 2.1 14.8 14.6 8.9 24.1 11.1 9.6 9.1 11.6 5.9 5.4 14.2 50.7 9.9 6.3 3.5 4.2 10.3 35.6 16.3 12.9 10.5 4.4 11.0 16.3 11.0 13.8 11.7 18.2 11.1 15.5 8.3 2.1 6.2 15.4 55.8 6.0 6.5 13.6 13.3 9.3 13.2 9.9 8.6 21.5 7.4 13.2 16.7 13.7 15.5 26.8 18.0 19.9 16.7 10.7 16.9 16.5 26.1 24.6 17.8 12.7 8.3 32.7 19.9 19.9 24.7 20.9 20.9 13.0 41.5 29.7 40.3 8.2 8.1 28.7 13.4 49.0 16.0 19.8 19.4 37.1 42.4 9.6 25.1 35.2 23.1 15.2 33.0 11.9 19.4 20.3 29.8 19.1 16.4 39.1 15.5 15.6 35.7 16.8 17.5 10.5 17.4 16.1 10.7 11.8 17.5 18.1 55.9 22.7 30.1 13.8 30.7 11.5 0.2 2.1 1.3 1.7 1.6 3.1 1.6 1.9 2.2 2.5 1.4 1.5 1.7 0.5 2.6 1.7 4.6 1.7 0.8 5.1 6.1 8.5 9.7 5.9 5.4 3.5 4.2 4.4 2.1 6.0 8.6 18.4 35.3 35.6 46.0 19.9 27.8 25.7 11.7 10.8 37.0 34.9 18.7 30.2 40.0 32.5 20.2 52.1 31.4 15.2 52.2 13.7 22.1 393.1 41.9 32.3 17.3 34.0 25.0 139.1 29.9 23.2 23.4 29.6 62.6 20.8 12.5 15.0 154.6 11.9 23.5 115.6 115.2 18.3 15.7 16.3 449.5 36.4 15.5 17.8 19.7 16.7 17.5 20.6 55.8 51.8 31.3 36.2 19.9 54.5 46.4 37.4 63.2 29.0 71.5 19.7 20.7 23.1 138.3 21.9 25.3 34.7 51.4 14.3 8.4 55.1 30.6 LDAH "C2orf43, FLJ21820" ENSG00000118961 "Lipid droplet associated hydrolase" Q9H6V9 2 20684014-20823130 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034729, HPA034730" Approved NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "HPA034729: AB_10603684, HPA034730: AB_2674304" "unprognostic (1.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" "unprognostic (2.21e-2)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.09e-6)" "unprognostic (3.57e-2)" "unprognostic (1.36e-1)" "unprognostic (1.27e-2)" "unprognostic (6.45e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.18e-4)" "unprognostic (1.05e-1)" "unprognostic (2.31e-1)" "unprognostic (2.22e-1)" "unprognostic (3.97e-2)" 7.3 14.1 5.1 7.3 6.8 5.0 7.6 4.8 5.6 7.9 6.8 10.8 7.4 7.3 9.3 8.0 6.2 6.8 4.3 5.3 6.4 16.8 12.1 5.5 11.1 5.7 5.1 8.0 7.4 9.4 5.8 8.7 5.8 7.0 11.7 8.3 6.9 6.2 1.2 6.1 6.5 8.1 5.9 9.0 7.8 5.0 6.0 11.7 8.2 1.7 13.4 9.7 6.0 7.7 20.2 18.3 45.6 0.0 18.6 24.6 28.5 17.9 12.2 14.5 11.1 19.8 12.3 25.3 0.0 13.1 25.4 16.9 34.8 12.9 14.9 31.6 17.2 37.1 16.6 30.5 19.0 28.2 8.9 20.9 18.9 14.0 3.6 19.7 27.7 33.8 49.7 18.6 25.5 13.0 41.1 19.4 29.1 41.7 0.0 33.1 36.6 28.8 29.0 29.4 25.0 37.9 11.8 18.7 19.9 37.9 15.9 19.7 25.6 13.0 6.6 17.0 10.7 22.7 45.2 11.6 25.3 26.8 24.6 0.9 3.2 0.3 6.6 4.9 4.3 7.8 6.5 5.6 5.8 5.5 5.9 5.9 0.2 5.5 3.9 5.4 6.1 4.2 5.1 6.8 4.8 5.6 5.3 6.4 5.7 5.1 5.8 5.9 6.0 7.7 5.0 16.0 10.6 0.0 9.3 0.0 3.4 0.0 5.7 9.3 5.3 3.9 2.8 7.2 4.3 7.3 16.7 12.0 4.6 3.4 7.9 7.4 8.7 4.2 10.9 6.3 3.6 13.3 0.0 6.4 11.6 5.1 9.7 6.1 6.3 14.8 8.6 7.9 9.0 11.8 0.0 6.0 0.0 9.8 0.0 2.7 7.5 5.5 0.0 0.0 4.7 15.0 5.2 0.0 0.0 6.5 5.5 6.8 9.9 3.7 5.0 12.0 0.0 9.6 6.6 4.2 5.4 4.3 5.2 7.7 0.0 11.5 6.7 15.8 6.1 3.6 LDHC CT32 ENSG00000166796 "Lactate dehydrogenase C" P07864 11 18412318-18452063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 177 "testis: 265.2" "Group enriched" "Detected in many" 7 "Early spermatids: 1441.7;Spermatocytes: 1584.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-BR-3: 2.1;U-2197: 5.1;U-266/70: 4.5;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA045442 Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA045442: AB_10966720" "unprognostic (2.32e-2)" "unprognostic (3.42e-3)" "unprognostic (1.87e-1)" "unprognostic (2.83e-2)" "unprognostic (2.19e-1)" "unprognostic (8.56e-4)" "unprognostic (1.35e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-2)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (4.25e-1)" "unprognostic (1.93e-1)" 0.1 0.2 0.6 0.0 0.6 0.4 0.4 1.2 0.9 0.1 0.4 0.3 0.3 0.0 0.6 0.3 0.6 0.0 0.3 0.7 0.3 0.6 1.4 0.2 0.4 0.3 0.3 0.4 1.4 0.0 0.2 0.1 0.4 0.3 0.0 0.6 0.5 0.0 0.7 0.4 0.7 0.1 0.1 0.1 0.1 265.2 0.5 0.3 0.6 0.2 0.7 0.2 0.0 0.4 0.0 0.0 0.1 1.2 0.9 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 2.1 0.3 0.0 0.1 0.0 0.5 0.2 1.6 5.1 0.0 4.5 4.2 0.2 0.1 0.0 0.0 0.6 0.2 0.3 0.1 0.3 0.6 0.2 0.5 0.6 0.0 0.7 1.0 0.7 1.1 0.0 0.3 0.9 0.6 0.3 0.6 0.6 1.2 0.9 0.7 0.3 0.3 0.3 0.4 0.1 0.5 0.4 1.9 0.0 0.0 1.3 1.3 0.1 0.8 0.4 1.2 0.1 2.5 3.2 0.9 0.0 1.0 1.8 0.0 0.0 0.1 0.4 3.9 1.6 1441.7 3.7 0.8 2.0 0.0 0.4 1.0 6.3 0.1 1.3 0.5 1.9 0.0 0.3 0.4 0.2 0.2 0.0 0.9 0.2 0.0 0.0 0.4 209.5 23.3 2.7 0.0 1.9 0.0 1.5 0.0 1.0 2.0 2.0 0.0 18.0 0.9 0.3 0.0 3.5 1.2 0.6 19.7 1.2 1.2 1584.7 30.7 1.0 0.6 0.0 1.4 0.1 0.0 0.3 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.3;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 0.9 1.0 0.7 0.3 1.0 0.2 1.6 0.9 0.7 0.5 1.9 0.6 1.0 0.7 3.4 0.3 3.8 0.4 0.9 0.9 1.1 1.4 0.7 0.6 1.0 1.9 1.7 0.9 1.0 1.5 1.5 0.2 1.5 0.9 0.6 1.8 0.6 0.6 0.2 0.4 0.6 0.4 1.6 0.5 0.9 12.8 1.1 0.7 2.3 0.2 0.4 0.5 0.2 1.0 3.3 1.2 0.0 0.7 0.4 0.2 0.1 0.1 0.5 0.6 0.5 0.1 1.7 0.0 0.9 0.4 1.2 1.2 0.0 0.3 1.3 0.5 0.3 1.0 0.1 0.0 0.0 1.0 0.2 1.5 0.8 0.1 0.9 0.3 0.3 0.0 0.7 0.6 1.2 1.2 0.0 0.7 1.0 0.9 0.7 0.0 0.8 0.8 1.0 0.2 1.9 0.7 1.0 0.7 0.0 0.2 2.2 1.8 0.0 0.1 0.3 0.2 0.5 2.9 0.5 0.0 0.5 0.7 1.0 0.6 0.0 0.0 0.2 0.0 0.4 0.8 0.4 0.0 0.3 0.9 0.4 0.2 0.0 0.7 0.0 0.5 0.6 0.1 0.7 1.0 0.9 0.7 0.9 1.1 1.9 1.7 1.5 1.6 1.1 1.0 0.5 0.0 1.1 19.9 6.3 1.3 1.1 1.4 2.8 1.2 2.7 3.9 1.5 1.5 2.8 3.7 2.1 0.3 0.7 1.5 3.9 0.7 96.8 20.7 1.4 0.6 0.0 2.1 6.5 1.6 0.1 1.1 9.7 2.8 1.3 1.4 0.0 1.8 0.2 3.3 11.8 0.9 0.0 1.6 1.3 47.7 1.5 1.8 1.8 3.7 1.1 1.7 0.0 8.0 8.0 1.0 0.6 1.9 2.5 0.7 1.2 5.4 28.0 4.8 0.0 0.6 1.4 65.2 4.3 2.2 0.9 0.1 2.3 1.1 0.9 0.8 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704481-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 65.5" "Cell type enriched" "Detected in some" 11 "Syncytiotrophoblasts: 88.7" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "EFO-21: 4.3;U-266/70: 9.8" HPA065180 Supported Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.1 0.0 0.7 0.3 0.8 0.6 0.4 2.2 1.2 0.2 0.4 0.1 0.3 0.2 0.3 0.0 0.0 0.1 0.0 0.7 0.7 0.0 0.0 0.2 0.4 1.1 0.6 0.2 0.5 0.0 0.0 65.5 1.0 0.1 0.1 0.5 0.1 0.0 0.1 0.9 0.1 0.2 0.2 0.4 0.3 0.2 1.2 0.1 0.1 0.2 0.6 0.1 0.0 2.2 0.1 0.0 0.2 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 4.3 0.1 0.1 0.5 0.0 0.0 0.1 1.2 0.1 0.1 0.5 0.2 0.0 0.1 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.3 0.1 0.8 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.5 0.0 0.1 0.0 0.3 0.4 0.5 0.1 9.8 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.8 2.2 1.2 0.7 0.7 1.1 0.6 1.0 0.2 1.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 88.7 0.2 0.0 0.0 0.0 LHX3 ENSG00000107187 "LIM homeobox 3" Q9UBR4 9 136196250-136205128 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "pituitary gland: 58.3" "Group enriched" "Detected in some" 11 "Bipolar cells: 24.0;Cardiomyocytes: 22.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (4.17e-2)" "unprognostic (4.72e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-1)" "unprognostic (3.31e-2)" "unprognostic (6.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 58.3 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 22.8 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 LRP2BP DKFZp761O0113 ENSG00000109771 "LRP2 binding protein" Q9P2M1 4 185363872-185395924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 28.9" "Cell type enhanced" "Detected in many" "Astrocytes: 57.5;Cone photoreceptor cells: 33.3;Early spermatids: 62.1;Inhibitory neurons: 34.2;Late spermatids: 42.3;Oligodendrocyte precursor cells: 40.2;Oligodendrocytes: 34.9;Rod photoreceptor cells: 34.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036664, HPA036665" Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA036664: AB_10672361, HPA036665: AB_10673660" "unprognostic (2.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-3)" "unprognostic (3.15e-5)" "unprognostic (2.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (9.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.84e-2)" "unprognostic (4.35e-4)" "unprognostic (2.17e-2)" "unprognostic (9.76e-3)" "unprognostic (2.15e-1)" "unprognostic (5.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.54e-4)" 1.7 2.1 6.7 0.7 6.9 0.4 1.6 15.0 7.9 2.7 9.8 3.6 0.3 1.8 2.3 1.0 6.9 0.9 3.6 6.5 7.5 4.8 1.6 4.4 0.7 11.4 10.0 8.5 3.2 0.2 17.4 0.6 8.7 3.7 0.4 28.9 1.5 0.5 3.0 1.5 1.9 0.3 9.8 2.7 1.7 10.7 8.1 0.2 3.5 0.7 0.1 2.1 1.7 10.8 0.5 0.4 0.5 1.1 0.3 0.1 1.0 1.5 0.4 0.0 0.3 0.5 0.5 1.8 0.1 0.1 0.5 0.3 0.3 0.2 0.2 1.7 0.9 0.4 1.5 1.6 0.2 0.3 0.5 0.3 0.2 0.7 0.2 1.5 0.4 1.3 0.6 1.4 0.4 0.1 0.6 1.2 0.6 0.0 0.2 0.3 0.3 0.4 0.4 0.3 1.2 0.8 0.3 0.4 1.0 0.7 0.4 0.1 1.4 0.8 0.6 0.2 0.8 5.3 0.5 0.3 1.3 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.2 0.0 0.5 0.3 0.2 0.1 0.1 0.1 0.5 0.2 0.0 6.7 6.9 15.0 7.9 6.5 7.5 11.4 10.0 8.7 9.8 8.1 10.8 3.1 9.6 2.6 57.5 3.5 2.4 4.1 1.3 2.8 28.8 3.0 2.4 5.5 0.0 1.8 0.0 33.3 1.2 3.3 1.7 0.0 1.5 62.1 17.6 3.1 3.2 7.8 0.0 28.0 0.9 2.5 2.1 2.6 4.4 0.0 1.9 1.4 0.3 0.5 26.9 34.2 2.4 4.1 1.2 1.4 42.3 2.8 1.9 5.4 3.7 0.8 10.4 0.0 40.2 34.9 1.0 0.2 3.8 2.5 4.3 2.6 1.6 14.1 34.0 0.0 5.4 2.8 8.4 1.9 0.8 3.1 1.6 3.1 2.1 1.0 2.1 LRRC47 "KIAA1185, RP1-286D6.3" ENSG00000130764 "Leucine rich repeat containing 47" Q8N1G4 1 3778559-3796498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 69.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008512, HPA012018" Enhanced Approved "Nucleoli fibrillar center" NA NA 29000 "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoli fibrillar center" "HPA008512: AB_1853324, HPA012018: AB_1853322" "unprognostic (2.25e-2)" "unprognostic (6.56e-2)" "unprognostic (6.24e-2)" "unprognostic (3.89e-2)" "unprognostic (2.86e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.49e-2)" "unprognostic (1.93e-2)" "prognostic favorable (2.75e-4)" "unprognostic (9.07e-2)" "unprognostic (4.81e-2)" "unprognostic (9.89e-2)" "unprognostic (2.25e-1)" 14.7 17.4 17.5 7.0 17.2 11.7 14.6 15.8 18.3 15.2 15.3 19.8 9.9 18.4 8.6 17.6 16.2 6.3 27.3 17.6 18.0 13.7 23.8 11.2 9.9 19.9 17.1 18.7 23.0 12.2 16.3 9.5 17.7 15.9 6.4 8.2 15.9 11.3 69.9 21.8 14.3 8.5 15.7 15.3 17.4 13.5 17.1 9.4 14.3 25.9 8.2 18.6 14.7 18.6 17.9 20.7 14.7 24.2 15.4 12.3 14.6 15.2 11.6 19.6 15.3 25.6 19.4 18.6 21.8 16.5 15.0 24.4 18.1 18.8 10.7 23.8 33.1 34.1 23.5 28.6 23.8 23.3 12.3 14.6 16.3 19.5 15.5 12.7 14.0 23.6 31.9 5.3 14.4 18.9 25.9 27.1 33.4 17.6 31.3 25.1 14.6 22.2 13.6 13.0 30.5 30.1 19.0 28.3 30.5 14.3 15.4 17.4 19.2 16.2 9.4 24.4 20.0 39.6 39.6 21.1 9.7 31.6 6.6 3.8 2.8 1.5 2.3 3.3 2.4 1.7 2.5 3.6 3.5 1.9 2.9 3.0 1.8 3.1 2.6 3.0 2.6 1.7 17.5 17.2 15.8 18.3 17.6 18.0 19.9 17.1 17.7 15.7 17.1 18.6 18.4 16.0 24.1 10.4 20.5 15.6 16.6 8.0 22.2 32.1 18.7 13.1 62.0 27.1 13.3 27.6 14.6 58.3 30.7 22.6 19.6 13.4 1.6 15.6 19.0 16.7 21.6 18.7 11.4 15.0 39.0 22.0 26.5 14.4 11.4 28.2 21.4 33.1 26.7 38.7 11.6 24.7 10.2 17.9 8.8 3.5 22.1 16.8 8.8 7.5 20.6 31.9 29.9 12.5 12.7 13.7 21.6 23.7 21.6 19.5 25.3 22.5 11.4 20.9 13.1 27.3 23.9 20.4 37.1 26.2 21.6 48.2 20.5 32.4 33.1 13.3 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.9" "Cell type enhanced" "Detected in many" "Early spermatids: 77.3;Late spermatids: 18.0;Microglial cells: 27.2;Oligodendrocytes: 27.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.3;SuSa: 5.2;U-266/70: 16.0;U-266/84: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.3 0.5 0.2 0.9 0.6 0.1 0.6 0.6 0.4 0.3 0.8 0.3 0.2 0.2 0.9 0.3 0.2 0.4 0.5 0.2 0.4 0.5 0.3 0.4 1.1 0.8 0.5 0.2 0.3 0.9 0.2 0.4 0.8 0.5 0.7 0.6 0.7 0.3 0.5 1.7 0.4 0.8 0.5 0.7 0.4 2.9 0.5 0.8 0.5 0.4 0.7 0.7 0.3 1.0 0.6 0.6 0.1 0.4 0.6 1.3 1.0 0.3 0.1 0.2 0.3 0.9 0.8 0.9 0.4 0.2 0.1 0.6 0.7 1.1 0.3 0.3 6.3 1.4 1.8 0.4 0.2 0.5 1.0 0.4 1.0 0.4 0.7 0.4 0.1 1.1 1.0 0.5 0.4 0.2 0.3 0.4 0.6 1.0 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 5.2 1.4 1.0 0.5 0.2 0.6 0.1 0.8 16.0 9.5 3.8 0.1 2.1 0.8 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.0 0.4 0.4 0.2 0.0 0.1 0.1 0.4 0.5 0.0 0.2 0.6 0.6 0.4 0.2 0.4 0.8 0.5 0.8 0.5 0.5 1.0 1.1 0.0 1.1 16.0 1.5 4.7 2.9 1.3 0.6 1.9 1.6 0.6 2.9 0.0 1.5 3.7 4.2 2.3 2.0 1.1 3.9 1.5 77.3 1.2 0.4 2.7 2.4 0.8 5.3 1.2 1.9 1.7 0.0 0.6 0.0 1.0 4.2 0.6 0.9 0.0 6.4 2.2 6.1 1.3 7.0 18.0 2.8 1.6 7.2 27.2 4.2 1.1 2.1 7.5 27.9 1.8 1.6 1.2 0.2 5.3 0.4 0.9 6.1 3.2 0.0 4.7 2.7 4.2 4.0 0.7 5.3 1.0 2.2 0.9 1.7 2.3 LY9 "CD229, hly9, mLY9, SLAMF3" ENSG00000122224 "Lymphocyte antigen 9" Q9HBG7 1 160796074-160828261 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1" "Cell type enhanced" "Detected in some" "B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050917 Approved Approved "Plasma membrane,Centriolar satellite" NA NA 43000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "Centriolar satellite" "HPA050917: AB_2681272" "unprognostic (8.04e-4)" "unprognostic (2.31e-5)" "unprognostic (8.08e-3)" "unprognostic (1.20e-3)" "unprognostic (9.83e-3)" "unprognostic (1.87e-5)" "unprognostic (1.16e-2)" "unprognostic (3.84e-3)" "unprognostic (1.23e-2)" "unprognostic (2.89e-3)" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.69e-2)" "unprognostic (9.47e-2)" "unprognostic (3.49e-2)" "unprognostic (6.88e-2)" 2.4 0.9 0.1 13.7 0.2 11.5 2.0 0.1 0.2 0.8 0.2 3.9 4.0 0.6 0.4 0.9 0.9 2.5 0.5 0.1 0.2 1.1 2.3 3.8 30.2 0.3 0.2 0.6 0.2 0.0 0.2 0.3 0.2 1.1 3.8 0.0 7.1 0.4 0.3 0.8 12.0 0.5 0.3 26.7 6.0 0.2 0.2 25.5 1.4 0.2 31.1 3.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 28.0 0.0 0.0 2.3 0.5 0.1 0.8 0.0 1.6 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 70.7 29.3 0.3 0.0 4.0 0.0 1.2 0.8 0.4 112.9 1.1 113.5 56.1 97.6 109.8 5.2 52.8 109.6 112.3 2.4 22.2 0.8 72.8 80.3 53.5 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.0 1.8 0.3 244.0 1.0 0.5 0.1 0.0 0.0 0.4 0.8 0.9 0.0 0.0 0.0 0.0 0.1 36.2 0.1 0.0 0.0 0.1 0.1 0.1 0.7 1.2 28.0 0.1 0.2 0.0 1.4 0.5 0.1 0.0 0.0 1.8 0.4 1.9 0.0 0.1 0.0 0.0 3.2 31.9 0.0 0.0 6.3 71.2 1.9 2.1 0.0 22.6 0.0 0.1 0.1 0.0 0.0 102.5 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.5 1.0 0.1 44.8 0.0 0.3 0.3 MAGEA8 "CT1.8, MAGE8, MGC2182" ENSG00000156009 "MAGE family member A8" P43361 X 149881141-149885835 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 13.3" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 74.6;Extravillous trophoblasts: 35.2;Syncytiotrophoblasts: 77.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-2 OS: 33.8;U-266/70: 63.6" HPA003998 Enhanced NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 29: U-266 - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA003998: AB_10965020" "unprognostic (6.81e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.27e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-2)" "unprognostic (2.49e-2)" "unprognostic (5.07e-3)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 63.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.9 6.3 0.0 0.0 77.7 0.0 0.0 0.0 0.0 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 3.7" "Group enriched" "Detected in some" 16 "Spermatocytes: 2.3;Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "U-266/70: 45.2;U-266/84: 32.9" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB1 "CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322" ENSG00000214107 "MAGE family member B1" P43366 X 30243730-30252040 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "testis: 15.5" "Group enriched" "Detected in some" 9 "Spermatocytes: 14.2;Spermatogonia: 14.6" "Cancer enriched" "Detected in some" 9 "testis cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 70 "K-562: 25.1;U-266/70: 53.8;U-266/84: 40.5" "HPA001193, HPA002820" Enhanced NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA001193: AB_1079296, HPA002820: AB_1079295" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 53.8 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 33 "testis: 3.3" "Group enriched" "Detected in some" 35 "Spermatocytes: 7.4;Spermatogonia: 13.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Centrosome "HPA055743: AB_2682902, HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 59.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.4 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB17 ENSG00000182798 "MAGE family member B17" A8MXT2 X 16167481-16171464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 2.0;testis: 1.7" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 2.7;U-2 OS: 6.0;U-266/70: 14.8" HPA003756 Uncertain Uncertain Nucleoplasm NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA003756: AB_2250114" "unprognostic (1.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-1)" "unprognostic (4.04e-4)" "unprognostic (2.75e-1)" "unprognostic (5.11e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (1.88e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-1)" "unprognostic (7.05e-2)" "unprognostic (2.88e-1)" "unprognostic (5.45e-2)" "unprognostic (6.44e-2)" 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 1.5 0.0 0.0 2.7 6.0 0.0 0.1 14.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215563-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 29.1" "Group enriched" "Detected in some" 4 "Spermatocytes: 24.7;Spermatogonia: 95.8" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 92.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 77.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 14.8 0.2 0.0 89.9 0.3 0.3 149.7 168.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 24.7 95.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 MAGEB3 CT3.5 ENSG00000198798 "MAGE family member B3" O15480 X 30230436-30237492 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 114 "epididymis: 17.7;testis: 5.1" "Group enriched" "Detected in some" 8 "Spermatocytes: 13.0;Spermatogonia: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SuSa: 1.3;U-266/70: 2.1" "Not detected" "Not detected" HPA072203 Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA072203: AB_2686492" "unprognostic (3.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAPKAPK2 MK2 ENSG00000162889 "MAPK activated protein kinase 2" P49137 1 206684905-206734281 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 21.9" "Lineage enriched" "Detected in all" 6 "dendritic cells: 21.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263" "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 61.9 80.4 34.8 56.2 39.1 174.6 50.5 36.9 33.9 47.3 38.7 50.3 65.5 53.3 24.1 55.8 50.8 52.5 190.1 30.8 36.6 79.5 66.8 79.3 57.8 53.1 42.1 44.8 53.8 38.0 63.3 25.7 43.9 42.8 35.3 17.6 54.9 33.1 196.7 54.4 61.7 45.4 40.1 78.3 68.2 46.9 45.2 45.6 47.7 94.3 54.4 63.5 46.6 38.6 85.4 33.1 44.8 50.6 128.4 75.0 55.1 57.3 130.0 86.0 80.7 63.8 40.4 40.6 38.8 116.9 54.1 63.0 33.8 61.7 61.4 46.5 25.4 69.1 41.7 41.3 99.0 102.3 219.5 104.1 77.3 82.8 91.3 71.8 71.7 54.1 79.7 180.2 70.5 105.2 41.2 73.3 51.5 29.9 45.1 103.7 94.0 13.5 64.9 51.5 35.7 45.7 68.0 114.2 83.1 83.0 55.4 97.2 68.7 77.6 64.7 91.0 79.7 232.0 220.6 33.2 87.8 60.9 26.0 1.6 0.8 1.8 1.8 1.4 1.6 1.1 1.3 1.7 0.7 1.2 0.6 1.2 3.7 2.6 1.3 21.9 1.8 0.7 34.8 39.1 36.9 33.9 30.8 36.6 53.1 42.1 43.9 40.1 45.2 38.6 49.2 54.5 49.9 15.7 27.9 85.4 52.3 18.3 20.5 12.4 61.4 37.8 102.5 37.1 26.8 31.3 20.9 6.4 185.9 51.9 15.6 30.6 76.2 32.2 40.9 43.7 61.7 15.4 4.7 58.5 9.2 33.4 32.1 46.6 34.9 24.8 19.2 40.0 24.8 0.0 10.6 38.1 16.2 34.6 82.7 36.1 22.7 60.9 33.8 13.1 23.7 21.7 74.2 8.5 17.4 61.6 34.4 17.3 69.6 67.3 22.2 25.0 14.4 16.0 26.3 36.9 48.5 13.7 10.3 31.5 72.0 16.6 46.0 19.2 30.5 75.0 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500779 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 170.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 33.3 32.6 15.7 24.4 22.6 79.8 27.5 21.8 24.9 43.5 0.0 43.6 16.0 48.9 14.3 19.2 39.1 20.2 54.9 24.1 4.8 17.8 19.6 37.0 21.1 1.3 3.2 44.5 31.6 27.9 26.1 22.9 1.0 31.1 13.9 50.0 21.6 24.1 170.9 32.8 27.0 25.6 1.5 29.4 28.2 14.7 2.7 27.5 25.2 69.2 14.8 33.8 32.8 14.0 19.7 32.2 7.2 10.7 15.6 22.2 12.4 26.1 29.6 12.0 12.5 10.4 24.1 42.5 30.3 31.4 12.7 18.8 8.2 13.2 7.1 65.7 11.6 10.8 42.1 6.2 19.2 25.6 32.8 24.5 21.6 21.0 27.9 24.8 22.5 13.5 8.6 72.7 19.1 16.6 18.6 56.4 10.6 10.2 20.5 80.6 16.5 48.3 10.4 8.7 12.0 19.2 24.1 48.2 39.6 13.4 13.7 211.3 40.2 29.1 29.3 22.1 19.7 193.0 214.3 81.3 24.5 19.2 15.9 1.1 1.4 1.7 1.3 0.7 1.5 1.1 0.9 1.2 1.0 1.0 0.5 0.8 5.3 1.1 1.4 5.8 1.3 0.7 15.7 22.6 21.8 24.9 24.1 4.8 1.3 3.2 1.0 1.5 2.7 14.0 21.8 6.4 18.6 21.9 29.8 37.2 10.9 10.6 25.6 82.3 25.2 19.7 42.0 17.2 16.2 1.8 173.0 5.0 72.5 60.6 0.0 7.7 2.5 26.4 26.0 24.0 21.5 11.0 28.7 11.1 4.9 25.1 25.0 43.1 3.8 9.0 22.9 13.2 18.0 70.7 18.8 32.2 8.2 25.4 64.1 4.4 31.4 35.5 14.2 20.6 17.7 19.0 33.0 13.0 20.2 25.8 46.3 32.4 44.6 19.7 17.2 3.4 9.1 85.3 98.6 48.8 46.1 5.1 10.7 16.6 38.1 15.3 33.1 11.0 14.0 19.3 MEI1 "MGC40042, SPATA38" ENSG00000167077 "Meiotic double-stranded break formation protein 1" Q5TIA1 22 41699503-41799456 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.4;testis: 39.5" "Cell type enhanced" "Detected in many" "B-cells: 32.8;Early spermatids: 61.3;Late spermatids: 50.8;NK-cells: 29.9;Plasma cells: 94.7;Spermatocytes: 38.1;T-cells: 28.4" "Cancer enhanced" "Detected in many" "cervical cancer: 5.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 11.6;HMC-1: 8.5;Karpas-707: 26.8;U-266/70: 29.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 7 "olfactory bulb: 1.4" HPA049240 Approved "Intracellular and membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA049240: AB_2680689" "unprognostic (1.95e-3)" "prognostic favorable (1.59e-6)" "unprognostic (6.13e-3)" "unprognostic (1.86e-2)" "unprognostic (9.70e-2)" "unprognostic (2.97e-3)" "unprognostic (9.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (5.96e-2)" "unprognostic (9.65e-2)" "unprognostic (2.62e-1)" "unprognostic (2.45e-10)" "unprognostic (2.82e-1)" "unprognostic (3.02e-1)" "unprognostic (1.85e-1)" "unprognostic (7.39e-2)" 1.3 1.0 2.3 6.7 4.0 12.1 3.0 2.1 2.9 1.5 1.7 6.4 2.6 0.7 0.3 1.6 1.8 1.3 1.0 2.1 2.2 2.8 1.4 4.5 6.6 2.5 3.5 0.8 0.6 0.1 0.9 0.8 2.3 1.5 3.0 1.3 7.0 0.5 0.5 1.2 8.5 0.8 2.1 22.4 4.4 39.5 4.9 2.5 2.3 0.1 8.1 2.7 1.3 2.6 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 2.3 0.0 0.3 0.6 0.2 0.5 0.5 0.2 0.2 0.2 0.0 0.0 0.0 6.7 0.0 2.0 11.6 1.3 1.8 1.4 8.5 0.1 0.1 0.0 0.0 0.3 0.5 0.8 0.4 26.8 0.1 0.0 0.0 6.5 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 3.7 1.0 0.5 0.0 0.0 0.1 29.9 5.1 1.2 0.4 2.8 0.1 18.5 7.2 15.7 29.9 5.6 29.1 21.7 30.1 25.8 6.5 15.4 21.7 24.0 1.3 16.9 2.3 2.3 57.2 18.1 2.3 4.0 2.1 2.9 2.1 2.2 2.5 3.5 2.3 2.1 4.9 2.6 0.7 0.0 3.2 0.0 32.8 0.9 0.3 0.3 0.0 0.6 0.3 0.3 0.9 0.0 0.1 0.0 0.0 0.1 19.9 0.0 0.0 0.1 61.3 0.3 1.0 1.4 0.0 0.4 2.1 0.0 0.2 2.0 2.0 0.1 14.0 0.5 3.3 0.5 7.0 0.0 1.1 2.9 0.0 1.2 3.5 50.8 0.6 11.1 17.8 3.7 15.5 0.1 29.9 1.0 1.1 5.3 0.0 1.2 94.7 0.3 0.1 0.4 0.1 1.1 0.0 0.7 1.7 38.1 26.1 0.0 1.0 0.0 28.4 0.1 0.4 0.3 MGAT2 GNT-II ENSG00000168282 "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" Q10469 14 49620799-49623481 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043721, HPA056824" Approved Supported "Golgi apparatus" NA Yes 5100000 "Cluster 44: Non-specific - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043721: AB_2678636, HPA056824: AB_2683248" "unprognostic (1.20e-2)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.84e-1)" "unprognostic (5.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (3.77e-1)" "unprognostic (1.92e-2)" "unprognostic (1.14e-1)" "unprognostic (7.44e-2)" "unprognostic (7.12e-2)" "unprognostic (5.63e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-2)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" 16.8 17.6 5.9 24.3 5.8 10.3 13.3 6.9 6.8 17.4 9.0 23.6 23.1 12.7 21.7 11.8 11.9 15.2 11.7 5.6 6.7 14.2 40.7 13.8 25.3 6.4 6.3 13.1 23.8 8.2 7.9 22.0 6.6 14.1 21.9 8.2 15.8 13.7 5.0 9.3 22.5 16.0 6.9 20.2 21.0 24.3 7.2 16.4 13.3 5.6 25.1 20.9 8.8 7.3 63.5 30.7 23.2 39.2 53.6 51.7 15.1 68.6 67.7 62.2 55.8 37.5 47.1 63.7 56.9 62.9 36.0 49.5 32.9 39.7 66.7 65.5 29.1 40.7 21.7 37.2 42.3 94.5 91.2 39.8 31.2 36.8 51.8 45.5 75.5 31.4 31.7 170.4 66.3 24.2 32.9 60.1 23.8 22.2 49.1 36.7 67.1 55.6 49.3 36.2 24.0 25.6 49.3 12.9 39.8 22.2 39.1 63.6 78.9 56.1 60.8 41.1 49.6 182.8 94.6 56.7 27.3 46.5 38.6 49.4 38.6 39.3 36.6 34.1 39.3 25.1 33.3 33.1 39.9 15.9 19.3 26.8 11.6 22.3 39.8 47.2 31.6 44.8 5.9 5.8 6.9 6.8 5.6 6.7 6.4 6.3 6.6 6.9 7.2 7.3 17.4 12.8 8.6 2.0 31.7 15.7 25.7 28.8 14.2 13.7 15.5 8.9 0.1 24.3 18.0 11.0 4.2 26.4 46.9 34.6 9.8 31.0 7.9 12.5 20.7 20.8 12.1 19.0 3.0 34.4 40.3 24.3 13.7 11.7 17.1 27.7 27.1 63.0 37.2 18.5 4.3 20.5 40.7 34.5 28.8 6.0 17.4 26.3 21.4 2.8 40.6 16.7 63.8 6.0 4.5 36.5 25.1 22.2 77.1 27.0 26.7 15.2 23.5 15.8 6.6 15.8 34.6 56.4 13.0 15.2 14.1 5.3 31.5 23.2 20.0 25.5 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA 23000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 15.0 22.4 12.8 8.6 16.3 19.1 19.2 21.9 19.0 18.6 2.9 15.0 9.3 19.5 20.6 14.1 15.6 14.2 9.9 14.7 10.5 16.8 17.5 12.1 12.4 10.6 11.4 18.5 13.7 20.5 5.3 21.1 10.9 19.3 18.7 20.0 11.5 16.4 4.3 16.4 11.6 16.4 11.3 10.5 15.7 21.3 15.5 7.5 18.3 2.4 11.6 15.3 10.3 17.7 12.4 11.1 21.5 22.9 30.9 28.9 17.9 38.1 19.4 28.4 33.1 9.6 19.0 9.2 7.2 41.8 19.9 11.2 18.5 22.8 25.5 28.2 25.5 30.0 16.0 10.8 39.3 6.2 24.3 22.5 19.6 25.3 18.1 27.4 23.1 21.7 18.6 7.6 28.5 13.4 13.2 7.5 7.8 19.9 21.6 6.5 12.5 6.4 32.1 9.2 17.6 19.2 18.5 17.5 16.1 19.2 20.4 13.4 23.9 18.5 14.4 31.4 11.2 45.6 18.8 15.7 21.2 13.6 15.1 2.6 1.7 1.5 2.2 3.5 1.8 1.3 1.5 2.4 1.9 1.9 1.0 2.0 1.5 1.7 4.0 2.0 3.1 1.5 12.8 16.3 21.9 19.0 14.7 10.5 10.6 11.4 10.9 11.3 15.5 17.7 17.3 22.4 14.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 9.7 7.4 0.0 0.0 3.7 14.7 0.0 18.7 10.7 0.0 19.6 11.6 0.0 8.2 18.1 5.2 0.0 0.0 0.0 8.3 17.0 7.5 0.0 9.7 1.3 11.5 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 9.0 0.0 0.0 4.0 0.0 0.0 17.7 11.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 32.7 3.0 13.7 0.0 0.0 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453033-140479536 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 129.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytosol" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 39.5 36.8 50.9 47.9 50.7 202.6 47.8 52.6 57.1 43.0 46.6 97.9 69.2 46.7 43.3 49.0 51.3 37.5 64.6 51.0 53.7 47.9 42.7 46.9 49.7 57.6 50.7 56.5 58.1 66.8 42.3 43.0 58.9 48.6 80.1 58.6 56.5 44.4 84.0 51.7 65.8 43.5 50.2 52.7 53.9 123.2 55.6 47.1 46.9 58.5 56.4 45.7 38.9 50.9 96.5 72.3 55.6 83.1 86.5 75.5 78.2 64.6 83.3 49.8 57.2 30.0 98.8 69.4 98.4 63.4 99.2 45.7 63.2 71.2 62.8 138.0 55.6 72.1 43.5 55.9 69.4 62.5 107.1 75.4 105.1 56.2 52.8 81.9 50.8 46.9 58.0 84.8 49.1 82.6 73.4 114.2 143.3 80.7 53.6 52.4 47.4 107.6 80.8 109.2 76.6 79.1 80.8 108.5 120.6 81.6 53.3 53.5 71.9 34.9 27.4 85.8 59.8 200.2 159.2 60.9 99.3 96.1 73.3 58.6 22.5 100.4 15.4 21.3 18.0 33.6 29.5 23.0 18.0 32.9 39.9 25.5 42.5 31.1 26.5 6.0 35.3 15.3 50.9 50.7 52.6 57.1 51.0 53.7 57.6 50.7 58.9 50.2 55.6 50.9 28.4 51.3 37.2 13.4 76.8 82.1 66.6 57.1 57.5 61.5 60.9 36.2 57.7 67.2 71.1 42.3 35.5 75.8 54.0 172.1 103.7 69.8 328.0 58.4 30.6 34.2 97.3 424.2 28.9 67.8 96.6 43.3 38.7 65.7 37.4 79.5 45.7 45.0 59.5 119.5 28.0 107.7 89.5 95.9 93.3 340.6 66.5 86.3 69.4 22.5 119.0 61.4 92.7 15.1 22.1 57.6 140.3 62.4 41.8 101.2 112.4 54.4 70.0 46.4 46.0 34.7 53.3 303.0 60.1 62.4 95.5 138.0 62.9 39.6 103.5 145.9 MMP23B "MIFR, MIFR-1, MMP22" ENSG00000189409 "Matrix metallopeptidase 23B" O75900 1 1632163-1635263 "Enzymes, Predicted intracellular proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 29.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 11.3" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.3" "Cell line enhanced" "Detected in some" "HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9" "Region enriched" "Detected in some" 5 "cerebellum: 7.8" "Low region specificity" "Detected in some" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 89: Fibroblasts - ECM organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (2.19e-2)" "unprognostic (6.31e-2)" "unprognostic (6.70e-3)" "unprognostic (1.29e-1)" "unprognostic (3.99e-2)" "unprognostic (9.31e-2)" "unprognostic (6.94e-2)" "unprognostic (1.20e-1)" "unprognostic (8.06e-2)" "unprognostic (8.37e-2)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.26e-11)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-2)" "unprognostic (6.66e-2)" 7.1 2.8 0.4 0.3 0.5 1.3 4.1 0.1 1.0 16.7 0.0 5.0 1.9 15.4 0.0 2.8 11.0 2.9 15.0 0.3 0.0 3.2 3.3 14.3 1.1 0.4 0.0 29.9 1.6 0.0 5.7 2.8 0.1 11.8 0.1 0.1 1.0 1.1 0.5 3.1 3.4 1.2 0.0 3.0 4.3 5.2 0.1 0.0 2.4 0.0 0.1 11.9 10.9 0.2 0.6 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.4 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.2 1.2 4.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.4 0.0 0.2 2.7 0.0 1.9 0.9 0.0 1.1 0.0 0.0 0.4 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.1 0.3 0.0 3.9 0.2 1.1 0.0 0.2 0.1 0.0 0.2 0.0 1.5 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.0 0.7 0.1 2.2 0.1 11.3 0.3 1.7 0.4 0.5 0.1 1.0 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.2 2.2 0.0 0.5 1.0 1.1 13.4 0.8 0.7 0.6 1.3 1.7 1.5 9.6 1.5 0.4 1.8 0.0 4.0 27.4 3.0 0.0 1.2 1.0 4.0 3.5 2.2 3.0 2.7 0.3 0.5 2.2 90.5 4.6 1.0 0.0 1.4 12.1 1.0 5.7 3.3 0.6 1.9 4.1 1.0 18.5 6.2 98.2 1.3 19.6 0.0 1.2 0.5 64.9 0.0 0.2 4.3 0.9 177.9 4.3 0.5 2.7 1.0 0.5 7.7 0.0 0.7 5.3 2.1 10.5 0.7 15.8 10.3 8.1 2.1 1.7 0.9 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515392-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 3.5" "Cell type enhanced" "Detected in some" "Early spermatids: 25.0;Late spermatids: 47.0;Spermatocytes: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045017, HPA063626" Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA045017: AB_10962976, HPA063626: AB_2685065" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 47.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756867-60776733 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lung: 43.9" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 1: 96.1" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 3.2" "Lineage enriched" "Detected in single" 12 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1" "Region enriched" "Detected in some" 28 "olfactory bulb: 166.8" "Region enriched" "Detected in single" 26 "olfactory bulb: 20.2" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 19: Lung - Lung function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.2 0.4 0.2 0.1 2.2 0.3 0.4 0.3 0.2 0.3 1.0 1.2 0.3 0.4 1.0 0.2 0.3 0.7 0.2 0.1 0.0 43.9 0.5 0.4 0.2 1.8 0.1 0.0 0.0 0.7 0.4 0.3 0.6 0.4 0.1 1.2 0.0 0.0 2.2 1.6 0.1 0.3 0.4 0.6 0.2 3.8 0.3 0.0 1.8 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.5 1.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 4.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 3.2 0.2 0.2 0.2 0.3 0.4 0.7 0.2 0.4 0.2 0.4 0.1 0.2 0.3 0.2 96.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.1 0.2 0.1 0.0 0.0 MYCL "bHLHe38, LMYC, MYCL1" ENSG00000116990 "MYCL proto-oncogene, bHLH transcription factor" P12524 1 39895426-39902256 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 67.8;skin 1: 41.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.9;Hepatocytes: 24.3;Intestinal goblet cells: 25.0;monocytes: 27.4;Squamous epithelial cells: 34.2;Urothelial cells: 27.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 28.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8" "Group enriched" "Detected in many" 72 "dendritic cells: 22.8;monocytes: 17.3" "Group enriched" "Detected in many" 7 "U-266/70: 444.0;U-266/84: 364.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA063132, HPA074515" Enhanced "Nucleoplasm,Mitotic chromosome" Yes NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 25: Pancreas - Digestion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Mitotic chromosome" "HPA063132: AB_2684946, HPA074515: " "unprognostic (7.45e-2)" "unprognostic (6.91e-2)" "unprognostic (7.36e-2)" "unprognostic (1.83e-3)" "unprognostic (1.61e-2)" "unprognostic (2.92e-3)" "unprognostic (6.72e-3)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-1)" "unprognostic (1.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.01e-3)" "unprognostic (2.75e-2)" "unprognostic (5.21e-2)" "unprognostic (1.53e-2)" "unprognostic (5.80e-2)" 0.8 0.3 1.8 4.7 2.0 0.6 3.3 1.2 2.0 5.2 1.8 6.1 4.8 0.9 7.2 22.1 3.1 1.5 0.5 2.2 1.7 1.5 11.4 3.3 6.4 1.5 1.5 0.3 67.8 0.3 2.9 6.7 1.6 4.2 6.7 0.2 6.4 7.5 0.5 41.5 5.7 1.1 1.9 7.6 6.2 1.3 2.0 6.5 5.3 0.5 9.5 15.9 12.8 1.6 1.2 0.4 14.4 3.5 0.2 0.1 31.8 0.5 0.2 1.0 0.7 0.4 0.8 2.2 1.4 0.1 0.4 3.3 10.4 2.7 0.8 2.0 4.9 0.5 0.3 0.5 0.4 0.3 7.5 1.0 12.1 0.4 1.3 0.2 1.2 5.4 3.2 0.4 0.6 1.2 0.2 0.3 13.4 2.2 0.4 1.3 15.5 2.9 1.1 58.0 2.5 3.1 1.4 2.1 0.8 5.5 3.7 18.7 0.0 0.0 4.6 6.2 0.5 444.0 364.6 1.0 0.1 2.3 0.3 0.0 17.3 0.0 0.0 8.2 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.2 0.0 3.4 22.8 0.0 6.7 1.8 2.0 1.2 2.0 2.2 1.7 1.5 1.5 1.6 1.9 2.0 1.6 0.4 0.0 1.1 0.0 0.8 6.6 10.0 2.1 13.1 0.4 3.8 6.0 3.7 0.0 5.5 9.2 0.0 34.9 20.1 13.4 0.0 1.5 0.1 5.1 0.6 0.5 17.3 0.0 0.2 5.8 15.4 0.9 5.1 6.3 0.0 0.0 1.4 24.3 5.1 0.0 0.3 25.0 8.2 8.3 13.1 0.4 0.0 10.6 1.8 0.0 27.4 0.8 0.0 1.0 0.0 2.9 6.5 0.0 3.6 5.3 6.4 0.1 4.9 0.1 0.0 1.4 0.7 0.0 1.2 34.2 11.8 17.5 0.3 0.0 10.8 27.1 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N-alpha-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326061 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 2.6;placenta: 4.2;testis: 6.2" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.1" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 2.6 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 4.2 0.3 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.3 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.0 32.9 11.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.6 0.1 0.1 0.2 0.5 0.4 0.3 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 15.9 0.0 0.0 13.3 0.0 0.0 0.0 0.0 NARF "DKFZp434G0420, FLJ10067, IOP2" ENSG00000141562 "Nuclear prelamin A recognition factor" Q9UHQ1 17 82458180-82490537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 292.6;Late spermatids: 474.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053006 Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm Nucleoli "HPA053006: AB_2682013" "unprognostic (1.84e-1)" "prognostic favorable (1.15e-4)" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (4.14e-1)" "unprognostic (6.52e-2)" "unprognostic (6.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (3.42e-3)" "unprognostic (3.80e-3)" "prognostic unfavorable (1.48e-10)" "unprognostic (3.57e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-2)" "unprognostic (1.83e-2)" 19.2 18.0 17.2 12.4 18.5 32.9 17.4 19.5 21.7 15.8 16.1 23.4 10.3 14.5 5.8 21.5 16.1 7.7 38.7 17.7 16.8 19.6 23.1 15.1 10.7 17.8 17.0 16.9 20.6 6.6 18.7 7.4 17.8 17.0 6.5 11.5 18.4 8.2 49.2 25.1 19.1 7.1 15.8 28.7 23.3 59.1 16.9 14.6 16.5 25.9 8.9 19.9 16.3 19.1 21.2 23.3 32.8 50.6 15.2 14.3 18.2 13.1 12.7 21.2 21.2 23.6 8.4 14.0 13.6 9.8 23.8 18.6 23.8 15.5 14.2 15.3 55.7 29.0 30.4 27.7 13.1 30.9 50.6 21.9 26.4 16.5 5.7 20.7 39.2 44.9 67.5 9.6 9.2 18.1 51.2 49.8 13.7 16.3 44.1 42.6 34.3 21.6 9.7 23.3 40.1 55.9 32.1 21.3 38.8 20.7 18.4 23.2 21.7 26.4 22.4 22.4 21.7 94.1 38.4 30.1 24.3 20.6 15.9 94.5 33.0 96.2 34.2 30.0 38.1 38.2 33.1 33.7 32.0 40.9 37.7 31.2 156.0 53.7 23.9 26.2 44.1 38.6 17.2 18.5 19.5 21.7 17.7 16.8 17.8 17.0 17.8 15.8 16.9 19.1 45.2 12.8 23.2 25.1 50.7 37.3 32.9 55.4 28.5 38.1 30.4 30.1 43.2 21.5 40.0 5.5 54.2 32.4 87.9 38.5 39.2 53.3 194.2 46.2 23.3 53.1 56.9 292.6 30.6 66.7 57.7 30.1 80.5 25.3 52.7 24.4 45.7 18.5 34.3 50.5 31.6 32.4 95.6 23.8 35.3 474.5 25.1 39.3 62.2 15.0 56.7 24.2 72.1 12.5 20.8 65.7 29.6 18.0 89.9 23.7 41.9 22.1 61.6 37.3 13.1 36.9 36.0 152.5 87.6 20.7 35.4 30.6 57.4 28.4 36.3 30.2 NCOA2 "bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2" ENSG00000140396 "Nuclear receptor coactivator 2" Q15596 8 70109782-70403808 "Cancer-related genes, Disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 161.6;Excitatory neurons: 158.9;Inhibitory neurons: 314.8;Microglial cells: 233.3;Oligodendrocyte precursor cells: 249.8;Oligodendrocytes: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060243 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear bodies" "HPA060243: AB_2684229" "unprognostic (9.79e-3)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.91e-2)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (2.06e-1)" "unprognostic (7.00e-2)" "unprognostic (2.20e-2)" "unprognostic (2.63e-2)" "prognostic favorable (5.08e-4)" "unprognostic (2.52e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-1)" 8.4 8.9 8.9 9.9 10.5 23.3 13.4 8.9 10.0 10.0 1.5 10.6 11.6 10.1 29.6 15.3 10.9 8.9 15.0 13.6 13.2 14.4 23.8 10.0 11.6 8.0 6.8 16.2 7.3 15.2 7.3 12.1 7.7 12.9 10.6 26.1 11.3 12.1 8.3 10.5 12.1 9.0 4.6 12.4 10.9 14.7 9.9 15.3 12.1 15.9 12.5 10.0 9.9 6.1 13.7 16.9 18.2 10.3 16.2 16.5 18.6 7.8 7.8 5.9 5.5 8.6 15.6 16.3 3.1 14.3 9.7 8.0 22.5 10.7 6.5 38.7 17.9 28.5 8.5 13.8 8.5 5.8 7.2 14.5 11.7 7.9 11.3 9.2 4.0 11.7 9.2 24.0 6.9 13.7 14.5 5.8 9.6 15.7 7.9 14.1 7.6 10.3 9.3 22.5 13.8 10.2 13.4 7.1 11.0 12.7 16.7 10.5 5.3 8.4 10.6 10.8 4.2 31.5 17.3 15.4 8.6 7.6 12.5 3.1 1.6 2.2 2.2 2.3 1.5 1.3 1.3 1.9 1.5 2.1 1.5 1.6 5.7 1.4 5.2 0.6 2.0 1.2 8.9 10.5 8.9 10.0 13.6 13.2 8.0 6.8 7.7 4.6 9.9 6.1 20.9 12.8 25.1 161.6 27.3 16.2 8.6 10.8 17.6 25.8 29.5 17.5 34.1 28.6 25.8 25.8 52.1 22.1 26.9 30.8 11.7 9.3 6.4 23.6 26.4 17.7 25.2 28.8 158.9 12.4 12.5 21.6 21.4 38.0 22.2 23.2 22.1 65.9 17.4 74.0 314.8 17.4 10.2 46.8 17.8 7.6 19.9 28.1 21.4 233.3 23.1 14.3 19.6 249.8 186.0 12.8 14.8 22.2 49.9 15.5 22.7 17.6 19.0 33.4 26.3 22.5 20.2 13.3 16.5 18.8 21.5 31.7 36.6 10.9 17.0 15.8 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061545 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1357.5;tongue: 858.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Cytosol "HPA063384: AB_2684998, HPA065424: AB_2685488" "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favorable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 154.3 130.5 109.3 75.0 99.3 31.1 91.1 101.6 98.3 103.5 225.0 107.6 106.0 149.4 88.2 126.0 130.6 97.3 430.8 112.4 146.3 159.6 104.0 83.3 63.8 135.0 131.1 148.8 65.2 115.2 82.5 100.6 131.0 95.7 80.1 67.1 92.1 123.5 1357.5 121.1 113.3 141.0 116.3 113.0 79.0 69.3 126.8 62.3 132.6 858.4 59.2 89.7 86.3 138.2 122.2 265.4 172.0 147.4 349.8 168.2 128.6 193.7 269.2 135.1 149.8 327.6 137.6 139.8 379.2 244.6 175.2 245.5 122.5 154.5 144.7 239.9 104.1 78.8 181.0 111.1 418.6 178.0 122.1 232.6 380.7 246.7 267.2 228.7 214.6 93.5 142.5 377.4 169.4 103.3 115.5 56.0 113.0 110.0 101.4 80.1 241.8 136.4 150.0 181.0 105.8 160.2 132.4 89.0 272.4 222.5 175.7 120.5 291.2 324.2 141.4 112.3 197.4 626.6 460.1 134.1 310.4 73.6 191.3 14.2 11.8 4.0 3.4 6.5 2.0 5.2 3.1 3.5 2.6 4.9 2.4 2.7 26.1 3.0 8.7 12.9 1.2 1.3 109.3 99.3 101.6 98.3 112.4 146.3 135.0 131.1 131.0 116.3 126.8 138.2 60.1 57.7 49.4 25.1 15.8 55.7 19.3 45.0 34.1 68.8 39.2 33.8 303.1 50.1 34.4 77.3 35.5 22.7 14.7 150.7 25.4 41.3 8.1 57.9 92.0 66.3 30.1 11.6 24.5 36.2 21.5 47.9 27.5 58.8 28.4 89.3 80.3 126.7 36.0 72.3 28.0 51.5 38.7 32.8 18.9 10.6 102.2 23.8 21.4 20.6 31.5 25.4 15.5 9.0 14.4 51.8 64.8 83.8 17.4 33.8 100.3 39.1 49.5 34.8 59.2 39.3 53.8 30.0 35.5 25.9 48.4 22.3 14.2 44.6 49.4 24.4 NKIRAS1 "kappaB-Ras1, KBRAS1" ENSG00000197885 "NFKB inhibitor interacting Ras like 1" Q9NYS0 3 23889951-23946591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6;Rod photoreceptor cells: 59.7;Spermatocytes: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077387 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum, Cytosol" "HPA077387: " "unprognostic (1.36e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (1.08e-2)" "unprognostic (4.25e-2)" "unprognostic (5.30e-2)" "prognostic favorable (3.69e-4)" "unprognostic (3.69e-3)" "unprognostic (8.07e-3)" "unprognostic (1.19e-2)" "unprognostic (3.37e-2)" "prognostic favorable (7.71e-13)" "unprognostic (1.98e-1)" "unprognostic (4.90e-2)" "unprognostic (1.18e-1)" "unprognostic (2.63e-3)" 10.0 13.4 23.0 4.5 23.4 8.0 8.7 23.9 29.9 9.0 16.0 9.4 3.4 8.7 8.4 8.4 7.9 6.2 16.4 24.1 25.1 16.4 25.0 6.2 4.4 22.8 22.9 11.9 5.2 37.8 14.9 6.3 23.9 9.5 4.0 47.3 6.9 13.1 32.8 4.9 4.1 9.2 20.9 5.9 6.2 22.9 22.1 3.8 9.8 27.2 4.5 6.6 6.1 21.7 13.3 12.9 11.0 11.7 31.6 14.6 11.4 32.4 19.8 23.5 18.9 10.9 3.6 7.0 14.4 18.8 13.9 7.0 20.4 14.1 20.0 28.7 13.8 3.4 10.2 10.5 17.1 6.0 3.4 12.1 19.1 30.3 13.9 21.3 7.0 6.6 6.7 26.6 26.1 6.4 4.5 5.5 15.2 8.2 15.6 6.7 17.3 6.0 16.2 5.2 4.3 21.6 11.0 14.5 23.4 11.4 11.7 9.9 12.6 10.9 11.8 28.2 26.5 57.1 64.0 4.2 14.4 10.3 9.0 13.9 5.1 6.7 8.9 4.1 9.8 6.1 6.2 8.5 5.1 8.1 9.6 7.8 2.4 4.3 4.3 3.6 5.3 4.5 23.0 23.4 23.9 29.9 24.1 25.1 22.8 22.9 23.9 20.9 22.1 21.7 5.7 6.4 8.2 7.5 5.3 11.2 10.3 18.0 13.6 34.1 9.0 8.3 22.3 4.3 13.1 5.5 64.6 12.2 6.0 3.0 15.6 7.5 27.5 18.0 12.0 5.5 1.2 3.0 15.3 4.5 9.7 11.6 3.1 21.0 7.0 5.7 6.1 13.3 7.3 13.5 16.9 2.2 14.2 3.2 12.9 7.7 7.5 6.8 10.6 5.6 4.6 44.0 3.1 11.6 10.7 5.3 2.4 9.1 4.2 8.1 4.1 23.2 17.2 59.7 13.1 7.3 12.9 68.6 41.1 7.9 9.9 10.4 6.7 10.7 3.0 7.2 NKPD1 FLJ33600 ENSG00000179846 "NTPase KAP family P-loop domain containing 1" Q17RQ9 19 45149750-45160815 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 15.9" "Cell type enhanced" "Detected in some" "Horizontal cells: 5.0;Spermatocytes: 2.4;Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 1.4;SiHa: 1.2;U-266/70: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA043339 Uncertain NA NA "Cluster 61: Skin - Cornification" "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA043339: AB_10962493" "unprognostic (3.98e-2)" "unprognostic (5.94e-2)" "unprognostic (2.14e-1)" "unprognostic (8.30e-4)" "unprognostic (2.23e-1)" "unprognostic (4.60e-2)" "unprognostic (2.41e-3)" "unprognostic (2.01e-2)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (7.73e-4)" "unprognostic (1.30e-1)" "unprognostic (2.77e-5)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" 0.1 0.1 0.4 0.0 0.1 0.2 0.5 0.2 0.4 1.3 0.0 0.0 0.0 0.1 0.2 1.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.5 0.0 0.5 0.8 0.0 0.3 0.5 0.5 0.1 15.9 0.1 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.2 3.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.3 0.2 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 1.2 0.7 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.4 0.1 0.2 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.4 0.0 0.6 0.9 0.2 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.1 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.1 5.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.2 0.5 1.3 0.1 0.0 0.2 0.0 0.1 NLRP6 "CLR11.4, NALP6, PAN3, PYPAF5" ENSG00000174885 "NLR family pyrin domain containing 6" P59044 11 278407-285388 "Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 39.9" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 9.9;T-cells: 2.6" "Group enriched" "Detected in some" 4 "colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 3.6" "Group enriched" "Detected in many" 4 "neutrophil: 15.4;non-classical monocyte: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 15.4;monocytes: 4.6" "Cell line enhanced" "Detected in some" "REH: 2.0;U-266/70: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043681, HPA048500" Supported NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "HPA043681: AB_2678614, HPA048500: AB_2680422" "unprognostic (6.37e-3)" "unprognostic (4.69e-2)" "unprognostic (4.26e-2)" "unprognostic (3.42e-2)" "unprognostic (6.40e-2)" "unprognostic (1.18e-2)" "prognostic favorable (4.23e-5)" "unprognostic (8.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (2.19e-1)" "unprognostic (3.11e-3)" "unprognostic (4.96e-2)" "unprognostic (2.14e-2)" "unprognostic (6.90e-3)" "unprognostic (3.69e-2)" 0.7 0.0 0.1 2.2 0.2 0.5 0.2 0.1 3.6 0.1 0.2 0.6 39.9 0.2 0.1 0.1 0.6 0.3 0.1 0.1 0.5 1.3 2.6 0.9 1.2 0.9 0.3 0.0 0.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.1 38.0 0.1 0.3 3.6 0.3 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.2 0.2 0.4 0.1 0.0 0.0 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 1.4 0.3 1.6 1.1 0.1 0.1 1.8 2.3 15.4 1.0 4.6 0.0 0.0 0.7 0.1 0.2 0.1 3.6 0.1 0.5 0.9 0.3 0.6 0.3 0.3 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.7 0.0 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 567.3;Alveolar cells type 2: 566.9;Club cells: 217.6;granulocytes: 278.8;Late spermatids: 223.3;Respiratory ciliated cells: 250.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039077, HPA057402" Approved Supported Mitochondria NA NA "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" Mitochondria "HPA039077: AB_2676336, HPA057402: AB_2683427" "unprognostic (9.45e-3)" "prognostic favorable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 7.5 7.4 17.7 4.9 26.7 19.3 8.3 46.5 45.4 6.7 8.2 6.9 9.2 9.4 8.1 5.4 13.6 5.4 11.6 21.5 10.9 9.2 6.6 4.3 4.8 8.6 5.3 20.1 12.0 8.9 5.5 2.2 15.1 6.5 7.5 30.6 9.3 5.5 29.6 19.0 7.8 5.6 2.5 5.4 5.6 11.3 14.6 3.0 7.6 20.3 5.3 5.5 6.8 50.1 9.2 3.6 4.0 4.6 0.9 0.9 5.0 3.7 0.4 0.6 0.5 5.1 6.4 5.9 10.8 0.7 4.3 4.5 3.0 1.2 0.7 5.8 5.3 31.4 9.1 6.9 2.4 5.6 5.5 1.4 7.8 1.0 1.7 9.3 0.5 3.6 5.0 13.1 0.6 6.2 5.3 4.6 9.0 16.5 3.7 4.4 4.5 4.3 1.2 6.3 9.2 5.4 9.2 4.8 3.3 7.3 12.6 15.6 5.6 5.7 12.6 7.2 5.5 23.1 11.0 4.2 3.8 9.0 5.4 11.4 3.6 2.2 2.8 3.4 1.9 2.7 2.4 2.4 2.8 4.5 3.4 3.6 7.0 4.0 3.4 2.9 1.6 1.7 17.7 26.7 46.5 45.4 21.5 10.9 8.6 5.3 15.1 2.5 14.6 50.1 5.5 567.3 566.9 34.9 1.9 4.1 6.3 6.6 6.2 2.7 8.2 7.1 9.7 8.6 217.6 9.2 4.2 0.4 0.8 2.3 11.7 3.3 128.2 2.1 2.4 38.8 6.7 27.1 37.2 3.1 0.2 38.3 3.1 1.7 278.8 9.7 2.5 2.7 2.0 1.7 26.0 6.5 8.2 4.1 2.9 223.3 7.8 31.8 7.2 12.2 1.8 12.3 0.0 46.8 16.9 0.8 2.9 6.4 0.7 6.1 3.5 16.1 250.6 18.5 6.6 13.2 3.8 67.1 3.5 4.4 9.7 0.1 21.5 5.9 10.6 4.8 NOTCH2NLA "N2N, NOTCH2NL" ENSG00000264343 "Notch 2 N-terminal like A" Q7Z3S9 1 146146203-146229026 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "B-cells: 1.6;dendritic cells: 2.8;Extravillous trophoblasts: 2.0;Fibroblasts: 1.2;Hofbauer cells: 2.1;Macrophages: 2.2;Plasma cells: 3.0;Smooth muscle cells: 1.4;Syncytiotrophoblasts: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB004669 Uncertain "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "CAB004669: AB_426149" "unprognostic (1.54e-1)" "unprognostic (8.28e-3)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (4.28e-4)" "unprognostic (1.26e-2)" "unprognostic (1.81e-1)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.91e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-2)" 14.5 5.9 6.3 6.8 4.2 5.3 13.4 2.1 9.7 18.9 17.1 7.8 5.1 9.0 13.6 22.0 9.8 6.9 10.6 8.9 6.1 8.6 15.5 13.1 5.9 6.9 4.9 11.6 10.9 8.8 3.7 9.6 4.9 14.5 6.4 8.6 14.9 7.8 9.1 29.0 7.1 8.5 2.4 11.4 7.4 34.0 7.7 5.4 10.6 3.8 6.8 9.1 21.0 6.5 22.8 7.8 12.2 4.4 11.4 31.4 4.8 12.3 20.7 14.1 16.0 4.3 10.5 5.0 5.1 9.7 7.6 10.1 6.9 15.7 22.1 13.5 5.8 17.1 15.8 2.0 12.9 7.6 6.1 28.5 4.9 15.5 33.2 17.4 10.2 7.4 5.4 26.6 20.1 15.9 4.2 5.2 3.6 1.7 14.9 4.1 11.9 16.2 7.4 12.0 1.9 1.2 21.0 12.2 4.9 7.9 20.5 7.7 42.2 9.5 8.2 19.9 16.1 51.0 14.2 12.5 15.6 6.1 8.4 16.8 13.4 27.9 4.3 13.4 4.1 14.3 4.0 4.0 10.5 11.4 5.8 4.2 19.5 4.5 18.1 17.3 4.2 3.0 6.3 4.2 2.1 9.7 8.9 6.1 6.9 4.9 4.9 2.4 7.7 6.5 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 NOTCH2NLB ENSG00000286019 "Notch 2 N-terminal like B" P0DPK3 1 148607040-148679779 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 26.2;U-266/70: 89.3;U-266/84: 29.2" "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: U-266 - Adaptive immune response" 2.4 1.1 3.4 1.1 3.0 4.7 3.7 2.4 4.5 11.4 4.6 1.8 0.9 1.6 2.9 3.0 2.0 3.0 1.2 3.5 2.6 1.9 3.5 2.0 2.1 3.5 2.9 2.0 3.3 2.3 2.0 2.7 3.6 1.6 1.2 2.0 2.4 2.2 3.1 1.7 2.4 2.8 3.3 1.0 5.5 3.7 0.9 2.1 0.0 2.3 2.6 3.4 8.6 3.4 2.1 2.1 2.7 2.3 1.3 6.1 6.1 4.3 4.2 1.9 6.1 0.7 1.4 1.4 3.7 2.8 2.0 7.1 2.7 3.5 3.2 6.9 7.2 0.8 2.6 4.2 1.9 9.4 3.3 3.4 15.6 6.6 4.8 2.9 1.3 26.2 8.9 6.7 1.2 2.7 1.0 2.6 7.2 2.6 3.7 9.9 7.7 1.8 0.1 0.1 11.9 6.1 0.7 0.8 7.8 2.4 12.8 1.6 3.5 7.4 4.7 89.3 29.2 3.4 5.7 2.9 5.9 11.5 14.1 29.3 2.3 12.6 2.1 18.0 2.6 2.3 14.4 15.5 3.3 3.0 15.8 4.1 13.5 15.2 3.1 3.8 3.4 3.0 2.4 4.5 3.5 2.6 3.5 2.9 2.7 2.8 3.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOTCH2NLC ENSG00000286219 "Notch 2 N-terminal like C" P0DPK4 1 149390614-149468030 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Notch signaling pathway" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 74.2;U-266/70: 121.3" "Secreted to blood" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 29: U-266 - Adaptive immune response" 7.3 2.0 9.6 5.5 8.2 18.0 12.1 6.4 16.4 13.2 14.5 5.4 3.5 6.4 9.8 9.8 7.7 6.4 6.9 10.4 9.3 3.9 21.6 6.1 8.3 10.0 9.0 7.1 5.7 7.6 5.6 8.1 9.5 6.1 14.3 6.8 8.1 2.5 12.7 2.6 5.2 7.3 7.3 3.1 20.8 10.6 7.4 6.1 3.9 8.3 8.4 8.8 14.2 6.0 4.0 5.0 9.0 11.1 2.5 4.5 39.9 17.9 23.8 3.6 12.2 2.2 3.6 17.1 9.6 5.0 5.1 19.7 10.8 7.1 3.4 11.7 43.8 1.8 37.9 6.1 3.7 33.5 8.1 28.3 74.2 10.7 14.4 8.3 3.1 50.7 17.0 29.8 5.1 7.7 1.6 8.6 13.6 4.8 7.9 27.3 17.9 16.4 0.5 0.4 12.9 12.3 2.0 5.0 10.6 9.5 12.8 5.4 8.8 9.5 9.8 121.3 35.9 7.6 11.9 6.4 8.0 17.8 29.3 47.3 3.6 21.4 5.0 57.7 5.9 5.8 44.3 26.6 5.9 4.0 14.1 8.3 18.9 23.6 8.2 11.3 9.6 8.2 6.4 16.4 10.4 9.3 10.0 9.0 8.1 7.3 10.6 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934396-33820863 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.8" "Group enriched" "Detected in many" 6 "Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0" "Group enriched" "Detected in some" 4 "endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 0.8 0.8 17.3 0.1 19.9 0.0 0.9 14.6 12.9 6.0 0.0 1.4 0.3 3.9 0.8 0.3 3.9 0.7 0.4 14.0 15.0 0.9 0.1 0.2 0.1 22.8 18.0 2.7 0.4 0.5 1.0 0.5 15.8 0.8 0.3 1.4 0.8 1.3 0.2 0.2 0.4 0.6 18.0 1.1 1.0 1.3 15.9 0.4 1.8 0.2 0.2 0.5 0.5 18.3 0.0 0.0 9.3 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 23.6 7.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 19.9 14.6 12.9 14.0 15.0 22.8 18.0 15.8 18.0 15.9 18.3 5.1 0.0 0.0 3405.1 0.1 1.0 1.0 0.0 0.6 8.9 3.8 5.1 2.1 0.0 0.1 1.8 0.0 1.5 0.1 0.1 1.9 0.1 22.2 24.6 5.7 3.2 1.2 0.0 341.9 0.0 0.1 3.5 0.0 72.3 0.0 0.7 4.2 0.1 0.5 10.1 1408.3 0.0 0.0 0.0 1.4 17.0 7.2 0.7 0.0 116.2 0.0 7.4 0.0 1893.0 1772.0 0.2 0.0 5.3 0.1 0.5 0.0 0.5 1.8 0.7 0.0 11.5 3.1 0.2 0.8 0.1 0.4 0.3 1.0 1.1 0.0 0.5 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family member B2" A6NJ64 16 11927259-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.1" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;granulocytes: 2.5;Granulosa cells: 3.1;Proximal tubular cells: 4.4;Respiratory ciliated cells: 2.2;Theca cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 15.5;U-266/70: 26.9" HPA053611 Supported Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 2.6 2.0 5.4 0.4 5.4 0.9 2.1 6.0 6.3 2.9 5.2 2.1 1.6 2.3 4.0 1.1 2.5 1.3 1.5 5.2 5.7 3.5 1.6 1.5 1.3 5.5 5.1 3.0 2.1 2.8 2.7 1.1 5.4 2.1 1.4 4.1 1.6 1.8 1.5 3.4 2.0 2.2 4.7 1.9 1.7 15.1 5.6 7.8 2.9 0.4 0.7 1.8 2.0 5.9 0.1 1.6 2.0 1.1 4.6 7.4 3.0 2.2 3.9 1.0 0.6 1.2 1.8 1.0 0.7 2.1 0.3 0.4 1.3 1.7 2.0 1.2 1.7 0.5 2.1 1.8 7.4 1.1 0.4 0.3 3.5 2.3 4.9 0.3 0.3 0.2 0.2 5.5 0.7 2.3 0.3 0.8 0.6 1.4 1.6 2.2 0.1 15.5 0.7 1.0 2.9 0.0 5.0 0.3 0.0 2.0 0.3 3.6 0.5 0.3 0.3 0.4 0.2 26.9 8.8 1.2 3.1 0.4 1.2 0.0 1.0 0.2 0.3 0.0 0.0 0.8 0.5 0.4 0.8 0.4 0.9 0.2 0.2 1.5 0.1 0.7 0.0 0.4 5.4 5.4 6.0 6.3 5.2 5.7 5.5 5.1 5.4 4.7 5.6 5.9 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 1.8 0.0 0.7 0.5 0.0 5.9 0.5 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.7 0.2 0.6 0.0 0.5 2.5 3.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 4.4 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.4 2.6 0.0 0.0 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24078662-24115010 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 75 "retina: 317.3" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 3720.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 4.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 79: Retina - Phototransduction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 0.8 2.5 1.7 0.5 1.5 0.5 1.0 2.3 2.2 1.1 0.6 0.9 1.1 1.1 0.7 1.1 1.0 0.9 2.2 1.5 1.5 3.1 3.6 1.0 1.0 2.3 1.8 1.2 1.7 1.9 2.4 0.3 1.7 1.5 0.3 317.3 1.0 0.7 2.5 0.7 1.3 0.3 1.7 2.1 1.2 4.2 1.6 1.2 2.7 1.4 0.7 1.1 0.8 1.7 0.3 1.2 1.6 1.6 0.3 0.2 0.4 0.3 0.3 0.5 0.3 0.7 0.5 1.2 0.4 0.5 1.0 0.5 0.6 0.3 0.2 0.6 0.5 0.7 0.6 2.2 0.6 1.4 1.6 0.4 0.5 0.2 0.7 0.7 0.5 2.2 0.7 1.2 0.3 0.9 1.2 0.6 1.8 1.8 0.9 1.2 1.5 0.0 0.4 1.3 1.7 1.2 0.8 0.7 0.8 4.8 0.9 1.5 0.4 1.1 0.5 0.1 0.7 3.6 1.9 1.5 0.3 0.9 1.1 0.2 0.3 1.3 0.2 0.4 0.1 1.0 0.2 0.4 0.3 0.7 0.8 0.6 0.1 0.5 0.3 0.4 0.2 0.3 1.7 1.5 2.3 2.2 1.5 1.5 2.3 1.8 1.7 1.7 1.6 1.7 1.4 0.0 0.5 5.5 6.2 0.8 1.6 0.1 1.2 434.4 2.0 1.9 2.1 0.0 0.7 7.3 431.6 1.4 3.2 1.5 13.7 0.6 2.7 1.3 0.7 24.1 1.8 3.2 1.8 1.1 0.9 0.7 2.6 1.0 0.0 0.7 0.7 3.3 2.0 250.7 2.6 1.7 0.0 1.3 0.4 4.2 1.2 1.4 1.8 0.0 1.1 636.4 5.2 2.0 4.4 0.3 5.3 1.9 1.7 2.0 5.6 6.7 0.1 3720.7 0.0 1.2 0.7 9.7 4.3 2.2 0.4 2.5 2.6 2.3 1.0 2.1 ODF3B FAP123 ENSG00000177989 "Outer dense fiber of sperm tails 3B" A8MYP8 22 50529710-50532580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 88.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 455.4;Late spermatids: 807.7;Respiratory ciliated cells: 417.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 92.0;intermediate monocyte: 75.6;myeloid DC: 55.5;neutrophil: 56.2;non-classical monocyte: 53.6" "Group enriched" "Detected in many" 16 "dendritic cells: 55.5;granulocytes: 56.2;monocytes: 92.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.5;Karpas-707: 40.8;U-266/70: 57.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062837 Enhanced NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA062837: AB_2684877" "unprognostic (4.30e-3)" "unprognostic (1.45e-2)" "unprognostic (5.98e-2)" "prognostic favorable (2.84e-4)" "unprognostic (2.60e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (5.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (2.72e-1)" "unprognostic (1.51e-2)" "unprognostic (6.10e-2)" "unprognostic (3.61e-2)" 21.9 6.0 6.3 26.8 4.0 13.3 24.3 6.6 4.4 13.8 22.3 8.4 6.9 6.1 0.9 14.4 88.8 9.8 18.6 8.4 11.8 16.4 32.4 36.4 14.0 32.7 35.3 2.1 9.0 3.9 7.9 6.8 16.0 19.9 1.6 0.0 46.5 5.5 5.4 13.5 12.3 2.1 17.0 24.1 12.2 16.3 11.9 5.9 21.9 1.7 4.2 6.8 11.3 6.4 2.9 1.8 0.3 0.7 0.0 3.6 1.7 0.1 0.6 0.1 1.8 3.2 13.5 1.0 3.4 0.1 0.5 8.1 0.0 0.0 0.0 1.4 0.9 0.6 2.5 2.4 10.0 0.0 6.5 2.1 1.7 0.0 0.0 1.0 0.2 1.0 0.8 40.8 0.0 0.0 0.0 1.5 0.2 0.8 1.9 1.5 0.2 7.2 0.0 0.0 0.2 11.6 1.3 1.6 0.2 0.2 1.2 2.0 1.0 0.3 1.1 0.8 0.2 57.9 5.9 0.9 1.3 0.2 1.0 10.1 92.0 11.3 0.6 75.6 0.9 4.2 1.6 1.1 55.5 2.2 1.0 0.6 56.2 0.1 53.6 5.3 2.3 28.6 6.3 4.0 6.6 4.4 8.4 11.8 32.7 35.3 16.0 17.0 11.9 6.4 73.3 19.2 52.9 0.0 32.3 24.1 21.9 70.0 61.5 0.2 63.8 61.8 5.3 24.3 66.5 3.7 0.0 3.4 8.9 8.6 0.0 76.7 144.5 455.4 8.9 33.0 20.4 0.4 0.0 74.8 39.6 29.1 27.5 22.0 6.3 0.0 21.0 30.2 36.2 0.0 0.1 23.6 46.8 66.0 33.2 807.7 5.3 82.5 17.8 1.0 113.8 0.0 7.2 0.0 0.0 35.0 29.4 3.4 73.3 30.4 53.0 16.9 417.1 0.1 0.0 36.0 27.6 10.0 3.7 46.4 36.1 5.5 11.4 0.0 9.2 33.7 OR56B4 ENSG00000180919 "Olfactory receptor family 56 subfamily B member 4" Q8NH76 11 6107684-6108835 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 29: U-266 - Adaptive immune response" "unprognostic (2.04e-3)" "unprognostic (8.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (3.83e-1)" "unprognostic (3.01e-1)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-1)" "unprognostic (2.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922024-48958386 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "U-266/70: 1503.3;U-266/84: 407.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 37.7 44.8 42.9 36.9 44.9 56.7 36.6 39.2 45.5 40.6 33.6 45.8 39.6 43.0 29.9 37.5 41.4 24.7 29.9 44.8 46.1 41.1 39.5 39.6 43.4 44.2 42.8 46.8 37.7 35.6 46.1 26.4 46.0 43.1 21.7 30.2 36.3 32.0 39.7 44.6 47.3 27.0 38.3 60.7 37.5 24.2 44.9 47.0 42.3 25.2 35.8 39.9 36.7 43.9 53.0 77.8 36.0 88.9 59.2 52.3 41.4 45.7 52.9 55.9 59.8 39.7 57.3 58.9 29.2 56.8 49.1 63.3 54.2 45.7 51.7 69.1 65.0 44.5 79.4 45.0 49.3 43.4 48.7 58.1 41.2 58.2 39.5 61.4 44.7 47.8 56.9 90.7 40.0 52.3 67.7 89.2 64.9 19.5 60.4 53.0 52.5 77.4 38.9 46.4 34.7 60.7 60.2 38.7 61.7 82.7 51.6 39.2 64.2 36.5 46.2 97.2 38.1 1503.3 407.1 56.5 56.3 58.9 25.7 5.5 3.3 7.6 6.6 5.2 5.6 8.6 5.1 5.7 4.8 5.3 4.8 7.1 8.5 20.3 5.1 6.2 7.3 3.6 42.9 44.9 39.2 45.5 44.8 46.1 44.2 42.8 46.0 38.3 44.9 43.9 21.3 9.6 22.3 17.3 33.3 22.2 21.2 13.7 13.1 35.5 23.7 19.7 11.5 15.7 16.3 27.6 27.1 13.3 38.2 28.4 9.8 13.6 1.9 24.5 23.2 19.6 48.2 32.6 15.5 18.3 16.3 18.4 21.4 33.1 7.0 28.5 22.1 24.3 16.7 28.6 15.7 28.5 10.2 22.9 33.9 2.9 20.8 25.7 26.6 15.9 22.6 18.0 30.9 14.1 14.1 21.5 19.0 23.7 38.1 27.5 28.1 21.7 21.6 27.9 13.1 19.9 20.1 10.4 12.6 15.9 25.6 30.8 33.3 28.6 20.1 27.4 OXCT2 "FKSG25, FLJ00030, SCOT-T" ENSG00000198754 "3-oxoacid CoA-transferase 2" Q9BYC2 1 39769523-39771348 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 73.0" "Group enriched" "Detected in some" 80 "Early spermatids: 420.5;Late spermatids: 1019.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 7.6;THP-1: 8.4;U-266/70: 6.2" "Not detected" "Not detected" HPA075423 Enhanced NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA075423: AB_2732292" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (6.50e-2)" "unprognostic (7.16e-2)" "unprognostic (9.68e-2)" "unprognostic (1.13e-1)" "unprognostic (1.32e-1)" "unprognostic (1.93e-3)" "unprognostic (2.74e-1)" "unprognostic (3.16e-1)" "unprognostic (2.57e-3)" "unprognostic (4.18e-2)" "unprognostic (5.39e-5)" "unprognostic (3.24e-1)" "unprognostic (4.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.85e-1)" 0.3 0.8 1.1 0.4 1.3 0.5 0.3 1.5 2.0 0.5 0.0 1.0 0.7 1.1 0.9 0.7 0.8 0.7 6.6 1.0 0.5 0.4 0.6 0.5 0.6 1.8 1.1 2.3 1.2 0.1 1.1 0.2 1.8 1.3 0.4 0.0 0.3 1.3 0.4 3.2 1.1 0.6 1.3 1.1 0.7 73.0 1.0 3.9 1.8 0.0 0.2 0.4 0.5 4.5 0.4 0.2 0.0 0.9 0.3 1.1 0.0 1.1 0.0 1.0 0.5 3.9 0.4 0.0 0.7 1.6 0.1 0.4 1.2 0.1 0.5 0.0 2.5 0.7 3.0 0.2 1.8 0.0 0.4 0.5 0.3 0.1 0.1 0.0 0.8 0.3 0.2 7.6 0.1 1.1 0.0 1.2 0.1 0.0 1.0 1.1 1.2 1.2 0.3 0.8 1.3 0.6 3.3 0.2 1.1 0.0 0.4 8.4 0.9 0.0 0.2 3.7 0.0 6.2 3.6 0.4 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 1.3 1.5 2.0 1.0 0.5 1.8 1.1 1.8 1.3 1.0 4.5 0.3 0.0 0.6 0.0 2.3 0.3 0.3 0.1 0.0 0.2 0.3 0.5 3.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.7 420.5 0.2 2.1 0.8 0.0 0.0 0.0 0.7 0.1 1.5 0.0 0.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.3 8.3 1019.0 4.1 3.0 1.8 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.1 6.4 8.9 0.5 0.6 0.0 0.1 0.1 0.0 1.1 2.7 3.4 2.7 0.1 0.4 0.0 0.8 0.6 0.5 0.2 PAGE2 "CT16.4, GAGEC2, MGC62094, PAGE-2" ENSG00000234068 "PAGE family member 2" Q7Z2X7 X 55089018-55092842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 27.9" "Group enriched" "Detected in some" 5 "Spermatocytes: 107.5;Spermatogonia: 234.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebral cortex: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "U-266/70: 1058.4;U-266/84: 1493.9" HPA052619 Supported NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA052619: AB_2681887" "unprognostic (3.49e-2)" "unprognostic (7.73e-2)" 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.1 27.9 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.3 0.3 0.0 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.3 0.0 0.0 255.7 0.9 1.9 1058.4 1493.9 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.3 9.7 0.0 0.0 0.2 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.8 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 107.5 234.6 0.0 0.0 4.0 0.0 0.0 0.0 0.0 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77322017-77474635 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 9 "classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6" "Group enriched" "Detected in all" 11 "dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 560000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 12.7 13.4 32.4 33.9 44.5 59.0 18.2 13.9 57.7 21.1 0.0 43.2 43.1 20.9 29.8 21.4 21.9 30.9 9.4 58.3 8.0 26.1 14.5 16.8 20.4 19.2 12.2 21.1 17.5 20.5 20.7 14.7 19.4 19.1 46.5 25.1 19.9 19.7 87.0 16.2 45.7 27.0 0.9 29.3 41.2 25.7 17.1 29.1 40.6 18.8 23.1 27.7 20.7 30.0 39.9 26.7 56.7 25.5 22.8 37.6 45.9 44.6 32.1 42.0 48.7 38.7 52.8 36.3 16.0 39.4 54.4 20.2 40.2 47.8 65.5 41.4 32.6 38.2 17.6 2.3 15.3 64.3 53.5 28.2 28.8 49.2 73.1 36.6 10.1 41.3 25.5 61.2 77.6 2.9 42.3 30.2 84.5 166.2 22.5 62.6 72.3 1.4 10.6 32.9 24.6 23.9 23.6 9.7 19.5 55.0 45.4 29.0 0.9 27.3 47.5 148.9 37.9 165.7 92.4 23.4 23.0 42.5 30.6 2.5 182.2 292.7 11.2 177.7 9.4 16.8 8.4 10.7 264.3 12.9 7.4 14.5 431.8 28.4 202.6 22.9 7.3 92.3 32.4 44.5 13.9 57.7 58.3 8.0 19.2 12.2 19.4 0.9 17.1 30.0 3.1 3.2 20.5 24.2 23.9 11.9 33.3 28.2 23.9 51.6 25.1 19.7 6.2 35.8 30.8 25.8 8.4 25.4 10.2 78.6 45.0 32.4 38.8 37.3 13.5 3.2 37.8 30.5 219.1 56.3 53.5 24.0 45.9 39.7 132.2 35.2 3.6 11.4 49.8 1.7 118.5 50.8 28.5 59.6 152.9 28.3 14.3 80.0 30.2 54.4 121.7 14.9 10.3 53.3 70.7 50.9 57.9 13.2 28.6 28.7 47.9 55.7 39.0 6.4 13.1 13.8 25.2 50.4 53.8 23.6 10.4 95.0 19.3 10.3 52.8 33.2 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379261-133391694 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.4" "Group enriched" "Detected in many" 6 "Early spermatids: 143.4;Late spermatids: 456.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;K-562: 3.9;U-266/70: 13.7" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 1.9 2.3 0.6 0.5 1.1 0.0 1.9 0.9 1.5 2.8 1.1 2.6 1.8 2.5 0.0 6.2 2.7 0.1 1.5 0.6 0.5 3.4 7.7 1.5 0.5 0.8 0.6 2.4 2.5 0.3 1.6 0.1 0.8 2.7 0.0 0.0 3.1 1.1 3.1 2.8 4.4 0.3 0.9 4.8 2.5 27.4 0.5 0.1 1.6 0.0 0.4 2.8 3.3 1.6 5.7 0.0 0.3 1.2 0.0 0.5 0.4 1.5 1.1 1.7 0.1 0.5 0.1 0.0 0.4 0.7 0.4 1.8 0.0 0.7 0.3 2.7 0.0 0.4 0.0 0.0 1.3 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.0 3.9 0.4 0.0 0.1 0.0 0.2 0.6 0.0 1.9 3.3 0.0 0.0 0.1 0.0 0.1 1.3 1.1 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.6 1.1 0.0 13.7 2.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.6 1.1 0.9 1.5 0.6 0.5 0.8 0.6 0.8 0.9 0.5 1.6 3.8 0.0 4.6 4.2 17.5 3.7 8.5 3.4 8.6 4.0 4.2 5.0 1.7 8.6 1.9 1.8 0.0 1.1 5.8 4.3 5.9 5.4 143.4 4.0 3.0 3.3 0.0 1.3 3.3 3.3 2.3 3.6 5.6 3.9 5.7 2.5 3.3 13.5 4.6 5.0 1.7 4.0 4.1 14.5 2.3 456.3 9.6 9.0 0.0 3.7 12.3 9.2 2.1 3.0 9.7 3.4 3.4 7.9 22.0 8.7 29.9 18.0 3.3 3.0 19.7 2.4 3.6 46.9 6.0 12.8 3.7 0.3 5.4 3.7 4.1 10.5 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243320-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 37 "brain: 674.6;choroid plexus: 196.2" "Group enriched" "Detected in many" 5 "Astrocytes: 44.1;Muller glia cells: 70.9;Oligodendrocytes: 65.1" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "NK-cell: 5.7" "Lineage enriched" "Detected in single" 7 "NK-cells: 5.7" "Cell line enhanced" "Detected in many" "RT4: 14.8;T-47d: 17.8;U-266/70: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "Cluster 48: NK-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.99e-4)" "prognostic unfavorable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.86e-4)" 1.9 1.8 275.4 0.8 321.1 6.1 2.7 319.1 674.6 3.2 196.2 7.9 1.3 0.9 0.4 4.8 3.4 1.3 2.3 240.1 271.1 6.3 7.2 2.6 0.4 413.7 327.9 1.8 1.9 0.4 11.8 0.7 397.2 7.0 0.8 6.7 3.1 1.0 1.5 11.2 3.7 0.5 369.6 4.7 3.3 4.2 320.9 0.6 3.7 0.3 0.7 1.9 4.2 380.4 1.7 1.5 3.8 3.1 0.8 0.5 9.9 0.3 0.6 0.2 0.2 1.3 6.7 3.7 2.0 0.7 0.4 7.5 0.0 1.6 0.5 2.2 2.6 2.4 2.6 1.5 0.5 1.2 7.5 1.6 4.3 2.8 3.0 3.7 0.2 8.6 2.4 9.4 0.5 7.4 0.5 1.1 5.3 1.1 1.3 1.8 0.9 2.4 3.0 14.8 3.3 6.8 0.5 1.3 5.0 6.9 17.8 1.7 0.6 1.2 6.2 2.0 0.8 27.4 7.7 2.4 0.5 10.5 1.2 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.6 0.0 0.1 275.4 321.1 319.1 674.6 240.1 271.1 413.7 327.9 397.2 369.6 320.9 380.4 0.6 0.0 0.5 44.1 1.7 1.3 0.5 1.8 0.0 3.9 1.8 2.0 3.5 1.5 1.3 0.0 0.0 0.1 1.0 0.9 0.0 0.7 0.4 1.3 0.6 0.7 4.2 3.2 1.5 3.4 0.2 1.3 4.6 1.7 1.3 1.1 0.7 0.9 0.6 6.7 1.4 0.5 2.0 1.3 0.4 0.8 0.3 0.9 0.0 3.7 0.6 70.9 0.0 6.0 65.1 1.8 0.0 2.2 3.5 0.7 0.8 0.4 2.3 11.2 0.0 0.6 0.5 1.3 0.5 0.6 1.4 0.3 2.3 0.5 1.1 0.5 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963674 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.5;retina: 9.6;testis: 20.4" "Cell type enhanced" "Detected in some" "Early spermatids: 42.1;Erythroid cells: 28.2;Hepatocytes: 18.4;Late spermatids: 98.3;Syncytiotrophoblasts: 36.5" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;AF22: 1.0;U-266/70: 3.3;U-266/84: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052798 Uncertain NA NA "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA052798: AB_2681955" "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.0 0.0 1.9 0.0 1.7 5.2 0.0 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 2.3 1.5 0.0 13.5 0.0 0.0 1.1 1.9 0.0 0.0 0.2 0.9 0.2 1.1 0.0 0.0 9.6 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 20.4 3.3 0.1 0.0 1.4 0.0 0.1 0.0 2.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 0.9 5.5 2.3 1.5 1.1 1.9 1.1 0.2 3.3 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 5.8 0.0 0.0 6.7 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 42.1 0.7 0.0 0.2 0.0 28.2 0.8 0.0 0.1 0.3 0.0 0.2 0.0 1.0 0.0 18.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 98.3 1.2 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.1 2.6 5.4 0.0 0.1 36.5 0.0 0.1 0.0 0.0 PATL2 Pat1a ENSG00000229474 "PAT1 homolog 2" C9JE40 15 44665732-44711316 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.7;lymphoid tissue: 17.2" "Cell type enhanced" "Detected in many" "B-cells: 29.2;dendritic cells: 19.1;NK-cells: 51.5;Plasma cells: 15.7;T-cells: 29.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8" "Lineage enriched" "Detected in many" 6 "T-cells: 21.6" "Cell line enriched" "Detected in some" 28 "U-266/70: 124.9" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (3.30e-3)" "unprognostic (5.55e-2)" "unprognostic (7.28e-2)" "unprognostic (1.11e-2)" "unprognostic (3.00e-3)" "unprognostic (7.82e-2)" "unprognostic (3.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.44e-2)" "unprognostic (9.48e-2)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (9.69e-4)" 0.9 1.1 0.8 7.7 1.1 7.7 1.3 0.6 0.8 0.3 1.5 2.1 2.4 1.1 1.7 0.6 1.4 2.3 0.7 0.7 0.8 0.5 1.7 3.9 17.2 1.8 1.1 0.9 0.6 0.4 0.2 1.0 1.1 0.8 2.5 0.1 2.5 0.6 0.3 2.7 3.2 0.8 0.9 13.9 3.2 0.5 1.2 3.6 0.7 0.0 10.8 2.1 0.2 1.4 0.2 0.0 0.0 0.1 0.0 1.1 2.8 0.1 0.4 0.9 0.9 0.6 1.2 0.9 0.1 0.3 1.8 1.3 0.1 0.2 0.5 2.1 0.0 1.2 0.0 0.1 0.5 0.5 0.7 1.2 0.1 0.5 0.3 0.2 0.0 1.4 0.2 4.5 0.3 0.3 0.1 1.4 0.4 0.1 0.1 1.8 0.0 0.5 0.1 0.4 0.1 0.0 0.0 1.3 0.1 0.2 0.1 0.9 0.6 0.3 0.0 0.8 0.0 124.9 4.3 0.4 1.2 3.1 0.4 1.5 0.3 2.6 21.6 0.7 3.2 3.3 6.0 17.7 0.7 3.5 3.6 12.8 1.6 2.7 0.5 0.6 0.9 3.7 0.8 1.1 0.6 0.8 0.7 0.8 1.8 1.1 1.1 0.9 1.2 1.4 1.4 3.2 1.7 1.6 29.2 0.9 0.6 0.5 0.6 0.0 0.6 0.6 11.7 0.0 0.4 0.0 0.0 0.2 19.1 2.0 0.0 0.4 0.3 2.4 1.0 1.8 0.0 3.0 0.3 0.6 0.5 1.9 8.2 0.8 0.0 1.2 1.4 1.0 2.0 0.0 0.4 1.4 0.0 4.8 2.3 0.0 0.3 5.6 0.0 3.7 5.2 0.0 51.5 0.5 1.3 0.4 0.3 0.0 15.7 0.6 2.2 0.4 8.5 0.0 0.0 1.0 2.6 0.1 0.4 1.4 0.9 0.3 29.8 1.8 0.9 1.3 PBX2 "G17, HOX12, PBX2MHC" ENSG00000204304 "PBX homeobox 2" P40425 6 32184733-32190202 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061478 Supported Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA061478: AB_2684535" "unprognostic (9.73e-3)" "unprognostic (2.16e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (4.98e-1)" "unprognostic (2.68e-2)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.81e-2)" "prognostic favorable (6.84e-4)" "unprognostic (3.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.06e-1)" "unprognostic (2.52e-2)" "unprognostic (2.27e-1)" 30.3 39.6 4.9 14.2 4.5 9.0 27.6 3.9 5.5 47.4 5.0 51.2 10.6 47.8 30.4 33.5 47.1 4.9 32.1 4.5 4.7 37.9 31.0 43.9 16.7 5.1 4.6 52.3 28.2 4.5 52.0 25.2 4.8 39.3 12.2 8.5 27.6 12.3 29.8 34.1 39.8 13.0 4.3 64.5 36.7 23.9 5.0 23.9 55.2 2.3 17.8 42.4 39.2 4.6 4.8 7.9 32.3 17.7 23.5 29.4 13.9 3.7 8.9 9.7 10.0 6.5 7.8 21.9 23.5 13.7 3.8 13.4 8.1 26.8 10.6 19.5 30.3 20.5 7.1 3.8 20.7 13.2 18.7 43.2 14.9 7.4 24.8 16.6 19.1 38.8 26.5 11.1 3.7 18.1 13.6 29.7 0.6 2.9 2.2 18.8 5.0 26.1 21.2 7.7 9.4 12.6 3.0 6.8 26.5 18.3 16.9 25.0 6.5 8.5 19.8 3.4 4.2 54.1 36.9 27.2 17.3 9.9 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 4.5 3.9 5.5 4.5 4.7 5.1 4.6 4.8 4.3 5.0 4.6 27.7 6.4 11.0 14.4 18.5 18.2 18.5 11.8 15.4 19.2 17.0 12.2 3.7 31.5 10.1 16.5 8.4 32.2 29.4 9.6 3.9 17.1 1.0 12.3 24.5 24.8 30.5 19.1 7.8 14.0 25.6 16.0 12.2 16.6 15.2 21.8 28.9 23.0 19.0 26.9 7.0 15.5 10.2 34.5 55.5 4.2 20.2 25.3 8.8 9.4 23.9 21.0 35.0 6.0 9.1 13.9 12.5 19.5 17.7 19.4 12.5 10.2 9.6 4.9 6.6 19.7 19.8 1.6 6.1 19.7 19.5 47.2 16.7 22.8 13.2 18.1 PCDH15 "CDHR15, DFNB23, USH1F" ENSG00000150275 "Protocadherin related 15" Q96QU1 10 53802771-55627942 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 19.0;brain: 21.2;retina: 61.7" "Cell type enriched" "Detected in some" 13 "Oligodendrocyte precursor cells: 2965.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.1;U-266/70: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074437 Supported "Intracellular and membrane" NA NA 22000 "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "HPA074437: " "unprognostic (1.38e-1)" "unprognostic (3.39e-1)" "unprognostic (8.15e-5)" "unprognostic (3.07e-3)" "unprognostic (2.79e-1)" "unprognostic (9.15e-4)" "unprognostic (2.02e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.31e-3)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (7.66e-3)" 0.2 19.0 13.4 0.3 9.5 0.1 0.0 3.1 10.3 0.2 0.0 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.5 16.6 19.6 8.0 0.0 2.5 0.4 13.8 13.7 0.0 0.0 0.5 4.7 0.2 12.6 0.2 0.0 61.7 0.1 0.0 0.0 0.1 0.2 0.0 9.7 0.7 0.3 3.3 21.2 0.1 0.0 0.0 0.5 0.5 0.0 6.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.1 0.0 0.0 3.3 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.5 3.1 10.3 16.6 19.6 13.8 13.7 12.6 9.7 21.2 6.2 0.0 0.0 0.0 14.4 0.0 0.3 0.0 0.0 0.0 5.1 0.6 0.0 4.8 0.0 0.0 0.0 87.6 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 0.3 0.0 0.0 27.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 216.2 0.1 0.0 0.0 0.0 7.5 0.0 0.1 0.0 3.7 0.0 4.4 0.0 2965.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 92.8 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 PCSK4 "DKFZp434B217, MGC34749, PC4, SPC5" ENSG00000115257 "Proprotein convertase subtilisin/kexin type 4" Q6UW60 19 1481428-1490752 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 66.0" "Group enriched" "Detected in many" 4 "Early spermatids: 277.1;Late spermatids: 679.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.7;HMC-1: 3.7;JURKAT: 5.3;U-266/70: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA005572 Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA005572: AB_1855087" "unprognostic (1.00e-2)" "unprognostic (9.12e-2)" "unprognostic (2.36e-3)" "prognostic favorable (9.45e-5)" "unprognostic (5.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.78e-1)" "unprognostic (6.34e-3)" "unprognostic (2.94e-1)" "unprognostic (8.29e-3)" "unprognostic (1.93e-2)" "unprognostic (7.44e-2)" "unprognostic (6.56e-2)" "unprognostic (3.82e-2)" "unprognostic (1.71e-2)" "unprognostic (3.57e-2)" "unprognostic (7.03e-2)" 0.8 1.4 1.1 0.3 1.1 0.6 1.2 0.9 2.5 1.7 1.3 1.3 1.7 1.1 0.1 1.1 3.2 0.6 0.5 1.4 1.6 3.7 4.0 1.1 0.3 1.9 2.8 1.1 2.8 0.9 7.1 0.2 1.5 1.8 0.1 0.6 1.1 1.2 0.3 0.6 1.1 0.1 1.8 0.7 1.4 66.0 1.6 0.4 3.4 0.0 0.1 1.0 1.2 0.9 0.6 0.3 1.2 6.7 0.1 0.2 1.8 0.5 0.1 0.0 0.2 0.6 1.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.1 0.3 1.1 1.0 0.4 0.0 3.7 0.6 0.0 0.0 0.1 0.3 0.2 5.3 1.2 1.8 0.0 0.0 0.1 0.3 0.1 0.3 0.4 1.2 0.1 0.1 0.4 0.0 0.0 1.4 0.1 0.3 0.1 0.4 2.5 0.4 0.0 0.5 0.0 0.1 0.0 7.7 1.5 0.3 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 1.1 0.9 2.5 1.4 1.6 1.9 2.8 1.5 1.8 1.6 0.9 0.2 0.0 1.1 12.1 0.1 0.6 0.9 1.8 0.6 1.5 3.1 2.2 2.3 1.5 3.6 0.0 8.4 0.5 1.7 1.6 5.9 1.8 277.1 5.2 1.0 0.5 0.0 1.7 3.2 1.0 0.5 0.8 3.1 1.1 0.0 3.3 0.0 3.2 0.8 3.3 3.7 1.4 0.0 0.3 0.0 679.2 6.2 1.1 3.6 3.7 0.0 2.4 0.0 1.0 1.6 0.9 1.1 5.3 1.4 0.5 2.8 1.9 8.3 9.1 0.0 0.2 0.5 98.0 9.6 1.2 0.0 0.3 0.7 2.4 2.1 0.7 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 505.4" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 786.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 295.6;U-266/70: 320.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 45.7 30.7 15.0 53.2 15.7 74.0 146.6 18.1 16.9 49.3 24.7 157.6 90.7 67.0 36.2 151.3 57.7 43.4 22.4 13.7 17.2 26.2 36.2 32.8 60.7 15.7 18.5 133.6 505.4 283.9 40.3 97.0 15.4 55.3 130.4 50.4 255.0 60.4 11.8 104.2 100.2 51.3 15.5 67.6 102.3 29.9 16.6 73.9 154.5 18.7 95.4 42.2 61.8 17.3 26.5 25.4 40.6 43.7 61.6 110.7 23.8 29.9 89.7 14.7 25.7 16.0 65.0 252.3 81.7 43.5 11.4 118.8 26.1 79.4 32.4 219.7 50.6 127.5 146.9 27.9 26.9 65.2 135.8 88.0 247.4 15.7 84.0 67.6 28.2 40.1 35.3 119.6 37.6 69.7 24.2 76.4 10.6 19.0 46.3 10.4 71.6 138.7 24.8 36.8 17.8 73.6 58.7 31.6 109.1 44.6 295.6 121.3 71.8 22.6 16.8 17.1 11.0 320.1 163.8 143.6 22.2 87.4 24.5 186.1 19.5 52.4 54.0 27.0 96.0 54.1 49.7 59.8 23.0 39.5 43.0 53.2 38.3 84.7 29.6 38.5 29.0 40.4 15.0 15.7 18.1 16.9 13.7 17.2 15.7 18.5 15.4 15.5 16.6 17.3 85.3 19.2 50.0 16.3 132.0 133.1 88.1 104.6 113.3 61.8 148.1 113.9 16.8 42.9 90.3 25.8 31.3 229.5 246.1 348.0 35.2 70.8 20.2 66.7 132.5 79.1 33.6 94.2 26.2 101.4 78.4 72.1 82.0 59.4 132.9 111.7 97.1 23.6 56.5 21.9 44.4 150.6 81.4 84.1 49.7 11.0 145.1 66.1 291.7 46.9 57.4 40.9 75.2 36.7 70.6 45.0 244.3 222.7 134.7 51.3 292.1 28.1 47.8 206.1 39.5 69.4 48.6 63.3 72.2 200.8 165.2 786.0 229.2 176.8 190.3 73.3 PDE3B HcGIP1 ENSG00000152270 "Phosphodiesterase 3B" Q13370 11 14643804-14872044 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" Angiogenesis Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 64.5" "Cell type enhanced" "Detected in many" "Astrocytes: 171.7;Excitatory neurons: 140.5;Inhibitory neurons: 158.0;Microglial cells: 192.0;Oligodendrocyte precursor cells: 118.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 13.5" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 3.8;T-cells: 6.3" "Cell line enhanced" "Detected in many" "HL-60: 23.5;Karpas-707: 25.7;THP-1: 28.4;U-266/70: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056111 Approved "Endoplasmic reticulum" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Endoplasmic reticulum" "HPA056111: AB_2683041" "unprognostic (1.05e-1)" "unprognostic (2.86e-2)" "unprognostic (4.12e-2)" "unprognostic (2.76e-3)" "unprognostic (4.25e-1)" "unprognostic (1.84e-3)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "prognostic favorable (7.91e-4)" "unprognostic (1.77e-1)" "unprognostic (2.33e-2)" "unprognostic (1.39e-2)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (9.03e-3)" 64.5 1.1 1.3 12.4 2.1 10.1 12.2 13.5 2.6 3.4 0.0 25.2 2.9 0.7 0.5 2.9 0.5 3.7 4.7 1.9 2.6 3.0 25.8 10.2 14.9 2.8 1.7 0.5 8.3 0.2 4.4 7.6 1.9 8.7 10.7 0.5 14.0 1.6 0.4 0.5 6.0 1.7 2.3 8.9 2.6 9.6 2.0 7.3 0.8 2.4 7.9 8.5 1.9 2.6 0.0 2.5 5.6 9.2 10.9 0.1 2.2 0.6 0.1 0.0 0.0 8.5 0.0 0.0 0.1 0.0 2.6 0.0 8.5 0.0 0.0 0.2 18.7 0.3 13.1 17.5 3.9 23.5 0.1 0.8 0.0 0.0 0.5 0.0 0.1 6.6 20.6 25.7 0.0 0.3 4.7 11.4 7.6 3.1 4.1 11.0 2.5 17.7 0.0 1.9 8.5 15.8 2.3 14.6 5.1 2.5 0.0 28.4 0.0 0.0 1.3 0.0 0.0 28.8 9.4 0.7 0.2 4.0 1.7 0.0 0.5 2.5 1.0 0.6 2.1 0.2 3.1 2.4 0.3 0.1 6.3 5.7 3.8 0.1 1.0 0.1 3.5 1.5 1.3 2.1 13.5 2.6 1.9 2.6 2.8 1.7 1.9 2.3 2.0 2.6 1.5 16.0 8.9 171.7 6.4 0.3 0.9 0.0 0.6 1.0 0.3 0.3 11.1 0.0 6.2 1.8 0.0 1.4 26.7 11.5 1.9 0.0 19.0 0.3 5.1 4.0 1.2 12.8 140.5 5.0 2.8 9.7 7.7 0.3 36.1 0.5 4.2 64.1 7.6 0.0 158.0 13.7 0.0 13.1 3.7 13.4 1.5 15.6 0.0 192.0 10.8 6.3 8.2 118.6 5.4 1.8 22.3 9.1 28.9 3.3 0.7 2.0 3.6 0.5 0.0 3.4 3.0 48.8 19.5 0.1 0.1 2.5 60.9 0.0 9.4 1.1 PDK1 ENSG00000152256 "Pyruvate dehydrogenase kinase 1" Q15118 2 172555373-172608669 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.4;Plasma cells: 144.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;granulocytes: 25.2;T-cells: 21.2" "Cell line enhanced" "Detected in all" "U-266/70: 71.8;U-87 MG: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017554, HPA027376" Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB017554: AB_2161138, HPA027376: AB_1855139" "unprognostic (2.14e-1)" "prognostic unfavorable (7.30e-5)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "unprognostic (6.47e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (9.69e-3)" "unprognostic (6.44e-2)" "unprognostic (5.44e-3)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.10e-8)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" "unprognostic (2.56e-2)" "unprognostic (5.34e-2)" 7.7 16.0 2.5 11.6 3.0 15.8 10.1 5.6 5.3 5.5 2.7 16.7 16.5 4.0 3.1 8.5 3.6 6.0 28.1 3.1 2.1 4.8 11.2 4.2 13.1 2.7 6.7 12.2 6.9 4.3 3.8 6.4 3.2 4.7 13.3 27.1 10.2 5.0 9.0 18.1 9.1 4.4 1.3 10.5 13.6 12.2 5.0 8.3 3.9 7.6 19.1 11.0 7.6 2.5 34.0 1.4 8.4 21.0 3.4 5.1 12.1 29.1 23.4 14.3 30.4 8.6 7.1 32.1 15.8 9.1 11.9 14.5 5.8 18.2 45.5 6.6 11.7 39.3 7.1 10.2 6.2 19.6 14.0 6.6 6.4 10.0 16.6 19.8 7.7 16.7 8.5 21.5 19.2 3.5 12.5 24.5 20.8 6.9 9.2 13.1 13.8 52.5 7.4 10.8 15.7 18.0 7.6 8.8 11.1 7.0 5.6 8.0 9.2 22.7 7.4 12.0 7.9 71.8 44.8 26.9 72.6 14.0 4.6 19.6 3.4 25.2 3.7 2.3 4.2 7.3 5.9 4.0 3.5 8.6 21.2 13.5 12.7 2.2 3.2 0.6 12.2 9.2 2.5 3.0 5.6 5.3 3.1 2.1 2.7 6.7 3.2 1.3 5.0 2.5 9.2 3.2 5.0 12.1 33.7 50.1 5.1 15.8 4.6 29.4 7.0 4.7 35.5 2.8 7.0 3.7 47.9 10.2 9.9 11.9 5.9 8.7 130.4 6.4 7.2 9.6 7.8 4.2 35.4 3.7 13.2 8.5 9.7 12.1 5.7 13.3 19.6 20.2 10.2 55.5 32.7 6.6 12.2 12.0 15.2 43.8 3.4 12.9 30.2 30.9 11.4 7.4 10.3 12.1 14.8 9.6 17.5 3.8 144.8 7.2 6.7 1.9 5.0 18.5 6.6 4.6 11.6 9.6 10.4 8.9 43.3 4.1 17.3 5.3 7.0 6.1 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535507 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 4781.7;tongue: 1519.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol NA NA 240000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.78e-3)" 36.3 11.5 12.7 25.7 13.3 0.0 34.5 16.8 14.8 22.7 10.9 201.2 20.8 235.3 59.1 216.2 97.5 40.1 314.0 12.0 15.7 13.9 7.7 55.2 10.7 19.9 14.2 38.1 18.7 0.8 20.7 18.8 13.8 87.0 32.5 11.2 56.3 148.1 4781.7 12.1 69.0 127.6 17.9 24.5 95.8 8.2 14.6 4.1 32.7 1519.6 26.2 141.1 40.8 14.2 0.0 0.0 0.9 0.0 0.3 0.0 0.8 0.0 0.0 0.3 1.0 1.2 0.4 0.0 0.0 0.0 6.0 0.0 0.0 0.2 0.0 0.0 15.1 0.0 0.8 4.7 13.5 0.0 0.0 8.7 0.0 2.6 0.0 12.3 9.1 0.0 0.0 0.0 115.6 0.0 0.0 0.1 2.4 0.0 1.0 0.0 26.9 0.3 0.0 0.0 17.6 13.3 0.0 0.0 7.3 2.8 0.6 0.0 7.9 0.0 7.6 0.1 7.1 111.2 34.8 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 13.3 16.8 14.8 12.0 15.7 19.9 14.2 13.8 17.9 14.6 14.2 22.4 9.6 6.0 37.2 2.6 8.9 11.4 0.7 12.5 12.1 72.8 105.7 228.9 5.7 2.2 0.0 12.5 2.5 0.6 0.2 0.0 332.7 0.4 1.4 0.8 39.0 3.5 0.0 2.5 16.7 2.7 82.9 1.1 1.1 0.0 1.3 67.5 0.9 1.6 5.0 0.5 0.5 2.0 1.8 11.7 2.6 19.6 2.3 124.5 1.0 3.2 36.4 0.0 6.6 2.6 31.2 0.0 196.0 7.3 12.2 0.0 0.2 3.2 44.3 105.2 428.3 131.4 4.0 12.6 2.4 7.1 12.2 2.5 2.4 0.3 3.9 PDZRN4 "DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4" ENSG00000165966 "PDZ domain containing ring finger 4" Q6ZMN7 12 41188320-41574745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 10.9;seminal vesicle: 17.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 371.6;Inhibitory neurons: 125.6;Oligodendrocyte precursor cells: 561.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "U-266/70: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042101 Enhanced Approved Mitochondria NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Mitochondria "HPA042101: AB_2732496" "unprognostic (6.74e-2)" "unprognostic (6.86e-2)" "unprognostic (3.82e-2)" "unprognostic (2.88e-2)" "unprognostic (1.49e-1)" "unprognostic (5.34e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-2)" "unprognostic (8.19e-2)" "unprognostic (7.85e-3)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" "unprognostic (7.44e-2)" "unprognostic (1.90e-3)" "unprognostic (1.80e-1)" "unprognostic (7.33e-2)" "unprognostic (1.41e-3)" 1.2 0.9 1.5 1.1 2.5 0.0 1.9 0.1 2.3 2.2 0.0 10.9 0.8 0.9 2.2 3.8 2.2 1.7 0.4 1.5 0.9 0.5 0.6 0.3 0.0 1.3 3.3 1.9 0.4 0.1 0.4 4.0 2.2 6.6 3.1 1.0 0.3 17.8 0.3 0.5 2.9 2.5 1.3 0.2 3.3 2.4 1.4 0.0 0.3 1.9 0.3 3.9 2.6 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.5 0.1 2.3 1.5 0.9 1.3 3.3 2.2 1.3 1.4 1.9 0.1 0.0 0.0 37.5 0.3 0.8 0.0 0.0 2.8 9.8 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.3 0.0 0.0 371.6 0.0 0.2 17.3 1.1 0.0 0.0 19.8 1.4 0.0 0.4 0.0 125.6 0.0 0.0 0.0 0.3 1.6 28.0 0.2 0.0 5.6 0.0 0.4 0.0 561.9 13.7 0.0 0.0 56.4 1.2 0.1 0.0 0.0 0.7 1.1 0.0 0.1 5.7 0.1 0.2 0.8 0.6 0.4 0.0 34.1 0.0 0.1 PEBP4 "CORK1, hPEBP4, MGC22776" ENSG00000134020 "Phosphatidylethanolamine binding protein 4" Q96S96 8 22713251-23000000 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 382.5;skeletal muscle: 670.8;tongue: 581.4" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 109.0;Alveolar cells type 2: 177.3;Cardiomyocytes: 144.7;Muller glia cells: 198.7" "Group enriched" "Detected in many" 13 "lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA025064 Uncertain "Secreted in other tissues" NA NA 190000000 "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" "HPA025064: AB_1855174" "unprognostic (1.34e-2)" "unprognostic (2.97e-2)" "unprognostic (4.11e-2)" "unprognostic (3.66e-1)" "unprognostic (3.35e-1)" "unprognostic (4.78e-2)" "unprognostic (1.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.60e-1)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "unprognostic (8.76e-3)" "unprognostic (9.70e-8)" "unprognostic (1.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.48e-1)" "unprognostic (4.59e-1)" 1.1 3.4 12.3 0.3 16.7 0.0 3.3 21.2 9.2 0.6 19.2 0.6 0.0 0.5 382.5 6.8 2.2 1.1 200.7 8.5 15.8 2.6 0.9 115.1 0.7 15.6 20.3 1.7 34.5 82.6 13.2 0.3 20.2 45.8 0.2 12.9 21.1 2.8 670.8 1.4 0.6 0.4 8.7 0.8 9.2 6.6 28.7 1.2 56.7 581.4 1.6 0.3 0.5 15.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 12.3 16.7 21.2 9.2 8.5 15.8 15.6 20.3 20.2 8.7 28.7 15.5 1.5 109.0 177.3 15.3 2.2 1.9 1.0 0.1 0.0 10.2 5.7 4.7 144.7 0.0 7.4 1.8 2.1 0.8 1.4 0.3 3.9 0.0 34.8 1.7 2.0 2.4 0.0 0.0 10.0 9.3 0.2 10.1 2.0 7.0 7.6 0.4 3.9 0.7 1.2 10.1 9.6 0.3 2.0 0.0 0.8 28.4 3.4 1.4 1.8 6.5 0.1 198.7 5.2 6.6 0.9 0.3 0.1 10.9 1.5 23.8 0.5 5.9 2.9 8.6 0.0 25.2 2.1 14.8 1.2 0.0 0.9 0.0 1.6 1.1 0.3 1.0 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716554-13287843 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.0;brain: 52.1" "Group enriched" "Detected in many" 4 "Excitatory neurons: 1954.8;Inhibitory neurons: 523.7" "Cancer enriched" "Detected in many" 5 "melanoma: 10.2" "Group enriched" "Detected in many" 6 "basal ganglia: 52.1;cerebral cortex: 27.3;hippocampal formation: 14.8" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 37.8" "Group enriched" "Detected in many" 18 "B-cells: 13.6;dendritic cells: 37.8;granulocytes: 18.7" "Cell line enhanced" "Detected in many" "HMC-1: 74.6;SK-MEL-30: 79.5;U-266/70: 176.1;U-266/84: 133.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 5.1 2.0 4.3 12.6 52.1 38.0 1.5 0.0 27.3 1.1 0.0 2.0 2.8 1.1 2.5 1.7 2.4 6.0 18.1 14.8 0.0 7.5 2.6 13.9 14.9 0.0 0.0 1.6 6.0 0.4 4.0 2.6 0.0 1.1 2.0 7.8 1.0 0.7 0.4 3.3 3.0 2.5 0.0 11.2 3.7 1.9 0.0 3.5 1.1 0.7 23.9 4.1 1.0 5.4 0.2 0.3 4.5 0.3 0.0 0.1 14.7 1.5 5.0 4.1 7.7 0.3 0.3 0.9 1.2 0.6 6.4 0.3 0.0 0.2 5.3 17.3 0.6 39.5 0.6 0.2 0.5 38.1 74.6 1.7 0.1 0.0 0.7 0.3 6.2 2.1 18.6 31.1 4.1 0.0 0.4 22.4 5.1 0.0 0.0 17.7 10.2 2.9 2.9 0.5 18.3 5.8 0.1 9.9 79.5 6.1 21.2 8.6 6.8 0.6 1.1 0.0 0.4 176.1 133.7 33.5 2.3 9.8 26.0 0.2 1.3 1.5 0.1 1.1 0.1 9.9 0.1 0.0 6.7 13.6 0.0 0.1 18.7 0.1 0.9 37.8 0.0 0.9 4.3 52.1 0.0 27.3 14.8 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.6 67.3 48.5 265.1 131.6 3.7 1.4 0.8 1.2 43.5 2.1 3.9 10.4 4.3 8.3 62.5 4.2 1.4 79.4 0.7 31.3 0.7 59.9 5.5 2.8 12.9 1.8 13.7 1954.8 2.9 2.3 8.6 0.5 15.0 81.2 2.7 13.6 1.1 83.1 180.0 523.7 0.2 0.0 138.2 91.5 79.8 4.7 188.5 48.0 114.3 20.5 28.4 6.2 186.5 247.8 0.8 0.2 6.4 59.6 1.0 0.3 1.0 5.1 14.0 0.0 4.0 4.3 2.0 4.8 2.1 3.1 1.9 8.6 6.6 1.0 0.8 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410660-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 212 "testis: 1216.7" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.8;U-266/70: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: AB_2686248" "prognostic favorable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favorable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 4.8 2.8 0.6 1.3 0.6 4.1 5.0 0.9 1.3 2.1 0.6 4.3 2.7 1.6 3.3 2.6 2.0 1.1 1.9 0.6 0.7 2.9 4.7 2.4 2.1 0.8 0.8 1.4 4.4 5.7 1.7 2.0 0.8 4.3 4.6 0.6 3.5 1.7 2.3 5.0 4.2 1.4 0.7 3.2 2.5 1216.7 0.7 2.8 2.2 0.9 2.2 2.4 2.3 0.8 2.2 0.6 1.6 6.8 1.1 1.6 2.8 2.1 2.2 1.7 2.1 1.1 0.9 3.6 0.2 1.6 1.0 1.2 1.2 3.4 2.9 4.5 1.6 4.1 0.6 2.5 1.1 4.6 7.5 1.0 3.7 1.6 3.5 0.5 2.5 8.3 2.5 14.8 1.3 1.0 5.4 1.7 0.7 0.7 4.6 2.4 1.5 4.5 1.8 0.9 1.1 1.3 2.0 0.1 1.6 2.0 1.0 2.3 1.8 2.8 1.9 3.0 4.5 17.4 9.0 2.1 1.2 10.4 1.7 0.3 1.1 1.8 0.9 1.2 1.1 3.4 1.0 1.6 0.5 1.8 0.7 1.5 0.2 1.1 0.6 1.1 2.5 0.9 0.6 0.6 0.9 1.3 0.6 0.7 0.8 0.8 0.8 0.7 0.7 0.8 4.3 3.2 4.6 15.7 7.8 4.6 4.8 3.5 13.6 11.2 6.2 5.0 9.7 4.3 1.3 7.3 8.4 3.5 5.8 7.7 13.7 3.6 2630.6 5.3 3.1 6.7 11.5 14.7 10.9 2.8 2.0 5.7 6.1 2.1 7.0 3.7 3.3 4.5 4.2 13.5 12.4 4.2 2.0 4.1 2.3 8698.5 77.0 7.9 8.8 1.9 4.4 8.1 7.2 5.5 16.3 3.7 2.4 63.2 7.6 1.7 12.7 7.3 6.0 15.3 52.6 6.0 4.5 1456.7 71.6 7.6 3.0 0.5 5.5 7.2 10.2 2.2 PIH1D1 "FLJ20643, MOT48, NOP17, Pih1" ENSG00000104872 "PIH1 domain containing 1" Q9NWS0 19 49446298-49453497 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047258 Approved Approved Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 50: Fibroblasts - ECM organization" Cytosol "HPA047258: AB_10964561" "unprognostic (2.28e-1)" "unprognostic (1.56e-1)" "unprognostic (2.14e-1)" "unprognostic (8.99e-2)" "unprognostic (7.77e-3)" "unprognostic (9.66e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (5.13e-2)" "unprognostic (1.22e-2)" "unprognostic (1.86e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" 38.0 37.1 31.4 26.8 32.0 34.5 37.1 31.5 39.5 38.0 33.8 40.4 43.5 32.4 13.2 45.0 39.7 27.0 31.5 33.0 31.8 41.4 47.7 30.5 43.6 31.7 30.9 29.9 39.7 50.4 34.5 33.1 32.0 39.6 29.5 11.8 49.5 33.8 67.5 45.3 37.2 26.3 31.9 39.4 41.3 17.8 33.1 46.1 37.1 57.6 36.1 33.0 39.4 31.8 133.6 67.0 84.6 130.3 40.1 37.2 54.0 52.9 68.8 79.8 122.3 72.4 89.6 89.1 48.6 56.7 20.0 79.9 44.8 96.6 46.2 85.5 85.1 79.9 89.6 93.0 63.1 86.7 115.3 43.5 40.4 59.0 55.8 74.8 74.8 79.2 119.5 76.8 50.5 59.9 98.4 173.3 101.1 118.4 63.2 83.1 93.6 90.4 65.1 107.2 109.2 158.0 54.3 91.2 53.2 41.1 44.0 104.3 44.9 66.9 52.0 26.9 84.2 205.5 172.8 49.8 36.6 93.6 47.5 166.8 104.5 121.0 88.3 104.0 75.6 116.1 98.8 94.9 105.1 110.1 79.5 73.4 11.8 103.7 108.7 100.2 158.3 107.0 31.4 32.0 31.5 39.5 33.0 31.8 31.7 30.9 32.0 31.9 33.1 31.8 45.5 38.5 36.6 10.7 54.8 55.8 61.9 80.2 59.7 20.9 46.8 50.0 11.2 41.5 46.4 20.2 18.8 101.7 48.8 48.6 62.6 74.1 18.1 47.4 24.1 39.2 57.5 33.4 10.5 46.3 116.5 59.9 43.8 30.6 52.6 30.8 35.3 44.3 71.2 23.5 8.5 63.9 38.7 40.8 55.7 9.9 62.4 40.7 64.0 11.2 59.0 55.0 40.2 10.1 10.9 47.3 75.4 47.0 60.3 65.6 90.2 115.9 59.4 22.6 26.3 44.5 46.8 40.6 29.9 49.0 67.1 94.0 50.4 48.2 59.4 66.2 PIK3CG ENSG00000105851 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma" P48736 7 106865278-106908980 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 43.6;lymphoid tissue: 19.7" "Cell type enhanced" "Detected in some" "B-cells: 24.9;dendritic cells: 26.5;Early spermatids: 28.9;granulocytes: 20.8;monocytes: 23.8;NK-cells: 25.7;Plasma cells: 88.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 29.4;HL-60: 28.8;HMC-1: 34.9;Karpas-707: 29.1;MOLT-4: 56.0;U-266/70: 71.4;U-937: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069976 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane" Cytosol "HPA069976: AB_2686224" "unprognostic (8.34e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.71e-2)" "unprognostic (3.20e-2)" "unprognostic (3.82e-3)" "unprognostic (3.02e-1)" "unprognostic (6.77e-2)" "unprognostic (1.16e-1)" "unprognostic (7.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (9.08e-2)" "unprognostic (1.23e-1)" "unprognostic (5.38e-1)" "unprognostic (5.24e-2)" 3.1 1.8 0.5 11.5 0.6 43.6 1.9 0.8 1.3 1.9 1.3 4.2 4.1 1.3 0.5 1.7 1.4 3.2 1.6 0.5 1.0 1.0 2.0 4.9 19.0 2.5 1.3 1.6 0.3 0.7 0.2 2.9 2.7 1.0 3.8 0.1 1.3 0.9 0.3 0.8 4.3 2.7 1.8 11.0 4.0 5.2 2.0 16.4 1.1 1.0 19.7 4.3 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 2.7 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 17.9 0.0 0.0 0.0 28.8 34.9 0.0 0.0 0.0 0.0 0.0 11.0 16.9 20.6 29.1 0.0 0.0 56.0 17.6 0.0 0.0 0.0 14.6 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.6 2.9 0.1 0.2 0.1 0.0 71.4 0.0 27.3 0.1 52.1 6.7 10.8 6.0 24.3 8.8 17.8 8.1 7.3 4.1 6.7 9.4 10.2 4.2 5.9 22.7 9.8 43.7 8.6 4.4 6.8 0.5 0.6 0.8 1.3 0.5 1.0 2.5 1.3 2.7 1.8 2.0 3.9 1.5 0.0 1.8 0.3 24.9 0.8 0.0 0.0 0.6 0.0 0.1 0.1 0.5 0.0 0.6 0.0 0.0 0.0 26.5 0.2 0.0 0.0 28.9 0.1 0.2 1.7 0.0 7.8 5.5 0.0 0.0 0.1 3.6 0.1 20.8 0.4 2.5 0.5 6.8 0.0 0.3 0.0 0.0 11.9 8.3 18.8 0.6 18.9 7.2 15.0 23.8 0.0 25.7 0.0 0.2 0.0 0.0 0.0 88.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 6.6 3.7 0.2 0.3 0.1 18.1 0.6 0.6 0.1 PIM2 ENSG00000102096 "Pim-2 proto-oncogene, serine/threonine kinase" Q9P1W9 X 48913182-48919024 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.3;intestine: 87.6;lymphoid tissue: 163.9" "Cell type enriched" "Detected in many" 4 "Plasma cells: 738.8" "Cancer enriched" "Detected in all" 6 "testis cancer: 171.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 5 "HDLM-2: 567.6;Karpas-707: 675.0;RPMI-8226: 703.9;U-266/70: 1218.7;U-266/84: 1160.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000285 Approved Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA000285: AB_1079619" "unprognostic (2.34e-3)" "prognostic favorable (4.05e-5)" "unprognostic (8.04e-2)" "unprognostic (7.30e-2)" "unprognostic (6.41e-3)" "unprognostic (2.74e-3)" "unprognostic (2.84e-1)" "unprognostic (5.23e-2)" "unprognostic (2.47e-2)" "unprognostic (4.01e-2)" "unprognostic (1.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.17e-11)" "unprognostic (3.36e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-1)" "unprognostic (4.38e-2)" 7.9 7.1 10.9 85.4 11.4 102.3 8.8 9.6 12.3 6.1 11.1 40.8 87.6 5.1 10.1 8.2 11.9 16.7 5.2 15.4 12.4 9.8 10.4 23.5 114.3 9.7 10.7 10.3 4.7 3.8 10.1 4.9 11.7 7.4 50.9 5.6 36.4 7.3 2.5 6.3 46.4 6.9 10.3 163.9 45.1 10.1 13.5 45.5 10.1 2.7 104.7 45.6 6.4 8.8 17.5 14.8 8.0 15.4 2.8 2.0 11.7 10.5 13.1 14.8 13.2 13.3 12.9 74.5 4.8 5.3 5.6 10.6 25.1 10.0 14.1 567.6 19.6 90.8 15.0 13.9 6.2 21.7 58.7 5.9 8.4 15.3 9.2 12.1 5.5 9.8 97.8 675.0 8.4 12.6 8.4 45.2 165.2 6.1 22.7 9.9 5.4 703.9 14.9 2.6 5.4 7.8 11.5 8.0 8.3 36.9 19.3 29.8 3.6 3.5 2.5 3.1 10.6 1218.7 1160.5 144.1 14.0 19.0 3.7 279.1 8.2 77.7 60.4 9.7 102.3 124.8 165.9 85.6 13.2 73.5 172.4 113.3 195.5 92.7 17.4 15.2 331.9 79.0 10.9 11.4 9.6 12.3 15.4 12.4 9.7 10.7 11.7 10.3 13.5 8.8 2.9 12.8 36.0 1.0 161.6 20.3 9.0 7.1 45.5 2.6 16.2 4.7 3.5 2.8 9.9 3.7 2.1 5.8 46.8 5.7 3.9 3.3 1.9 15.6 1.0 5.3 13.1 49.9 2.3 3.5 9.1 5.1 10.7 3.9 23.4 1.3 4.2 6.3 7.2 11.8 2.2 7.5 18.3 7.5 123.1 1.8 1.8 19.8 94.3 0.0 99.5 2.2 38.1 0.5 1.0 2.0 3.7 4.1 738.8 4.6 4.1 6.8 16.3 2.1 0.0 3.8 6.2 2.2 1.6 15.7 13.8 2.5 97.1 8.6 11.8 3.4 PKD1L1 PRO19563 ENSG00000158683 "Polycystin 1 like 1, transient receptor potential channel interacting" Q8TDX9 7 47740202-47948466 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7" "Not detected" "Not detected" "HPA020422, HPA022424" Uncertain NA NA "Cluster 11: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA020422: AB_1855434, HPA022424: AB_1855435" "unprognostic (5.47e-2)" "unprognostic (5.33e-3)" "unprognostic (1.49e-2)" "unprognostic (9.74e-2)" "unprognostic (4.03e-2)" "unprognostic (6.31e-2)" "unprognostic (2.52e-2)" "unprognostic (1.11e-1)" "unprognostic (9.63e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (1.88e-4)" "unprognostic (1.88e-3)" "unprognostic (2.56e-1)" "unprognostic (2.50e-1)" "unprognostic (1.90e-1)" 1.7 0.1 1.1 0.4 0.9 1.1 0.5 2.1 1.9 0.2 0.0 0.4 0.9 0.3 0.6 0.4 0.3 0.4 2.6 0.4 1.3 0.3 0.8 0.4 0.9 0.5 0.7 0.3 0.3 0.1 0.4 0.6 0.7 0.3 0.5 1.7 0.4 0.1 2.8 0.5 0.4 0.4 0.1 0.3 0.4 1.5 0.8 1.5 0.4 3.3 0.6 0.6 0.1 1.1 0.4 0.7 0.6 0.8 0.1 0.0 1.2 0.3 0.2 0.2 0.4 0.8 0.4 0.3 0.3 0.4 0.4 0.8 0.5 0.6 0.6 0.2 0.4 0.3 0.3 0.8 0.0 0.5 0.3 0.2 0.1 0.3 0.2 0.2 1.1 0.4 0.4 1.1 0.5 0.2 0.3 0.3 0.4 0.0 0.2 0.2 0.3 0.3 0.1 0.7 0.5 0.4 0.5 0.3 0.4 0.5 5.9 0.1 0.1 0.5 1.1 0.2 0.3 14.7 5.7 0.5 0.2 0.2 0.3 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.1 1.1 0.9 2.1 1.9 0.4 1.3 0.5 0.7 0.7 0.1 0.8 1.1 9.1 0.0 0.0 13.4 0.3 0.1 0.0 0.0 0.0 3.1 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.8 0.5 0.1 3.7 0.0 0.0 25.7 0.2 0.2 1.7 0.0 0.3 0.0 0.2 2.2 0.1 1.4 1.7 37.9 0.7 0.0 0.3 0.0 5.3 0.3 0.2 0.0 15.0 0.0 0.5 0.0 11.6 17.1 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.5 0.0 0.4 0.2 1.4 0.6 0.0 0.0 0.0 0.1 0.3 0.8 0.0 PKHD1L1 ENSG00000205038 "PKHD1 like 1" Q86WI1 8 109362461-109537207 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.5;thyroid gland: 68.8" "Cell type enhanced" "Detected in some" "B-cells: 24.4;Endometrial ciliated cells: 47.0;Endothelial cells: 14.0;Glandular and luminal cells: 49.9;Plasma cells: 28.2" "Group enriched" "Detected in some" 18 "endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HHSteC: 1.4;TIME: 1.6;U-266/70: 3.9" "Not detected" "Not detected" HPA044458 Uncertain NA NA 13000000 "Cluster 1: Thyroid gland - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "HPA044458: AB_2678949" "unprognostic (9.07e-3)" "unprognostic (3.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.61e-4)" "unprognostic (5.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.91e-2)" "unprognostic (3.45e-2)" "unprognostic (3.31e-2)" "unprognostic (1.98e-1)" "unprognostic (9.65e-3)" "unprognostic (1.92e-1)" "unprognostic (7.76e-6)" "unprognostic (4.56e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-3)" "unprognostic (2.73e-2)" 25.5 2.7 0.2 0.5 0.2 0.4 2.6 0.1 0.2 13.7 1.4 2.6 1.1 5.9 0.3 1.7 14.1 0.4 9.3 0.1 0.3 1.9 0.6 6.9 1.2 0.2 0.2 2.6 0.5 0.0 0.8 0.0 0.1 0.7 1.6 0.0 0.7 0.2 0.2 1.7 4.3 0.4 0.1 0.5 1.6 0.5 0.1 0.1 68.8 0.6 1.1 1.2 1.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.4 1.3 0.0 2.8 0.7 24.4 0.3 0.0 0.0 0.6 0.0 0.1 0.0 1.9 1.5 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 47.0 3.4 14.0 1.8 0.4 0.2 0.0 0.1 6.6 1.1 49.9 1.3 0.0 10.4 0.6 0.0 0.0 0.2 0.0 0.0 0.9 0.3 0.5 0.6 0.3 1.8 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 28.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 1.9 0.0 0.1 0.0 PLAAT2 "FLJ20556, HRASLS2, PLAAT-2" ENSG00000133328 "Phospholipase A and acyltransferase 2" Q9NWW9 11 63552770-63563379 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 67.9" "Cell type enhanced" "Detected in single" "dendritic cells: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 17.3;naive B-cell: 8.2" "Lineage enriched" "Detected in many" 10 "B-cells: 17.3" "Cell line enriched" "Detected in some" 8 "U-266/70: 128.9" HPA058997 Approved Approved Mitochondria NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Mitochondria "HPA058997: AB_2683874" "unprognostic (4.76e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.3 0.0 0.6 0.8 0.6 0.1 9.1 0.5 0.9 0.9 0.3 11.2 67.9 0.3 1.2 1.5 4.7 0.6 0.2 0.5 0.5 8.6 4.6 3.6 0.3 0.7 0.6 0.2 0.0 0.0 0.2 0.2 0.6 0.4 13.7 0.0 0.9 0.5 0.0 0.3 42.5 0.3 0.5 0.7 12.4 0.5 0.6 0.3 0.9 0.0 0.3 1.3 0.2 1.1 0.4 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 0.1 0.3 15.6 0.0 0.9 0.0 0.4 1.0 0.6 0.2 0.1 0.2 0.0 0.1 1.0 0.1 0.2 0.0 0.1 0.1 1.2 0.3 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.3 0.1 8.7 1.9 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.1 4.0 0.0 0.1 2.2 0.1 0.0 0.0 0.0 0.1 0.0 128.9 16.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.9 17.3 0.2 1.0 0.1 8.2 0.2 0.7 0.1 1.6 0.0 0.9 0.0 3.9 0.6 0.6 0.5 0.9 0.5 0.5 0.7 0.6 0.6 0.5 0.6 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148577-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 57.0;Macrophages: 62.5;Melanocytes: 96.0;monocytes: 53.8" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.4" "Group enriched" "Detected in all" 4 "granulocytes: 16.4;monocytes: 8.6" "Cell line enhanced" "Detected in many" "HAP1: 33.3;Karpas-707: 25.8;SK-MEL-30: 41.4;U-266/70: 64.3;U-266/84: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066899 Approved Mitochondria NA NA 150000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Mitochondria "HPA066899: AB_2685743" "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.1 8.8 6.4 20.5 7.1 17.4 4.7 8.9 7.5 8.5 1.9 5.7 4.1 7.0 2.7 3.8 4.8 10.2 1.9 7.1 15.9 4.0 2.5 11.4 16.2 5.3 12.7 14.8 2.4 0.9 4.1 9.4 4.7 2.3 6.5 2.2 2.3 4.5 4.0 8.3 5.5 6.9 4.2 19.8 4.5 15.2 18.6 5.7 3.4 4.1 13.0 9.5 3.8 8.7 1.1 0.4 2.7 0.5 1.5 1.2 0.4 1.3 1.8 1.7 5.1 9.1 0.1 21.8 0.1 2.0 1.6 0.1 33.3 1.4 1.2 15.3 0.7 1.2 0.6 6.1 17.7 4.5 7.2 17.7 0.0 1.9 0.8 2.3 0.0 2.0 0.6 25.8 0.5 0.3 1.0 2.4 5.5 0.2 1.2 3.6 1.0 12.1 0.1 1.7 2.2 1.6 0.3 0.2 41.4 6.3 0.1 3.7 0.7 0.6 2.3 0.2 0.8 64.3 73.3 1.4 0.4 11.7 1.4 0.0 3.6 15.1 1.6 6.1 1.7 2.6 1.7 1.9 2.9 1.7 1.6 1.6 16.4 1.1 8.6 1.1 1.3 2.0 6.4 7.1 8.9 7.5 7.1 15.9 5.3 12.7 4.7 4.2 18.6 8.7 4.9 3.2 2.4 9.8 17.9 6.1 0.3 0.3 1.2 3.6 3.2 2.5 8.1 1.5 0.2 0.0 0.0 0.2 5.6 1.2 1.9 0.2 9.4 3.2 14.9 4.3 19.8 26.1 36.1 0.5 0.2 16.0 1.1 1.6 16.5 29.8 6.1 1.6 18.8 0.0 57.0 1.8 0.0 39.4 13.8 6.2 1.5 62.5 96.0 40.3 53.8 0.3 3.1 34.2 12.6 0.3 1.8 3.4 24.4 0.2 0.1 3.4 2.3 0.5 6.6 2.8 2.5 3.0 1.1 0.7 1.6 0.1 9.4 4.8 1.9 0.3 PNMA5 KIAA1934 ENSG00000198883 "PNMA family member 5" Q96PV4 X 152988824-152994116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 22.8;testis: 8.7" "Group enriched" "Detected in some" 14 "Spermatocytes: 20.3;Spermatogonia: 71.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 578 "HMC-1: 356.2;U-266/70: 560.6;U-266/84: 355.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044690, HPA073946" Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA044690: AB_2679049, HPA073946: " "unprognostic (5.25e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (3.55e-2)" "prognostic favorable (3.16e-4)" "unprognostic (1.15e-1)" "unprognostic (1.16e-3)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.76e-9)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" 0.0 0.0 8.8 0.1 11.2 0.0 0.0 0.3 9.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 22.8 0.0 0.0 0.0 0.1 3.0 5.2 0.0 0.0 0.0 0.9 0.1 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 2.0 0.5 0.1 8.7 20.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 356.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 560.6 355.8 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.8 11.2 0.3 9.4 8.9 22.8 3.0 5.2 3.5 2.0 20.1 2.4 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 1.7 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 2.6 0.4 1.3 0.3 1.2 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 71.9 0.0 0.0 0.3 0.9 0.1 0.0 0.0 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603552 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 9.3;retina: 2.6" "Cell type enriched" "Detected in some" 10 "Skeletal myocytes: 28.6" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 4 "medulla oblongata: 9.3;midbrain: 5.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 14.1;HEL: 15.5;JURKAT: 12.2;REH: 10.9;RH-30: 17.9;SCLC-21H: 17.1;U-266/70: 16.1" "Group enriched" "Detected in some" 23 "midbrain: 2.5;pons and medulla: 2.1;thalamus: 2.2" "Region enhanced" "Detected in some" "medulla oblongata: 4.1" HPA068024 Enhanced Approved NA NA "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 50: Fibroblasts - ECM organization" "HPA068024: AB_2685943" "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.0 0.0 0.4 0.1 0.3 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.5 9.3 5.2 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.9 0.8 0.7 0.0 0.1 0.8 0.0 0.0 0.8 0.0 0.7 2.7 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.6 0.0 5.1 0.0 0.0 0.0 14.1 15.5 0.0 2.0 0.0 7.7 4.4 0.0 0.1 0.0 0.0 0.0 0.0 12.2 3.1 0.0 0.7 0.0 1.2 1.4 0.0 2.1 0.0 10.9 17.9 0.0 0.0 0.0 17.1 0.2 0.0 0.0 0.7 0.2 0.0 1.5 0.2 0.0 0.0 0.3 0.0 16.1 5.1 0.0 0.0 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.2 0.4 0.6 9.3 5.2 1.6 1.7 0.8 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.8 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 2.0 0.0 28.6 0.1 2.5 2.7 0.0 0.4 0.0 0.1 0.0 0.1 0.0 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514428-195543386 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 431.9;Spermatocytes: 354.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 142.1;U-266/70: 224.2" "Low region specificity" "Detected in all" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 18.3 15.0 15.4 21.3 16.2 68.1 22.6 12.9 16.9 18.0 16.5 22.8 25.8 21.2 25.2 22.4 18.3 19.7 24.7 16.6 21.0 21.0 15.0 17.4 29.1 15.1 15.4 13.9 13.5 16.8 15.6 17.5 17.2 20.9 19.8 16.0 16.9 19.1 85.8 17.2 22.3 21.6 14.3 21.5 17.7 29.2 15.2 28.2 23.1 56.2 25.2 21.1 18.2 15.0 43.8 9.8 14.7 17.0 24.1 25.8 29.1 25.8 36.6 26.4 22.6 142.1 18.0 17.3 99.2 31.1 27.8 18.1 15.1 25.6 32.1 33.0 30.3 18.6 14.0 47.5 37.2 20.5 18.8 31.4 19.4 19.7 39.6 20.8 23.0 17.1 14.7 33.4 23.4 32.3 34.4 22.9 15.6 49.2 42.1 16.6 25.6 50.4 31.8 32.1 34.9 20.0 31.6 33.1 46.5 27.0 52.5 19.9 27.9 16.9 19.3 28.8 36.7 224.2 105.7 79.5 23.9 37.0 33.3 120.6 64.7 257.5 71.8 68.2 98.2 100.3 149.3 99.1 68.8 95.8 178.6 122.8 152.3 94.2 69.0 103.5 168.4 129.2 15.4 16.2 12.9 16.9 16.6 21.0 15.1 15.4 17.2 14.3 15.2 15.0 106.9 22.4 47.8 13.1 165.7 94.2 138.6 70.1 89.4 51.5 80.6 61.5 53.5 38.6 56.3 22.0 58.4 67.7 148.2 48.6 125.2 69.5 431.9 119.5 65.0 99.6 57.4 33.6 30.8 66.3 43.0 62.5 45.3 67.9 111.0 26.7 51.0 27.1 61.0 52.2 41.7 48.5 69.2 73.3 170.6 243.8 51.6 103.4 97.8 25.3 120.9 50.5 74.2 23.1 19.1 74.5 65.1 63.6 188.4 123.0 77.3 106.0 80.3 91.1 26.3 48.7 71.1 354.3 92.4 88.2 77.6 103.2 230.1 58.0 54.7 186.2 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295652-23302859 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 47.0" "Cell type enhanced" "Detected in all" "Early spermatids: 111.9;Late spermatids: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 41.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 5.8 8.0 15.2 5.7 17.9 3.9 6.4 17.9 23.8 10.2 9.7 7.4 6.3 6.4 10.1 6.0 9.5 3.3 6.2 15.0 15.3 11.6 11.2 5.7 9.5 18.5 16.5 12.5 10.6 5.7 19.3 2.7 19.4 12.1 5.9 47.0 8.5 6.2 14.9 10.9 13.3 3.4 13.8 15.1 9.0 14.7 17.7 8.2 14.9 5.4 8.2 7.9 8.5 23.3 1.1 3.0 3.6 2.5 6.9 2.9 1.7 1.2 2.2 2.0 1.7 1.7 5.8 11.2 0.8 1.6 2.2 7.6 2.1 1.2 2.5 4.0 2.1 2.0 6.9 4.0 1.8 2.3 4.4 2.5 4.5 1.2 6.1 3.3 0.9 6.0 1.9 9.8 1.7 2.6 2.1 3.6 0.9 3.6 2.8 3.4 2.5 7.2 1.1 2.5 4.5 1.2 1.8 1.6 1.2 1.8 1.9 0.8 1.7 2.4 1.3 4.1 0.9 41.1 4.6 5.1 1.9 4.0 1.5 0.2 0.4 0.2 0.5 1.4 0.6 1.0 0.1 0.2 0.3 0.6 0.5 0.3 0.4 0.2 1.8 0.3 0.4 0.3 15.2 17.9 17.9 23.8 15.0 15.3 18.5 16.5 19.4 13.8 17.7 23.3 5.8 3.2 4.8 30.0 25.4 5.6 9.0 5.3 11.4 59.4 7.8 11.6 8.8 7.2 5.0 20.2 37.5 8.2 12.8 8.0 5.9 2.1 111.9 3.7 6.6 7.2 8.4 7.2 25.0 3.3 2.0 6.1 20.4 4.3 3.8 9.4 7.5 7.2 7.4 32.0 33.0 7.7 4.1 9.5 9.6 62.9 27.4 9.2 10.6 15.9 8.1 20.4 26.8 16.1 56.1 2.4 11.6 25.9 11.9 6.7 19.5 9.5 4.8 38.1 13.1 3.5 5.4 36.5 13.9 8.4 9.1 5.2 15.7 7.2 9.6 8.6 PRDM13 PFM10 ENSG00000112238 "PR/SET domain 13" Q9H4Q3 6 99606774-99615578 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Bipolar cells: 4.8;Horizontal cells: 1.7;Spermatogonia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;HMC-1: 1.1;JURKAT: 2.7;RPMI-8226: 2.0;SCLC-21H: 2.3;U-266/70: 2.7;U-266/84: 1.4;WM-115: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA070592 Uncertain NA NA "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA070592: AB_2686283" "unprognostic (4.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.30e-1)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (3.16e-2)" "unprognostic (1.24e-2)" "unprognostic (2.93e-1)" "unprognostic (1.86e-2)" "unprognostic (7.54e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.3 0.0 1.1 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.7 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.6 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRDM9 "KMT8B, MSBP3, PFM6, ZNF899" ENSG00000164256 "PR/SET domain 9" Q9NQV7 5 23443586-23528093 "Enzymes, Predicted intracellular proteins, Transcription factors" "Meiosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;epididymis: 1.6;testis: 4.0" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 44.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "U-266/70: 6.9" HPA059555 Uncertain NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA059555: AB_2684061" "unprognostic (1.23e-4)" "unprognostic (8.64e-2)" "unprognostic (2.18e-2)" "unprognostic (8.34e-2)" "unprognostic (4.11e-1)" 0.0 0.0 0.4 0.0 1.6 0.9 0.0 0.4 1.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.4 1.4 0.1 0.0 0.0 0.1 1.6 1.0 0.1 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 4.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.0 6.9 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.2 0.1 0.2 0.3 0.2 0.1 0.1 0.4 0.2 0.2 1.2 0.6 0.1 0.1 0.1 0.0 0.4 1.6 0.4 1.0 0.4 1.4 1.6 1.0 2.0 0.4 1.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR5 "FLJ20185k, PP610, Protor-1" ENSG00000186654 "Proline rich 5" P85299 22 44668547-44737681 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 91.3;NK-cells: 77.2;Proximal tubular cells: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 19.1;T-cells: 28.6" "Cell line enhanced" "Detected in many" "U-266/70: 99.2;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054072 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA054072: AB_2682369" "unprognostic (2.63e-2)" "unprognostic (6.63e-3)" "unprognostic (2.61e-2)" "prognostic favorable (2.47e-5)" "unprognostic (1.83e-2)" "unprognostic (3.99e-2)" "unprognostic (7.52e-2)" "unprognostic (1.37e-1)" "unprognostic (8.98e-2)" "unprognostic (5.13e-2)" "unprognostic (1.34e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" 16.2 2.4 7.2 3.2 7.7 7.2 12.2 5.9 11.3 8.4 11.9 6.0 8.6 3.8 2.1 7.6 4.3 2.9 3.5 7.9 9.7 11.5 18.5 3.5 3.9 8.1 8.2 4.0 6.2 2.3 16.1 4.5 8.5 7.9 2.4 0.4 5.7 3.8 0.8 7.4 9.4 1.1 5.9 20.5 5.2 5.1 10.5 2.3 4.5 1.2 2.5 6.9 7.1 5.8 8.1 9.6 2.0 6.8 0.2 0.3 25.0 7.0 6.2 4.2 3.4 24.4 3.4 0.0 5.2 8.2 4.9 7.2 2.1 7.1 0.7 0.2 19.9 15.9 1.3 28.5 5.8 2.9 5.8 2.9 7.9 0.4 2.2 1.0 0.2 3.7 10.1 0.5 0.9 21.4 1.1 4.6 1.3 11.4 1.4 0.7 4.5 14.5 1.4 3.8 7.0 1.0 1.9 11.4 9.5 5.5 5.3 2.8 0.0 0.1 11.0 1.0 0.1 99.2 31.3 0.2 0.0 6.4 0.8 0.5 0.3 0.1 24.8 3.4 28.6 1.6 8.3 18.8 0.7 0.9 3.5 13.0 0.6 5.6 19.1 0.4 14.8 6.8 7.2 7.7 5.9 11.3 7.9 9.7 8.1 8.2 8.5 5.9 10.5 5.8 6.0 0.0 3.9 11.4 9.2 8.3 12.0 2.1 4.0 0.7 13.6 13.2 2.0 10.0 2.3 5.5 0.0 32.1 50.3 20.5 5.9 5.2 0.5 4.4 5.4 12.5 9.6 91.3 2.0 7.9 3.3 23.2 8.2 4.7 7.6 5.4 21.4 19.9 32.1 0.0 1.8 22.8 2.0 13.5 8.2 0.5 5.3 7.7 8.8 3.7 3.0 6.0 77.2 1.0 0.2 8.4 7.6 3.8 29.0 24.2 50.9 55.2 1.4 1.5 0.0 11.4 5.3 0.3 20.4 8.0 8.5 44.1 37.1 51.8 25.5 13.5 PRR5-ARHGAP8 ENSG00000248405 "PRR5-ARHGAP8 readthrough" 22 44702233-44862706 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 4.9;Collecting duct cells: 5.5;Pancreatic endocrine cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 2.1;HEK 293: 2.7;MCF7: 2.1;U-266/70: 6.8" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "unprognostic (5.52e-2)" "unprognostic (3.65e-2)" "unprognostic (6.61e-3)" "unprognostic (3.29e-2)" "unprognostic (1.77e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-2)" "unprognostic (2.53e-2)" "unprognostic (6.47e-3)" "unprognostic (9.28e-8)" "unprognostic (8.64e-2)" "unprognostic (9.91e-2)" "unprognostic (2.41e-2)" "unprognostic (3.45e-1)" 0.5 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.3 0.2 0.2 0.7 0.5 0.1 0.1 0.6 0.6 0.5 0.0 0.1 0.1 1.5 0.2 0.4 0.2 0.1 0.2 0.0 0.8 0.4 0.5 0.2 0.1 0.8 0.3 0.0 0.7 0.8 0.0 0.6 0.4 0.0 0.0 1.0 0.4 0.1 0.1 0.0 1.4 0.0 0.2 0.3 0.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.3 0.0 0.0 2.1 0.3 0.0 0.1 0.0 0.0 0.7 0.5 1.4 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.6 0.1 0.7 0.2 0.0 0.0 0.9 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 3.2 1.5 4.9 0.0 0.4 1.0 0.2 0.0 0.0 0.6 0.3 0.1 0.0 0.8 5.5 0.0 0.7 0.1 0.6 1.9 1.9 0.0 0.6 0.1 0.0 1.2 0.0 0.9 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.9 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.2 0.5 0.9 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393766-40414793 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 34.6" "Cell type enhanced" "Detected in many" "Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in some" 8 "spinal cord: 114.2" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 4.5 4.7 6.2 1.3 6.8 1.6 3.9 5.2 6.5 4.8 2.9 3.6 1.1 4.4 1.0 2.0 4.2 1.8 3.1 4.7 4.4 6.7 1.0 34.6 1.3 5.4 4.9 6.2 3.8 5.9 1.5 5.1 6.7 4.6 0.7 0.8 3.8 3.5 4.9 3.2 2.2 2.0 4.9 2.0 3.7 1.6 5.7 0.7 9.6 5.5 0.8 4.3 3.1 4.1 1.6 2.6 2.1 2.7 1.3 4.4 2.6 1.4 1.5 1.9 1.4 1.0 1.7 0.5 1.6 1.3 1.2 0.9 1.0 0.6 0.7 0.8 0.9 0.3 0.3 0.5 2.1 0.1 2.3 3.3 3.2 1.2 1.1 1.7 1.6 2.9 2.0 0.5 1.0 2.2 1.0 0.6 0.6 3.8 1.7 3.2 1.8 1.5 0.4 1.8 0.2 1.0 2.7 2.3 2.0 0.9 3.2 1.2 1.4 3.8 2.9 1.6 0.8 5.3 5.0 0.7 1.1 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 6.2 6.8 5.2 6.5 4.7 4.4 5.4 4.9 6.7 4.9 5.7 4.1 17.8 3.2 5.9 0.7 1.4 6.2 2.3 0.3 5.7 0.1 8.1 23.2 15.4 2.8 0.9 1.8 0.0 1.1 1.7 1.0 0.0 0.3 0.1 1.3 1.7 9.2 0.0 0.4 0.6 0.6 0.7 7.0 0.0 3.0 0.0 2.0 6.8 1.3 1.1 0.0 0.5 0.7 2.0 1.6 2.5 0.1 3.4 2.5 3.6 7.5 0.3 3.3 0.0 0.0 0.5 0.5 1.4 4.5 0.9 1.7 1.2 1.9 0.2 0.1 0.0 30.3 6.1 0.3 0.7 5.0 4.1 2.7 1.1 1.3 1.5 1.0 RAB37 ENSG00000172794 "RAB37, member RAS oncogene family" Q96AX2 17 74670578-74747335 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.5;brain: 20.8;lymphoid tissue: 21.3" "Cell type enhanced" "Detected in many" "dendritic cells: 33.4;Excitatory neurons: 33.2;granulocytes: 50.7;Inhibitory neurons: 29.6;NK-cells: 87.6;T-cells: 31.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 269.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 269.7" "Cell line enhanced" "Detected in some" "HEL: 50.6;HMC-1: 58.7;OE19: 25.4;U-266/70: 84.9;U-937: 34.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" "unprognostic (2.10e-2)" "unprognostic (7.04e-4)" "unprognostic (5.95e-2)" "unprognostic (9.80e-4)" "unprognostic (3.49e-1)" "unprognostic (7.04e-5)" "unprognostic (1.74e-1)" "unprognostic (1.48e-2)" "unprognostic (7.62e-3)" "unprognostic (9.47e-3)" "unprognostic (3.05e-2)" "unprognostic (2.02e-2)" "prognostic unfavorable (8.80e-6)" "unprognostic (7.30e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (7.80e-2)" "unprognostic (4.01e-2)" 1.4 1.9 1.5 10.5 2.7 24.5 1.0 20.8 10.5 1.8 0.0 5.4 5.2 1.3 1.8 1.9 1.6 4.8 1.3 1.2 2.8 1.0 12.2 6.8 19.2 11.8 4.6 0.5 0.7 1.7 0.6 1.8 11.3 3.9 5.1 3.3 2.3 0.9 0.6 0.8 8.3 1.9 0.6 17.0 6.7 0.8 11.1 21.3 0.6 2.7 14.9 4.2 1.9 3.7 0.0 7.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 50.6 0.2 0.3 0.1 3.9 58.7 0.5 0.0 0.0 0.0 0.0 0.0 7.3 0.0 18.3 0.0 0.2 15.3 13.0 0.0 25.4 0.0 2.8 0.0 0.0 0.1 0.0 0.8 0.0 0.0 3.6 0.0 2.9 0.2 11.4 0.0 0.0 0.3 0.0 0.0 84.9 3.6 1.1 0.1 34.3 0.0 269.7 13.6 201.5 51.1 28.9 12.9 12.3 22.4 37.8 7.3 12.2 12.5 28.3 63.2 54.0 50.3 1.4 42.8 48.9 1.5 2.7 20.8 10.5 1.2 2.8 11.8 4.6 11.3 0.6 11.1 3.7 0.9 3.2 3.2 1.6 23.1 0.1 0.2 0.3 0.0 7.6 0.8 0.4 1.8 5.7 1.8 0.0 6.2 0.1 33.4 1.3 0.0 1.3 0.0 0.1 0.1 0.9 5.4 16.0 33.2 0.9 0.1 2.0 8.2 0.5 50.7 0.0 2.2 12.6 0.6 3.3 29.6 7.7 14.2 2.2 0.0 0.4 0.6 18.5 0.0 1.9 11.8 1.3 87.6 2.0 1.6 0.4 2.8 1.2 6.3 0.1 0.2 1.5 2.3 1.0 6.6 3.0 1.1 0.0 1.5 0.3 0.1 0.0 31.0 0.5 0.5 0.3 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;skeletal muscle: 42.0" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 186.5;Plasma cells: 64.8;Urothelial cells: 106.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 13.9;memory B-cell: 12.3;naive B-cell: 15.2" "Group enriched" "Detected in many" 16 "B-cells: 15.2;granulocytes: 13.9" "Group enriched" "Detected in many" 7 "Daudi: 88.7;HEL: 92.0;U-266/70: 143.5;U-266/84: 59.1;U-698: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus" "HPA058937: AB_2683858" "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.9 17.7 15.1 35.2 4.8 5.3 29.8 21.6 3.7 10.2 4.7 7.3 2.5 1.1 2.4 2.5 6.5 34.2 15.1 20.2 6.5 5.5 7.7 27.9 37.4 27.1 1.0 3.4 6.8 2.4 11.0 34.6 1.6 6.6 1.0 6.1 2.0 42.0 1.8 4.7 4.7 25.0 14.8 7.4 0.9 30.7 4.2 6.7 17.6 33.6 6.7 1.2 56.4 0.1 0.0 0.0 0.0 0.0 0.5 0.2 1.2 0.7 4.3 12.4 2.3 0.5 88.7 0.4 0.7 1.0 0.1 0.0 0.0 1.1 9.0 0.8 92.0 0.6 0.0 1.3 0.4 12.4 0.1 0.0 0.1 0.2 1.8 5.3 0.8 0.3 4.8 2.0 0.0 0.7 7.2 0.4 0.5 0.1 0.2 4.1 0.1 1.0 5.3 0.6 0.0 0.0 0.3 4.6 0.1 0.1 0.4 1.7 0.3 0.3 0.4 0.8 143.5 59.1 38.7 0.2 0.4 0.3 13.9 0.0 0.0 0.3 0.0 0.4 12.3 0.6 0.6 0.3 15.2 0.9 0.2 0.0 0.3 0.1 0.0 0.8 1.1 17.7 35.2 29.8 21.6 15.1 20.2 37.4 27.1 34.6 25.0 30.7 56.4 41.4 0.0 5.8 2.0 46.7 5.4 31.2 0.9 0.0 1.6 4.8 2.8 50.8 1.5 3.7 5.5 0.0 0.5 3.6 1.1 11.7 21.1 1.6 10.0 3.9 57.9 0.0 7.4 4.9 54.6 1.3 4.4 3.6 31.0 17.8 2.4 60.7 6.0 44.5 0.0 3.5 0.0 2.0 9.4 26.1 0.8 0.9 29.1 40.9 34.7 13.8 0.2 0.0 2.5 186.5 44.8 0.1 1.9 64.8 37.0 0.2 14.3 3.9 1.3 0.0 5.5 4.1 1.4 2.1 0.4 3.7 0.5 8.1 3.8 0.4 106.4 RBAK-RBAKDN ENSG00000272968 "RBAK-RBAKDN readthrough" 7 4983718-5073221 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "testis: 57.6" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 33.6;Spermatocytes: 44.7;Spermatogonia: 39.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 2.7" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "unprognostic (3.78e-2)" "unprognostic (3.57e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (3.23e-1)" "unprognostic (5.44e-3)" "unprognostic (6.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.62e-7)" "unprognostic (2.86e-1)" "unprognostic (4.96e-2)" "unprognostic (9.57e-2)" "unprognostic (3.10e-2)" 0.4 0.3 1.1 0.1 0.6 0.5 0.3 0.9 0.8 0.4 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.1 0.4 2.9 0.2 0.3 0.3 0.3 1.2 2.1 0.3 0.3 0.1 0.1 0.1 1.4 0.2 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.2 0.3 0.4 0.3 57.6 2.3 0.4 0.3 0.1 0.2 0.2 0.2 1.1 0.7 0.2 0.2 1.4 0.2 0.5 0.2 0.5 0.3 0.3 0.2 0.9 0.2 0.5 1.6 0.5 0.4 0.6 0.0 0.2 0.6 0.0 0.8 0.4 0.5 0.6 0.6 1.9 1.7 0.0 0.7 0.3 0.9 0.4 0.5 0.7 1.2 0.0 0.0 2.5 0.1 0.3 0.7 0.1 1.5 0.2 0.1 1.0 0.1 0.1 0.6 1.1 0.1 0.7 0.6 0.7 0.6 1.4 0.0 0.5 0.8 0.7 0.5 2.7 1.0 0.5 0.6 0.5 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.4 0.4 0.0 0.2 0.2 0.1 0.0 0.0 1.1 0.6 0.9 0.8 0.4 2.9 1.2 2.1 1.4 0.3 2.3 1.1 11.2 0.0 1.1 0.7 7.2 7.5 6.7 3.6 0.6 27.9 9.2 11.0 0.0 5.7 2.8 1.8 12.5 2.7 13.2 0.6 5.9 6.6 7.6 3.3 5.6 7.2 2.4 4.8 0.8 5.3 7.1 6.1 1.1 3.3 1.3 6.4 6.8 7.7 6.9 26.9 0.9 2.1 2.0 5.0 9.1 4.5 15.8 5.4 5.4 1.0 6.2 15.0 22.6 0.5 1.0 8.2 6.4 7.5 4.7 10.6 3.6 8.3 2.7 33.6 6.6 8.1 6.3 44.7 39.5 0.8 7.2 2.2 9.7 4.4 2.8 5.3 RBMY1F MGC33094 ENSG00000169800 "RNA binding motif protein Y-linked family 1 member F" Q15415 Y 22168542-22182982 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 325 "U-266/70: 29.7;U-266/84: 35.2" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Nucleoplasm, Nucleoli" "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1J ENSG00000226941 "RNA binding motif protein Y-linked family 1 member J" Q15415 Y 22403461-22417881 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 193 "U-266/70: 25.2;U-266/84: 13.3" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RGS1 "1R20, BL34, IER1, IR20" ENSG00000090104 "Regulator of G protein signaling 1" Q08116 1 192575763-192580024 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 25.7;T-reg: 21.9" "Group enriched" "Detected in many" 5 "granulocytes: 25.7;T-cells: 21.9" "Cell line enriched" "Detected in some" 4 "U-266/70: 962.6" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 85.5" HPA074572 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "HPA074572: " "unprognostic (3.68e-3)" "unprognostic (1.14e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-1)" "unprognostic (4.37e-1)" "unprognostic (3.87e-3)" "unprognostic (6.61e-2)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.91e-5)" "prognostic unfavorable (9.57e-4)" "unprognostic (4.01e-2)" "unprognostic (9.90e-2)" "unprognostic (4.56e-2)" 34.7 88.2 18.2 170.3 17.4 151.6 57.9 22.1 77.4 50.7 42.2 75.4 24.7 19.2 5.2 68.3 22.8 112.8 31.4 14.6 43.7 19.9 59.9 78.9 142.9 39.1 21.7 14.3 19.1 25.6 40.0 22.2 27.9 50.7 112.7 26.6 56.0 13.8 2.9 17.9 72.7 44.9 29.3 74.6 36.6 8.5 25.3 154.2 23.9 5.1 90.7 127.7 39.3 46.7 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 4.3 0.0 0.0 2.8 4.6 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 220.6 0.0 0.0 0.4 5.6 0.2 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 962.6 4.1 3.5 0.0 0.1 0.2 0.0 0.0 25.7 0.8 0.1 1.9 0.0 5.1 4.5 0.7 0.0 0.4 3.7 0.1 0.7 0.1 4.9 21.9 0.7 18.2 17.4 22.1 77.4 14.6 43.7 39.1 21.7 27.9 29.3 25.3 46.7 10.8 12.8 103.2 0.0 170.6 49.2 6.9 0.3 5.7 0.7 11.7 18.7 1.2 4.3 13.2 0.0 0.0 2.1 148.8 1.4 0.0 1.4 1.8 1.7 2.0 32.7 4.8 16.4 0.0 2.8 2.8 15.4 47.4 2.5 1398.7 0.0 5.3 3.8 390.4 0.0 0.0 1.6 0.0 211.2 1133.6 7.4 3.1 860.4 250.8 7.5 333.9 0.9 2.1 0.0 0.0 0.2 3.5 0.7 902.4 3.7 1.3 1.2 11.3 1.9 19.7 2.0 8.5 0.4 1.2 3.5 40.2 6.0 748.2 0.2 4.0 8.3 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675671-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No "Cluster 48: NK-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 0.8 5.0 9.2 0.4 9.7 1.0 1.0 9.1 17.7 2.0 0.0 2.2 2.4 1.0 0.6 1.2 1.6 0.4 2.4 7.9 6.1 4.1 2.0 1.1 0.4 5.5 4.8 2.1 2.6 0.6 8.3 0.3 4.9 2.7 0.3 2.1 2.4 0.9 0.5 2.6 2.5 0.2 3.2 0.9 2.7 4.2 7.4 1.4 0.9 0.0 0.1 1.5 1.5 7.7 1.7 2.1 1.2 1.8 0.9 2.3 6.1 0.7 1.1 0.4 0.1 4.4 1.2 0.6 1.4 0.4 0.2 1.1 0.1 0.3 0.0 1.5 7.7 0.8 9.8 1.8 0.8 1.6 1.1 1.6 2.8 0.3 0.0 0.9 0.1 2.8 1.3 1.2 0.1 9.2 0.4 4.4 1.1 2.3 0.6 7.6 1.1 1.6 0.1 1.5 1.5 2.0 0.9 0.4 2.2 0.7 3.2 4.5 0.5 2.5 2.2 0.8 0.6 10.5 1.5 2.2 0.9 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 9.2 9.7 9.1 17.7 7.9 6.1 5.5 4.8 4.9 3.2 7.4 7.7 0.6 0.0 0.0 15.3 2.8 2.2 3.8 10.3 12.5 17.6 2.5 4.2 0.9 0.0 2.4 0.0 12.5 0.2 0.3 2.7 0.0 0.7 2.7 1.4 1.1 0.3 2.4 0.0 30.1 0.5 0.2 1.1 3.1 1.0 0.0 1.9 0.4 0.7 0.3 15.2 27.1 6.1 18.3 0.9 1.2 1.4 1.5 0.4 0.0 1.9 0.2 2.9 0.0 10.6 4.1 1.4 3.8 2.6 0.9 1.6 17.3 9.9 10.8 31.8 0.0 0.4 1.2 1.5 1.7 1.4 1.8 0.3 0.6 3.0 5.5 2.8 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487382-228496188 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 189.0" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol Yes No "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 26.8 66.6 16.2 7.5 16.2 11.3 25.8 14.8 24.3 40.5 3.4 28.1 8.6 31.8 4.3 59.1 28.7 5.6 35.4 15.9 16.9 40.7 52.0 23.6 7.3 19.4 15.2 39.3 34.5 22.5 47.7 5.5 18.4 33.5 3.7 9.0 39.7 8.2 64.2 45.0 22.5 5.6 15.6 37.0 27.6 20.8 18.5 8.5 36.1 19.8 6.1 29.9 41.2 19.8 26.7 23.1 14.8 28.9 16.8 12.5 26.6 21.5 17.3 15.6 12.7 12.8 19.2 65.9 43.1 28.9 11.4 20.9 19.1 22.1 5.8 25.9 28.5 20.8 13.2 12.6 46.1 22.1 34.4 20.4 44.7 11.6 15.8 18.3 14.0 52.6 35.6 115.2 12.4 17.7 35.2 20.8 30.7 19.1 24.0 27.8 12.5 61.5 11.4 17.2 29.9 30.0 21.9 44.1 62.3 4.3 34.6 50.2 27.8 18.3 16.9 19.6 19.3 189.0 56.7 36.4 46.7 22.7 28.7 0.0 0.5 3.6 0.6 1.0 0.7 0.5 0.7 1.0 0.6 1.0 0.6 0.7 0.1 0.4 1.4 0.7 0.6 0.3 16.2 16.2 14.8 24.3 15.9 16.9 19.4 15.2 18.4 15.6 18.5 19.8 54.0 25.6 15.5 8.1 47.2 36.2 42.9 10.6 38.7 85.2 59.5 58.5 70.8 65.8 14.2 40.5 18.8 19.7 52.2 39.8 113.5 15.2 0.8 35.5 47.2 32.1 40.0 118.4 16.6 24.5 27.1 54.4 34.7 32.0 44.5 45.0 41.7 67.4 27.4 55.5 17.2 36.6 2.0 40.1 30.5 4.2 24.5 35.8 39.2 12.2 29.7 145.3 62.8 7.1 12.6 21.4 23.4 25.9 35.4 44.0 32.9 126.4 10.3 47.7 19.7 52.2 38.4 4.2 21.5 57.0 55.3 17.6 54.6 217.5 38.6 31.7 ROR2 "BDB, BDB1, NTRKR2" ENSG00000169071 "Receptor tyrosine kinase like orphan receptor 2" Q01974 9 91563091-91950228 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "cerebellum: 7.2;spinal cord: 3.7" HPA021868 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA021868: AB_1856406" "unprognostic (9.38e-3)" "unprognostic (4.69e-1)" "unprognostic (2.26e-1)" "unprognostic (8.48e-3)" "unprognostic (1.23e-1)" "unprognostic (2.38e-1)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (8.03e-2)" "unprognostic (2.03e-1)" "unprognostic (5.76e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (2.16e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (1.25e-2)" 6.9 5.7 0.8 3.9 0.6 0.1 4.4 0.4 0.5 18.7 28.2 32.7 2.2 23.7 1.5 8.2 11.6 8.6 11.1 1.4 0.8 1.4 0.5 5.5 0.5 1.7 2.1 13.9 1.6 16.6 1.6 3.5 0.9 13.9 2.2 1.0 1.6 13.3 0.3 4.2 7.7 11.0 1.2 3.3 12.8 3.4 1.2 3.0 5.6 0.7 1.0 17.5 10.6 0.7 0.0 0.2 24.5 0.0 5.3 0.5 6.8 0.4 6.3 4.0 7.8 0.0 0.0 0.0 0.1 0.8 3.9 0.2 5.2 0.0 1.7 0.0 4.2 0.0 18.3 0.0 63.1 0.0 0.0 52.2 0.0 5.6 0.0 0.0 0.0 0.2 14.7 0.0 0.0 0.4 0.1 3.6 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 7.2 0.6 0.0 0.0 5.0 14.8 0.0 0.0 0.0 4.8 2.0 0.0 38.3 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.5 1.4 0.8 1.7 2.1 0.9 1.2 1.2 0.7 0.3 0.0 0.0 1.6 0.1 3.1 11.3 0.9 1.2 1.4 3.7 3.0 8.2 1.5 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.5 4.5 18.4 19.3 1.4 3.0 0.0 1.4 1.5 0.2 14.4 2.6 7.5 1.3 0.1 0.4 0.0 0.8 0.0 18.6 2.8 0.0 0.0 4.8 8.6 5.9 0.4 5.4 15.9 1.6 7.4 0.0 27.6 0.4 0.6 1.6 9.1 0.1 8.6 0.0 0.0 0.2 0.5 6.6 0.0 2.9 2.3 14.3 0.1 2.3 0.4 0.7 0.4 0.8 5.3 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364616-89412273 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 129.1;Distal tubular cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 7 "granulocytes: 3.3;monocytes: 2.4" "Cell line enhanced" "Detected in many" "Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Vesicles, Centrosome" "HPA068664: AB_2686016" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 9.8 9.1 14.0 2.3 18.9 11.6 8.2 31.8 16.1 9.4 17.9 4.0 1.7 1.5 6.9 13.8 13.7 3.6 38.4 15.9 13.9 26.5 4.4 7.0 2.8 16.4 12.2 1.6 6.4 22.7 11.4 3.2 17.2 6.1 1.8 21.8 52.2 2.8 84.5 6.7 2.0 2.1 21.5 4.8 1.7 6.9 14.8 5.5 28.1 60.3 2.5 5.8 6.2 23.8 0.1 1.7 4.4 3.3 0.4 0.0 0.3 0.0 0.0 0.5 0.9 0.1 0.1 0.0 1.5 0.0 22.6 0.1 24.5 0.1 0.0 0.0 12.1 5.8 0.1 0.1 1.8 16.9 19.0 0.4 1.5 0.0 0.1 0.0 0.0 16.9 0.5 63.9 0.1 1.8 8.2 8.4 3.6 0.0 1.8 16.8 23.1 0.2 5.8 0.6 33.1 1.8 0.6 2.2 28.8 1.3 0.7 13.2 0.0 1.8 2.8 11.5 3.0 80.0 39.8 0.0 6.1 12.5 1.9 2.6 0.6 1.4 0.0 0.5 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.3 3.3 0.1 2.4 0.3 0.0 0.1 14.0 18.9 31.8 16.1 15.9 13.9 16.4 12.2 17.2 21.5 14.8 23.8 1.4 9.6 16.7 5.2 3.7 16.2 17.0 5.8 4.0 21.7 17.4 9.7 129.1 17.2 13.9 14.7 31.3 0.6 4.7 0.1 117.4 20.2 25.6 10.4 2.5 4.8 1.2 5.0 17.6 16.9 1.5 10.0 1.1 15.0 4.5 2.9 2.5 9.7 51.9 47.1 20.6 0.5 42.7 25.8 9.2 15.5 3.1 23.2 39.2 3.7 10.4 29.6 0.0 13.0 17.2 8.1 0.0 4.1 8.0 28.4 0.0 18.6 19.4 16.3 0.0 11.8 7.0 21.7 30.3 32.4 22.6 0.7 3.9 0.2 0.2 30.2 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.0" "Group enriched" "Detected in many" 6 "Early spermatids: 139.7;Late spermatids: 252.0" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 7.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 7.7" "Cell line enhanced" "Detected in some" "GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.3 2.0 7.7 0.2 9.4 0.2 0.4 5.9 11.8 1.0 9.4 0.6 0.2 0.8 3.5 0.4 12.4 1.3 0.4 8.3 9.9 7.3 0.4 1.5 0.2 8.6 10.9 3.9 0.9 2.4 3.7 0.1 7.7 0.8 0.2 11.4 0.6 1.7 0.7 1.1 0.3 0.3 7.6 0.5 0.7 25.0 7.2 0.1 1.9 0.1 0.2 0.2 0.4 9.5 0.2 2.5 1.9 2.0 0.0 0.9 0.1 0.0 0.5 0.4 0.4 0.4 0.7 0.5 0.7 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.1 1.0 0.0 0.2 0.4 0.0 1.2 0.0 0.8 0.0 1.0 0.0 0.3 0.3 0.4 0.0 0.6 0.0 0.1 0.0 2.0 4.2 0.0 2.7 0.9 0.0 0.0 0.1 0.1 0.3 0.5 0.0 1.5 0.5 0.1 0.0 4.9 1.9 1.6 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 7.7 0.1 1.8 0.0 0.0 0.6 7.7 9.4 5.9 11.8 8.3 9.9 8.6 10.9 7.7 7.6 7.2 9.5 1.9 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.0 1.1 0.2 0.5 0.1 1.5 3.7 0.0 4.2 0.0 0.2 0.0 7.9 1.0 139.7 17.8 0.5 0.4 0.0 0.0 3.5 0.2 0.0 0.5 0.0 0.5 0.0 1.2 0.7 0.0 0.1 11.8 2.8 0.1 0.0 0.0 0.0 252.0 2.1 0.3 0.0 0.0 0.0 4.6 0.0 1.0 1.1 0.4 0.0 1.9 0.1 0.2 0.0 17.7 29.2 5.1 0.0 0.8 0.9 29.4 8.3 0.0 0.0 0.0 0.4 2.8 0.1 0.3 RSPO2 MGC35555 ENSG00000147655 "R-spondin 2" Q6UXX9 8 107899316-108083642 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" "Developmental protein, Heparin-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;intestine: 13.9;placenta: 17.3" "Group enriched" "Detected in some" 8 "Excitatory neurons: 75.3;Inhibitory neurons: 86.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;U-266/70: 4.2" "Group enriched" "Detected in many" 7 "amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2" "Group enriched" "Detected in many" 4 "amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7" "HPA024764, CAB025900, HPA053068" Uncertain "Secreted in other tissues" NA NA "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031" "unprognostic (1.10e-2)" "unprognostic (2.18e-1)" "unprognostic (3.97e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.19e-1)" "unprognostic (8.33e-3)" "unprognostic (1.82e-1)" "unprognostic (9.48e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (8.45e-2)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" 0.2 0.0 2.8 0.7 4.4 0.1 0.0 1.3 16.2 3.4 2.6 13.9 3.4 0.0 1.7 5.9 0.0 3.2 0.2 6.6 13.2 0.0 0.4 7.1 0.0 2.6 23.0 0.3 0.0 0.0 2.9 17.3 2.0 8.7 7.8 0.3 0.0 2.3 0.0 0.0 4.6 0.3 2.1 0.0 7.6 0.7 3.5 0.0 0.0 0.0 0.0 1.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.4 1.3 16.2 6.6 13.2 2.6 23.0 2.0 2.1 3.5 6.6 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.3 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 86.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.0 1.7 0.0 0.0 1.0 0.0 0.2 0.0 0.0 SCGB2B2 "SCGB4A2, SCGBL" ENSG00000205209 "Secretoglobin family 2B member 2" Q4G0G5 19 34593329-34675699 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 8.6" "Cell type enhanced" "Detected in some" "Astrocytes: 63.6;Excitatory neurons: 32.8;Inhibitory neurons: 45.3;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 104.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;U-266/70: 1.0" HPA046806 Uncertain "Secreted in other tissues" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA046806: AB_10962373" "unprognostic (9.99e-2)" "unprognostic (3.62e-1)" "unprognostic (9.51e-2)" "unprognostic (1.38e-5)" "unprognostic (4.80e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-3)" "unprognostic (3.67e-1)" "unprognostic (3.52e-2)" "unprognostic (2.90e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" 0.3 0.4 0.7 0.0 1.0 0.1 0.9 0.4 0.9 0.1 0.1 0.2 0.1 0.3 2.6 0.9 0.3 0.2 0.3 0.6 0.7 0.3 0.5 0.5 0.3 1.0 1.0 0.2 8.6 0.3 0.3 0.2 0.9 0.3 0.2 0.6 0.3 0.5 0.7 2.9 0.2 0.1 0.5 0.4 0.3 2.0 1.0 0.1 0.5 1.1 0.3 0.4 0.1 0.9 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.2 0.4 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.4 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 1.0 0.4 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.4 0.9 0.6 0.7 1.0 1.0 0.9 0.5 1.0 0.9 0.0 0.0 0.0 63.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.1 0.0 0.2 0.0 0.0 32.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.3 0.0 0.0 0.0 0.0 31.0 0.0 0.0 3.6 17.8 0.0 0.0 0.0 52.8 104.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 SCNN1B ENaCbeta ENSG00000168447 "Sodium channel epithelial 1 subunit beta" P51168 16 23278231-23381294 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 82.8;intestine: 94.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Club cells: 64.8;Collecting duct cells: 57.0;Distal enterocytes: 262.8;Ionocytes: 107.8;Paneth cells: 73.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 26.4" "Region enriched" "Detected in single" 9 "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 33.3;RPMI-8226: 9.2;RT4: 18.5;U-266/70: 55.4;U-266/84: 20.2" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Low region specificity" "Detected in many" HPA015612 Uncertain NA NA "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA015612: AB_1856629" "unprognostic (7.45e-2)" "unprognostic (1.76e-3)" "unprognostic (1.39e-1)" "unprognostic (6.74e-3)" "unprognostic (1.74e-2)" "unprognostic (5.11e-3)" "unprognostic (7.74e-2)" "unprognostic (5.49e-3)" "unprognostic (2.60e-1)" "unprognostic (2.40e-1)" "unprognostic (3.68e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.32e-1)" "unprognostic (4.66e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-2)" 18.5 0.4 0.0 1.1 0.0 0.2 17.7 1.0 0.0 48.5 0.0 94.2 2.5 2.8 0.1 82.8 3.7 0.5 0.3 0.0 0.0 31.7 0.2 23.9 0.8 0.0 0.0 0.7 2.1 0.3 1.0 3.6 0.1 10.5 35.6 0.0 39.5 2.4 1.4 36.0 4.3 0.8 0.0 3.7 24.1 0.3 0.0 0.7 9.2 0.8 5.4 8.3 56.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 0.0 7.0 0.0 0.0 9.2 0.0 18.5 0.2 0.0 0.0 0.5 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 55.4 20.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.7 99.3 28.3 0.0 7.1 3.1 15.4 27.8 5.7 0.0 4.4 3.0 0.7 0.0 64.8 57.0 0.0 0.7 0.1 262.8 0.0 0.0 0.1 11.9 1.6 6.2 7.7 0.0 0.3 0.4 0.3 1.0 36.7 23.4 8.2 0.0 1.1 0.1 0.1 0.0 0.3 21.4 107.8 0.0 0.0 0.2 0.0 1.0 10.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 73.7 0.0 38.7 6.1 0.0 0.1 9.2 0.0 0.0 0.1 0.7 0.1 0.4 29.8 5.4 2.2 1.4 0.0 15.2 19.7 SCT ENSG00000070031 Secretin P09683 11 626309-627181 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 44.2" "Cell type enhanced" "Detected in some" "dendritic cells: 92.8;Enteroendocrine cells: 267.8;Intestinal goblet cells: 46.4;Proximal enterocytes: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 138 "plasmacytoid DC: 126.7" "Lineage enriched" "Detected in single" 138 "dendritic cells: 126.7" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050961 Enhanced "Secreted to blood" NA NA 571000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA050961: AB_2681291" "unprognostic (5.28e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.72e-1)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" "unprognostic (2.43e-3)" "unprognostic (4.19e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-2)" "unprognostic (1.88e-1)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (8.37e-2)" "unprognostic (5.45e-1)" "unprognostic (6.09e-2)" "unprognostic (1.13e-1)" 0.1 0.2 0.7 0.1 1.8 0.6 0.0 1.9 1.9 0.3 0.0 0.9 44.2 0.1 0.3 0.3 0.2 0.0 1.8 0.7 0.3 0.4 0.4 2.2 1.3 1.3 0.7 0.4 0.2 0.0 2.0 0.7 1.5 0.6 0.1 0.2 0.2 0.0 10.3 0.1 8.6 0.0 0.1 3.3 0.7 3.0 1.4 0.4 0.5 1.3 0.7 0.3 0.1 4.1 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.9 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.9 0.0 126.7 0.0 0.4 0.7 1.8 1.9 1.9 0.7 0.3 1.3 0.7 1.5 0.1 1.4 4.1 0.1 0.0 0.0 0.7 4.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.4 1.5 0.0 0.0 0.0 0.1 92.8 1.6 1.9 0.0 1.7 0.3 0.3 0.1 267.8 0.0 0.0 0.0 0.0 1.9 1.1 0.4 0.0 3.5 0.4 0.0 0.2 0.0 0.1 46.4 0.0 0.0 1.2 1.1 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.2 39.2 0.2 0.0 0.0 0.0 1.6 0.2 0.8 10.2 0.0 0.1 0.0 0.1 0.1 3.2 0.2 SEL1L "Hrd3, IBD2, SEL1L1" ENSG00000071537 "SEL1L adaptor subunit of ERAD E3 ubiquitin ligase" Q9UBV2 14 81471547-81533853 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 403.4" "Cell type enhanced" "Detected in all" "Plasma cells: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 339.5;U-266/84: 313.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024267 Enhanced "Intracellular and membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 25: Pancreas - Digestion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA024267: AB_1856659" "unprognostic (4.94e-1)" "unprognostic (8.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.91e-1)" "unprognostic (5.93e-2)" "unprognostic (1.16e-1)" "unprognostic (3.29e-1)" "unprognostic (2.78e-1)" "unprognostic (9.97e-2)" "unprognostic (2.58e-2)" "unprognostic (2.76e-3)" "unprognostic (4.86e-1)" "unprognostic (3.31e-2)" "unprognostic (1.30e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-2)" "unprognostic (1.25e-2)" 30.6 19.1 13.9 31.1 17.8 17.7 25.2 17.0 17.0 21.4 11.5 35.7 36.7 24.2 18.1 16.8 17.1 22.0 22.8 14.5 17.4 28.8 66.6 27.6 21.6 18.9 16.7 17.1 403.4 29.9 8.7 38.4 19.3 31.6 31.8 15.7 19.6 22.8 22.2 15.5 32.5 28.1 18.4 30.6 35.0 11.2 17.6 17.8 54.3 21.1 29.3 29.0 12.1 25.9 35.3 69.3 27.4 35.5 60.2 58.6 48.5 54.6 52.3 31.2 33.0 26.6 53.7 36.0 58.8 63.2 38.1 32.8 19.2 30.6 56.1 56.0 13.6 26.3 21.7 33.2 86.0 53.6 60.3 47.8 72.0 31.4 68.0 45.9 51.7 29.5 16.2 195.2 38.6 42.7 30.6 15.1 8.7 58.7 29.6 21.2 38.9 28.4 24.0 54.1 15.5 25.7 42.7 39.4 44.9 23.5 68.5 35.5 86.8 87.7 49.0 49.2 34.1 339.5 313.1 35.4 96.5 24.1 34.4 31.5 19.7 24.8 16.8 25.6 13.7 14.2 12.9 13.4 18.9 13.1 12.0 12.9 45.7 16.7 22.5 13.7 14.0 14.5 13.9 17.8 17.0 17.0 14.5 17.4 18.9 16.7 19.3 18.4 17.6 25.9 51.6 12.8 35.2 27.1 44.8 26.8 19.0 27.1 15.9 23.5 31.5 18.9 67.0 32.9 24.9 27.6 31.3 23.5 44.1 48.8 5.9 24.1 3.5 21.1 48.9 40.0 21.6 15.4 35.9 45.6 21.9 44.7 37.8 28.0 34.2 32.0 38.9 125.7 31.9 30.3 35.2 38.9 50.8 58.1 40.4 5.4 23.6 47.6 53.4 29.0 39.7 18.3 30.9 42.3 70.7 40.1 33.1 28.2 238.9 40.0 34.8 20.2 27.8 18.3 46.0 28.5 51.8 14.0 18.8 16.0 26.1 41.9 32.9 38.9 32.0 33.9 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 96.0 167.2 38.4 31.6 41.1 39.4 95.6 36.4 70.0 91.4 39.5 82.0 31.7 73.7 11.9 135.0 72.7 20.6 117.5 39.9 43.2 125.6 171.2 85.9 42.5 38.2 38.7 96.4 110.8 9.2 104.6 26.2 39.6 110.6 13.1 5.4 99.4 16.2 117.0 79.6 88.0 15.0 37.5 130.1 91.3 66.8 41.1 14.5 103.2 6.2 27.9 87.0 86.3 39.7 116.5 84.5 79.8 47.6 7.6 29.1 18.8 43.1 30.3 36.4 19.8 26.7 56.2 51.0 120.7 15.4 31.0 50.9 26.6 47.1 8.3 75.7 85.3 67.8 59.0 66.4 63.7 105.1 140.0 38.4 43.3 39.0 19.4 39.9 50.4 68.9 70.2 44.0 23.7 112.6 103.5 181.1 155.6 32.8 89.6 122.5 75.6 106.7 23.6 62.2 46.0 105.1 39.1 35.2 133.6 18.3 102.2 79.7 64.1 41.1 101.2 90.3 64.2 269.8 226.2 41.3 95.3 89.0 106.1 295.2 385.8 204.5 160.2 417.6 151.4 346.4 209.6 171.4 396.4 349.2 282.1 208.8 29.7 187.7 394.2 488.1 175.3 469.5 38.4 41.1 36.4 70.0 39.9 43.2 38.2 38.7 39.6 37.5 41.1 39.7 182.7 166.7 151.8 0.0 61.0 0.0 0.0 0.0 0.0 0.0 273.3 267.0 0.0 0.0 74.3 150.8 0.0 288.7 77.7 0.0 444.1 256.7 0.0 175.5 95.2 90.2 0.0 0.0 0.0 315.1 280.8 68.4 0.0 104.1 133.7 148.5 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.1 0.0 0.0 102.4 0.0 0.0 0.0 0.0 288.7 0.0 0.0 14.8 0.0 0.0 588.6 142.8 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 147.2 49.0 190.5 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690665-169711702 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 150.4;lymphoid tissue: 231.4" "Group enriched" "Detected in many" 5 "B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 4700000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 29.3 2.3 2.8 118.8 4.5 150.4 2.6 8.4 6.2 3.7 2.7 6.8 3.2 2.6 1.7 5.5 4.7 24.1 3.1 3.2 4.0 3.0 12.1 19.4 231.4 7.4 4.5 1.0 3.7 28.0 13.9 11.2 6.1 3.7 7.1 1.0 3.8 1.9 3.4 0.6 17.0 14.5 6.4 166.8 5.6 1.1 3.9 132.2 2.8 13.6 202.0 37.9 1.4 8.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.7 0.0 0.3 11.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 7.7 1.3 0.5 0.0 0.0 0.0 0.0 1.8 29.4 0.1 1.4 0.0 1.8 21.2 0.3 0.1 0.4 0.3 7.8 0.2 0.7 6.1 0.3 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.0 0.0 0.6 0.2 0.0 0.0 38.8 0.0 19.4 2.0 11.1 0.3 3688.4 992.6 1696.7 284.3 211.6 78.1 613.0 528.9 294.2 756.3 734.4 1169.2 683.6 4201.4 2551.1 93.1 622.9 1011.2 2052.5 2.8 4.5 8.4 6.2 3.2 4.0 7.4 4.5 6.1 6.4 3.9 8.0 1.8 9.6 13.7 0.7 221.4 0.4 0.3 0.0 0.6 0.1 0.5 0.3 0.6 2.8 1.8 11.0 0.0 13.9 206.0 0.1 0.0 0.2 0.0 0.1 0.0 3.4 0.0 25.2 0.2 0.0 0.6 3.3 2.6 0.1 10.1 0.5 3.9 1.1 5.6 0.0 0.1 0.1 0.0 68.9 2.7 0.2 0.6 86.3 1.8 1.0 208.7 2.5 110.2 0.0 0.8 0.1 0.0 0.0 25.8 0.0 0.0 0.9 1.5 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.1 28.5 104.9 0.5 0.0 0.6 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541998-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 542.5;U-266/70: 735.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 74.6 94.0 52.9 64.4 56.5 86.8 103.9 51.5 67.7 104.3 55.1 78.5 63.4 51.0 158.0 80.6 80.2 48.2 39.0 54.2 56.1 73.9 157.7 82.3 66.1 54.3 51.2 80.7 255.6 57.2 84.6 60.2 53.2 92.4 67.8 26.1 185.5 69.8 16.9 52.8 64.2 45.0 56.1 87.8 114.8 37.5 56.0 66.4 113.3 17.0 74.5 64.6 64.2 58.8 216.1 46.3 68.9 52.5 99.7 116.0 152.9 150.4 98.7 82.2 96.5 121.6 93.7 175.8 274.8 111.7 67.7 102.2 113.6 79.5 108.6 104.7 93.3 187.1 38.4 123.9 193.9 170.8 117.4 69.6 139.4 47.7 236.7 89.2 97.7 118.1 92.7 241.0 70.8 95.3 144.5 143.3 128.1 138.5 115.1 181.2 52.5 542.5 100.4 69.7 116.8 99.3 57.8 128.4 244.5 83.2 112.8 165.0 93.8 38.9 69.6 84.4 117.0 735.1 230.5 236.0 70.9 165.2 36.8 347.2 410.6 375.2 237.4 399.6 304.5 239.7 250.3 238.5 317.6 222.1 244.0 227.3 299.9 188.5 456.8 321.1 268.0 508.0 52.9 56.5 51.5 67.7 54.2 56.1 54.3 51.2 53.2 56.1 56.0 58.8 168.0 67.3 162.7 66.0 468.4 538.0 677.4 277.8 363.7 74.5 500.8 451.2 44.5 158.7 246.5 172.9 58.4 284.6 337.7 351.1 365.9 231.3 361.1 246.5 198.9 189.5 254.0 157.5 51.6 304.3 553.8 213.0 218.2 359.7 219.7 135.4 249.5 480.7 373.5 42.1 48.0 563.2 168.9 662.6 477.8 627.0 219.6 512.6 348.6 25.3 558.1 174.5 279.1 63.3 60.6 349.0 564.2 190.3 923.0 744.8 326.1 293.7 218.5 69.6 111.7 98.1 192.4 208.0 91.3 347.4 592.7 944.7 335.5 94.2 404.3 1101.9 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741125-150763477 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 85: Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: AB_2684470" "prognostic favorable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 15.8 78.6 16.4 20.8 19.0 44.7 17.1 17.4 24.9 48.0 17.3 17.7 13.5 33.4 18.6 46.1 27.2 14.3 16.2 16.9 16.7 12.1 61.2 13.2 35.8 15.8 15.5 24.4 20.9 15.9 11.0 43.1 17.9 19.4 15.4 7.8 16.4 34.7 12.3 30.4 12.9 29.4 15.5 24.4 17.9 8.0 16.5 25.1 8.0 12.8 45.3 23.5 39.6 26.0 54.0 13.4 10.5 20.1 35.4 26.4 41.7 22.9 26.5 27.3 32.4 28.4 24.7 31.3 31.0 24.1 22.8 31.4 28.6 20.7 25.6 24.4 19.5 61.5 16.0 94.7 50.4 34.3 16.0 24.1 47.0 16.3 36.9 21.7 21.5 60.2 15.5 110.8 17.4 66.4 58.7 17.4 33.1 52.3 26.0 44.0 22.7 110.4 17.4 17.9 38.4 19.1 17.4 15.4 39.8 23.8 99.5 50.0 15.0 17.7 15.8 40.1 31.0 130.6 55.9 42.0 17.6 48.6 9.2 8.9 2.2 8.6 1.6 1.2 2.5 2.2 2.8 2.5 2.0 2.2 1.4 1.4 4.7 1.4 1.3 2.6 1.6 0.9 16.4 19.0 17.4 24.9 16.9 16.7 15.8 15.5 17.9 15.5 16.5 26.0 15.9 6.4 4.8 6.8 99.0 146.7 82.3 11.8 153.1 47.0 32.3 22.2 17.8 25.8 11.7 22.0 37.5 192.0 62.6 30.2 13.7 8.5 3.4 56.0 29.2 22.5 38.3 226.7 14.1 6.6 23.4 28.8 44.4 96.5 10.2 18.7 20.7 54.4 32.6 35.3 11.0 39.9 14.2 115.5 102.7 2.1 44.1 70.4 44.4 14.0 22.7 32.7 32.0 5.0 11.5 10.5 17.9 30.9 128.7 56.7 20.7 17.9 16.5 2.8 13.1 11.8 29.9 0.7 10.8 154.1 142.4 389.4 86.1 28.6 34.5 81.8 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959117-31969751 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047122, HPA051959, HPA054419" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Mitotic spindle, Cytosol" "HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavorable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 21.9 33.1 0.0 5.2 0.3 4.1 21.6 0.0 0.4 26.5 0.0 25.1 10.5 22.6 9.4 23.0 25.0 0.0 22.0 0.0 0.1 24.0 54.7 22.2 3.4 0.0 0.5 24.6 25.7 2.4 39.7 2.6 0.0 31.9 2.4 2.1 22.4 3.2 20.4 20.2 31.2 5.7 0.0 40.6 27.6 16.6 0.1 4.3 27.7 5.3 2.7 23.6 20.9 0.0 0.2 12.7 13.3 0.0 16.5 11.8 27.1 10.9 11.7 13.6 13.2 0.4 0.0 0.0 26.0 25.5 13.2 11.9 0.0 30.8 9.9 14.8 15.7 0.0 0.0 0.2 0.0 0.1 0.2 28.3 17.9 0.1 0.0 12.7 0.0 19.3 0.0 13.6 0.0 0.0 0.0 0.3 20.6 0.0 0.0 0.3 0.0 0.0 11.2 0.0 0.0 0.0 23.6 0.0 17.6 11.5 0.0 15.7 12.8 16.0 7.2 18.7 0.2 42.2 35.7 12.0 20.4 0.1 0.0 0.3 0.5 0.2 1.5 1.4 1.1 0.2 0.7 0.3 1.1 0.9 0.8 0.8 0.1 0.0 2.2 0.5 0.2 0.4 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 6.4 16.0 11.3 10.1 13.3 2.8 5.0 7.9 11.4 5.0 9.3 5.1 8.5 10.0 8.8 7.3 8.4 12.6 12.7 19.7 1.9 9.5 3.1 7.7 7.9 7.9 12.6 6.5 7.2 8.6 7.9 7.4 28.1 6.3 8.2 10.8 8.6 19.4 9.2 0.0 5.0 13.2 8.2 6.3 4.1 1.5 9.3 7.8 7.2 2.8 10.2 4.9 18.6 3.0 4.8 9.4 16.0 6.0 20.2 5.9 25.5 6.9 16.5 8.3 0.0 4.1 10.2 4.7 7.5 6.6 3.7 12.4 14.4 12.3 11.0 5.2 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834582 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.6;Early spermatids: 20.5;Late spermatids: 36.2;Spermatocytes: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.0;U-266/70: 2.4;U-266/84: 2.0;U-698: 2.1" "Group enriched" "Detected in some" 11 "cerebellum: 3.7;pons and medulla: 1.2" "Region enriched" "Detected in single" 5 "cerebellum: 5.0" HPA071150 Enhanced NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 0.5 0.4 0.4 0.0 0.3 0.3 0.5 5.5 1.2 0.7 0.0 0.7 0.2 0.7 0.1 0.2 0.6 0.1 0.3 0.4 0.8 0.3 0.2 0.4 0.0 2.5 0.5 0.9 0.4 0.0 1.1 0.1 1.6 0.5 0.0 0.5 0.3 0.1 0.4 0.8 0.5 0.1 2.1 0.4 0.4 1.1 0.3 0.2 0.4 0.0 0.0 0.5 0.5 0.9 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.1 0.5 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.1 2.4 2.0 2.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 5.5 1.2 0.4 0.8 2.5 0.5 1.6 2.1 0.3 0.9 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.6 0.7 0.2 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 20.5 0.0 0.1 0.4 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 36.2 0.9 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.6 0.0 0.0 0.7 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.5 0.3 8.0 0.3 0.1 0.4 0.0 0.0 0.2 0.1 0.1 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.6;lymphoid tissue: 62.0;stomach 1: 34.2" "Cell type enhanced" "Detected in many" "dendritic cells: 58.3;monocytes: 120.2;NK-cells: 76.2;Plasma cells: 240.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "U-266/70: 283.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles NA NA 1200000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 2.2 3.0 0.2 34.6 0.2 9.7 11.3 0.2 0.6 3.4 0.7 32.6 32.2 2.2 1.7 5.9 2.1 8.7 1.6 0.2 0.2 1.4 7.9 14.5 50.8 0.4 0.2 2.3 1.1 0.4 0.3 1.4 0.6 2.6 28.6 0.0 13.7 2.4 0.5 1.7 25.5 3.7 0.4 42.3 34.2 1.4 0.3 14.7 1.6 0.2 62.0 22.2 2.1 0.5 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 1.0 0.8 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.2 0.0 7.6 0.0 2.5 0.7 0.0 0.2 0.0 7.2 0.0 0.0 0.1 0.0 0.2 1.4 0.0 0.1 0.1 10.0 0.0 0.8 0.0 0.1 0.0 0.0 59.5 0.0 0.0 0.1 0.2 0.0 3.8 0.0 0.2 283.7 26.4 0.2 7.9 0.2 0.0 0.2 5.1 1.4 100.5 34.8 77.3 11.0 10.2 69.0 23.6 2.3 3.0 40.1 3.5 55.5 53.1 89.7 0.0 33.6 0.2 0.2 0.2 0.6 0.2 0.2 0.4 0.2 0.6 0.4 0.3 0.5 0.4 9.6 6.0 0.0 37.4 0.8 1.6 0.3 0.0 0.0 0.2 0.6 1.3 1.5 1.0 0.0 0.0 0.1 58.3 0.2 0.0 0.7 0.0 0.2 0.2 1.4 0.0 3.6 0.0 2.7 0.1 1.7 1.5 0.4 8.8 0.0 0.7 0.6 8.4 0.0 0.0 0.0 0.0 7.3 9.2 0.1 0.0 28.2 19.6 1.0 120.2 0.0 76.2 0.0 0.0 8.6 0.0 0.0 240.9 2.5 0.0 0.2 1.7 0.0 0.0 4.8 1.3 0.0 0.1 0.7 0.4 0.3 37.1 0.0 0.4 3.7 SLC14A2 "HUT2, UT2" ENSG00000132874 "Solute carrier family 14 member 2" Q15849 18 45212995-45683688 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.5;kidney: 3.2" "Cell type enriched" "Detected in many" 7 "Collecting duct cells: 77.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enriched" "Detected in single" 7 "U-266/70: 4.9" "Region enhanced" "Detected in many" "basal ganglia: 16.9" "Not detected" "Not detected" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (2.33e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.54e-2)" "unprognostic (7.80e-2)" "unprognostic (1.11e-2)" "unprognostic (7.89e-3)" "unprognostic (3.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-3)" "unprognostic (8.96e-2)" "unprognostic (3.50e-3)" "unprognostic (1.20e-1)" "unprognostic (7.64e-2)" "unprognostic (7.52e-2)" "unprognostic (6.62e-2)" 1.5 1.1 0.2 0.2 0.2 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 3.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.7 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.2 4.9 0.2 0.1 0.2 0.7 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 6.4 9.6 5.2 0.7 0.6 0.9 0.3 0.0 1.1 0.4 0.3 0.9 0.0 1.9 77.3 2.1 0.3 0.6 0.3 0.0 0.0 1.3 0.2 0.3 0.9 0.0 0.0 8.8 0.0 0.5 2.4 0.0 0.3 3.8 0.1 1.1 0.0 0.4 1.7 10.6 0.5 0.0 0.3 2.0 1.4 0.6 0.8 1.8 2.8 0.2 0.9 1.0 6.6 1.0 0.1 1.2 0.7 0.1 0.5 4.9 0.2 1.5 2.0 0.0 0.4 0.2 0.3 0.4 0.0 0.1 0.8 1.0 0.2 0.2 0.5 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 9.1" "Cell type enhanced" "Detected in some" "Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075017 Approved Approved "Intermediate filaments,Focal adhesion sites" No NA "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 0.5 0.3 1.1 0.0 3.3 0.2 0.6 0.2 6.0 0.7 0.0 0.3 0.1 0.4 0.0 0.3 0.9 0.1 0.6 0.8 1.1 0.4 0.2 0.3 0.0 4.0 1.4 0.3 0.4 0.0 1.6 0.0 3.6 1.7 0.0 0.1 1.2 0.0 0.5 0.7 0.2 0.0 0.3 0.3 0.4 0.8 2.8 0.0 0.7 0.0 0.0 0.4 0.7 9.1 0.3 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.4 0.1 2.1 0.0 0.2 0.1 1.3 0.0 0.0 0.0 1.2 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.3 0.2 6.0 0.8 1.1 4.0 1.4 3.6 0.3 2.8 9.1 0.6 0.0 0.0 0.7 0.0 1.3 0.5 0.6 0.6 0.1 0.6 0.8 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.3 0.1 0.9 0.2 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.4 0.0 1.7 0.7 0.1 1.0 0.0 0.4 0.2 0.0 0.8 1.4 2.5 4.4 0.7 5.4 0.0 0.0 1.4 0.0 0.5 4.0 0.3 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 1.5 2.4 2.1 7.7 0.5 0.9 0.0 0.3 0.6 0.1 0.7 SLC23A1 "SLC23A2, SVCT1, YSPL3" ENSG00000170482 "Solute carrier family 23 member 1" Q9UHI7 5 139367196-139384553 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 54.2;intestine: 65.3;kidney: 40.2;liver: 22.5" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0" "Group enriched" "Detected in many" 5 "endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9" "Region enhanced" "Detected in some" "midbrain: 3.2" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047612 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "HPA047612: AB_2680102" "unprognostic (4.00e-3)" "unprognostic (2.66e-3)" "unprognostic (2.63e-2)" "unprognostic (1.75e-3)" "unprognostic (1.93e-1)" "unprognostic (6.36e-6)" "unprognostic (7.41e-2)" "unprognostic (6.55e-2)" "unprognostic (5.88e-2)" "unprognostic (3.90e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (4.16e-2)" "unprognostic (1.55e-2)" "unprognostic (3.65e-3)" 0.2 0.1 0.1 1.2 0.2 2.8 0.2 1.1 0.2 2.3 0.1 3.3 26.3 0.7 0.0 0.3 54.2 2.4 0.1 0.2 0.4 40.2 22.5 0.9 1.7 1.1 3.2 0.3 1.2 0.3 0.2 0.1 0.8 6.3 1.5 0.6 3.2 0.6 0.4 1.9 65.3 0.2 0.1 1.3 1.5 0.2 0.2 5.5 0.2 0.0 1.2 0.4 0.3 0.6 0.3 2.1 0.4 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.4 1.3 5.8 3.0 0.0 0.1 0.3 0.0 0.0 0.1 8.3 0.1 0.2 0.8 13.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 15.5 0.1 10.9 0.0 0.2 5.7 1.0 0.1 0.8 0.1 6.8 0.3 10.9 0.5 0.4 0.3 0.3 0.3 1.9 0.0 0.7 5.0 0.1 0.3 0.3 0.3 0.1 0.0 16.6 2.2 7.6 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.1 0.2 1.1 0.2 0.2 0.4 1.1 3.2 0.8 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.3 1.5 2.0 0.0 4.2 0.4 0.4 1.9 5.9 0.2 0.0 65.2 0.7 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 1.5 0.0 0.1 0.4 19.3 0.1 0.0 1.2 3.6 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.1 3.1 0.0 0.4 0.9 131.7 27.0 13.4 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.0 4.2 0.2 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 61.8" "Cell type enhanced" "Detected in some" "Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "U-266/70: 48.0;U-266/84: 36.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 4.1" HPA076165 Enhanced NA NA "Cluster 25: Pancreas - Digestion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA076165: AB_2732304" "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.0 0.0 0.3 0.0 0.4 0.3 0.6 0.2 0.2 0.1 0.0 0.3 0.6 0.7 0.0 0.2 0.1 0.2 0.2 0.3 0.2 4.3 0.0 0.1 0.1 0.2 0.1 0.0 61.8 0.3 0.3 0.3 0.3 0.1 0.2 0.2 12.9 0.0 0.0 0.8 1.0 0.2 0.0 0.0 1.1 2.0 0.1 0.1 0.1 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 48.0 36.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.2 0.3 0.2 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 4.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.0 0.9 5.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.8 5.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 SLC4A5 NBC4 ENSG00000188687 "Solute carrier family 4 member 5" Q9BY07 2 74216242-74343414 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Sodium transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 73.4;retina: 42.0;thyroid gland: 26.7" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 168.2" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 3.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-266/70: 8.8" "Group enriched" "Detected in many" 5 "basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5" "Low region specificity" "Detected in many" HPA036621 Uncertain NA NA "Cluster 11: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA036621: AB_10696779" "unprognostic (1.30e-1)" "unprognostic (3.78e-2)" "unprognostic (2.75e-2)" "unprognostic (1.83e-4)" "unprognostic (3.38e-1)" "unprognostic (2.36e-2)" "unprognostic (2.56e-3)" "unprognostic (5.37e-4)" "unprognostic (1.39e-1)" "unprognostic (2.55e-1)" "unprognostic (1.55e-3)" "unprognostic (3.24e-2)" "unprognostic (1.72e-5)" "unprognostic (1.57e-1)" "unprognostic (1.06e-2)" "unprognostic (8.47e-2)" "unprognostic (9.27e-4)" 1.6 0.7 3.3 1.1 5.2 2.3 1.4 12.5 4.6 1.3 73.4 1.2 0.7 1.4 2.3 0.9 2.1 1.0 1.4 6.1 4.1 1.0 1.0 2.6 1.8 5.3 4.8 1.6 1.5 12.4 2.4 0.6 4.8 1.2 0.7 42.0 1.7 1.3 1.8 5.0 1.0 1.5 2.8 1.3 0.9 16.1 5.3 1.0 26.7 1.5 0.8 1.1 1.1 8.5 0.3 0.5 0.9 0.9 0.9 1.6 0.9 0.2 0.9 0.5 0.7 0.3 0.7 1.5 0.2 0.0 0.3 0.1 1.0 0.1 0.2 1.2 0.6 2.2 0.7 0.5 0.1 0.5 1.3 0.4 1.3 0.0 0.2 0.5 0.3 1.0 0.5 1.5 0.2 3.5 0.3 1.5 0.4 0.5 0.3 0.8 0.7 0.0 0.2 0.6 0.6 1.2 0.3 1.1 1.6 0.7 0.8 1.5 0.0 0.9 1.6 0.9 0.3 8.8 1.4 1.0 0.6 0.8 0.2 4.3 0.3 0.3 0.6 0.3 0.4 0.7 1.0 0.9 0.3 0.9 0.8 1.0 1.9 0.7 0.1 2.5 1.2 0.2 3.3 5.2 12.5 4.6 6.1 4.1 5.3 4.8 4.8 2.8 5.3 8.5 1.1 3.2 10.8 16.0 0.5 0.6 0.6 0.3 0.0 13.9 0.6 0.5 0.4 1.5 2.6 0.0 35.5 0.1 3.3 0.3 0.0 0.4 0.6 1.0 0.7 0.9 0.0 0.4 7.3 0.6 0.0 0.8 0.0 0.8 0.0 1.1 0.7 0.0 0.1 168.2 10.6 0.5 0.0 0.0 0.4 0.6 1.2 0.4 1.8 4.7 0.1 3.3 2.1 4.0 31.1 0.5 0.3 0.4 0.1 0.6 0.3 0.1 4.1 40.4 0.0 2.5 1.1 1.7 1.3 0.0 0.4 0.0 0.6 0.3 0.2 0.7 SLC51A OSTalpha ENSG00000163959 "Solute carrier family 51 subunit alpha" Q86UW1 3 196211487-196243178 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "intestine: 64.5;liver: 71.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7" "Cancer enriched" "Detected in many" 7 "liver cancer: 15.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.9;U-266/84: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045488 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "HPA045488: " "unprognostic (1.63e-2)" "unprognostic (1.27e-3)" "unprognostic (2.80e-1)" "unprognostic (7.66e-2)" "unprognostic (5.16e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.02e-2)" "unprognostic (1.07e-1)" "unprognostic (5.98e-3)" "unprognostic (5.41e-2)" "unprognostic (2.90e-2)" "unprognostic (2.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-5)" 1.3 5.2 0.2 1.3 0.2 5.9 1.2 0.1 0.7 2.0 0.0 11.3 30.5 0.8 0.8 1.4 1.6 0.6 1.3 0.2 0.4 5.5 71.3 2.0 0.6 0.2 0.1 1.4 0.9 2.7 1.2 0.2 0.3 1.1 0.7 0.7 1.2 0.0 1.6 2.5 64.5 0.2 0.0 1.8 0.9 4.1 0.7 0.1 1.5 0.0 0.5 1.0 1.8 0.5 0.5 0.7 0.6 0.7 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.5 0.0 0.4 0.0 0.0 0.0 0.3 1.3 0.5 0.4 0.8 0.1 0.6 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 1.5 0.0 0.3 0.0 0.6 0.0 0.1 0.9 3.9 0.0 0.2 0.0 0.4 0.1 0.2 0.2 1.4 0.1 0.1 1.1 0.2 0.2 0.7 0.3 0.6 0.4 1.5 2.0 0.2 0.5 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.7 0.2 0.4 0.2 0.1 0.3 0.0 0.7 0.5 1.1 0.0 0.5 0.3 1.0 3.3 2.5 10.9 0.0 0.5 0.6 0.3 4.1 1.5 18.2 0.0 4.2 0.7 3.0 43.5 3.9 0.2 20.7 2.7 1.6 1.6 0.0 2.7 1.0 0.2 0.4 2.4 0.0 1.6 0.0 2.3 3.9 49.1 0.6 1.7 0.7 8.4 22.4 4.4 7.3 12.9 61.5 1.3 3.6 1.0 0.8 0.4 1.0 0.5 0.2 0.1 12.1 101.5 0.8 1.5 271.8 11.5 18.0 1.1 144.7 2.3 2.6 2.4 1.3 0.0 2.6 1.0 3.0 13.6 11.8 2.8 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019719 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 40.4" "Group enriched" "Detected in many" 4 "Early spermatids: 177.8;Late spermatids: 106.0;Spermatocytes: 224.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.0 0.8 1.7 0.6 2.6 0.6 0.5 2.0 2.1 0.4 0.0 0.4 0.7 1.3 2.1 0.3 0.6 1.5 0.8 1.2 1.8 0.5 0.2 0.5 1.0 2.5 2.3 1.4 1.2 0.7 0.5 0.8 2.9 0.9 0.7 1.7 0.2 0.7 0.2 1.8 0.5 0.6 2.5 0.9 0.4 40.4 2.3 1.1 1.0 0.0 1.0 0.8 0.2 4.1 0.1 0.0 0.9 1.5 1.9 1.4 0.3 0.3 0.4 0.0 0.1 0.0 0.1 0.7 0.2 0.8 0.3 0.0 0.7 0.4 0.6 1.5 0.9 1.2 1.0 0.0 0.0 0.4 0.2 0.2 0.4 0.0 0.8 0.4 0.5 2.0 0.5 0.8 0.7 0.6 0.4 1.0 0.4 0.2 0.0 1.3 0.8 0.2 0.4 0.2 0.9 2.3 0.2 0.3 1.1 0.6 0.2 0.8 0.3 0.4 0.1 0.5 0.5 2.5 1.9 0.7 0.5 0.4 1.0 0.2 0.2 0.0 0.4 0.1 0.5 0.5 0.3 0.6 0.2 0.5 1.5 0.9 0.1 0.1 0.1 0.6 0.6 0.2 1.7 2.6 2.0 2.1 1.2 1.8 2.5 2.3 2.9 2.5 2.3 4.1 1.3 3.2 1.5 26.1 3.4 1.3 0.5 1.8 1.8 1.8 1.0 0.6 0.9 1.5 0.4 0.0 16.7 0.6 1.1 0.2 1.9 0.3 177.8 0.8 1.1 1.7 0.0 0.4 6.0 0.4 0.4 2.3 0.0 0.6 0.0 1.9 1.4 0.2 1.3 3.3 8.3 0.1 6.1 3.9 3.1 106.0 5.3 1.3 1.8 4.7 1.5 2.5 1.0 24.1 40.5 1.1 0.0 3.0 1.8 0.9 0.4 0.9 0.2 5.0 0.0 6.4 1.8 224.8 9.5 0.7 0.6 0.5 2.9 2.0 0.3 0.6 SMTNL1 CHASM ENSG00000214872 "Smoothelin like 1" A8MU46 11 57542641-57550274 "Predicted intracellular proteins" "Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "skeletal muscle: 711.3;tongue: 192.9" "Cell type enriched" "Detected in some" 5 "Skeletal myocytes: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.6;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (1.35e-2)" "unprognostic (3.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.79e-3)" "unprognostic (3.09e-1)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (8.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.53e-3)" "unprognostic (4.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.04e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (4.49e-1)" "unprognostic (1.44e-2)" 0.4 0.2 0.7 0.9 0.1 2.3 0.4 0.2 0.3 0.4 0.0 0.2 0.3 0.3 0.0 8.8 0.5 0.3 0.3 0.2 0.2 0.2 0.8 0.9 0.8 2.5 0.6 0.5 0.1 0.0 0.5 0.1 0.5 1.6 0.0 0.6 6.1 0.0 711.3 0.3 0.5 0.0 1.3 1.1 0.2 0.5 0.9 0.0 0.4 192.9 0.0 0.2 0.4 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.1 0.7 0.3 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.6 1.0 0.0 0.1 0.4 0.0 0.6 0.3 0.7 0.4 0.4 0.4 0.2 0.3 0.5 0.2 0.3 0.6 0.4 1.1 0.2 0.5 0.2 0.2 0.1 0.7 0.1 0.2 0.3 0.2 0.2 2.5 0.6 0.5 1.3 0.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833834-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 37.8;choroid plexus: 15.0" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Early spermatids: 11.3;Excitatory neurons: 48.4;Inhibitory neurons: 34.2;Late spermatids: 12.3;Oligodendrocyte precursor cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.5;HSkMC: 5.8;REH: 1.9;SH-SY5Y: 2.3;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.3 0.1 22.8 0.1 24.0 0.3 0.3 17.1 37.8 0.6 15.0 1.0 1.0 0.7 0.2 0.1 0.7 0.8 0.2 23.7 17.8 0.2 0.0 0.1 0.1 18.1 18.2 0.7 0.1 0.2 0.4 0.0 18.3 0.2 0.4 1.1 0.0 0.1 0.0 0.4 0.5 0.5 16.9 0.2 0.2 2.1 18.7 0.4 0.1 0.2 0.2 0.4 0.2 23.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.5 5.8 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.0 1.9 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 7.0 1.2 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.3 0.2 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 22.8 24.0 17.1 37.8 23.7 17.8 18.1 18.2 18.3 16.9 18.7 23.1 0.3 0.0 0.6 25.5 0.6 0.4 0.3 0.0 1.2 2.4 0.7 1.0 0.8 0.0 0.6 0.0 0.0 0.1 0.1 0.6 0.0 0.1 11.3 0.3 3.6 0.6 0.0 0.8 48.4 0.0 0.4 0.9 1.1 0.5 3.8 2.8 0.4 0.0 0.3 0.0 34.2 0.8 0.0 0.3 0.3 12.3 0.3 0.2 1.8 3.7 0.0 0.9 1.0 12.1 10.2 0.2 0.5 1.2 0.5 0.2 3.9 0.4 0.7 0.6 0.0 1.0 0.8 6.1 1.7 0.5 0.4 0.0 0.7 1.3 1.7 0.1 SPACA3 "ALLP17, CT54, LYC3, LYZL3, SLLP1" ENSG00000141316 "Sperm acrosome associated 3" Q8IXA5 17 32970376-32997877 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 125.3" "Group enriched" "Detected in some" 75 "Early spermatids: 1298.4;Late spermatids: 933.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enriched" "Detected in some" 16 "U-266/70: 91.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA023633 Enhanced "Secreted in male reproductive system" NA NA "Cluster 37: B-cells - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA023633: AB_1857407" "unprognostic (6.48e-2)" "unprognostic (2.83e-1)" "unprognostic (1.30e-1)" "unprognostic (7.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.31e-2)" "unprognostic (3.37e-1)" "unprognostic (5.91e-2)" "unprognostic (1.68e-1)" "unprognostic (5.70e-4)" "unprognostic (3.86e-2)" "unprognostic (1.79e-1)" "unprognostic (4.63e-1)" 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.7 0.3 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 20.9 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.2 125.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 91.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1298.4 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 1.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 933.6 13.1 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 4.9 0.4 0.0 3.8 0.0 0.7 0.0 6.6 0.0 0.0 14.7 6.9 0.0 0.0 0.0 0.0 0.1 0.9 0.0 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25 component of NDC80 kinetochore complex" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.5;Erythroid cells: 29.9;Extravillous trophoblasts: 37.9;Muller glia cells: 17.2;Spermatocytes: 26.2;Spermatogonia: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "HPA047144: AB_2679952, HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.74e-6)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.6 0.8 0.6 0.7 0.6 4.2 1.0 0.3 1.5 0.7 0.5 2.1 3.7 0.5 0.0 4.4 0.3 0.5 0.4 1.6 0.7 1.1 0.8 0.9 3.9 0.6 0.7 0.5 1.3 0.1 0.1 1.1 0.8 0.4 1.6 1.7 1.0 0.0 0.6 1.1 2.1 1.0 0.1 2.1 1.6 3.4 0.6 8.5 0.2 0.1 3.7 0.5 1.5 1.8 1.0 16.8 40.6 22.8 1.8 1.9 14.5 22.9 9.3 23.5 18.1 5.6 16.2 15.7 9.0 3.4 31.9 20.9 15.9 0.0 20.7 10.0 21.5 30.2 7.2 2.2 0.1 20.3 8.9 0.3 1.0 14.3 0.0 4.7 10.3 28.2 0.8 15.7 6.4 9.8 16.1 26.3 0.9 11.2 21.0 28.8 38.1 5.6 9.6 13.7 30.4 0.5 16.8 14.4 3.9 13.5 0.4 16.4 2.5 3.6 42.1 13.4 18.2 31.4 56.0 12.5 4.1 0.5 14.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.6 0.6 0.3 1.5 1.6 0.7 0.6 0.7 0.8 0.1 0.6 1.8 0.4 0.0 1.1 0.7 4.2 5.4 1.5 7.1 1.2 0.0 1.5 2.4 0.6 0.0 2.6 0.0 0.0 23.5 1.5 3.7 0.0 0.2 2.0 0.5 1.8 1.6 0.0 29.9 0.3 0.0 37.9 4.6 2.0 1.8 0.0 10.1 2.9 1.2 15.1 0.0 0.5 5.2 2.0 1.9 2.4 1.6 0.6 2.0 0.0 0.0 0.0 17.2 0.0 5.0 0.2 0.5 0.1 1.2 15.3 1.0 1.0 0.2 0.1 0.6 0.0 1.3 4.4 26.2 20.1 7.3 1.4 5.7 2.7 1.7 9.9 2.5 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor Kazal type 2" P20155 4 56809860-56821742 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "epididymis: 5310.4" "Group enriched" "Detected in many" 10 "Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "NK-cell: 146.4" "Lineage enriched" "Detected in many" 7 "NK-cells: 146.4" "Cell line enriched" "Detected in some" 4 "U-266/70: 90.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB020824, HPA026813" Enhanced "Secreted to blood" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favorable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.5 0.1 0.1 1.1 0.2 13.5 1.3 0.1 0.6 1.3 1.8 2.8 1.9 0.3 5310.4 0.2 0.3 0.1 7.4 0.2 0.2 0.3 0.2 0.2 4.7 0.3 0.3 0.4 0.1 0.0 4.2 0.0 0.2 3.5 2.1 0.0 2.0 240.7 1.8 0.5 3.1 0.3 0.2 1.7 3.0 346.1 0.3 3.9 0.6 2.3 4.8 0.5 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.7 2.9 18.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 6.0 0.3 3.0 0.0 0.0 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 90.5 0.4 0.0 0.0 0.0 0.0 4.4 0.0 1.1 0.5 0.1 0.6 9.1 5.1 5.4 1.4 10.5 11.1 21.6 0.9 146.4 0.0 0.8 0.3 5.4 0.1 0.2 0.1 0.6 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.1 0.2 0.0 0.0 0.0 7.2 2.0 14.2 1.8 1.8 0.0 0.2 0.6 3.4 0.0 0.2 0.0 0.0 0.0 2.5 1.4 0.0 0.0 1217.2 0.2 0.1 1.6 1.8 32.4 0.3 0.0 0.3 0.8 0.5 0.2 1.3 0.3 0.0 0.0 0.1 0.0 0.2 10.4 0.0 0.0 3.6 1399.4 37.9 2.5 12.4 0.0 1.6 1.5 1.0 0.0 0.1 0.0 13.1 24.5 35.2 9.5 0.4 0.3 0.3 0.0 13.1 0.4 1.9 1989.6 149.9 0.1 0.3 0.0 16.8 0.0 2.6 2.6 SPOPL BTBD33 ENSG00000144228 "Speckle type BTB/POZ protein like" Q6IQ16 2 138501770-138573547 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034687 Uncertain Approved Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA034687: AB_10670573" "unprognostic (1.39e-3)" "unprognostic (1.24e-1)" "unprognostic (2.48e-2)" "unprognostic (3.02e-2)" "unprognostic (3.37e-1)" "unprognostic (3.12e-2)" "unprognostic (4.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (2.75e-2)" "unprognostic (8.90e-2)" "prognostic favorable (3.63e-4)" "unprognostic (2.25e-2)" "unprognostic (1.15e-1)" "unprognostic (9.09e-2)" "unprognostic (1.91e-3)" 7.9 5.9 6.1 9.7 8.1 14.2 12.7 6.7 8.0 6.6 4.8 8.3 7.9 8.5 3.6 6.2 6.6 7.3 5.4 5.5 6.2 8.8 9.4 7.6 11.3 7.6 9.1 10.3 5.6 7.3 4.3 6.8 7.9 9.4 8.9 9.8 11.5 8.1 4.6 8.5 8.4 7.4 7.6 11.2 9.3 3.7 7.1 4.9 8.5 8.0 9.7 8.0 6.3 9.1 13.3 4.0 7.2 7.0 5.8 9.7 13.8 9.6 7.2 5.9 7.0 14.8 10.6 14.2 9.0 8.3 5.3 5.1 9.5 8.4 12.4 11.1 7.7 9.0 9.2 23.2 6.0 10.0 12.1 6.4 12.3 11.7 10.8 12.0 9.6 3.3 3.0 19.2 10.1 12.9 1.0 9.4 6.5 9.3 6.9 5.0 12.6 8.1 9.3 18.7 8.4 10.3 14.7 13.8 7.3 8.5 7.6 10.9 9.6 9.5 8.1 12.0 14.7 27.6 21.6 10.3 15.9 9.2 8.8 0.4 1.6 2.8 0.3 1.5 0.3 1.1 0.2 0.3 2.2 1.1 0.1 0.2 5.7 0.4 1.3 0.9 0.4 0.6 6.1 8.1 6.7 8.0 5.5 6.2 7.6 9.1 7.9 7.6 7.1 9.1 16.9 12.8 13.6 25.8 25.9 55.6 11.4 7.9 13.6 9.9 38.8 13.8 13.2 15.7 20.6 3.7 4.2 6.4 15.0 20.3 7.9 10.1 1.7 11.9 10.3 12.4 19.2 5.0 55.3 13.3 7.3 12.3 17.3 11.8 8.8 12.5 8.9 13.8 8.9 18.5 67.2 19.8 18.3 31.5 37.7 2.8 17.1 33.2 12.4 48.7 27.5 9.2 9.2 63.8 54.1 21.1 12.6 15.8 11.8 19.5 11.0 16.4 16.1 16.6 6.6 18.8 18.5 10.0 18.8 10.3 44.8 6.2 10.8 4.9 12.0 21.3 ST6GAL1 SIAT1 ENSG00000073849 "ST6 beta-galactoside alpha-2,6-sialyltransferase 1" P15907 3 186930325-187078553 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 495.9;lymphoid tissue: 148.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 237.3;Hepatic stellate cells: 258.5;Hepatocytes: 608.7;Microglial cells: 602.4" "Cancer enhanced" "Detected in all" "liver cancer: 70.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 250.6;U-266/70: 628.0;U-266/84: 887.9;U-698: 334.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015018, CAB016122" Supported "Secreted to blood" NA NA 15000000 3300000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 85: Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" "CAB015018: AB_629203, CAB016122: AB_627178" "unprognostic (5.85e-3)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.62e-1)" "unprognostic (2.64e-1)" "unprognostic (2.44e-2)" "unprognostic (1.38e-3)" "unprognostic (3.43e-2)" "unprognostic (3.17e-1)" "unprognostic (2.20e-1)" "unprognostic (3.99e-1)" "unprognostic (1.43e-1)" "unprognostic (1.91e-2)" "unprognostic (7.30e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-2)" 24.5 12.5 27.0 50.2 26.2 15.2 32.5 29.8 24.8 61.4 33.3 38.1 13.9 16.1 5.9 13.5 27.0 17.8 36.0 25.8 33.9 60.0 495.9 30.1 101.7 44.0 37.5 10.1 8.1 45.5 9.8 18.5 50.3 48.8 45.4 2.6 39.3 14.6 12.8 8.3 29.1 18.9 44.1 67.5 28.8 3.5 39.2 66.6 64.8 20.2 148.1 28.0 8.9 48.3 4.3 5.0 20.6 17.1 1.1 0.0 36.3 1.6 3.0 1.4 2.0 1.9 2.0 250.6 19.5 0.1 8.8 10.1 132.7 15.4 1.6 11.3 7.4 10.1 0.8 119.0 1.3 22.8 75.0 1.7 28.3 0.0 11.5 19.9 77.5 24.2 52.2 20.3 5.2 8.7 17.0 14.7 49.9 11.3 7.6 38.2 0.4 8.1 9.9 0.5 36.4 4.1 1.5 26.6 64.6 29.1 38.9 16.8 32.6 0.2 3.3 0.6 2.1 628.0 887.9 334.0 0.5 45.4 84.7 22.6 8.9 3.6 46.9 16.2 42.9 87.9 51.3 39.7 14.2 83.3 80.4 58.4 4.2 26.9 29.3 11.9 43.8 58.7 27.0 26.2 29.8 24.8 25.8 33.9 44.0 37.5 50.3 44.1 39.2 48.3 34.6 44.8 27.4 13.4 110.0 4.0 13.8 68.0 4.6 0.3 5.1 4.1 26.2 75.8 55.9 237.3 0.0 0.3 26.3 20.7 0.0 17.1 0.5 8.9 5.0 56.0 94.1 24.8 47.2 0.9 3.5 3.7 7.7 16.1 10.8 7.3 258.5 608.7 20.3 0.0 31.5 10.9 34.6 61.3 16.4 1.1 0.3 18.2 7.2 602.4 17.2 0.1 26.8 145.3 2.8 6.0 17.8 0.7 124.3 103.6 0.6 0.5 39.8 1.1 0.0 2.2 6.8 0.0 0.5 0.8 1.6 0.7 28.4 0.3 37.3 39.0 STARD6 ENSG00000174448 "StAR related lipid transfer domain containing 6" P59095 18 54324358-54357964 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 26.6" "Group enriched" "Detected in some" 53 "Early spermatids: 189.8;Late spermatids: 271.2;Spermatocytes: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;Karpas-707: 2.7;U-266/70: 3.2;U-266/84: 1.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (7.81e-2)" "unprognostic (1.50e-1)" "unprognostic (5.56e-3)" "unprognostic (1.70e-1)" "unprognostic (3.25e-1)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (8.98e-3)" "unprognostic (6.98e-5)" "unprognostic (1.90e-1)" "unprognostic (2.33e-3)" "unprognostic (2.68e-1)" "unprognostic (9.97e-2)" "unprognostic (1.91e-3)" "unprognostic (1.16e-3)" 0.1 0.3 0.3 0.0 0.5 0.1 0.1 0.5 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 26.6 0.6 0.3 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.3 0.2 0.1 0.0 0.4 0.1 0.0 0.7 0.1 2.0 0.3 0.1 0.0 0.0 0.2 0.7 0.3 0.5 0.1 0.2 0.1 0.2 0.3 0.7 0.1 2.7 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.7 0.3 0.7 0.7 0.4 0.0 0.1 0.2 0.0 0.2 0.7 0.2 0.5 0.3 0.2 3.2 1.6 0.3 0.9 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.5 0.5 0.6 0.4 1.1 0.4 0.3 0.5 0.1 0.6 0.7 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 189.8 0.0 0.1 0.2 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.4 271.2 2.5 0.2 0.0 0.0 0.0 1.3 0.0 2.0 1.6 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 103.9 3.5 0.0 0.0 0.3 0.2 0.0 0.0 0.1 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7147237-7804358 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 26.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 41.8;Excitatory neurons: 32.2;Inhibitory neurons: 39.3;Syncytiotrophoblasts: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 48.5;RPMI-8226: 69.8;U-266/70: 110.2;U-698: 47.2" "Low region specificity" "Detected in all" HPA002904 Enhanced NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 18.2 4.6 3.7 4.5 4.8 2.1 5.8 4.0 12.1 5.6 1.3 6.8 2.8 4.3 2.4 3.1 4.8 7.3 6.6 4.2 3.7 4.8 8.7 8.7 4.1 5.8 6.1 4.7 3.0 2.8 1.2 26.6 5.5 5.2 5.9 6.1 3.1 5.6 5.2 4.9 3.2 6.8 1.3 4.7 12.0 2.4 12.1 4.4 3.9 6.6 3.6 9.4 3.9 7.8 11.5 3.7 7.5 3.0 48.5 24.9 37.5 22.3 7.8 5.8 5.3 19.2 11.2 21.4 5.0 15.5 5.0 3.0 5.4 3.9 5.8 3.3 8.6 1.8 12.7 5.7 2.7 3.8 11.5 8.3 0.7 3.8 2.3 4.0 8.8 2.0 1.4 23.5 15.2 2.9 2.2 3.1 3.3 0.2 4.8 3.9 4.8 69.8 14.2 16.0 5.6 4.8 4.7 8.3 3.0 11.8 3.8 1.6 15.8 22.5 2.2 30.0 4.4 110.2 0.8 47.2 5.9 3.0 6.5 0.9 1.7 0.4 0.4 2.0 0.2 0.4 0.2 0.2 0.9 0.7 0.1 0.3 1.3 0.7 1.3 0.3 0.3 0.6 3.7 4.8 4.0 12.1 4.2 3.7 5.8 6.1 5.5 1.3 12.1 7.8 10.2 12.8 2.2 10.4 1.8 0.9 1.8 2.9 0.6 3.5 3.3 1.5 7.5 1.5 8.5 1.8 0.0 41.8 1.6 16.7 0.0 8.6 0.3 4.5 4.5 4.2 3.6 3.2 32.2 19.9 18.9 6.1 5.1 5.2 7.0 6.7 3.6 8.2 7.7 1.7 39.3 4.6 10.2 7.5 1.7 0.4 2.8 2.8 1.8 10.3 4.7 2.6 0.0 19.1 12.1 10.2 6.5 6.8 1.9 7.8 4.6 3.0 7.5 0.8 0.0 17.5 5.7 0.5 1.7 0.4 1.0 94.0 1.0 4.0 4.3 8.9 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 232.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 232.0" "Cell line enhanced" "Detected in many" "HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" NA Yes "Cluster 38: Basophils - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favorable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 5.5 1.8 1.5 7.5 1.7 13.9 4.3 2.2 1.6 6.0 23.9 4.2 3.8 3.5 6.4 4.0 14.4 4.8 7.1 2.3 2.7 5.3 2.5 16.8 8.4 3.8 2.9 2.8 1.5 1.8 2.1 1.6 3.4 5.4 2.4 0.4 15.3 5.8 14.9 3.3 9.9 2.8 2.9 19.8 7.1 3.8 2.9 17.4 25.2 8.2 6.0 5.0 3.6 4.6 7.1 1.0 0.1 0.5 0.9 0.9 0.4 3.1 2.0 0.8 2.1 0.6 5.8 0.1 0.5 5.3 2.6 0.8 0.1 0.9 2.9 15.1 0.4 5.8 0.2 0.0 1.7 1.7 23.9 3.1 2.1 6.1 1.0 2.6 1.4 1.1 0.3 5.6 6.8 0.3 0.1 2.0 0.1 1.3 1.0 0.0 5.6 0.7 2.8 0.4 15.6 1.2 1.0 9.7 0.8 0.3 2.0 0.3 8.8 18.9 19.1 0.5 0.6 28.5 7.1 0.6 12.0 8.3 0.6 232.0 16.0 0.8 37.3 3.3 22.0 1.0 14.7 25.3 4.6 0.3 15.7 19.3 35.5 43.1 1.4 1.3 16.4 18.9 1.5 1.7 2.2 1.6 2.3 2.7 3.8 2.9 3.4 2.9 2.9 4.6 2.8 16.0 13.1 2.3 23.5 4.6 2.9 4.4 1.8 0.2 4.4 3.7 4.1 1.5 15.9 14.7 2.1 1.3 334.2 1.0 5.9 0.8 10.8 51.0 3.0 4.2 0.0 4.4 3.4 0.6 0.5 4.8 17.3 37.4 135.4 0.4 3.9 1.9 4.2 0.0 4.8 1.8 4.1 11.5 20.3 18.1 0.0 26.6 10.6 28.1 17.6 0.1 132.8 2.0 2.5 0.6 0.1 0.7 135.2 1.8 2.0 1.9 51.5 0.5 0.0 2.3 2.4 2.1 8.4 2.6 4.4 1.9 230.2 0.9 1.3 3.1 TAC1 "NKNA, NPK, TAC2" ENSG00000006128 "Tachykinin precursor 1" P20366 7 97732084-97740472 "Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 55.6;lymphoid tissue: 46.1" "Cell type enriched" "Detected in some" 7 "Inhibitory neurons: 99.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-266/70: 22.8" "Region enhanced" "Detected in all" "basal ganglia: 560.0" "Region enriched" "Detected in all" 10 "basal ganglia: 388.8" HPA014429 Enhanced "Secreted to blood" NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA014429: AB_1857722" "unprognostic (9.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (2.08e-1)" "unprognostic (7.95e-2)" "unprognostic (3.24e-1)" "unprognostic (1.70e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (3.86e-2)" 2.1 8.6 7.3 10.9 34.2 0.0 2.1 2.0 12.1 0.6 1.9 9.8 8.3 0.8 1.6 0.0 1.0 6.6 1.4 6.1 45.1 7.3 0.3 0.5 0.0 53.2 55.6 0.2 0.6 0.5 1.5 0.0 21.5 1.3 3.6 3.4 6.8 2.1 0.3 1.2 10.3 7.5 16.4 46.1 3.0 0.4 23.9 0.1 7.4 0.0 0.0 1.5 0.8 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 34.2 2.0 12.1 6.1 45.1 53.2 55.6 21.5 16.4 23.9 6.4 0.1 0.0 0.0 2.9 0.5 0.4 0.1 0.0 0.0 0.0 0.4 0.6 0.3 7.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 13.2 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.0 99.4 5.4 0.0 0.0 0.4 0.1 0.3 0.1 0.0 1.9 0.0 0.0 0.0 1.5 3.4 0.5 0.0 0.0 0.0 4.2 0.3 9.1 0.0 0.0 0.0 1.1 1.3 0.2 2.1 0.0 0.1 0.0 0.4 0.0 0.5 0.9 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 5.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.6;REH: 5.0;U-138 MG: 6.6;U-266/70: 10.3;U-266/84: 4.3;U-698: 5.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.9 1.9 0.8 0.0 0.9 0.2 0.7 0.8 5.2 1.7 0.8 1.1 0.0 2.3 0.0 2.3 0.7 1.0 0.8 0.9 0.6 1.6 2.0 1.1 1.3 0.9 0.8 1.5 1.2 1.0 2.1 0.0 0.9 2.0 1.4 2.9 1.4 0.1 0.9 2.3 4.1 0.0 0.6 1.5 1.1 3.7 0.8 0.0 1.3 0.0 2.1 1.7 1.8 0.7 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.6 0.0 0.0 0.0 10.3 4.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.8 5.2 0.9 0.6 0.9 0.8 0.9 0.6 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TDRD15 ENSG00000218819 "Tudor domain containing 15" B5MCY1 2 21123968-21144368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.4" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Late spermatids: 12.1;Sertoli cells: 6.6;Spermatocytes: 34.5;Spermatogonia: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.5;U-266/70: 7.5;U-266/84: 3.0" "HPA051770, HPA054675" Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA051770: AB_2681601, HPA054675: AB_2682569" "unprognostic (4.20e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 12.1 0.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 34.5 8.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 TDRD5 "FLJ34823, TUDOR3" ENSG00000162782 "Tudor domain containing 5" Q8NAT2 1 179591613-179691272 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 6.5;testis: 21.9" "Group enriched" "Detected in some" 4 "Early spermatids: 36.1;Late spermatids: 12.1;Spermatocytes: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.7;SK-BR-3: 5.8;T-47d: 10.3;U-266/70: 14.3;U-266/84: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA029418 Enhanced NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA029418: AB_10603035" "unprognostic (1.87e-1)" "unprognostic (1.43e-1)" "unprognostic (2.08e-1)" "unprognostic (2.15e-4)" "unprognostic (3.96e-1)" "unprognostic (4.39e-3)" "unprognostic (4.41e-4)" "unprognostic (3.18e-1)" "unprognostic (4.30e-1)" "unprognostic (3.75e-2)" "unprognostic (1.18e-1)" "unprognostic (3.37e-1)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (6.89e-2)" "unprognostic (2.31e-1)" 0.2 0.3 0.8 0.1 1.4 0.3 3.6 0.0 0.8 0.1 0.0 0.6 0.5 0.0 6.5 0.5 0.9 0.2 0.0 0.7 0.4 1.8 0.0 0.1 0.0 0.9 0.9 0.0 0.2 0.3 2.3 0.2 1.0 0.6 0.7 0.3 0.8 0.3 0.0 0.3 0.4 0.0 0.6 0.0 0.3 21.9 1.1 0.1 0.8 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.8 0.0 0.7 10.3 0.2 0.0 0.0 1.5 0.0 0.0 14.3 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.8 0.7 0.4 0.9 0.9 1.0 0.6 1.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 3.5 1.8 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 36.1 1.0 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.9 0.0 0.0 0.0 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 5.7 0.0 0.3 0.0 0.0 0.0 0.3 0.1 TEC PSCTK4 ENSG00000135605 "Tec protein tyrosine kinase" P42680 4 48135783-48269838 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 20.7;eosinophil: 13.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 20.7" "Cell line enhanced" "Detected in many" "HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005733, HPA024657" Approved Supported "Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "HPA005733: AB_1857878, HPA024657: AB_2671637" "unprognostic (7.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.41e-2)" "unprognostic (4.07e-3)" "unprognostic (4.21e-2)" "unprognostic (8.57e-2)" "unprognostic (3.14e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-2)" "prognostic favorable (7.12e-4)" "unprognostic (7.46e-3)" "unprognostic (7.83e-2)" "unprognostic (1.01e-4)" "unprognostic (4.24e-2)" "unprognostic (2.16e-1)" "unprognostic (7.39e-2)" "unprognostic (4.96e-3)" 0.9 1.7 0.1 2.1 0.2 6.1 1.4 0.1 0.4 1.2 1.0 1.3 1.6 1.1 4.2 3.4 1.9 1.1 1.3 0.0 0.4 1.1 2.5 2.0 3.1 1.1 0.3 0.4 0.8 1.2 0.6 1.1 1.1 0.5 1.3 1.8 2.3 1.0 0.6 3.6 1.5 0.8 0.3 1.7 1.1 1.2 0.7 2.0 1.3 0.5 3.3 1.0 1.6 0.2 3.0 0.8 0.0 0.0 0.0 0.0 0.1 0.5 2.2 1.3 2.7 0.0 2.2 1.9 2.0 0.0 0.1 0.6 1.1 0.0 1.8 0.1 0.8 13.5 1.0 0.1 0.0 2.2 20.3 0.0 0.3 1.7 0.0 1.4 0.0 0.6 7.5 0.5 4.1 1.0 1.3 4.9 0.4 1.4 0.8 3.1 2.7 0.0 3.4 0.9 0.0 0.2 0.6 0.3 0.5 1.1 0.7 4.2 0.0 0.0 0.0 2.8 0.0 20.3 15.4 2.6 0.0 3.0 0.1 20.7 0.6 13.3 0.1 0.7 0.3 1.0 0.2 0.5 1.5 0.7 0.5 0.5 0.5 3.6 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.4 0.0 0.4 1.1 0.3 1.1 0.3 0.7 0.2 0.6 6.4 6.8 0.7 6.8 2.5 1.7 0.2 2.8 0.9 1.7 1.1 1.8 7.2 2.6 0.0 0.0 1.5 3.3 2.1 0.0 1.7 6.4 13.9 1.5 1.2 3.0 12.6 6.7 1.1 0.1 0.8 0.0 25.1 19.6 0.7 0.0 2.9 4.9 0.0 1.6 1.4 4.1 4.6 1.8 2.6 0.0 5.9 1.8 10.3 1.7 6.6 0.0 0.5 0.2 1.0 0.6 0.4 15.4 1.3 3.0 2.0 0.2 3.1 6.6 1.8 0.8 0.7 1.4 9.8 3.0 0.8 3.4 0.3 2.1 1.6 TIMD4 TIM4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919292-156963226 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 55.3;testis: 144.0" "Group enriched" "Detected in some" 23 "Early spermatids: 1336.2;Late spermatids: 1946.7" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.6;naive CD8 T-cell: 1.6;T-reg: 4.0" "Lineage enriched" "Detected in single" 18 "T-cells: 4.0" "Group enriched" "Detected in some" 18 "U-266/70: 96.7;U-266/84: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015625, CAB026027" Approved Approved "Plasma membrane" NA NA 32000000 "Cluster 35: T-regs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favorable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 14.9 0.4 0.4 6.9 0.3 16.1 0.4 0.3 1.4 0.1 1.8 1.1 0.4 0.0 1.3 0.1 0.1 1.3 0.7 0.5 0.4 3.4 16.3 1.6 55.3 0.5 0.4 0.0 0.2 0.1 0.0 5.0 0.5 0.3 0.8 0.0 0.2 0.0 0.1 0.3 1.7 1.0 0.3 8.0 0.2 144.0 0.5 22.4 1.1 0.0 17.4 4.8 0.1 0.5 0.1 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 96.7 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.3 2.4 0.0 0.0 1.6 1.6 0.0 0.0 0.0 0.0 4.0 0.7 0.4 0.3 0.3 1.4 0.5 0.4 0.5 0.4 0.5 0.3 0.5 0.5 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.4 5.9 0.1 1336.2 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.7 0.1 0.5 0.0 0.0 0.0 0.7 0.3 46.4 0.0 0.3 0.0 0.0 69.4 1.9 1946.7 14.9 1.9 0.0 2.8 0.0 0.0 1.0 0.0 0.3 0.0 0.0 10.9 6.5 0.0 0.0 0.8 0.0 0.0 13.1 0.0 0.1 16.6 8.1 0.0 0.0 0.3 1.7 0.1 0.1 0.0 TMEM143 FLJ10922 ENSG00000161558 "Transmembrane protein 143" Q96AN5 19 48332356-48364059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 43.6;skeletal muscle: 95.5;tongue: 61.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014476, HPA058645" Approved Approved "Nucleoli fibrillar center" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli fibrillar center" "HPA014476: AB_1858092, HPA058645: " "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (5.23e-2)" "unprognostic (2.50e-1)" "unprognostic (5.94e-2)" "unprognostic (2.11e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (4.08e-1)" "unprognostic (2.25e-1)" "unprognostic (7.29e-2)" "unprognostic (9.82e-2)" "prognostic favorable (1.53e-7)" "unprognostic (5.46e-2)" "unprognostic (1.24e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-1)" 6.5 9.0 5.2 2.6 6.0 2.7 5.2 5.3 6.8 4.9 4.3 7.2 4.5 4.3 2.5 4.6 4.5 3.2 43.6 5.2 5.4 10.4 18.1 4.3 3.7 5.5 5.5 4.7 5.7 3.7 5.1 2.7 5.5 5.3 2.7 3.3 5.6 2.6 95.5 5.8 6.8 2.2 4.7 7.7 6.8 4.2 5.7 6.2 6.4 61.2 2.3 6.2 4.3 5.9 4.6 7.4 2.3 4.2 4.5 6.3 4.7 4.2 2.5 2.9 3.7 6.3 5.9 8.6 7.5 2.8 1.4 5.2 2.3 3.0 1.6 10.6 5.2 5.2 6.3 10.1 3.6 4.1 4.8 5.8 3.7 1.5 3.7 3.3 2.4 12.9 3.8 12.5 3.1 2.6 5.9 14.8 2.9 8.7 2.5 8.6 1.4 14.2 3.9 3.4 8.6 8.5 2.5 3.1 2.1 2.6 4.4 2.9 2.9 3.5 3.9 2.6 1.6 24.3 8.2 6.5 2.9 5.4 2.8 1.9 1.2 1.4 2.2 0.7 2.7 2.1 1.7 2.1 1.5 1.5 2.6 1.5 1.0 3.4 1.2 0.6 1.3 1.3 5.2 6.0 5.3 6.8 5.2 5.4 5.5 5.5 5.5 4.7 5.7 5.9 2.3 3.2 1.1 8.1 3.7 0.3 3.0 3.4 2.8 3.3 3.2 1.8 27.0 0.0 2.0 1.8 8.4 9.5 2.8 3.7 13.7 3.5 0.7 2.0 1.4 2.2 3.0 4.8 9.8 2.4 6.1 3.3 5.6 1.3 1.3 4.6 1.4 7.5 5.5 0.0 8.7 4.4 4.1 2.1 1.0 1.3 2.5 2.6 8.8 6.5 2.5 3.9 2.1 5.5 9.9 1.2 7.1 1.2 7.6 0.9 8.5 14.6 5.3 6.7 0.0 2.5 3.1 8.7 5.5 3.1 1.0 3.7 3.6 3.4 4.3 1.2 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: AB_2682604" "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favorable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 114.9 119.8 59.6 68.7 62.3 82.4 112.4 59.9 74.5 111.8 71.3 117.4 66.8 108.0 22.3 114.7 110.9 48.0 129.9 57.0 61.3 119.3 162.6 128.5 75.2 72.1 65.6 106.5 127.3 83.2 154.2 50.3 63.7 126.3 33.9 39.1 109.2 45.6 112.7 128.6 135.7 35.2 58.9 191.5 115.5 101.2 66.1 71.9 133.2 48.2 47.8 103.3 113.1 75.5 125.0 78.3 53.6 61.3 64.7 62.2 94.4 101.1 89.5 83.7 89.9 73.2 68.6 84.8 98.5 78.9 39.4 138.9 54.4 102.0 36.9 108.5 88.0 50.4 102.9 81.2 114.6 98.1 122.5 83.7 102.2 67.5 83.6 79.5 73.7 85.6 85.5 168.2 56.8 54.9 106.5 89.9 78.3 63.1 60.2 120.8 40.6 110.1 66.3 115.1 73.7 77.8 64.9 82.2 73.9 43.0 80.9 125.3 87.0 83.0 47.2 118.5 108.2 240.2 95.7 96.2 98.3 79.3 84.6 0.6 1.7 1.0 2.2 1.4 1.6 1.6 1.3 2.2 2.5 1.3 1.3 1.6 1.1 1.2 2.3 2.9 1.4 1.6 59.6 62.3 59.9 74.5 57.0 61.3 72.1 65.6 63.7 58.9 66.1 75.5 73.6 32.1 49.9 64.6 70.1 62.3 54.5 26.0 51.2 118.5 50.3 44.7 14.1 30.0 27.6 66.2 98.0 59.2 90.0 114.1 11.7 28.4 18.3 46.5 56.4 50.4 40.2 21.0 36.3 34.3 51.4 49.6 122.3 63.5 15.2 89.4 40.7 52.0 51.1 104.3 40.8 78.4 18.3 30.0 58.1 11.4 42.6 55.2 44.4 36.5 28.7 65.9 26.8 35.2 58.4 42.9 75.8 34.3 89.1 63.7 56.2 20.7 26.3 170.2 32.9 48.5 51.2 45.4 38.5 53.8 64.9 82.4 69.3 126.4 62.6 66.3 TMPRSS9 ENSG00000178297 "Transmembrane serine protease 9" Q7Z410 19 2360238-2426239 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 4.1;lymphoid tissue: 2.4;testis: 3.7" "Cell type enhanced" "Detected in some" "Early spermatids: 23.4;Erythroid cells: 48.6;Granulosa cells: 22.1;Late spermatids: 59.9;Theca cells: 41.0" "Cancer enhanced" "Detected in some" "liver cancer: 1.5;melanoma: 1.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2;SK-BR-3: 1.2;U-266/70: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051483 Uncertain NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA051483: AB_2681501" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (5.62e-3)" "unprognostic (1.86e-1)" "unprognostic (1.54e-2)" "unprognostic (1.87e-3)" "unprognostic (3.30e-1)" "unprognostic (6.44e-2)" "unprognostic (7.29e-2)" "unprognostic (2.07e-1)" "unprognostic (6.30e-2)" "unprognostic (9.20e-3)" "unprognostic (2.28e-3)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (3.07e-3)" "unprognostic (6.73e-2)" 0.1 0.7 1.5 0.1 0.5 0.8 0.4 0.7 1.3 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.0 4.1 0.0 0.1 0.6 0.4 0.2 0.7 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.2 0.0 0.6 0.5 0.1 0.0 0.1 2.4 0.1 3.7 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.2 0.0 0.3 0.0 0.1 0.2 0.0 0.3 0.4 0.0 0.3 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.7 0.1 0.3 0.3 0.3 0.3 2.2 0.5 0.4 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.5 0.7 1.3 0.4 0.2 0.6 0.4 0.7 0.1 0.6 0.3 0.2 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.0 0.7 0.2 0.9 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 23.4 0.2 0.5 0.1 0.0 48.6 2.4 0.0 0.1 0.5 0.0 0.9 0.0 22.1 0.7 4.8 0.2 0.0 2.1 0.0 0.0 0.0 0.3 59.9 0.9 0.4 0.0 0.0 0.1 0.1 0.0 2.5 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 11.0 3.5 0.0 0.0 0.5 0.1 41.0 0.0 0.0 TMX4 "DJ971N18.2, KIAA1162, PDIA14, TXNDC13" ENSG00000125827 "Thioredoxin related transmembrane protein 4" Q9H1E5 20 7977346-8019805 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 690.2;Late spermatids: 1524.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000399, HPA015752" Enhanced Approved "Nuclear membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear membrane" "HPA000399: AB_1858471, HPA015752: AB_1858470" "unprognostic (3.93e-2)" "unprognostic (5.96e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-3)" "unprognostic (5.14e-2)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" "unprognostic (3.66e-1)" "unprognostic (2.96e-1)" "unprognostic (5.80e-3)" "unprognostic (3.16e-1)" "prognostic favorable (2.60e-5)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" 19.5 38.8 19.8 18.5 20.5 30.7 19.8 17.1 27.5 41.7 29.2 24.4 13.4 29.3 33.5 15.1 29.4 19.8 59.4 20.7 55.8 29.7 28.8 19.4 15.0 29.0 24.9 35.8 15.1 38.0 28.9 12.1 23.9 26.6 12.9 37.8 37.2 42.3 30.3 8.1 14.3 26.7 20.6 17.6 17.5 64.9 43.5 15.3 26.4 32.5 14.7 17.9 13.7 18.4 10.4 14.5 14.0 15.9 30.4 33.5 4.2 25.7 34.0 15.4 11.0 10.0 24.0 27.3 20.2 24.9 22.6 9.5 10.1 15.2 16.0 14.0 12.9 13.1 5.7 16.0 28.6 48.5 19.0 20.5 19.1 13.4 31.0 36.9 18.1 19.5 16.3 65.4 17.3 6.7 1.5 30.3 12.0 14.9 16.5 17.5 50.4 27.6 21.8 5.7 28.1 35.2 42.2 1.9 24.6 8.8 17.7 23.4 26.1 41.4 12.1 15.9 25.2 69.3 21.6 51.6 20.1 23.8 29.7 81.5 28.0 78.2 39.0 16.4 37.9 35.8 39.1 55.8 32.9 27.5 23.4 32.0 164.1 41.8 18.0 11.2 55.1 52.7 19.8 20.5 17.1 27.5 20.7 55.8 29.0 24.9 23.9 20.6 43.5 18.4 52.7 35.3 29.2 22.2 66.4 16.4 65.1 23.7 22.2 57.9 38.6 52.6 257.5 40.0 20.8 58.8 58.4 19.5 91.5 21.9 21.5 31.0 690.2 266.2 44.4 49.7 55.8 51.1 85.8 32.7 5.2 80.3 38.7 29.4 60.3 34.5 45.7 53.3 24.7 92.5 68.6 21.1 40.7 33.8 40.3 1524.7 77.0 55.1 46.2 20.6 37.5 85.7 64.9 38.7 38.4 24.7 20.4 56.1 72.9 45.3 31.1 23.8 29.4 99.0 32.9 136.4 43.1 178.7 39.7 30.9 15.6 8.2 99.2 28.2 24.6 30.4 TNFRSF17 "BCM, BCMA, CD269, TNFRSF13A" ENSG00000048462 "TNF receptor superfamily member 17" Q02223 16 11965210-11968068 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.0;lymphoid tissue: 47.9;stomach 1: 24.4" "Cell type enriched" "Detected in some" 4 "Plasma cells: 449.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "memory B-cell: 124.9;naive B-cell: 108.5;plasmacytoid DC: 103.3" "Group enriched" "Detected in many" 63 "B-cells: 124.9;dendritic cells: 103.3" "Cell line enhanced" "Detected in some" "Karpas-707: 179.6;RPMI-8226: 296.0;U-266/70: 829.4;U-266/84: 453.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 2000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.35e-5)" "unprognostic (3.41e-2)" "unprognostic (4.00e-3)" "unprognostic (1.41e-2)" "unprognostic (6.47e-2)" "prognostic favorable (1.58e-6)" "unprognostic (9.75e-3)" "unprognostic (5.93e-2)" "unprognostic (2.13e-2)" "unprognostic (7.96e-3)" "unprognostic (2.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.85e-6)" "unprognostic (2.06e-1)" "unprognostic (2.48e-1)" "unprognostic (3.54e-2)" "unprognostic (1.10e-1)" 0.4 1.1 0.0 14.9 0.3 1.9 14.1 0.4 0.4 1.4 0.0 28.9 29.0 0.5 0.2 1.9 0.6 3.1 0.4 0.2 0.3 0.3 1.0 2.0 31.9 0.3 0.0 0.8 0.5 0.1 0.1 0.1 0.3 0.4 22.1 0.1 15.4 0.9 0.0 0.3 15.2 0.6 0.0 20.3 24.4 2.2 0.3 14.8 0.7 0.1 47.9 9.9 0.3 0.6 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.8 0.3 0.1 0.0 0.0 49.2 0.1 0.3 0.1 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 179.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.6 0.0 296.0 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.1 0.0 0.6 0.0 0.5 0.5 0.0 0.5 829.4 453.4 68.1 0.7 0.2 0.0 1.2 0.4 0.2 0.3 0.1 0.4 124.9 0.2 0.2 0.2 108.5 0.1 0.2 1.8 0.7 0.1 103.3 0.1 12.6 0.0 0.3 0.4 0.4 0.2 0.3 0.3 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 91.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 10.9 0.0 0.0 0.7 0.0 5.3 0.1 0.0 0.0 0.4 2.0 0.0 0.0 0.4 1.8 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 5.0 0.0 0.3 106.7 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 449.5 0.2 0.0 0.1 0.0 0.0 6.6 0.0 0.1 0.7 0.6 0.0 0.6 0.0 6.0 0.0 1.0 0.0 TOR3A "ADIR, ADIR2, FLJ22345" ENSG00000186283 "Torsin family 3 member A" Q9H497 1 179082070-179098023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 112.6;Plasma cells: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 281.7;U-266/84: 322.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028766 Approved "Intracellular and membrane" NA Yes 24000 "Cluster 19: B-cells - Humoral immune response" "Cluster 52: Non-specific - Ribosome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA028766: AB_10602251" "unprognostic (5.55e-2)" "unprognostic (6.52e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (3.90e-1)" "unprognostic (8.82e-3)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (4.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "prognostic unfavorable (4.78e-8)" "unprognostic (4.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" 17.0 15.5 16.9 30.8 17.9 39.7 19.5 16.4 18.6 16.7 19.3 26.1 23.3 16.1 12.8 15.8 17.8 18.1 12.8 17.2 19.4 17.0 27.8 20.4 46.4 18.3 17.2 14.8 23.4 22.5 16.9 15.3 17.2 17.9 26.0 9.5 23.9 17.0 24.4 17.8 23.1 18.8 17.6 37.4 26.5 4.3 19.9 26.7 18.6 13.9 44.8 23.3 13.5 19.3 56.8 65.5 18.6 52.6 38.2 29.9 57.1 41.4 50.0 48.0 34.8 29.8 86.4 90.0 70.2 41.1 28.9 68.5 53.7 34.6 25.3 70.8 49.4 98.3 38.5 45.9 62.9 109.6 80.6 33.1 31.0 35.3 31.9 19.2 35.5 34.8 123.9 164.3 33.8 121.4 66.3 60.5 38.6 68.0 36.4 49.4 33.9 88.4 30.5 76.8 37.8 49.3 61.9 96.9 25.5 32.5 71.5 80.1 22.0 36.2 25.6 59.9 54.3 281.7 322.8 77.4 25.1 77.3 26.5 5.2 71.3 19.3 33.6 56.5 41.4 97.8 29.9 37.7 85.7 73.1 22.7 27.6 14.1 31.5 59.4 93.1 43.3 53.3 16.9 17.9 16.4 18.6 17.2 19.4 18.3 17.2 17.2 17.6 19.9 19.3 24.8 3.2 11.7 4.9 65.2 17.0 14.0 19.2 10.8 3.7 14.8 11.3 11.5 25.8 11.1 11.0 10.4 30.1 32.5 18.6 3.9 34.0 1.1 10.6 16.8 19.3 14.4 18.3 4.4 44.5 57.5 19.8 20.9 11.1 10.8 14.3 13.9 10.7 57.4 0.0 4.6 18.9 32.6 22.0 112.6 1.1 17.1 36.4 16.0 5.6 50.6 17.1 16.5 3.0 4.0 18.9 17.9 18.8 153.7 19.5 15.1 10.3 13.4 9.6 6.6 18.9 17.3 0.8 5.3 12.7 15.8 10.9 24.8 21.2 27.0 12.3 TRAV22 "TCRAV13S1, TCRAV22S1" ENSG00000211802 "T cell receptor alpha variable 22" A0A0B4J277 14 22070557-22071208 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "lymphoid tissue: 22.8" "Group enriched" "Detected in some" 4 "NK-cells: 1.0;T-cells: 3.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 59.6" "Lineage enriched" "Detected in many" 6 "T-cells: 59.6" "Cell line enriched" "Detected in single" 5 "U-266/70: 2.7" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.18e-2)" "unprognostic (6.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.82e-3)" "unprognostic (3.00e-5)" "unprognostic (4.27e-1)" "unprognostic (3.45e-2)" "unprognostic (2.51e-2)" "unprognostic (1.40e-2)" "unprognostic (4.79e-2)" "unprognostic (2.93e-2)" "unprognostic (2.63e-5)" "unprognostic (6.15e-2)" "unprognostic (1.12e-2)" "unprognostic (7.56e-3)" "unprognostic (3.15e-2)" 0.1 0.0 0.0 1.9 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.6 0.6 0.5 0.0 0.6 0.4 0.6 0.6 0.0 0.0 0.4 0.2 1.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 1.1 0.0 0.2 0.1 0.1 0.1 0.8 0.1 0.1 2.3 0.6 0.1 0.0 22.8 0.2 0.4 4.5 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.0 0.0 2.9 0.0 35.2 18.3 0.0 0.1 31.3 18.7 0.1 3.8 0.1 10.3 59.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRIM61 RNF35 ENSG00000183439 "Tripartite motif containing 61" Q5EBN2 4 164954446-164977668 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 34.5;Late spermatids: 14.0;Spermatocytes: 50.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 15.1;SuSa: 10.2;U-266/70: 17.2" "Not detected" "Not detected" HPA049109 Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA049109: AB_2680636" "unprognostic (2.05e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (1.02e-2)" "unprognostic (8.24e-2)" "unprognostic (1.51e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (7.81e-2)" "unprognostic (1.51e-1)" "unprognostic (3.67e-1)" "unprognostic (2.92e-1)" "unprognostic (9.77e-5)" "unprognostic (4.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.36e-1)" "unprognostic (4.32e-2)" 2.1 3.6 1.9 2.2 2.2 3.7 1.3 2.2 2.3 2.9 0.3 1.3 1.9 1.5 2.1 1.0 3.5 2.9 3.0 1.8 3.1 1.0 1.1 2.2 3.2 2.4 2.6 5.0 1.4 1.1 1.0 1.7 2.3 1.8 1.4 2.7 0.9 2.0 0.9 1.1 1.4 2.2 1.7 2.1 1.3 8.9 2.5 2.6 5.6 1.4 2.9 2.3 0.2 2.7 0.9 0.8 2.0 2.1 1.1 1.1 1.2 4.2 1.3 0.9 0.8 0.7 1.4 0.9 1.1 5.3 1.0 1.0 1.4 1.5 0.9 1.6 0.8 1.6 1.5 0.9 15.1 1.6 1.4 9.0 1.3 3.7 1.4 8.5 0.8 1.3 1.8 3.6 0.8 1.0 1.4 1.0 6.5 1.0 0.7 1.4 1.1 1.2 0.6 2.6 1.7 1.1 1.0 1.5 1.2 10.2 0.5 1.6 0.9 2.7 1.8 0.9 1.7 17.2 8.2 2.3 1.0 0.9 1.9 5.4 1.4 0.1 2.9 1.2 3.3 3.5 1.8 3.3 1.5 5.8 4.4 3.6 0.3 8.0 1.1 4.1 0.8 1.4 1.9 2.2 2.2 2.3 1.8 3.1 2.4 2.6 2.3 1.7 2.5 2.7 0.2 0.0 3.3 1.0 3.8 0.3 1.2 0.4 0.0 1.1 0.1 0.1 2.3 0.0 0.2 3.7 4.2 0.3 2.3 0.0 0.0 0.3 34.5 0.4 2.1 0.9 0.0 1.3 1.9 0.7 0.0 1.6 0.5 0.1 0.0 4.8 0.0 0.4 1.1 1.7 1.4 0.0 0.0 0.6 0.7 14.0 1.2 0.9 0.0 0.0 1.7 2.7 1.0 3.5 4.3 0.1 0.1 1.5 6.4 0.6 0.0 3.7 0.1 0.4 0.0 1.5 1.3 50.1 3.7 0.2 0.0 0.3 2.2 2.8 0.0 0.6 TRIM69 "RNF36, Trif, TRIMLESS" ENSG00000185880 "Tripartite motif containing 69" Q86WT6 15 44728988-44767829 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.0" "Cell type enhanced" "Detected in all" "Early spermatids: 213.2;Late spermatids: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "T-reg: 4.2" "Lineage enriched" "Detected in single" 7 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4;U-266/70: 8.2;U-266/84: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA028894 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA028894: AB_10603136" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" "unprognostic (4.10e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-2)" "unprognostic (4.20e-1)" "unprognostic (9.27e-2)" "unprognostic (4.95e-2)" "unprognostic (6.49e-2)" "unprognostic (3.53e-3)" "unprognostic (1.38e-1)" "unprognostic (3.72e-2)" "prognostic favorable (2.26e-5)" "unprognostic (4.79e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-2)" "unprognostic (1.49e-2)" 0.8 0.8 5.2 0.4 5.2 0.2 0.8 4.7 7.1 0.9 4.5 1.2 0.4 0.6 0.4 0.7 0.8 0.5 2.8 5.0 5.1 1.6 1.5 1.3 0.9 5.2 5.0 0.8 0.4 0.3 1.5 0.2 5.1 0.8 0.5 0.6 0.8 0.2 5.9 1.0 1.3 0.6 5.0 2.4 0.7 35.0 5.0 0.5 0.6 6.0 1.2 0.7 0.8 5.4 0.1 0.1 0.2 0.6 0.2 0.7 0.0 0.1 0.3 0.8 1.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 1.7 0.0 0.2 0.1 0.0 0.7 0.0 0.1 0.9 0.6 0.1 0.1 1.1 0.2 0.7 0.0 2.4 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.2 8.2 2.3 1.4 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.6 0.8 0.9 0.0 0.0 0.2 0.6 0.1 0.0 0.2 0.0 4.2 0.1 5.2 5.2 4.7 7.1 5.0 5.1 5.2 5.0 5.1 5.0 5.0 5.4 41.8 6.4 5.1 9.4 22.1 21.3 21.3 8.0 12.0 10.8 9.3 9.1 60.2 8.6 11.0 9.2 4.2 6.1 20.4 16.5 41.1 42.1 213.2 9.0 12.2 22.2 4.2 5.7 16.0 16.0 4.2 17.8 13.7 10.6 14.0 10.5 11.4 5.1 36.3 23.5 9.8 7.5 8.2 25.4 39.7 93.9 9.3 22.6 12.4 1.0 52.7 21.2 20.6 9.5 1.7 14.8 13.4 11.7 21.9 11.4 18.6 27.0 8.8 4.2 6.6 27.0 19.7 78.8 1.7 25.0 41.2 1.5 25.6 5.1 7.0 52.5 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 16.4 17.9 21.4 14.8 23.0 19.8 17.8 22.2 27.9 17.1 15.4 20.6 11.6 17.4 28.1 15.1 14.7 12.3 21.9 21.1 22.6 14.7 15.3 16.6 19.1 23.1 20.4 11.6 17.3 15.9 11.8 17.5 22.5 17.2 13.6 21.7 15.2 15.2 36.2 14.1 11.5 17.8 19.9 14.7 15.3 14.6 22.3 28.1 21.0 22.8 18.7 16.4 12.3 29.7 83.3 28.2 39.2 41.6 30.1 31.7 96.6 40.1 77.9 64.1 61.7 30.0 35.8 54.3 40.2 50.4 41.0 38.8 44.2 38.7 69.6 78.1 23.4 28.2 19.7 34.7 60.1 103.4 32.3 21.1 67.2 29.7 60.9 25.4 38.1 95.5 55.9 144.0 59.7 43.4 97.8 46.5 72.6 107.6 30.7 60.3 65.0 113.0 37.6 26.6 35.2 52.3 54.0 39.0 102.7 41.2 51.1 57.8 20.0 39.5 83.9 26.5 61.9 190.4 141.7 87.1 36.7 52.5 86.1 33.5 16.7 24.7 33.7 27.5 30.2 24.8 32.3 35.3 35.9 18.1 24.4 33.7 3.1 54.3 25.4 31.8 39.8 35.0 21.4 23.0 22.2 27.9 21.1 22.6 23.1 20.4 22.5 19.9 22.3 29.7 15.5 48.1 8.1 22.2 26.1 11.1 12.4 17.3 16.5 8.7 18.4 13.7 32.0 10.0 17.1 12.9 4.2 42.5 31.4 3.4 54.8 33.0 1.6 6.7 13.1 15.9 6.7 22.7 30.9 41.8 48.9 20.0 14.3 11.7 32.3 18.0 18.2 34.0 31.7 3.3 32.7 8.4 10.2 13.1 29.1 2.5 21.8 16.6 33.8 13.1 21.6 19.8 64.9 42.7 91.7 35.9 4.5 19.5 45.7 13.3 5.4 71.4 6.9 12.5 13.1 11.3 24.9 46.0 44.6 23.1 13.2 22.6 34.8 19.1 9.8 10.5 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144707-129169699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 64.8" "Cell type enhanced" "Detected in many" "B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favorable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 3.2 4.4 8.2 9.1 8.0 3.9 3.0 6.9 7.2 2.0 5.4 6.4 3.6 1.5 10.9 3.9 2.1 3.1 8.6 6.8 11.9 64.8 28.2 5.0 16.3 10.8 13.4 2.4 21.2 11.1 19.9 3.8 12.2 7.4 3.4 1.3 18.8 7.0 13.0 7.6 12.3 2.2 11.0 16.9 6.2 11.4 14.1 6.7 8.4 4.4 14.4 7.9 3.8 10.0 1.5 4.3 1.0 23.2 0.0 0.0 0.9 0.0 0.2 0.5 0.1 0.7 2.1 18.4 1.8 0.4 12.9 1.7 12.3 4.0 0.5 18.7 14.0 38.2 0.8 8.2 0.9 5.5 0.8 0.9 3.8 0.2 1.2 0.0 0.5 9.4 0.4 2.6 0.0 4.6 11.5 0.1 8.5 0.8 4.5 3.9 0.5 0.4 1.4 5.0 5.8 6.9 2.3 0.7 13.6 5.3 4.7 2.4 0.1 0.1 1.8 1.9 0.6 48.8 5.8 8.1 0.4 18.4 2.7 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.6 1.3 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.4 8.2 8.0 6.9 7.2 6.8 11.9 10.8 13.4 12.2 11.0 14.1 10.0 0.9 0.0 0.6 3.3 27.8 2.5 0.7 0.8 0.6 3.5 10.5 9.8 6.2 0.0 0.2 5.5 4.2 0.1 7.6 0.7 13.7 2.2 2.5 2.7 0.5 1.4 3.5 5.2 3.6 8.7 0.2 6.7 0.0 1.6 0.0 1.4 0.4 15.8 8.4 0.0 1.7 0.6 0.0 23.6 84.0 4.2 2.8 32.0 1.8 3.7 44.8 8.4 0.0 3.5 0.1 2.4 1.1 32.7 1.3 1.9 1.0 59.2 2.2 1.7 0.0 11.3 1.0 0.8 4.1 0.4 3.0 0.1 2.2 8.4 0.4 1.3 TSPY1 "CT78, TSPY" ENSG00000258992 "Testis specific protein Y-linked 1" Q01534 Y 9466955-9469749 "Disease related genes, Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 74 "testis: 7.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 366 "U-266/70: 248.7;U-266/84: 249.2" "HPA049384, HPA067289" Supported Approved Cytosol NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 248.7 249.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY2 TSPYQ1 ENSG00000168757 "Testis specific protein Y-linked 2" A6NKD2 Y 6246223-6249019 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 7.5" "Group enriched" "Detected in some" 34 "Spermatocytes: 7.7;Spermatogonia: 27.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 656 "U-266/70: 107.3;U-266/84: 119.3" "HPA049384, HPA067289" Supported Approved Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (3.69e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.3 119.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY3 CT78 ENSG00000228927 "Testis specific protein Y-linked 3" P0CV98 Y 9398421-9401223 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 3.0" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "U-266/70: 148.5;U-266/84: 145.3" "HPA049384, HPA067289" Supported Approved Cytosol NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 148.5 145.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY4 ENSG00000233803 "Testis specific protein Y-linked 4" P0CV99 Y 9337464-9340284 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 138 "testis: 32.7" "Cell type enriched" "Detected in single" 11 "Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 591 "U-266/70: 1954.4;U-266/84: 2232.7" "HPA049384, HPA067289" Supported Approved Cytosol NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "HPA049384: AB_2680738, HPA067289: " 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.4 1954.4 2232.7 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY9P TSPY9 ENSG00000238074 "Testis specific protein Y-linked 9, pseudogene" Y 9487313-9489893 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 625 "U-266/70: 678.1;U-266/84: 699.0" "HPA049384, HPA067289" Supported Approved Cytosol NA NA "Cluster 29: U-266 - Adaptive immune response" Cytosol "HPA049384: AB_2680738, HPA067289: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 678.1 699.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUBG2 ENSG00000037042 "Tubulin gamma 2" Q9NRH3 17 42659284-42667006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB011495 Approved Supported "Centriolar satellite" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Centriolar satellite" "CAB011495: AB_443396" "unprognostic (2.60e-1)" "unprognostic (5.85e-3)" "unprognostic (6.21e-3)" "unprognostic (5.79e-2)" "unprognostic (1.33e-3)" "unprognostic (5.11e-2)" "prognostic unfavorable (4.68e-5)" "unprognostic (3.53e-2)" "unprognostic (2.20e-2)" "unprognostic (7.88e-3)" "unprognostic (1.82e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.31e-2)" "unprognostic (3.59e-2)" "unprognostic (3.73e-1)" "unprognostic (7.61e-3)" 20.7 38.8 87.1 6.4 94.1 3.0 21.3 78.1 109.1 38.5 67.3 34.2 6.1 28.2 14.6 13.8 28.6 10.9 24.3 87.8 81.6 35.1 18.1 18.6 7.8 90.0 84.4 28.2 76.0 18.2 43.8 9.6 88.1 33.7 5.4 13.9 17.0 22.9 8.8 13.5 14.4 14.3 76.4 17.0 30.5 19.1 94.3 5.8 23.7 9.0 5.5 33.1 31.4 99.3 10.2 20.2 9.9 14.6 38.4 20.8 6.4 17.7 19.8 13.8 13.7 11.4 7.0 5.0 10.6 25.6 14.8 36.8 0.0 16.1 11.3 9.9 11.5 3.8 29.0 23.3 16.6 0.0 13.0 22.7 16.1 15.7 17.5 24.0 10.1 11.4 1.1 10.8 27.3 20.9 9.8 8.2 3.5 10.1 5.1 7.5 6.2 11.3 15.0 10.4 11.2 7.6 11.3 18.0 12.1 17.7 34.7 4.8 11.7 43.9 3.1 11.0 10.3 56.5 10.8 1.5 15.6 0.0 26.3 0.0 0.9 0.2 3.0 0.5 1.4 1.2 3.3 1.1 0.9 0.5 3.5 2.3 0.2 1.0 0.1 4.5 1.6 1.8 87.1 94.1 78.1 109.1 87.8 81.6 90.0 84.4 88.1 76.4 94.3 99.3 6.9 3.2 4.2 22.9 3.6 5.5 15.9 7.8 36.5 17.6 9.6 13.7 11.3 4.3 5.6 3.7 4.2 5.5 3.0 0.5 17.6 5.1 7.7 1.8 7.9 7.3 1.2 24.4 44.9 9.1 4.2 13.4 14.3 1.9 11.4 6.7 9.3 3.7 3.6 20.2 33.1 1.7 2.0 2.5 3.7 11.1 17.4 2.8 16.0 10.3 3.1 7.8 1.0 19.6 25.8 5.1 0.4 21.4 9.7 5.2 0.1 24.3 7.1 5.4 13.1 10.3 11.4 5.1 5.0 9.4 4.0 2.5 3.9 7.9 0.5 7.3 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530032 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1" "Group enriched" "Detected in all" 10 "dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6" "Not detected" "Not detected" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 11000000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 46.8 19.5 6.1 77.7 6.0 22.0 37.9 7.1 7.9 32.2 12.7 20.4 26.1 7.8 0.5 58.5 30.0 7.2 26.7 6.4 8.6 38.2 82.0 63.4 31.5 22.1 18.3 4.0 13.8 4.5 8.8 15.4 15.9 21.0 3.6 0.0 40.0 5.6 10.7 24.5 32.5 9.1 10.9 86.1 31.2 3.0 18.0 15.6 25.4 1.6 15.3 22.9 27.0 12.2 27.0 2.5 0.4 0.8 1.8 2.2 5.1 3.7 0.5 6.1 17.4 0.1 40.0 1.8 4.1 5.8 1.3 21.0 0.2 1.0 0.0 9.0 16.5 1.8 3.9 3.5 95.2 1.3 26.9 4.7 4.6 5.4 0.0 0.1 0.1 0.5 2.8 68.6 0.9 1.9 1.5 9.9 0.6 1.9 9.1 5.7 0.4 35.1 0.3 1.2 0.7 5.6 22.9 17.3 6.5 0.2 4.2 13.8 6.7 0.8 4.7 1.5 1.5 68.6 15.9 5.7 1.9 1.5 1.6 19.5 135.8 74.9 2.0 98.4 1.2 6.7 2.9 1.2 39.5 6.9 1.6 1.3 114.1 9.5 77.1 9.3 3.1 10.1 6.1 6.0 7.1 7.9 6.4 8.6 22.1 18.3 15.9 10.9 18.0 12.2 122.6 12.8 29.0 0.3 122.9 58.5 57.4 169.9 53.5 3.4 101.5 90.8 3.2 50.1 88.6 33.1 4.2 17.2 65.8 154.8 29.4 340.2 2.2 55.7 56.0 55.7 16.8 19.6 0.3 643.9 300.8 81.9 38.7 59.2 53.4 3.0 38.2 93.0 477.4 0.0 0.4 50.2 24.4 371.8 409.4 8.7 5.0 561.7 113.8 4.7 2174.6 2.9 71.1 0.5 0.2 364.0 86.4 1.9 102.1 109.8 214.5 105.1 78.0 6.6 26.3 93.3 62.4 1.5 8.0 71.7 56.7 33.5 62.5 3.7 51.1 76.0 UBE2J1 "CGI-76, HSPC153, NCUBE1, UBC6" ENSG00000198833 "Ubiquitin conjugating enzyme E2 J1" Q9Y385 6 89326625-89352722 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 498.7;Late spermatids: 1426.6;Plasma cells: 1003.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 294.1;Karpas-707: 247.4;U-266/70: 274.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003509, CAB073419" Enhanced NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB073419: , HPA003509: AB_1858531" "unprognostic (1.82e-1)" "unprognostic (3.20e-2)" "unprognostic (1.55e-3)" "prognostic favorable (2.87e-4)" "unprognostic (3.41e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (6.90e-5)" "unprognostic (1.19e-1)" "unprognostic (9.36e-2)" "prognostic favorable (7.43e-4)" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (5.11e-2)" "unprognostic (2.83e-1)" "unprognostic (3.87e-2)" "unprognostic (9.38e-2)" 25.9 23.2 14.9 52.3 15.9 119.3 31.4 16.8 18.8 33.3 15.0 48.9 55.0 27.8 28.6 23.2 20.9 26.6 14.7 15.2 16.5 22.0 26.9 29.9 90.5 16.9 17.8 23.7 32.0 21.8 12.9 33.3 17.1 42.3 49.6 19.4 44.7 21.2 12.0 14.3 45.9 30.2 16.9 43.7 49.1 24.6 16.2 57.8 31.9 15.6 97.1 36.7 14.5 18.3 38.8 13.4 36.3 46.5 37.0 47.8 0.2 60.4 53.4 36.7 40.0 21.9 23.7 294.1 32.9 63.0 30.6 15.3 23.9 35.1 59.4 41.6 37.0 53.6 16.1 36.0 98.2 68.2 33.4 36.7 34.4 30.8 52.1 48.9 83.1 34.7 43.9 247.4 43.4 23.8 28.5 52.1 12.5 27.3 19.0 110.1 46.5 143.6 46.2 26.9 18.3 36.7 25.6 55.7 56.9 52.2 22.0 149.3 56.1 20.2 19.1 36.3 47.0 274.1 146.1 80.0 40.3 48.3 34.4 24.6 13.5 24.7 6.2 22.0 7.2 37.5 8.2 7.6 12.4 29.6 7.6 7.0 30.7 12.8 37.4 45.5 13.0 13.3 14.9 15.9 16.8 18.8 15.2 16.5 16.9 17.8 17.1 16.9 16.2 18.3 65.3 16.0 33.9 18.6 185.6 24.9 60.0 39.1 31.3 34.6 39.5 29.5 9.7 30.0 38.5 20.2 29.2 89.7 136.8 71.0 50.9 60.5 498.7 35.6 50.3 104.6 77.3 34.7 26.9 101.4 91.8 60.0 72.9 50.2 25.3 27.1 99.2 45.5 75.8 23.5 28.9 80.3 42.7 107.7 53.0 1426.6 54.7 105.5 72.9 23.4 65.4 18.6 30.9 26.2 31.0 112.0 74.3 47.8 1003.3 99.5 72.4 49.2 33.4 16.0 32.9 54.3 61.1 22.5 20.5 54.4 34.7 129.4 52.3 32.6 65.0 123.7 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448859-6496723 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.1;heart muscle: 16.8;retina: 28.3;skeletal muscle: 54.5;tongue: 13.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favorable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 1.2 1.4 14.3 0.4 14.6 0.0 1.1 16.5 26.1 2.1 1.8 5.3 0.3 0.8 1.0 0.4 0.7 0.4 16.8 17.9 11.4 3.4 1.2 0.1 0.1 12.0 7.9 2.6 0.6 0.1 3.2 0.0 11.6 3.5 0.3 28.3 0.8 5.5 54.5 1.5 1.4 0.7 5.6 0.2 2.9 0.7 10.1 0.3 1.2 13.9 0.2 0.3 1.3 17.7 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 29.7 0.0 5.3 0.0 0.0 0.3 0.0 24.6 0.1 0.0 11.5 0.0 0.0 23.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.4 52.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 14.6 16.5 26.1 17.9 11.4 12.0 7.9 11.6 5.6 10.1 17.7 0.2 0.0 0.0 5.5 0.3 1.3 0.5 0.5 0.0 30.0 0.4 1.0 27.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 5.9 0.0 0.0 0.2 0.4 1.0 5.4 0.0 47.8 0.2 0.0 3.6 1.1 0.1 0.0 45.5 0.0 1.0 0.1 45.4 35.3 0.0 0.0 0.3 0.3 0.3 4.1 0.1 0.0 2.8 0.0 9.4 0.0 12.1 5.4 0.1 0.0 6.8 1.8 0.9 0.0 0.2 0.0 63.6 0.0 3.2 1.4 0.1 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 UCN "UI, UROC" ENSG00000163794 Urocortin P55089 2 27307400-27308445 "Predicted secreted proteins" Hearing Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Cell type enhanced" "Detected in many" "Astrocytes: 7.8;Excitatory neurons: 6.5;Inhibitory neurons: 5.5;Oligodendrocytes: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 19.4" "Low region specificity" "Detected in many" CAB010911 Approved Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 133000 "Cluster 40: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "CAB010911: AB_261834" "unprognostic (7.35e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.42e-2)" "unprognostic (5.08e-2)" "unprognostic (7.72e-2)" "unprognostic (5.69e-3)" "unprognostic (2.66e-1)" "unprognostic (2.48e-1)" "unprognostic (1.15e-1)" "unprognostic (3.80e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.84e-7)" "unprognostic (4.84e-2)" "unprognostic (3.87e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" 1.5 5.1 8.6 0.6 8.2 1.1 1.5 8.4 13.5 3.3 4.2 2.4 0.3 2.4 0.5 0.9 3.0 0.8 4.2 8.0 7.3 2.0 5.9 1.9 0.7 9.7 18.2 2.9 2.3 0.0 4.3 1.0 14.9 3.0 0.0 0.9 0.9 0.3 4.8 1.3 1.9 0.4 7.1 2.9 1.3 2.8 8.4 0.6 1.7 0.4 0.2 2.8 1.7 10.1 1.2 2.7 0.4 0.7 1.2 1.0 5.1 0.4 1.0 0.4 0.4 0.2 2.1 1.1 0.6 0.4 1.2 0.4 0.4 0.3 0.0 3.4 4.4 2.4 2.0 2.2 2.9 0.2 2.6 1.5 2.0 0.2 2.4 2.6 0.0 2.0 2.4 1.9 0.1 2.0 1.3 7.2 4.4 0.1 2.8 3.5 2.3 1.5 0.1 0.5 0.7 2.3 1.1 0.1 6.4 0.3 1.1 3.2 0.2 0.8 4.8 1.4 1.9 19.4 2.3 0.7 3.7 5.7 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 8.6 8.2 8.4 13.5 8.0 7.3 9.7 18.2 14.9 7.1 8.4 10.1 0.8 0.0 0.5 7.8 1.1 0.5 0.3 0.3 0.0 2.3 1.8 1.0 0.4 4.3 0.2 0.0 0.0 0.6 3.2 0.5 0.0 0.7 0.6 0.5 0.9 0.8 0.0 2.7 6.5 3.8 0.6 0.7 0.0 0.5 0.0 1.2 1.1 1.1 0.7 1.7 5.5 0.3 2.0 1.3 2.4 0.4 1.5 0.9 0.0 3.7 0.9 1.8 0.0 2.5 6.0 0.6 1.1 0.7 0.1 0.7 1.1 0.5 0.5 3.5 0.0 1.5 1.2 1.1 0.6 0.0 0.0 0.8 0.8 0.4 0.5 0.1 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;fallopian tube: 1.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Early spermatids: 4.3;Endometrial ciliated cells: 3.9;Ionocytes: 2.0;Late spermatids: 2.4;Spermatocytes: 2.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.9" "Region enriched" "Detected in single" 4 "cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 1.6;U-266/70: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA067245 Uncertain NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA067245: AB_2685810" "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 3.9 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 2.0 0.0 0.0 2.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.1 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 53978201-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 103.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 73.1;Early spermatids: 184.4;Excitatory neurons: 130.3;Inhibitory neurons: 301.3;Late spermatids: 65.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Karpas-707: 73.7;U-266/70: 97.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 198.6" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.1 0.2 10.5 0.1 11.2 0.1 0.1 103.6 25.6 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.2 19.0 26.4 0.9 0.0 0.1 0.3 29.5 38.4 0.8 0.0 0.0 1.1 0.0 34.9 0.0 0.1 19.1 0.1 0.0 3.5 0.1 0.1 0.0 6.2 0.1 0.1 8.7 16.9 0.0 0.6 0.0 0.3 0.0 0.0 11.7 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 97.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 11.2 103.6 25.6 19.0 26.4 29.5 38.4 34.9 6.2 16.9 11.7 0.1 0.0 0.0 8.5 0.1 0.4 0.4 0.0 0.0 73.1 0.1 0.3 0.8 1.5 0.0 3.7 6.2 1.0 1.3 0.0 0.0 0.0 184.4 0.0 0.0 0.4 0.0 0.0 130.3 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.7 0.0 0.1 0.0 301.3 0.0 0.0 0.0 0.6 65.9 2.1 0.3 0.0 3.7 0.0 3.2 0.0 4.5 3.2 0.0 0.0 0.4 0.0 0.3 0.0 0.4 0.0 33.8 0.0 2.2 0.7 1.2 1.2 0.0 0.1 0.3 0.1 0.5 0.0 0.5 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381711 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 168.3" "Group enriched" "Detected in many" 5 "Early spermatids: 460.0;Late spermatids: 1094.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 14.5;U-266/70: 56.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 7.0 13.4 11.9 1.6 22.6 1.9 4.1 18.8 19.0 6.0 32.7 10.2 13.9 5.2 5.7 9.8 11.6 2.3 73.5 18.6 9.4 53.4 18.9 3.4 0.1 12.0 13.1 6.2 18.1 24.2 18.9 1.3 7.7 4.1 6.0 76.2 7.6 3.0 168.3 12.8 17.4 6.8 8.2 0.6 6.2 86.5 15.1 0.6 3.8 62.8 0.6 4.5 4.8 17.5 6.0 0.5 0.9 3.2 0.1 0.2 1.3 0.7 0.4 0.0 0.6 6.1 0.8 10.2 1.8 1.1 1.4 1.0 7.9 2.9 0.2 7.2 1.0 2.8 4.4 12.5 2.7 0.0 2.8 0.9 0.6 0.7 2.0 1.3 0.6 7.6 14.5 0.8 1.7 4.1 0.0 0.6 1.6 2.0 1.3 0.1 2.1 1.5 4.6 0.3 11.9 3.6 3.4 2.6 0.7 1.7 8.8 6.2 0.0 0.0 1.5 0.8 1.0 56.9 13.5 0.2 0.1 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 22.6 18.8 19.0 18.6 9.4 12.0 13.1 7.7 8.2 15.1 17.5 0.6 3.2 2.7 10.7 0.6 2.4 5.3 1.5 1.2 75.2 3.3 2.4 85.2 7.2 6.1 5.5 95.9 0.5 1.6 25.5 113.5 3.1 460.0 39.0 3.0 3.6 0.0 0.4 15.7 1.6 0.9 7.4 2.0 8.4 0.0 2.0 2.2 23.0 17.2 10.1 11.6 2.0 0.0 1.3 2.9 1094.1 6.5 2.1 0.0 1.9 0.0 49.7 0.0 8.0 12.5 1.2 11.8 7.2 0.1 1.1 41.3 41.6 35.0 140.0 19.7 43.3 24.0 50.5 16.5 12.9 4.0 1.4 1.3 0.5 2.6 2.9 UTS2R GPR14 ENSG00000181408 "Urotensin 2 receptor" Q9UKP6 17 82371400-82375586 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;testis: 3.2;thyroid gland: 1.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.2;U-266/70: 15.2;U-266/84: 2.7" NA NA "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (1.55e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.92e-1)" "unprognostic (1.46e-2)" "unprognostic (8.26e-2)" "unprognostic (2.30e-2)" "unprognostic (3.98e-1)" "unprognostic (6.38e-2)" "unprognostic (4.44e-2)" "unprognostic (8.73e-2)" "unprognostic (1.81e-1)" "unprognostic (1.32e-1)" "unprognostic (7.84e-2)" 0.0 0.0 0.3 0.1 0.6 0.0 0.1 0.0 1.5 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.1 3.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 1.8 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 15.2 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCX "VCX-10r, VCX-B1, VCX1, VCX10R" ENSG00000182583 "Variable charge X-linked" Q9H320 X 7842262-7844143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 33.4" "Group enriched" "Detected in some" 9 "Spermatocytes: 855.2;Spermatogonia: 1008.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.7;RPMI-8226: 1.4;THP-1: 1.5;U-138 MG: 1.4;U-266/70: 2.8" "HPA044996, HPA049357" Supported NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.65e-1)" "unprognostic (3.39e-1)" "unprognostic (1.17e-3)" "unprognostic (1.71e-1)" "unprognostic (1.50e-1)" "unprognostic (2.73e-1)" "unprognostic (7.89e-2)" "unprognostic (6.44e-2)" "unprognostic (1.20e-1)" "unprognostic (7.18e-3)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 33.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 1.7 0.8 0.3 0.2 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.6 1.5 0.0 1.4 0.3 1.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 98.1 7.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 85.5 0.0 0.0 855.2 1008.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 VCX3A "VCX-8r, VCX-A, VCX3" ENSG00000169059 "Variable charge X-linked 3A" Q9NNX9 X 6533618-6535118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 122 "testis: 56.1" "Group enriched" "Detected in some" 7 "Spermatocytes: 598.9;Spermatogonia: 754.0" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.9;PC-3: 2.5;U-138 MG: 7.4;U-2197: 1.8;U-266/70: 4.6" "HPA044996, HPA049357" Supported NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (2.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.64e-2)" 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 56.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 7.4 0.0 1.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 33.6 6.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 92.1 0.0 0.0 598.9 754.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 VCY1B BPY1B ENSG00000129862 "Variable charge Y-linked 1B" O14598 Y 14056227-14056958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 572 "testis: 57.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-266/70: 2.9" "HPA044996, HPA049357" Supported NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VIPR2 "VPAC2, VPAC2R" ENSG00000106018 "Vasoactive intestinal peptide receptor 2" P41587 7 159028175-159144867 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 20.6;Excitatory neurons: 15.2;Muller glia cells: 38.9;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 45.1" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 17 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 17 "dendritic cells: 12.3" "Cell line enhanced" "Detected in some" "HeLa: 6.6;HMC-1: 9.0;MOLT-4: 12.9;U-266/70: 40.5" "Region enhanced" "Detected in many" "olfactory bulb: 27.1" "Low region specificity" "Detected in many" HPA062707 Approved Approved "Focal adhesion sites" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 46: Fibroblasts - ECM organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Focal adhesion sites" "HPA062707: AB_2684842" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (4.26e-2)" "unprognostic (2.04e-2)" "unprognostic (6.31e-2)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (8.58e-2)" "unprognostic (2.32e-2)" "unprognostic (1.02e-1)" "unprognostic (9.60e-2)" "unprognostic (1.74e-1)" "unprognostic (1.88e-1)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (8.89e-2)" 12.5 0.8 2.2 0.9 1.6 0.4 2.5 0.6 6.9 16.8 1.4 13.8 1.7 6.8 12.2 1.4 4.5 2.5 16.4 2.1 2.0 1.1 0.4 0.6 1.1 2.2 0.8 12.0 17.5 0.9 2.7 5.7 2.6 9.2 1.1 6.5 0.3 20.5 7.4 0.7 4.8 4.2 2.1 0.8 8.6 2.2 1.3 8.2 0.2 5.4 0.4 6.8 11.2 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.2 12.9 0.1 1.0 0.0 0.0 3.2 0.1 0.7 0.0 0.0 2.8 2.3 0.1 0.2 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 40.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.3 0.0 0.1 2.2 1.6 0.6 6.9 2.1 2.0 2.2 0.8 2.6 2.1 1.3 2.9 0.8 0.0 0.0 2.9 0.7 0.6 2.9 0.0 1.8 1.7 1.6 1.8 7.5 0.0 0.0 0.0 2.1 0.0 20.6 0.0 0.0 0.0 1.3 0.4 6.9 0.4 0.0 0.0 15.2 6.7 0.0 10.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.3 1.9 10.2 0.5 1.8 1.9 0.0 38.9 4.1 49.8 0.3 0.8 0.0 2.6 2.4 2.0 0.0 0.5 0.0 45.1 0.0 2.9 5.6 3.6 10.2 0.1 0.0 0.0 3.8 0.1 0.0 0.3 VMAC ENSG00000187650 "Vimentin type intermediate filament associated coiled-coil protein" Q2NL98 19 5904872-5910853 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 28.1;Late spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (6.81e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.67e-6)" "unprognostic (3.59e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.40e-1)" "unprognostic (1.73e-3)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (9.52e-2)" "unprognostic (5.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (7.24e-4)" 4.6 5.1 3.1 5.0 5.3 6.0 5.0 4.0 4.4 5.2 4.1 5.2 3.1 5.3 2.4 5.1 5.1 2.6 3.5 2.7 2.6 3.8 4.5 3.7 5.3 6.1 4.4 5.1 7.8 2.0 6.9 2.6 5.3 7.3 3.1 2.2 7.0 3.5 2.9 5.3 6.7 2.8 3.2 6.3 7.6 2.6 4.7 3.3 7.2 0.9 4.2 5.9 4.4 9.3 1.4 0.7 1.4 2.4 2.4 1.6 1.4 0.9 1.4 0.4 0.6 1.0 1.5 1.4 3.6 1.4 0.8 2.2 0.3 1.8 0.2 2.9 2.1 1.3 1.6 0.8 1.8 1.7 3.0 3.9 2.1 0.5 1.8 3.5 1.4 4.4 1.0 4.7 0.6 1.6 2.5 1.7 0.7 5.1 2.8 1.9 0.4 3.8 0.9 2.4 0.9 3.9 1.3 4.4 2.0 3.4 3.4 2.5 3.0 1.0 0.4 3.6 1.2 15.9 3.7 1.1 1.7 1.4 1.6 6.6 4.2 3.2 4.6 4.6 3.4 4.0 4.0 5.0 2.6 4.2 5.5 5.2 3.6 3.9 6.3 5.9 6.0 3.9 3.1 5.3 4.0 4.4 2.7 2.6 6.1 4.4 5.3 3.2 4.7 9.3 3.6 0.0 1.1 2.3 5.2 1.8 5.1 3.9 1.8 1.5 5.0 8.0 1.0 2.8 2.8 11.0 0.0 16.3 11.2 3.7 13.7 6.1 28.1 19.9 3.8 3.0 4.9 5.2 0.9 8.7 5.9 4.3 6.6 5.6 2.5 5.9 5.0 3.4 8.6 0.0 1.1 6.7 6.1 9.1 3.7 31.8 1.2 5.0 3.6 1.9 5.5 4.5 12.3 0.5 2.9 5.1 2.9 2.6 2.6 3.7 4.9 5.4 2.0 3.6 0.0 2.1 3.2 1.3 1.4 3.8 3.0 8.8 6.1 6.0 4.2 4.3 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3" "Not detected" "Not detected" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.5 1.0 2.2 0.2 2.4 0.3 0.7 4.5 2.4 0.6 1.8 1.2 0.0 0.5 2.2 0.6 0.8 0.3 2.0 2.3 1.9 1.2 1.0 0.8 0.4 1.8 1.9 1.2 0.6 1.1 3.4 0.6 1.4 1.3 0.3 8.2 0.9 0.6 2.3 1.7 0.7 0.3 1.3 1.1 0.5 1.3 1.9 0.4 1.7 2.7 0.3 0.9 0.6 2.2 0.2 0.0 0.8 0.9 0.0 0.2 0.4 0.2 0.3 0.2 0.8 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.3 0.0 2.9 0.4 0.0 0.3 0.1 0.2 0.5 0.3 0.3 0.0 0.1 0.4 0.1 0.3 0.1 0.4 0.4 0.1 0.2 0.9 0.2 0.0 0.3 0.2 0.5 0.4 0.2 0.5 1.5 0.6 0.0 0.2 0.0 0.4 0.4 0.3 0.0 0.6 0.1 0.1 0.3 2.5 3.3 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.4 4.5 2.4 2.3 1.9 1.8 1.9 1.4 1.3 1.9 2.2 0.4 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 4.5 0.2 0.0 0.3 0.0 0.6 0.0 2.1 0.2 1.4 0.0 0.0 0.3 0.0 0.2 0.1 0.6 0.0 0.4 1.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.1 6.7 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.0 2.5 0.3 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 4.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.2 VPS37B FLJ12750 ENSG00000139722 "VPS37B subunit of ESCRT-I" Q9H9H4 12 122865330-122896127 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038217, HPA038218" Enhanced NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA038217: AB_10672740, HPA038218: AB_2675898" "unprognostic (1.63e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-1)" "unprognostic (1.38e-1)" "unprognostic (8.33e-2)" "unprognostic (2.58e-1)" "unprognostic (4.30e-2)" "unprognostic (3.25e-2)" "unprognostic (8.26e-3)" "unprognostic (2.51e-1)" "unprognostic (5.57e-2)" "unprognostic (3.01e-1)" "prognostic favorable (1.35e-6)" "unprognostic (2.58e-3)" "unprognostic (6.38e-2)" "unprognostic (4.02e-2)" "unprognostic (2.44e-2)" 19.9 28.3 24.1 15.7 19.6 46.6 18.7 17.2 26.1 13.8 23.6 29.5 17.8 11.8 5.2 63.4 14.9 18.1 23.5 25.5 16.4 30.6 11.0 28.1 14.5 19.5 17.7 15.3 27.2 10.8 23.5 10.7 16.4 19.5 17.4 9.3 36.2 9.2 10.3 23.0 23.6 7.2 17.9 34.5 37.3 25.4 19.6 10.8 28.3 6.8 16.7 17.1 19.2 21.6 55.2 19.2 52.0 21.0 8.7 15.6 49.6 26.6 24.7 20.5 17.6 21.4 42.1 1.4 19.3 16.8 33.7 35.6 29.1 39.0 15.6 15.1 28.3 106.2 13.3 15.2 19.8 13.9 82.7 18.9 34.3 28.2 24.8 38.5 30.5 65.3 40.6 34.5 27.1 10.4 33.0 40.5 29.3 57.1 52.4 25.3 32.2 17.0 31.8 51.3 31.4 35.4 23.6 25.7 58.8 21.9 45.5 23.2 28.2 20.7 28.3 24.3 48.1 116.5 116.8 0.6 26.3 20.4 123.6 12.1 4.5 10.4 14.2 6.6 10.2 10.3 4.7 8.3 1.7 12.7 4.2 6.0 27.6 8.3 9.0 0.2 4.5 4.7 24.1 19.6 17.2 26.1 25.5 16.4 19.5 17.7 16.4 17.9 19.6 21.6 57.3 54.5 34.3 18.9 159.3 43.2 98.7 66.6 46.1 32.0 30.8 18.8 2.6 25.8 75.0 31.3 68.8 19.9 198.7 123.1 17.6 53.6 40.5 88.1 24.8 37.6 44.3 30.5 26.2 42.7 34.1 16.0 141.2 168.2 90.9 14.1 30.0 13.4 17.6 10.1 16.7 49.5 63.1 19.0 66.3 52.5 8.1 46.7 39.2 19.7 9.5 20.8 62.8 12.1 27.2 71.0 83.6 7.9 168.3 104.4 43.8 5.8 56.6 20.7 6.6 14.1 29.1 14.1 12.5 49.2 44.6 43.6 119.0 30.6 61.3 158.0 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" No No 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489" "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 24.2 18.3 10.5 25.5 13.1 52.6 28.8 13.2 17.8 26.8 9.3 42.3 35.1 22.7 19.5 75.4 18.6 23.7 16.2 10.3 14.6 23.8 28.4 23.8 31.2 13.5 15.9 19.3 17.3 27.8 11.5 28.7 14.0 23.4 37.0 7.0 24.7 19.5 11.0 32.3 36.4 21.0 12.6 28.8 32.5 12.1 12.5 31.4 28.5 13.0 39.1 30.2 31.1 15.6 57.1 21.9 22.4 24.5 33.5 47.1 38.9 48.6 45.5 36.4 39.2 15.7 39.4 54.1 31.2 35.7 30.9 119.6 26.8 53.1 47.5 40.6 22.3 27.6 27.8 23.7 48.6 94.5 56.8 43.1 80.3 32.3 56.2 36.5 33.9 31.0 14.3 49.4 52.1 20.2 59.9 29.2 23.2 22.7 32.3 48.8 47.2 52.4 45.6 66.2 38.2 33.6 36.9 35.4 55.3 28.3 34.2 50.5 52.8 55.4 27.3 21.6 32.7 163.6 86.5 69.3 31.9 44.0 42.3 163.6 54.6 125.0 52.2 56.5 49.0 64.8 54.3 54.2 46.2 73.4 48.2 51.1 185.9 68.4 76.5 45.6 66.7 56.6 10.5 13.1 13.2 17.8 10.3 14.6 13.5 15.9 14.0 12.6 12.5 15.6 52.0 115.4 57.4 21.5 62.4 68.8 47.2 66.5 44.9 37.0 54.4 46.0 39.5 47.1 72.4 33.1 22.9 70.0 92.2 142.0 45.0 48.0 113.3 92.2 74.0 44.6 45.5 27.8 27.3 42.1 56.7 51.0 47.4 145.5 59.3 37.7 36.8 55.8 46.4 43.7 29.6 76.8 67.1 58.8 33.0 15.5 49.0 58.0 32.0 18.7 53.4 39.2 76.2 18.6 49.5 91.3 120.7 36.5 42.1 43.1 61.8 57.9 85.1 31.5 59.2 45.6 54.7 30.1 29.4 87.5 83.4 140.4 67.4 56.5 72.6 79.5 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629545 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Vesicles "HPA048751: AB_2680512" "unprognostic (1.13e-1)" "prognostic favorable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 29.4 23.6 17.7 15.1 19.9 44.5 30.6 19.6 24.8 37.0 16.9 28.3 17.5 33.8 6.9 25.4 32.0 11.8 24.3 17.8 17.9 27.7 27.8 27.2 20.7 19.9 18.0 45.8 35.9 13.4 27.1 15.4 20.2 32.7 5.4 9.0 31.1 17.5 35.6 39.0 27.6 9.3 18.6 34.5 30.9 37.7 18.3 21.1 34.7 13.3 10.6 29.1 29.6 25.5 39.8 35.7 21.2 27.9 21.9 16.3 41.2 22.8 26.5 39.6 40.0 46.4 25.4 26.7 44.1 21.3 28.9 34.2 30.2 33.2 10.0 47.1 39.0 35.5 30.2 41.3 28.3 47.5 30.8 28.8 27.0 28.0 20.2 21.3 24.2 56.4 32.4 69.0 12.4 44.0 44.9 73.8 48.3 24.8 69.6 49.3 26.8 47.0 15.8 30.7 30.2 34.4 25.9 25.1 23.2 13.8 32.0 41.6 24.1 18.1 29.5 41.3 39.0 117.7 75.0 39.0 31.0 40.1 27.4 8.8 10.0 9.3 11.8 10.2 11.3 10.1 11.0 9.1 8.0 12.2 13.1 10.0 6.4 8.3 13.9 6.9 14.2 12.1 17.7 19.9 19.6 24.8 17.8 17.9 19.9 18.0 20.2 18.6 18.3 25.5 18.3 0.0 1.8 3.9 22.9 19.6 16.2 28.1 14.2 14.1 89.4 54.4 1.4 25.8 20.1 47.8 12.5 46.0 24.8 28.3 35.2 19.8 39.9 24.7 13.3 16.4 18.6 14.1 2.3 34.4 26.4 16.7 33.6 32.3 19.7 27.7 17.5 46.4 19.8 3.3 2.5 21.2 24.4 19.2 11.0 19.1 28.3 18.3 26.6 3.7 26.5 13.9 23.7 1.0 3.7 15.1 12.4 21.8 19.4 12.2 28.9 159.5 13.4 14.2 39.5 15.9 21.6 36.1 57.3 14.6 17.8 65.9 20.6 17.8 23.9 14.3 XAGE3 "CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3" ENSG00000171402 "X antigen family member 3" Q8WTP9 X 52862525-52868083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 121 "placenta: 382.1" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 2223.5;Extravillous trophoblasts: 1309.1;Syncytiotrophoblasts: 2678.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;U-266/70: 2.2;U-266/84: 2.1" "HPA052507, HPA060900" Supported Approved "Vesicles,Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 29: U-266 - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Plasma membrane" "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (6.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.92e-1)" 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 382.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2223.5 0.0 0.1 0.0 0.2 0.3 0.1 0.0 4.5 0.0 0.0 0.0 0.4 1309.1 11.1 0.0 0.3 0.0 0.0 0.0 4.6 191.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 15.1 7.0 0.0 0.0 2678.1 0.0 0.0 0.1 0.0 ZBTB21 "KIAA1227, ZNF295" ENSG00000173276 "Zinc finger and BTB domain containing 21" Q9ULJ3 21 41986831-42010387 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.2" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 60.4;U-266/84: 57.0" "Low region specificity" "Detected in all" "HPA024655, HPA031757, HPA031758" Enhanced Enhanced Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032" "unprognostic (1.16e-2)" "unprognostic (3.51e-2)" "unprognostic (8.79e-2)" "unprognostic (1.79e-1)" "unprognostic (5.88e-2)" "unprognostic (4.61e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-2)" "unprognostic (2.67e-1)" "unprognostic (6.21e-3)" "unprognostic (2.67e-2)" "unprognostic (4.59e-2)" "unprognostic (1.35e-3)" "unprognostic (1.81e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-3)" "unprognostic (4.02e-1)" 8.9 35.6 3.2 6.0 3.6 41.2 8.1 4.6 5.6 7.9 2.2 5.7 4.0 13.7 7.1 6.5 6.6 11.9 4.6 3.9 7.2 6.5 11.2 6.9 5.1 5.3 7.2 8.5 9.4 14.0 4.8 6.9 5.0 7.8 4.9 14.2 4.1 4.2 2.5 8.8 4.7 8.5 2.2 6.5 6.5 12.2 5.3 6.4 9.5 3.1 5.4 9.6 5.1 5.4 12.8 10.0 9.6 10.9 13.3 10.2 9.3 11.6 16.6 10.9 16.5 12.0 6.2 22.5 5.1 11.6 19.6 9.5 14.1 8.2 17.6 11.9 13.9 2.6 10.3 7.3 10.2 8.9 5.2 5.9 17.2 15.2 19.9 4.8 6.2 12.2 15.1 38.0 7.8 18.6 24.0 4.3 9.5 9.3 12.3 10.1 10.7 26.4 4.8 10.1 13.6 7.9 16.1 23.8 11.2 4.8 8.5 4.2 7.0 16.0 8.9 11.3 11.5 60.4 57.0 20.9 21.0 14.5 10.6 0.1 2.4 1.2 1.6 2.8 1.9 2.6 1.8 1.3 2.4 1.9 2.6 1.9 2.3 0.5 3.2 2.1 1.3 1.2 3.2 3.6 4.6 5.6 3.9 7.2 5.3 7.2 5.0 2.2 5.3 5.4 19.0 6.4 41.1 8.1 24.7 60.0 32.9 6.2 26.2 14.5 15.6 15.9 4.9 12.8 12.4 7.3 2.1 6.7 20.8 7.1 11.7 5.4 14.0 20.8 34.8 19.6 4.2 2.1 13.8 5.0 5.5 31.9 10.2 27.1 16.5 6.7 9.3 20.4 6.1 32.0 15.5 10.2 10.2 6.3 24.8 5.3 4.1 14.5 35.6 5.6 7.2 10.1 5.2 4.5 8.1 3.9 6.0 10.5 20.3 24.7 5.4 4.8 13.5 13.6 6.6 36.1 21.0 21.5 14.1 19.3 63.2 9.7 20.8 7.3 5.6 20.9 ZBTB34 "KIAA1993, MGC24652, ZNF918" ENSG00000177125 "Zinc finger and BTB domain containing 34" Q8NCN2 9 126860665-126885878 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023893 Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA023893: AB_2219180" "unprognostic (2.96e-2)" "unprognostic (1.83e-1)" "unprognostic (2.72e-3)" "unprognostic (6.59e-3)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.96e-2)" "unprognostic (5.15e-2)" "unprognostic (9.32e-3)" "unprognostic (3.94e-2)" "unprognostic (2.55e-2)" "unprognostic (3.23e-2)" "unprognostic (9.71e-2)" "unprognostic (3.69e-2)" "unprognostic (2.01e-2)" 3.8 2.7 4.9 4.3 6.1 14.7 3.7 7.6 5.3 3.1 2.8 3.5 3.0 3.6 3.1 3.2 3.2 3.9 3.1 4.2 4.8 3.3 2.9 5.3 4.8 5.9 6.2 3.6 3.2 3.7 3.5 6.7 5.6 3.0 2.9 12.7 4.4 2.9 3.3 4.1 3.7 3.1 5.4 5.4 3.8 3.0 6.0 4.8 3.5 4.8 4.6 3.3 3.1 6.8 2.6 3.5 9.9 4.1 7.6 7.6 13.8 3.1 4.6 3.6 4.0 8.3 4.8 5.0 3.3 3.3 3.3 7.9 12.1 3.1 3.6 5.2 5.0 5.7 9.8 4.4 5.3 7.9 9.1 6.7 4.9 4.2 4.8 4.7 4.8 8.6 12.3 3.9 3.4 3.7 5.1 6.6 8.7 4.9 2.6 9.5 11.5 5.2 4.7 3.8 3.1 10.7 4.1 3.6 5.6 8.9 3.6 11.6 5.2 3.3 6.0 4.7 3.4 6.8 8.5 4.2 3.0 6.4 3.2 0.7 0.3 1.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.1 1.4 0.4 0.2 0.3 0.0 0.1 4.9 6.1 7.6 5.3 4.2 4.8 5.9 6.2 5.6 5.4 6.0 6.8 5.6 3.2 4.6 5.2 1.3 5.4 2.5 1.6 2.8 6.8 5.9 3.9 2.2 2.8 3.5 1.8 6.2 3.8 3.8 5.6 1.9 2.4 8.4 2.1 4.0 5.4 1.8 3.0 6.9 1.6 3.1 4.7 4.1 4.8 0.0 3.7 6.8 4.1 7.8 8.4 8.1 4.1 2.0 13.6 8.4 31.8 6.8 7.2 5.4 7.5 8.3 2.1 2.1 7.1 12.4 3.2 5.0 0.7 1.7 4.4 4.0 2.5 2.3 12.7 0.0 4.5 5.6 4.0 2.5 3.8 8.2 3.3 2.2 2.1 2.4 4.7 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064109-75119502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 23.9;testis: 55.3" "Group enriched" "Detected in many" 5 "Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 1.1 2.5 2.5 0.6 2.7 0.4 1.7 2.8 2.9 1.8 5.1 2.7 3.1 1.3 23.9 1.3 11.0 1.6 5.2 2.4 2.9 5.5 8.4 2.5 0.2 3.1 3.7 0.6 5.1 6.9 6.1 0.8 2.9 1.3 2.4 2.6 2.9 3.4 4.7 1.6 2.4 1.0 2.8 0.8 1.6 55.3 2.9 2.3 7.0 1.5 0.5 1.4 0.6 3.3 3.8 2.8 0.3 3.3 0.2 0.0 1.8 0.3 1.1 1.4 0.8 4.8 6.9 3.3 2.6 0.4 2.6 1.0 0.0 0.0 1.2 3.9 0.3 0.6 1.0 2.3 2.5 0.0 1.8 0.3 0.4 1.6 0.0 1.7 1.1 0.2 5.8 1.0 0.7 0.6 0.4 0.3 0.7 2.4 1.8 0.0 0.2 0.7 4.3 0.3 5.7 1.3 2.4 2.0 1.5 0.6 2.9 0.9 0.7 0.9 0.9 1.0 0.8 4.0 4.9 1.1 1.4 0.4 0.6 0.3 0.0 0.2 0.6 0.0 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.2 0.1 0.2 0.9 0.1 2.5 2.7 2.8 2.9 2.4 2.9 3.1 3.7 2.9 2.8 2.9 3.3 0.8 6.4 9.7 2.0 0.9 1.8 1.9 1.3 4.6 4.5 7.9 5.1 7.0 2.8 6.6 11.0 10.4 2.3 1.6 2.5 3.9 4.6 165.2 21.0 2.1 2.0 5.3 0.4 2.4 1.4 1.1 2.5 1.1 1.9 1.3 1.1 2.9 4.7 1.7 11.8 2.1 2.3 0.0 1.0 0.7 195.1 3.1 1.0 3.6 1.0 0.9 3.0 8.2 0.5 1.0 1.6 0.6 2.6 0.6 2.8 4.2 7.4 32.5 8.5 6.6 5.2 2.0 198.5 5.5 1.9 0.9 5.1 0.9 2.3 3.9 1.3 ZNF227 ENSG00000131115 "Zinc finger protein 227" Q86WZ6 19 44207547-44237268 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030573 Uncertain Approved "Plasma membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane" "HPA030573: AB_10610702" "unprognostic (3.01e-2)" "unprognostic (1.79e-2)" "unprognostic (7.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.66e-2)" "unprognostic (8.05e-2)" "unprognostic (7.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.68e-3)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.21e-2)" "unprognostic (9.91e-2)" "prognostic favorable (2.64e-4)" 6.3 6.9 9.5 5.9 10.3 5.0 8.3 14.0 10.7 7.8 8.8 6.9 5.4 8.0 7.6 6.6 8.0 5.9 5.7 9.2 10.5 6.9 7.4 6.1 10.3 9.7 10.1 11.0 6.6 10.4 8.0 7.7 9.9 8.5 5.8 8.7 5.6 6.9 6.4 6.5 5.8 6.8 9.6 9.5 8.6 7.4 10.1 17.2 8.3 6.4 11.2 7.1 6.5 13.2 9.6 13.4 15.8 19.7 12.6 10.9 7.4 9.2 13.1 8.7 17.0 6.6 7.3 16.8 13.9 8.6 10.4 5.5 18.2 9.7 11.7 21.9 22.8 29.3 14.7 8.2 9.0 25.8 12.4 9.9 10.6 8.6 16.0 14.5 13.1 19.2 2.9 0.4 9.4 5.1 24.3 6.8 25.3 9.8 7.0 14.4 15.9 14.4 9.0 17.2 26.7 27.3 20.6 9.2 7.2 15.2 7.7 13.7 11.3 9.6 15.8 7.4 11.8 37.6 54.5 36.1 6.3 10.6 13.1 17.3 4.8 9.9 10.8 3.5 11.8 12.0 10.2 10.6 5.9 12.2 13.3 11.2 4.2 11.9 3.5 6.2 13.5 5.7 9.5 10.3 14.0 10.7 9.2 10.5 9.7 10.1 9.9 9.6 10.1 13.2 8.0 0.0 1.5 13.7 8.1 3.1 3.8 4.8 3.4 6.0 5.4 4.6 7.0 1.5 6.4 5.5 2.1 5.6 6.3 3.3 3.9 4.2 22.6 4.0 4.6 8.4 2.4 7.8 10.5 4.0 4.5 4.4 3.6 3.7 1.3 8.7 8.9 3.9 4.4 8.4 10.3 4.7 2.0 5.7 3.7 30.0 5.6 3.9 1.8 9.4 5.2 6.3 11.3 17.1 16.8 6.1 3.3 5.7 4.0 6.0 4.2 3.3 4.1 5.4 6.6 5.9 5.5 4.4 8.7 3.3 3.8 2.2 6.9 8.6 3.3 2.9 ZNF275 ENSG00000063587 "Zinc finger protein 275" Q9NSD4 X 153334147-153360110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.5" "Cell type enhanced" "Detected in many" "Granulosa cells: 76.3;Peritubular cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 57.3" HPA000566 Approved Approved Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoli "HPA000566: AB_1080700" "unprognostic (6.96e-2)" "unprognostic (8.97e-2)" "unprognostic (3.10e-2)" "unprognostic (1.11e-3)" "unprognostic (5.25e-2)" "unprognostic (1.45e-1)" "unprognostic (9.59e-2)" "unprognostic (9.37e-2)" "unprognostic (2.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (4.33e-2)" "unprognostic (2.69e-1)" "unprognostic (1.95e-1)" "unprognostic (3.74e-2)" "unprognostic (1.14e-2)" 8.5 77.5 10.1 5.1 10.5 3.1 7.6 10.6 9.7 7.9 10.1 5.2 3.9 8.4 17.6 2.8 8.5 7.2 4.4 9.5 11.9 5.5 13.5 4.1 6.3 11.3 10.8 42.6 10.1 32.3 11.0 3.1 11.1 7.2 4.3 5.2 6.5 14.5 4.8 2.4 6.1 7.3 11.7 11.1 6.0 8.5 12.9 6.3 6.9 7.3 8.0 4.7 3.0 12.7 10.2 4.1 8.4 6.1 10.0 9.6 4.1 7.0 11.7 4.4 6.6 4.3 2.1 17.0 14.0 13.3 6.7 1.7 10.1 6.2 6.5 4.1 7.8 5.7 3.8 6.6 13.4 7.0 4.8 11.4 4.5 3.7 7.2 7.2 5.5 9.2 8.5 0.0 8.1 7.4 8.2 5.8 3.7 10.3 7.2 9.6 9.3 6.0 3.3 6.1 4.3 5.8 3.5 0.3 8.4 5.2 1.5 13.0 5.8 6.5 7.8 10.9 9.1 57.3 16.9 32.9 5.9 13.5 4.6 0.3 0.8 0.1 1.6 0.7 1.9 1.9 1.5 1.5 0.7 2.0 2.1 1.8 0.0 1.4 0.7 1.3 2.4 1.0 10.1 10.5 10.6 9.7 9.5 11.9 11.3 10.8 11.1 11.7 12.9 12.7 26.1 0.0 4.6 7.8 10.9 3.3 4.0 3.6 3.4 6.5 6.2 3.9 5.2 10.0 2.3 9.2 12.5 1.4 9.8 2.6 7.9 2.8 1.3 4.5 15.3 6.6 0.0 8.2 3.8 5.0 4.4 10.5 8.6 8.8 2.5 76.3 7.5 28.3 2.5 0.0 4.8 5.8 4.1 6.0 3.5 4.4 14.3 3.5 3.6 2.8 4.5 6.5 6.2 7.5 3.7 3.9 3.2 39.5 28.7 6.1 2.1 8.3 1.6 2.8 13.1 12.8 11.8 3.5 3.7 4.3 2.3 0.8 7.0 21.5 5.3 2.1 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003251 Uncertain Approved Vesicles,Microtubules NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 2.8 3.7 1.8 5.1 2.0 5.2 6.0 5.8 2.7 5.5 3.2 2.8 2.2 4.6 3.9 3.1 4.6 3.1 5.6 1.7 2.9 2.9 3.0 3.4 6.7 1.5 1.8 9.1 2.4 7.8 2.5 6.5 2.3 6.0 2.9 7.3 4.2 4.4 2.2 4.0 3.6 3.3 1.1 7.7 3.5 2.8 1.7 7.4 4.8 3.3 5.4 3.6 1.3 2.9 4.3 3.0 8.4 8.0 2.8 6.9 0.0 5.7 4.8 5.0 2.1 3.7 3.9 1.2 3.9 4.2 4.0 3.6 4.4 5.0 6.3 0.1 23.2 11.5 10.9 4.9 4.1 10.1 4.3 5.8 3.0 3.9 11.2 6.9 4.2 10.6 1.8 0.1 5.4 1.0 15.5 4.4 9.2 1.3 5.8 12.3 8.7 12.1 2.7 7.6 7.8 11.0 7.2 4.8 3.5 5.9 5.5 6.6 4.8 6.9 4.2 2.6 5.6 24.0 24.0 10.0 2.8 5.8 6.1 0.4 1.4 2.0 3.6 1.9 4.5 1.8 4.5 2.5 2.0 2.6 5.8 3.4 0.4 5.2 0.6 0.7 4.5 2.3 1.8 2.0 5.8 2.7 1.7 2.9 1.5 1.8 2.3 1.1 1.7 2.9 4.5 0.0 1.1 4.2 8.9 5.1 3.9 2.6 5.7 4.5 4.7 3.6 7.2 2.8 3.4 0.0 6.2 4.2 4.9 0.5 1.9 2.8 1.0 3.4 4.7 5.8 3.6 5.0 4.8 1.2 4.4 3.9 0.5 2.9 5.1 8.3 5.0 3.2 2.3 11.8 5.3 2.8 4.1 1.9 2.2 0.6 4.7 1.4 3.6 2.8 2.5 3.0 12.3 4.0 3.7 2.2 0.8 0.7 3.4 6.7 1.2 0.9 6.5 5.1 0.0 3.3 4.4 3.2 5.0 4.4 6.8 5.2 6.2 4.4 2.7 4.3 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 13.4 14.8 13.4 11.7 14.8 13.5 13.1 17.9 14.1 13.3 14.6 16.1 11.3 14.3 7.7 19.1 14.9 7.8 30.2 12.8 13.4 22.3 26.1 17.0 14.8 17.2 14.8 11.1 18.0 16.2 17.1 9.3 14.8 24.0 8.4 10.7 17.6 8.2 49.5 17.9 16.8 8.1 14.0 19.8 16.9 16.0 14.9 15.8 20.2 35.7 14.0 16.8 13.7 15.8 19.4 21.5 17.2 19.5 9.4 6.6 33.0 17.8 9.7 12.7 13.6 11.8 19.7 22.0 18.1 11.7 9.6 18.8 9.4 13.3 8.0 32.5 5.3 33.7 20.0 16.0 12.0 14.6 24.4 7.4 10.7 16.6 11.5 10.2 11.7 15.2 41.5 17.6 8.8 13.8 26.8 14.5 20.0 22.3 36.5 49.1 16.3 17.4 12.9 15.6 25.5 22.2 16.0 24.0 15.9 10.2 13.8 30.1 10.0 17.5 10.5 11.6 37.3 52.8 22.2 13.2 16.0 25.1 14.5 9.2 16.3 11.9 8.8 15.9 7.2 11.9 6.3 8.8 24.3 15.0 6.7 6.3 9.2 12.7 15.4 13.6 7.8 14.0 13.4 14.8 17.9 14.1 12.8 13.4 17.2 14.8 14.8 14.0 14.9 15.8 10.7 3.2 15.2 5.9 22.3 13.0 28.2 10.1 6.8 22.0 12.8 9.8 20.2 14.3 8.1 16.5 12.5 32.0 22.0 19.5 21.5 18.3 7.8 9.5 5.7 12.0 18.0 17.0 2.2 10.7 19.9 10.0 10.2 8.9 28.0 12.5 7.5 17.2 16.8 10.1 4.0 17.6 8.2 16.4 16.9 14.6 5.6 20.6 12.4 1.9 17.8 19.5 20.6 2.5 5.2 14.6 19.7 5.7 9.6 21.1 26.5 15.8 9.0 30.5 6.6 17.5 11.7 32.4 23.4 5.5 14.6 71.3 13.5 10.6 16.9 22.5 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 31.3;Early spermatids: 39.6;Horizontal cells: 48.8;Rod photoreceptor cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 11.6;RT4: 10.0;U-266/70: 18.4;U-266/84: 12.7" "Low region specificity" "Detected in all" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 1.8 4.4 6.1 2.4 5.7 1.2 3.6 10.0 5.9 4.9 4.3 3.7 1.8 5.3 3.8 3.3 4.6 2.5 4.2 5.5 5.5 5.3 0.8 2.1 3.7 4.4 4.4 8.1 2.5 6.0 9.2 2.7 4.2 4.6 3.3 14.7 2.8 3.2 2.4 6.4 2.5 3.3 3.2 3.6 3.0 9.0 5.3 2.8 6.5 2.3 2.8 3.7 4.5 6.0 0.1 0.2 4.5 11.6 0.9 0.9 0.3 3.7 0.2 0.7 0.4 0.2 1.5 3.4 5.6 1.9 1.0 0.5 0.3 2.9 0.3 0.8 4.2 0.4 0.4 0.3 2.4 0.2 2.9 3.5 2.2 0.7 0.1 0.3 0.1 0.4 0.1 0.5 0.5 3.2 0.4 0.4 7.3 0.0 0.2 0.1 0.1 0.8 3.3 10.0 3.4 6.8 0.1 0.1 0.0 8.2 6.7 0.3 0.4 0.1 1.8 0.2 3.5 18.4 12.7 0.2 0.0 0.2 0.6 4.0 0.6 0.5 0.6 0.2 0.9 0.9 1.1 1.0 0.4 1.4 0.7 0.9 1.6 1.6 0.2 0.9 1.0 0.7 6.1 5.7 10.0 5.9 5.5 5.5 4.4 4.4 4.2 3.2 5.3 6.0 6.5 3.2 5.8 24.2 4.0 3.3 3.8 2.6 6.2 29.1 5.0 5.8 9.7 7.2 5.0 12.9 31.3 5.5 2.9 1.7 3.9 3.6 39.6 5.0 8.7 7.0 9.0 2.1 14.9 1.5 4.1 4.6 1.1 3.9 2.5 21.5 6.4 0.5 0.9 48.8 16.3 2.9 0.0 0.3 3.4 11.2 5.0 0.9 0.0 2.8 1.5 13.6 8.2 19.6 16.7 2.0 1.0 10.1 1.1 2.8 1.0 2.7 5.7 33.6 0.0 8.7 5.3 6.0 6.9 4.0 3.3 1.9 4.0 12.7 3.7 1.9